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Abstract
Localised steroid metabolism is important in proliferative disorders o f the 
endometrium. The metabolism of testosterone, an important precursor in 
endometrial disorders, was investigated by mass spectrometry and RT-PCR (real­
time polymerase chain reaction), allowing determination o f steroid metabolites and 
expression o f steroid converting enzymes; aromatase, 17P-HSD1, 2, 4, 5, 7, 8, 
(hydroxysteroid dehydrogenase) and 5AR1, 2 (alpha reductase). Samples were 
derived from cell lines (Ishikawa, HEC-1A, HEC-1B, RL95-2, COV434), and 
biopsies; fertile, endometriosis, poly-cystic ovary syndrome (PCOS), endometrial 
hyperplasia, unexplained infertility, endometrial polyp.
Optimum mass spectrometry techniques, determined using steroid standards, were 
LC/MS for androgens and LC/MS/MS for oestrogens, following dansyl-chloride 
derivatisation. GC/MS was less sensitive.
The route o f testosterone metabolism varied in the cell lines and clinical biopsies, the 
major metabolite was correlated with high expression o f 5AR1 or 17p-HSD2, 4 and 
8. If DHT (dihydrotestosterone) was produced high basal expression of 5AR1 was 
observed and if androstenedione was produced high basal expression o f HSD2, 4 or 
8 was observed. A mixture o f DHT and androstenedione was correlated with 
expression of 5AR1 and 17P-HSD2, 4 or HSD8.
Changes in enzyme expression were correlated with changes in steroid concentration 
after testosterone treatment, as follows:
1. Increased 5AR1 expression was correlated with increased DHT concentration 
in Ishikawa, HEC-1B, COV434, PCOS, endometriosis, stromal hyperplasia 
and ovarian cyst biopsies.
2. Increased expression o f 5AR2 was correlated with increased androsterone 
concentration in fertile and unexplained infertility biopsies.
3. Increased 17p-HSD5 expression was correlated with increased testosterone 
concentration in HEC-1A cells.
4. Increased aromatase expression was correlated to increased oestradiol and 
oestrone concentrations in a hyperplasia biopsy.
Analysis of a range o f enzymes and steroids produced testosterone metabolism maps 
of the endometrium (and associated disorders) highlighting steroids which could 
contribute to endometrial disorders and viable enzyme target(s) for inhibition (5AR1, 
17P-HSD2, 4, 8).
DECLARATION
This work has not previously been accepted in substance for any degree and 
is not being concurrently submitted in candidature for any degree.
STATEMENT 1
This thesis is the result of my own investigations, except where otherwise 
stated. Where correction services have been used, the extent and nature of 
the correction is clearly marked in a footnote(s).
Other sources are acknowledged by footnotes giving explicit references. A 
bibliography is appended.
Signed  (candidate)
STATEMENT 2
I hereby give consent for my thesis, if accepted, to be available for 
photocopying and for inter-library loan, and for the title and summary to be 
made available to outside organisations.
Signed .... (candidate)
Date
Date
Signed . (candidate)
Date
iii
Contents
Chapter One
Steroid Metabolism in the Human Endometrium
1.0 Introduction................................................................................................................
1.1. Stmcture o f .steroids.....................................................................................................
1.2. S tero id Metabo 1 ism .....................................................................................................
.1 -2-l Important sterpids in the bio-path w ay........................ .............................
1-3. Steroid converting enzymes.......................................................................................
1_.3_._1_ Cholesterol .lyase P45 Oscc.........................................................................
1 • 3_._2 The. aro m at as e. en zym e................................................................................
1.-3..3. The.5.a-Reductas .........................................................................
.1 .• 3 .4 The hy droxy stero id dehy drogenases CH S D)............................................
.1 -3...5 Stero id sulphatases and steroid. sulphptransferases................................
.1.4 S[teroid m etabplism......................................................................................................
1.5 The .hum an endpmetrium.........................................................................................
1..-.5.1. S tm ctoeof en d o m ^  ..........................................................................
1 •.5.2. The.role o f strom al cells............................................................................
.15 -3. The role o f ep ithelial cells.........................................................................
1.6. CuiTent stero id. m etabol ism. in v e st igat ion s ..............................................................
1_._6...1 Endpmetrial. cancer and.endpmetrial. established cell .1 ine.pathologies
1 _-6-2 Benign .endpmetrial..disorders.....................................................................
L.7. D e t e c t ....................................................................................................
IZaI. Steroid.extraction itechniques.....................................................................
LZZ.Chrpmatpgraph^..........................................................................................
1 ..7.3. M ass .Sp.ectrpm.etry......................................................................................
1,1.4 Ionisation methods in m ass. spectrometry..............................................
1Z.. 5. Mass Analysers in mass spectrpmetry.....................................................
1 ...7-6..Detection o f ions in mass spectrometry...................................................
1.8 Real-time reverse transcription polymerase chain reaction (RT-PCR) for
the..detection o f RNA re]atmg to steroid converting, enzyme expression...................
.1 •.?. .AMlys.is.methp.ds.........................................................................................................
.1 .-.10. Project Aims..............................................................................................................
1 -.11. .References. C hapter One...........................................................................................
Chapter Two
Materials and Instrumentation
2.0. Generallabpratory .chemicals....................................................................................
2.1. Gases.............................................................................................................................
2.2. Solvents.........................................................................................................................
2.3.Steroj^.s^da^.s  ................................ ............. ........... .......................................... .
2.4. Ceji. culture.................................................................................................................
2...4..1.BiPP.sy.sample. s ...........................................................................................
2,5RealtimeReyerseTranscripfipn-PplymeraseChm ............
2.6. Steroid .extractions........................................................................................................
2.7. Chrpm atpgraphy co him n s..........................................................................................
2.8. Instmmentatipn............................................................................................................
2.8.1 HPLC linked to.the. mass spectrometer..................................................
2.8.2. Typical, conditions for foil scan mass spectrometry (LCQ DEC A)......
.2.8.. 3. GC/MS .1 iriked. to. the m ass .spectrpm eter................................................ .
2
.3
5
6
.7
.7
8
9
9
. 1.1.
. 1.2
.13
14
15
15
15
16
16
20
2.0
22
.23.
.24
27
29
29
30
30
.31
36
36
37
38
39
40
41
.42
43
.43
43
.43
44
v
2.8.4 Typical .conditions. for .foil scan. mass spectrometry. .(GC/MS M D 8.0 Q) 4.4
2^8.5.Typical conditipns.fgr.foili scOT.mass s p e c t r o ^ ^ 44
2.8.6.Laboratory e.quipment..................................................................................45
2.^ .9 Software......................................................................................................................... 46
Chapter Three 
Experimental methods
3.0 .Introduction...............................................................................................................  .48
3.1 Cell culture methods and reverse transcription (real-time) polymerase
chain, reaction (RT-PCR). m.efopdo logi.es........................................................... .48
3.2 Cell culture methodologies; growth and maintenance o f cell lines
. through cell, culture.mefojodp.logi.es.....................................................................48
3..2.1 .General cell culture mefop.dqlpgies...........................................................49
3 3 _ _ P r o . c e d u r e s _ r e l _ a t i n g _ t o ^ ....................................... 49
3.4 RT-PCR methodologies: RNA extraction, reverse transcription
and reaLtime PCR..................................................................................................50
3.4.1 Primer design for specific gene expression detection
in cells..and .biopsies.................................................................................. 5.1
3.5 Mass Spectrometry: Methodology for identification, and detection o f a
.Yariety.of s t e r p i d . s t a n d a r d . s . . ^ ..............5.1
3.6..General.set-up.pf.LCQ.DECA mass .sp.ectrometer..................................................54
3.7 Additives for improved resolution in liquid chromatography
massi.spectrometry..................................................................................................56
3.8 Procedure for statistical analyses from calibration graphs in both
GC/MSandLC/MS.usingstandardref^  5.6
3.8.1 C alcu lation. Q f  R  ^and.] _im.it .of .detection .(L.O.D)...................................... .5.7
3• .8,2 Statistical analysis methods for quantitatiye .calibration by LC/MS.....58
T9.Gaschromatographymassspectrometryfpr  58
3.9.1. Gas. chromatpgraphy. GC/MS MD8.00 set-up......................................... .5.8
3.9.2 Gas chrpmatography.Agilent GC MS D set-up........................................5.9
3.9.3 Statistical analyses from GC/MS calibration graphs using
standardjrefere^  6.0
3.10 .Deriyatisatipn of steroids for analy sis by GC/MS and LC/MS.........................60
.3AlQ..l.T.nmefoy.l-s.ilyl.£TMS)..deriyatis^  .6.1.
3..1_Q..2_Dansy][.chlpridederiyati.sa.tipn  6.3
3...1.1. .Separation. o f a.m ixfore.p^  by. .GC/MS .and .LC/MS.................................64
.3.J.2.Sterpid.exfractip.^...................................................................................................... 65
3..12.1 _ Solubility _o_f stero ids. .in. methanol and water.........................................6.5
3.vl.2.2..Simpleliquid-liquidextrac^  6.7
3.12.3 Determination of the ideal solvent for liquid-liquid extraction 
. o f . s t e r q i d ^ ..............................         ..............  ....67
.3.J_3__Sp_lid_ Phase E x t r a c t ^ .............................................................. 68
.3-i 3_.LTnal. method for solid phase extractions .with.steroid standards......... 69
.3 .,13.2 Solid .phase extractions o f steroids from established cell lines......... .6.9
31.3 .3 Solid .phase, extractions .from cell m ed ia................................................. 7.0
3.1.4Methpdfprsterpidfreatmentso.f  71
3^14...1.T.estp.sterpne. freafopient.of.bippsies......................................................... .73
3..15. .References.Chapter.Three.........................................................................................74
Chapter Four
Optimisation of analytical procedures for the detection and extraction of 
steroids
4.0. Introduction.................................................................................................................16
4.0.1 Chapter 4 Part One: Optimisation and Validation o f Mass
Spec trom etry. M ethod s ..........................................................................................76
4_. 0.2 Chapter .4 .Part Two:. E xtractio n o  f  ste ro ids from bio logical sam p.les 76 
Part One: Detection and separation o f steroid standards by mass spectrometry
4.1 Optimisation o f liquid chromatography mass spectrometry for 
detection o f steroids; solvents, mobile phase additives, and
flu.antitatiy e _ca_l_ ibrations........................................................................................11
4• l.-.l. Steroid analysis.by. LC/MS......................................................................... 77
4.1.2 Androgen mass spectra and fragmentation data in LC/MS
and.MS/MS................................................................................................78
4.1.3 Progestin mass spectra and fragmentation data in LC/MS 
and.LCMSMS........................................................................................ 78
4.1.4 Mass spectra and fragmentation data o f oestrogens in LC/MS and
LC/MS/MS.................................................................................................79
4.2Separatipnofsteroidstandards^ ............................................................... 81
4-.3. Effect o f mobile phase .additives on resolution p f steroid peaks............................83
4 3  O p t i m u m ^ .......................................................................................83
4.4. Optimum separation by .GC/MS.............................................................................. 84
4.4.1. GC/MS MD800 analys.is pf .sterpid st  ^ ....................................... 84
4.4.2 GC. M SJD.analy.sisi.of steroid .standards................................................... 87
4.5 Reproducibility of steroid retention times and peak areas: variation in results
withusep.f m  jntemal.s1^daM........................................................................... 90
4.5.1 Reproducibility o f instrument response (peak area) produced by 
analysis .of andrpstene.dipne .^   92
4.5.2 Comparison of reproducibility for GC/MS MD800, GC MSD and
LCMS.LCQ.DECA................................................................................. 95
4_.6 Statistical .analy ses.from, cal.ibratipn.graphs using. standard reference materials 97
4.7 Statistics for GC/MS calibration graphs using the GC/MS MD800
and.GC.MSD...........................................................................................................99
4.8 Comparison o f GC/MS and LC/MS for determination o f ideal technique for
analys.ispf.standard steroids................................................................................100
4-9_.Deriyatisatipn for i signal in GC/M S and LC/MS....................................1.01
4A9J.TMS.dmvatisj^ ...................................................................................... 102
4 •9.2. Pansyl-chloride deriyatisation................................................................... 105
4*9.3. Sep.aratip.npf.Oesfrpgen.dan.syl-chlp.nde.der^ ............................ 1.10
4..9.4 Optimisation ofdansyLchlpride deriyatisafion...................................... .11.1
4..9.5 Limit o f detection for dansyl-chlpride oestrp^ens..................................112
4.-.10. Opt iPI al. stero id anajys i s m ethod s............................................................................ 1.1.3
Part Two: Optimisation of extraction o f steroids from biological samples
4j.11. .Qptini isation of.extractipn. procedures o f sterpi.dsfrpm MQlQgic.^.s^ples.„.ll^
4.-.12. Solubility pf testo ste^  and pregnenplone in water and methanol................ 1.1.5
4. .1.3. .Cell media extractions- simple steroid .extraction methods............................ 1.1.6
4.14 Development o f solid phase extraction for the extraction o f steroids
from.liquids........................................................................................................... 118
4 . 1 4 Solid phase exfractipn method yalidatipn............................................. 118
4.-.14.2 S o lid phase exfractjpn s of stero ids from cel 1 s ......................................119
vii
4.14,3 .Optim isation o f so fid phase .extractions of steroids from cell .media. .119
4.1.5 C.onclusions..............................................................................................................124
4.16 References Chapter Four..........................................................................................125
Chapter Five
Steroid metabolism by endometrial cancer established cell lines, and 
endometrial biopsies
5.0 Introduction............................................................................................................... 128
.5.1. Stero id Metabolism..................................................................................................... 130
5.j2 Established.ceHJines:.w  1.30
.5.2 .J..Ish.ikawa.cells.........................................................................................  131
.5.2.2.RL95-2 cells.............................................................
5 -2 -.3 H EC - 1A and HEC -IB cells............................... 131
5 i i . C ( ^ 3 4 . c d i s .............................................................................................. i31
5.3. En.do.metrial biopsies................................................................................................ 131
.5-4 Sterpidprofi}es of established cell lines...................................................................132
5.5 Treatment o f Ishikawa and HEC-1B cells with pregnenolone, testosterone and
Oestrad.i.ol............................................................................................................... 1.3.3
5.6. Metabolism o f testosterone, in endom.etri.al. established .cel 1 .lines...................... 13 6
5...6.1 E n z ^   13.6
5 ,7 Testosterpne.uti.li[satipn .in.established, cell .lines...................................................... 137
5-8 S tero id m etabol ism by e stab 1 i shed cel 1 lines.............................................................13 8
.5.8_JSterpid.metabpnsmby.theIshikaw  139
.5-.8,2 Sterpid .prpd.uction by RL95-2 cells after testosterone treatm ept_........1.42
5..8.3 _S terpid.metaboli.sm by HEC-1A cells.after testosterone treatment.....144
5.8.4 Sterpid.metaboli.sm by HEC-1B ceJls.after te stpstprone treatment..1.47
5^8-5Sterpjd.metabplismbyC.O_V434cellsaftertest  15.1
5.8.6 .Conclusions-.cellj .............................................................................1.5.2
5.8.7. Conclusions testpsterone.^  1.5.6
5.9 Analysis o f endometrial biopsies from women with benign endometrial
disorders................................................................................................................. 1_58
.5.9_,_1_ T esto.s^  by.endpmefrial.bipp.si.es.................................... 1.60
5..9.2 .Productionof.steroids fo.l .lowing .testosterone .treatm ent by. fertile biopsies... .1.60
5.9.3 Production o f DHT by endometrial biopsies after testosterone
treatment.................................................................................................... 1.64
5.9.4 Production of androstenedione by endometrial biopsies
afteffjestosterone.tre^ .....................................................................1.65
5.9.5 Production o f androsterone by endometrial biopsies after
testosterone.tre ............................................................................. 1.67
5.9.6 Production of androstanediol by endometrial biopsies after
  ..........    .....1.69
5.9.7 Production o f oestrogens by endometrial biopsies after testosterone
treatment.................................................................................................... 1.69
5.10 Testosterone metabolism by a stromal and epithelial endometrial atypical
.hyp.e^lasia.bippsj............................................................................................... 17.3
5-T1 Testosterpne metabolism by an .endometrial po 1 yp b i.pp sy_................................. 178
5J 2 C o n c l u s i o n s . ^ ................................................................ 180
5<J2.1.Conclusions.oe^ ........................................................................... 1.8.1.
. 5 . . 1 2 . , 2 _ C _ p n c l u s r o ^ ...................................................................... 18.2
.5*12..3.Conc.lusionsUne^  .1.8.3
viii
5J 3. Conclusion  1.83
5 J 4  . R e f e r e e ...........................................................................................185
Chapter Six
Real time polymerase reaction (RT-PCR) for analysis of steroid converting 
enzyme expression in established endometrial cell lines and biopsies 
6 0^.hitroduction...................................................................................................................188
6.1 Primer design and housekeeping genes for quantitative real-time reverse
transcription poly m erase chain reaction. (RT:PCR)......................................... 191
6.2 Relative enzym e. expression, in cell, lines..................................................................1.91
6.2.1 .Arom atase .expression..................................................................................192
6.2...2.17^  193
6.2..3..17£r.HSD2 «   194
6 2..4. .1.7 P.r.H S.D4 e.xpression.................................................................................19.5
6.2...5. .1.7 P.r.H S.D5 .expressipn.................................................................................195
6.2.6 17 P.:HSD7 .exp.ressipn................................................................................ .196
6.2.7 17 P. 7HSD8 exp re s s io n .................................................................................197
6 2...8. .5 AR1. expression.......................................................................................... 19.8
6..2...9.5 AR2 .exp.ressipn...........................................................................................199
6.2.10 Summary o f basal enzyme expression in established
ceUlines.....................................................................................................200
6.3 Changes in gene expression after Testosterone treatment in
established cell .lines............................................................................................. 20.1
6_._3_..LChangesinenzyme_expres_si^  202
6.3.2 Changes in enzyme expression, in the RL9 5 -2 cell line...................... 203
6.3.3 Changes.in enzyme..expression.in the HEC-1 A. cell..line...................... 204
6.3.4 Changes in enzyme expressipn in the HEC-1 B cel 1.line...................... 204
6.3.5 Changes in enzyme expression, in. the .COV434 cell line...................... 20.5
6_._3_.6_ Cone l.usipns established cell 1 ines.............................................................205
6.4 Relative expression o f steroid converting enzymes in a number of
endpmetri.al pathplp^ie .(biopsies}.....................................................................207
6.4.1 Comparison o f basal starting quantity expression o f steroid
converting enzymes in stromal cells isolated from fertile and
en.domefriqste  ^  208
6-4.2 Cpnclusipns. Endometriosis samples........................................................ 2.13
6.4.3 Comparison o f average starting quantity expression o f
steroid converting enzyme RNA in ovarian disorder biopsies to
fertile, biopsies.......................................................................................... .21.4
.6.4.4 Cpnclu?ions ovarian disorders...................................................................2.19
6.4.5 Comparison o f basal starting quantities o f enzymes in
averaged fertile biopsies to biopsies from patients
.with, u n e^   22.0
6.4 -6. Case Reports............................................................................................. 222
6.4.7 Basal starting quantities o f steroid converting enzymes in
stromal and epithelial cells from a patient with
endqmetrial hy compared to.fertile.biops_i.es.......................... .222
6.4.8 Comparison of basal starting quantities of steroid converting
enzymesinanendpmetrialpglypbippsytofertilebipps.ies............. .224
6.4.9 Summary o f enzyme expression in fertile biopsies and benign
endometrial disorders 226
ix
6.5 Changes in enzyme expression after testosterone treatment over 72 hours
in endom etrial .biop.s.i e s.........................................................................................227
6.5.1 Changes in enzyme expression in fertile biopsies 227
6.5.2 Changes in enzyme expression in unexplained
infertility biopsies 228
6.5.3 Changes in enzyme expression in endometriosis biopsies 228
6.5.4 Changes in enzyme expression in endometrial biopsies from
patients with PCOS 229
6.5.5 Changes in enzyme expression in an endometrial biopsy from
an ovarian cyst 230
6.5.6 Changes in enzyme expression in endometrial biopsy from an
endometrial hyperplasia biopsy 230
6.5.7 Changes in enzyme expression in an endometrial sample from
a patient with an endometrial polyp 232
6.5.8 Conclusions biopsies 233
6.6 Conclusions Chapter Six 234
6.7 References Chapter Six 235
Chapter seven
Testosterone utilisation by endometrial cells: Comparison of metabolic (mass
spectrometry) and enzyme expression profiles 
7.0 Introduction 238
7.1 Androgen production in established cell lines and endometrial biopsies 
from fertile women and women with benign endometrial disorders 242
7.2 The roles o f androgens in the endometrium 246
7.3 Aromatase expression and oestrogen production in endometrial cell lines 
and biopsies 247
7.4 Comparison o f testosterone metabolism from fertile endometrial biopsies 
to established cell lines 250
7.5 _ C o m p a r is o n _ s  p f  cell .lines with similar steroid profiles......................................... 254
7.6 Changes in enzyme expression combined with steroid profiles for
endometrial cell lines and biopsies (and an ovarian cell line)
.following testoste^   258
7.6.1 Correlations between enzyme expression and steroid concentrations
In .the J.shikawa ce] 1. 1 ine after testo sterpnetreatment......................... 259
7.6.2 Correlations between enzyme expression and steroid concentrations
in the RL95-2 _ce 1H ine after.testpsterpne treatment............................262
7.6.3 Correlations between enzyme expression and steroid concentrations
in the HEC-1A cell Hne_after testpsterpne treatment..........................262
7.6.4 Correlations between enzyme expression and steroid concentrations
in the HEC-IB cell .1 ine .after testo sterpne treatm ent..........................264
7.6.5 Correlations between enzyme expression and steroid concentrations
in theC.O V43 4 cejj line after testo stero n e treatment..........................265
7.6.6 Correlations between enzyme expression and steroid concentrations
in .fertile biopsies following testostei^  266
7.6.7 Correlations between enzyme expression and steroid concentrations
in unexplained i n f e r t i l i t y ^  26.8
7.6.8 Correlations between enzyme expression and steroid concentrations
in endom etrios is biopsies .after testosterone treatm ent...................... 271
x
7.6.9 Correlations between enzyme expression and steroid concentrations
in endometrial biopsies from patients with PCOS following 
testosterone.trea^ ............................................................................. .273
7.6.10 Correlations between enzyme expression and steroid concentrations 
in an endometrial biopsy from a patient with an ovarian cyst 
following.testosteronefrea ............................................................ 274
7.6.11 Correlations between enzyme expression and steroid concentrations 
in a biopsy from a patient with endometrial hyperplasia after
testosterone treatment 276
7.6.11.1 Epithelial endometrial hypeiplasia biopsy 276
7.6.11.2 Stromal endometrial hyperplasia biopsy 277
7.6.12 Correlations between enzyme expression and steroid concentrations
in an endometrial biopsy from a patient with an endometrial polyp
following testosterone treatment 279
7.7 Summary and discussion of correlations between steroid concentration 
and enzyme expression in cell lines and endometrial biopsies after 
testosterone treatment 280
7.8 Conclusions 281
7.9 Discussion 283
7.10 Further Work 285
7.11 References Chapter Seven 288
Appendix 1:
A 1.1: Conferences Attended
A 1.2: Example of positive identification o f a steroid in cells via comparison to a 
steroid standard.
A 1.3: Representative graphs produced by Icyclers for determination of steroid 
converting enzyme expression by QRT-PCR.
Appendix 2:
Examples of determination of steroid concentrations and enzyme expression 
using mass spectrometry and QRT-PCR.
A2.1: Determination o f testosterone in HEC-1B cells.
A2.2: DHT production by COV434 cells.
A2.3: Calibration method for DHT.
A2.4: Determination o f rate of decay o f androstenedione in RL95-2 cells.
A2.5: Determination of basal expression o f HSD4 in HEC-1B and RL95-2 cells. 
A2.6: Determination of a changing expression o f HSD4 in HEC-1 A cells 
(combination of two experiments).
A2.7: Comparison o f enzyme expression and steroid production in Ishikawa cells.
Tables
Table
number
Title Page
Chapter One
1.0 Steroid grouping, structure, origin and biological function in females 4
Chapter Two
2.1 Chemicals required for derivatisation, extraction and analysis o f steroids. 36
2.2 Table of solvents employed 37
2.3 Steroid standards. 38
2.4 Cell culture chemicals 39
2.5 Growth conditions and descriptions of five cell lines. 40
2.6 Primer sequences for a number of steroid conversion enzymes. 42
2.7 Type of columns used in liquid and gas chromatography experiments. 43
2.8 Laboratory equipment 45
Chapter Three
3.1 Structure, molecular weight and nomenclature of nine steroids standards which 
were studied and considered to be relevant in this study of endometrial tissues.
53
3.2 Standard operating parameters for LCQ DECA full scan analysis o f steroid 
standards, using an ESI source in positive mode.
55
3.3 Standard operating parameters for GC/MS MD800 full scan analysis o f steroid 
standards using an El source in positive mode.
59
3.4 Standard operating parameters for GC MSD full scan analysis of steroid standards 
using an El source in positive mode.
60
3.5 Solvents investigated and their polarity indices. 68
Chapter Four
4.1 LC/MS/MS fragmentation data of androgens analysed on the LCQ DECA mass 
spectrometer with an ESI source in positive mode.
78
4.2 LC/MS/MS fragmentation data of progestins analysed on the LCQ DECA mass 
spectrometer with an ESI source in positive mode.
78
4.3 Fragmentation data LC/MS/MS of oestrogens analysed on the LCQ DECA mass 
spectrometer with an ESI source in positive mode.
79
4.4 Method development steps for optimisation of separation of a mixture of steroid 
standards by LC/MS with an ESI source in positive mode using a methanol/water 
gradient system with 0.1% acetic acid.
81
4.5 Acidic additives producing optimum resolution and signal intensity for a series of 
steroids. The percentage of each acid additive was 0.1% in all solvents and steroid 
solvent solutions.
83
4.6 Major ions present for a series of androgens using the GC/MS MD800 with an 
electron ionisation source (El) in positive mode.
84
4.7 Major ions present for progestins and cholesterol using the GC/MS MD800 with 
an electron ionisation source (El) in positive mode.
85
4.8 Major ions present for a oestrogens using the GC/MS MD800 with an electron 
ionisation source (El) in positive mode.
85
4.9 GC/MS MD800 Temperature programmes to optimise the chromatographic 
performance (separating steroid standards as a function of oven temperature).
86
4.10 Reproducibility comparison of instrument response (peak areas) produced in 
GC/MS (GC/MS MD800 and GC MSD) and LC/MS (LCQ DECA): A 
comparison of RSD variations (calculated variation of 10 measurements recorded 
on 2 separate days).
94
4.11 Comparison o f retention time reproducibility in GC/MS and LC/MS. A 
comparison of RSD variations (calculated variation of 10 measurements recorded 
on 2 separate days).
97
4.12 Limit of detection and R2 values for 8 steroids analysed on the LCQ DECA using 
a Cig reversed-phase column ESI source in positive mode. Methyl-testosterone 
was the internal standard.
98
4.13 Limit of detection and R2 values for nine steroids analysed by GC/MS MD800 
(without an internal standard).
99
4.14 Limit o f detection and R2 values for nine steroids analysed by GC MSD (with an 
internal standard).
100
4.15 Comparison of the limit of detection (LOD) for GC MSD and LC/MS with 
internal standard.
101
4.16 Limit o f detection and R2 values for dansyl-chloride derivatised oestrogens. 
Analysed on the LCQ DECA mass spectrometer with an ESI source in positive 
mode.
112
4.17 Optimal analysis method for ten steroids. This table represents the ideal method 
for analysis in terms of sensitivity and resolution.
113
4.18 Percentage recovery of steroids when extracted by SPE using three different 
elution solvents analysed on the GC/MS MD800 with an El source. Percentage 
recovery was calculated by assuming the control sample steroids produce a peak 
area representative of 100% recovery.
121
4.19 Percentage recovery of steroids from SPE cartridges using methanol, 2-butanol 
and ethyl-acetate analysed on the LCQ DECA mass spectrometer using an ESI 
source in positive mode. Percentage recovery was calculated by assuming the 
control sample steroids produce a peak area representative of 100% recovery.
122
Chapter Five
5.1 Steroid present in cell media of the Ishikawa and HEC-1 B established cell lines 
under basal conditions.
132
5.2 Steroids produced after treatments of HEC-IB and Ishikawa cells with 20mL 
lOOnM media solutions of oestradiol, testosterone and pregnenolone.
134
5.3 Steroid nomenclature and colours on graphics (observed throughout this chapter). 139
5.4 Times and maximum concentrations of androstenedione and DHT in established 
cell lines. Detected on the LCQ DECA mass spectrometer using a Cjg column, 
with an ESI source in positive mode using an optimised methanol/water elution 
system with 0.1% acetic acid.
153
5.5 Table of maximum concentrations of androsterone and androstanediol in all 
established cell lines. Detected on the LCQ DECA mass spectrometer using a Ci8 
column, with an ESI source in positive mode using an optimised methanol/water 
elution system with 0.1% acetic acid.
154
5.6
Table of maximum concentrations of oestradiol and oestrone in all established 
cell lines (concentrations at time zero were not included). Detected on the LCQ 
DECA mass spectrometer using a luna phenyl hexyl column, with an ESI source 
in positive mode using an optimised methanol/water elution system with 0.1% 
formic acid.
155
5.7 Reaction kinetics for testosterone metabolism in established cell lines. 156
5.8 Reactions kinetics for the decay of DHT and androstenedione in HEC-1 B and 
RL95-2 cells.
157
5.9 Biopsy histology showing the number of biopsies in each category and the 
average age and age range within each group.
159
Chapter Six
6.0 Steroid converting enzymes nomenclature and major reactions under investigation ] 1 $9 
in these experiments. 1
6.1 Relative expression of enzymes investigated in established cell lines. Enzyme | 200 
expression (high, medium or low) was relative to expression in the other cell lines ! 
calculated from a mixed calibration series.
6 .2 Enzyme nomenclature and corresponding colours in chapters 6 and 7. j 202
6.3 Significant enzyme expression changes (relative to basal expression) over 72 ; 206 
hours after testosterone treatment of the cell lines Ishikawa, RL95-2, HEC-1 A,
HEC-1B, and COV434. |
6.4 Basal enzyme expression in benign endometrial pathologies relative to the | 226 
averaged fertile biopsies. s
6.5 Basal enzyme expression in benign endometrial pathologies relative to the 
averaged fertile biopsies. H was higher expression, L was lower expression and, 
-  was comparable expression all relative to the fertile biopsies.
233
xiii
Chapter Seven
7.1 j Observed enzyme expression related to the production of DHT and/or 
! androstenedione in cell lines and endometrial biopsies.
246
7.2 I Correlations between enzyme expression and changes in steroid profile for the
| cell lines Ishikawa, RL95-2, HEC-1A, HEC-1B and COV434 and the endometrial 
| biopsies after testosterone treatment.
280
Table of figures
Figure
number
Title Page
Chapter One
1.0 Numbering of the steroid skeleton. 3
1.1 Metabolism of Cholesterol. The left hand side of the diagram illustrates the bio­
pathways for the production of the mineralocorticoid aldosterone and the 
glucocorticoid cortisol. The right hand side of the diagram illustrates the 
reversible metabolism of the androgens, androsterone, androstanediol and the 
non-reversible metabolism of the oestrogens, oestradiol and oestrone. a = alpha b 
= beta, OH= hydroxyl. Steroid converting enzymes are coloured. Aromatase is 
the rate limiting enzyme in oestrogen bio-synthesis (red). HSD= hydroxysteroid 
dehydrogenase these are either oxidative or reductive enzymes, which have a 
number of different isoforms.
6
1.2 Illustration of the conversion of cholesterol to pregnenolone via the P450scc 
enzyme.
8
1.3 Illustration of the aromatase conversion reaction. Testosterone aromatisation to 
oestradiol.
8
1.4 Illustration of a 5-a reductase conversion of C4-ene group in steroid skeleton to 
the saturated compound. Testosterone to DHT.
9
1.5 Illustration of a 17(3-HSD reaction conversion of a hydroxyl to a ketone group at 
position 17. The oxidative reaction is the conversion of testosterone to 
androstenedione and the reductive reaction is the conversion of androstenedione 
to testosterone.
9
1.6 Illustration of a 3J3-HSD reductive conversion at the 3 keto group to a 3 hydroxyl 
group.
10
1.7 Illustration of the steroid sulphatase/sulphotransferase conversion reaction. 
Conversion of DHEA to DHEA-sulphate by the steroid sulphatase (DHEA 
sulphatase), and the reverse by the steroid sulphotransferase (DHEA 
sulphotransferase).
11
1.8 Diagram o f the Uterus. The endometrium is the inner lining of the uterus labelled 
above.
14
1.9 Structure of the uterine wall. The uterus has four distinct sections the 
perimetrium, myometrium, endometrial stroma and endometrial epithelium.
14
1.10 Illustration of the electrospray ionization process at the capillary tip. LC = liquid 
chromatography MS= mass spectrometry.
26
1.11 Diagram of magnetic separator. 27
1.12 Diagram of Quadrupole Ion Trap system. 29
Chapter Three
3.1 Diagram illustrating the TMS derivatisation reactions for testosterone and 
pregnenolone both products produce a mass shift of +73.
62
3.2 Diagram illustrating the TMS derivatisation of oestradiol, two products produce a 
mass shift of +73, these are mono-derivatised compounds. One product (bottom) 
has a mass shift o f+156 this was the di-derivatised compound.
62
3.3 Diagram illustrating the dansyl-chloride derivatisation o f oestradiol and oestrone. 64
3.4 Flow chart illustrating the method for determination of the solubility of 
testosterone and pregnenolone in methanol, water and a 50/50 mixture of 
methanol and water.
67
ii
xiv
3.5
Flow chart illustrating the method for determination o f the optimum solvent for 
steroid extractions from SPE cartridges. Steroid solutions 1, 2 and 3 and the 
100% steroid solution all contain lpM  solutions of DHEA, androsterone, DHT, 
oestrone, androstenedione, oestradiol, pregnenolone, testosterone and 
progesterone. Elution solvents were 2-butanol, methanol and ethyl-acetate.
71
Chapter Four
4.1 Mass spectra of a standard androgen top (testosterone), progestin middle 
(pregnenolone) and an oestrogen bottom (oestriol). Samples were analysed using 
the LCQ DECA mass spectrometer with an ESI source in positive mode by direct 
infusion using 3pM solutions in 50/50 methanol/water (0.1% formic acid).
80
4.2 Optimised separation o f eight steroids on the LCQ DECA mass spectrometer via 
a C]8 column with an ESI source in positive mode using a methanol/water 0.1% 
acetic acid gradient system. Selected ion chromatograms of androstenedione, 
testosterone, DHEA, methyl-testosterone, androstane-3,17diol, androsterone, 
progesterone and pregnenolone selected molecular ions [M+H]+ were m/z 287, 
289, 289, 303, 257,291, 315, and 317 respectively.
82
4.3 Representative mass spectra obtained on the MD800 GC/MS using an El source 
in positive mode, samples were a concentration of lOpM in methanol. Top mass 
spectra was a progestin (pregnenolone) middle was an androgen (androsterone), 
and bottom was an oestrogen (oestradiol). The molecular species was clearly 
observed for each steroid.
86
4.4 Separation of 10 steroids by GC/MS MD800 with an El source in positive mode. 
Some steroids co-elute but can be distinguished from their unique peaks in the 
mass spectra, for example the peak on the left o f the chromatogram was the co­
elution of a mixture of DHEA and androsterone.
87
4.5 Mass spectra produced by the GC MSD with an El source in positive mode for 
oestradiol (top), DHEA (middle) and progesterone (bottom). The molecular ion 
[M'+] were abundant for each steroid.
88
4.6 Cholesterol GC MSD mass spectrum with an El source in positive mode. The 
molecular ion [M-+] was abundant for cholesterol observed at m/z 386.
89
4.7 Optimised separation of ten steroids by GC MSD using an HP-1 1 metre column 
in positive mode with an El source.
90
4.8 Reproducibility instrument response (peak area) for androstenedione and 
androsterone analysed by GC/MS MD800 in positive mode using an El source. 
Graph on the left demonstrated variation without an IS and the graph on the left 
demonstrates variation with an IS.
93
4.9 Reproducibility of peak area relating to androstenedione (m/z 286) and 
androsterone (m/z 290) when analysed by GC MSD in positive mode using an El 
source with an internal standard (methyl-testosterone).
93
4.10 Reproducibility of instrument response (peak are) relating to androstenedione 
(m/z 287) and androsterone (m/z 291) when analysed by LC/MS on the LCQ 
DECA mass spectrometer analysed in positive mode using an ESI source. Left 
plot illustrates reproducibility without an internal standard right plot illustrates 
reproducibility with an internal standard variance was calculated as RSD.
94
4.11 Reproducibility of retention times o f androstenedione and androsterone. Left 
hand graph shows retention time reproducibility analysed on the GC/MS MD800, 
with an El source in positive mode. The right hand graph shows relative retention 
times of androstenedione and androsterone analysed using the GC MSD in 
positive mode with an El source.
94
4.12 Plot showing the reproducibility of retention times o f androstenedione and 
androsterone. These were analysed on the LCQ DECA in positive mode using an 
ESI source.
95
4.13 Representative calibration graph for a series o f concentrations of DHT. 
Instrument response (peak area ratio to IS) was plotted against concentration. 
Analysed on the LCQ DECA mass spectrometer in positive mode using an ESI 
source.
98
4.14 Testosterone TMS derivatisation analysed on the GC/MS MD800 in positive 
mode with an El source. Testosterone-TMS derivative and some remaining 
testosterone were observed at 16 minutes.
102
XV
4.15
Chromatograms showing the four peaks produced after oestradiol TMS 
derivatisation. These chromatograms were produced on the GC/MS MD800 in 
positive ionisation mode using an El source. The top peak is representative of di- 
derivatised oestradiol m/z 416, the middle peaks of selected mass m/z 345 were 
due to the two mono-dervatised compounds which can be produced with 
oestradiol-TMS derivatisation (OH groups at position 3 and position 17). The 
final peak of selected mass m/z 272 is un-derivatised oestradiol indicating that the 
derivatisation was not 100% efficient.
102
4.16 Chromatograms and mass spectra showing incomplete derivatisation of 
pregnenolone. Two peaks were seen in the total ion chromatogram representative 
of pregnenolone-TMS and un-derivatised pregnenolone. These samples were 
analysed in positive mode using the GC/MS MD800 with an El source.
103
4.17 The chromatogram at the top shows two peaks after TMS derivatisation of 
oestrone. The top chromatogram and top mass spectrum is the derivatised 
oestrone m/z 342 the second chromatogram and the lower mass spectrum prove 
that incomplete derivatisation of oestrone has occurred as the derivatised 
molecular ion m/z 270 is observed. Analysed on the GC/MS MD800 using an El 
source.
104
4.18 Full scan mass spectra o f dansyl-chloride-oestrone (top spectra), the protonated 
molecular species can clearly be seen at [M+ derivative +H]+ = m/z 504. This 
was produced from direct infusion into the LCQ DECA with an ESI source in 
positive mode. The LC/MS/MS generated fragmentation pattern of the 
protonated molecular ion (m/z 504 spectra) showing fragments which further aid 
identification using selected reaction monitoring (SRM).
106
4.19 Full scan mass spectra of dansyl-chloride-oestradiol (top spectra), the protonated 
molecular ion can clearly be seen at [M+ derivative +H]+ = m/z 506. This was 
produced from direct infusion into the LCQ DECA with an ESI source in positive 
mode. The LC/MS/MS generated fragmentation pattern of the protonated 
molecular ion (m/z 506-bottom spectra) showing fragments which further aid 
identification when using SRM.
107
4.20 Full scan mass spectra o f dansyl-chloride derivatised testosterone and dansyl 
chloride derivatised pregnenolone. Analysed on the LCQ DECA mass 
spectrometer with an ESI source in positive mode. No derivatisation has occurred 
as the calculated dansyl-chloride representative peaks at m/z 523 for testosterone 
and m/z 551 for pregnenolone were not present.
109
4.21 Separation of DC-oestradiol and DC-oestrone (2pM solutions) on the LCQ 
DECA mass spectrometer with an ESI source in positive mode using a 
methanol/water 0.1% formic acid using al 50x1 mm 3p Luna phenyl hexyl 
column. Oestradiol-DC SRM m/z 506—>171(top), and oestrone-DC SRM m/z 
504—>171 (bottom).
111
4.22 Optimisation of the dansyl-chloride derivatisation procedure by changing reaction 
conditions. Peak areas were proportional to concentration the largest peak area 
equates to the largest percentage conversion of oestrogen to the dansyl-chloride 
oestrogen species analysed on the LC/MS LCQ DECA in positive mode using an 
ESI source. Oestrone is represented in blue and oestradiol in red.
112
4.23 Top graph illustrates the solubility o f testosterone in water, methanol/water 
(50/50) and methanol. Lower graph illustrates the solubility o f pregnenolone in 
water, methanol/water 50/50 and methanol. Testosterone was more soluble in 
methanol than in water, with 50/50 solution having a mid-range value. 
Pregnenolone was more soluble in methanol than water with the half and half 
solution producing a mid-point value. All errors were calculated from the 
standard deviation of two experiments.
115
4.24 Relative extraction efficiencies of different solvents for testosterone and 
pregnenolone extraction from a water solution. Average peak area to an internal 
standard was plotted against the solvent used for extraction (chloroform, ethyl- 
acetate, hexane and MTBE), analysed by LC/MS in positive mode using an ESI 
source. Testosterone is represented in blue and pregnenolone in purple.
117
4.25 Separation of testosterone and pregnenolone after solid phase extractions from 
1 pM solutions, using the LCQ DECA with an ESI source in positive mode.
119
4.26 Extraction efficiency o f nine steroids by SPE using three different solvents 
methanol, 2-butanol and ethy 1-acetate. The control was a non-SPE 100% steroid 
solution. The peak area (proportional to concentration) was expressed as a ratio 
to the internal standard methyl testosterone. These results were from the GC/MS 
MD800 in positive mode using an El source. Errors were produced from the 
standard deviation o f the peak area ratio to an internal standard of two 
experiments.
121
4.27 Extraction efficiency of eight steroids by SPE using three different solvents 
methanol, 2-butanol and ethy 1-acetate. Control is a non-SPE 100% steroid 
solution. The peak area (proportional to concentration) was expressed as a ratio 
to the internal standard methyl testosterone. These steroids were detected on the 
LCQ DECA with an ESI source in positive mode. Errors were produced form the 
standard deviation o f the peak area ratio to an internal standard of two 
experiments.
122
Chapter Five
5.1 The metabolism of testosterone and androstenedione through steroid converting 
enzymes into androgens and oestrogens. 17b-HSD = hydroxysteroid 
dehydrogenase which acts on position 17 of the steroid ring 3-HSD acts at 
position 3 (the number after the name donates the isoform). 5AR = five alpha 
reductase two isoforms 1 and 2.
130
5.2 Illustrative chromatogram showing the detection of steroids in HEC-IB cell 
media. Androsterone, oestrone, testosterone and cholesterol were observed in 
HEC-IB cell media without addition of steroid precursor.
132
5.3 Chromatograms of HEC-IB cell lines before (top) and 72 hours after treatment 
with oestradiol (below) using the GC/MS MD800 mass spectrometer with an El 
source in positive mode.
135
5.4 Chromatograms for Ishikawa cell lines before (top) and 48 hours after treatment 
with testosterone (below) using the GC/MS MD800 mass spectrometer with an El 
source in positive mode.
135
5.5 Illustration of a model first order decay of testosterone by the HEC-IB cell line. 136
5.6 The reduction in testosterone concentration in Ishikawa (pink), COV434 (dark 
blue), RL95-2 (yellow), HEC-1 A (light blue) and HEC-IB (purple) cell lines over 
72 hours after addition of a lOOnM testosterone media solution.
137
5.7 Top chromatogram and spectra shows positive determination of testosterone in 
RL95-2 cells via matching chromatogram and mass spectra.
138
5.8 Rate of decay of testosterone in Ishikawa cells over 72 hours after addition of a 
lOOnM testosterone media solution.
139
5.9 Steroid profiles of four androgens over 72 hours in Ishikawa cells after addition 
of a lOOnM testosterone solution in 20ml of culture medium.
140
5.10 Oestrogen production in Ishikawa cells after addition of a 1 OOnM media solution 
of testosterone over 72 hours.
141
5.11 Androgens detected over 72 hours by RL95-2 cells after addition of a testosterone 
solution of lOOnM.
142
5.12 Diagram illustrating the active pathway (highlighted yellow) of androgen 
synthesis in RL95-2 cells.
143
5.13 Androstenedione is produced from testosterone in RL95-2 cells over 72 hours 
after addition of a lOOnM testosterone media solution.
143
5.14 Oestrogen production in RL95-2 cells over 72 hours after addition of a lOOnM 
testosterone media solution.
144
5.15 Androgen production in HEC-1 A cells over 72 hours after addition of a lOOnM 
testosterone media solution.
144
5.16 Decay of testosterone is HEC-1 A cells over 72 hours after addition of a lOOnM 
testosterone media solution.
145
5.17 Oestrogen production in HEC-1 A cells over 72 hours after addition of a 
lOOnM/pL testosterone media solution.
146
5.18 Production of androgens in HEC-IB cells over 72 hours after addition of a 
lOOnM testosterone media solution.
147
5.19 Major testosterone metabolic route in HEC-IB cells. 148
xvii
5.20 Decay of testosterone in HEC-IB cells over 72 hours after addition of a lOOnM 
testosterone media solution.
148
5.21 Decay of DHT in HEC-1B cells over 72 hours after addition of a lOOnM 
testosterone media solution.
148
5.22 Decay of androstenedione in HEC-IB cells over 72 hours after addition of a 
lOOnM testosterone media solution.
149
5.23 Production of oestrogens in HEC-IB cells over 72 hours after addition of a 
lOOnM testosterone media solution.
150
5.24 Androgen production in COV434 cells over 72 hours after addition of a lOOnM 
testosterone media solution.
151
5.25 Testosterone decay in COV434 cells over 72 hours after addition of a lOOnM 
testosterone media solution.
151
5.26 Oestrogen production in COV434 cells over 72 hours after addition o f a lOOnM 
testosterone media solution.
152
5.27 Testosterone utilisation in stromal cells from endometrial pathologies monitored 
over 72 hours after addition of a lOOnM testosterone media solution.
160
5.28 Androstenedione production in fertile biopsies over 72 hours after addition o f a 
lOOnM testosterone media solution.
161
5.29 Production of androsterone in fertile biopsy samples over 72 hours after addition 
of a lOOnM testosterone media solution.
161
5.30 Production of oestrone in endometrial stromal cells over 72 hours after addition of 
a lOOnM testosterone media solution.
162
5.31 Production of oestradiol in endometrial stromal cells over 72 hours after addition 
of a lOOnM testosterone media solution.
163
5.32 Production of DHT in endometrial stromal cells from patients with endometriosis 
over 72 hours after addition of a lOOnM testosterone media solution.
164
5.33 Production of DHT in endometrial stromal cells from women with ovarian 
disorders over 72 hours after addition o f a lOOnM testosterone media solution.
165
5.34 Production of androstenedione in patients with unexplained infertility over 72 
hours after addition o f a lOOnM testosterone media solution.
165
5.35 Comparison o f endometriosis androstenedione production and fertile 
androstenedione production in endometrial stromal cells over 72 hours after 
addition of a lOOnM testosterone media solution. .
166
5.36 Production of androstenedione comparison between patients with ovarian 
abnormalities and fertile endometrial biopsies over 72 hours after addition of a 
lOOnM testosterone media solution.
166
5.37 Comparison o f androsterone production in endometrial stromal cells from biopsy 
samples from fertile and unexplained infertility patients over 72 hours after 
addition of a lOOnM testosterone media solution.
167
5.38 Production of androsterone in stromal cells from patients with endometriosis over 
72 hours after addition of a lOOnM testosterone media solution.
168
5.39 Production o f androsterone in patients with ovarian disorders over 72 hours after 
addition of a lOOnM testosterone media solution.
168
5.40 Oestrone production in unexplained infertility over 72 hours after addition o f a 
lOOnM testosterone media solution.
169
5.41 Oestrone production in endometriosis samples over 72 hours after addition of a 
lOOnM testosterone media solution.
170
5.42 Oestrone production in ovarian disorders over 72 hours after addition of a 1 OOnM 
testosterone media solution.
170
5.43 Oestradiol production in unexplained infertility biopsies over 72 hours after 
addition of a lOOnM testosterone media solution.
171
5.44 Oestradiol production in endometriosis samples over 72 hours after addition of a 
lOOnM testosterone media solution.
172
5.45 Production of oestradiol in patients with ovarian disorders over 72 hours after 
addition of a lOOnM testosterone media solution.
172
5.46 Comparison o f DHT production in stromal and epithelial cells from a hyperplasia 
biopsy over 72 hours after addition o f a lOOnM testosterone media solution.
174
xviii
5.47 Production of androstenedione comparisons between stroma and epithelia from an 
endometrial hyperplasia biopsy and fertile stromal cells over 72 hours after 
addition of a 1 OOnM testosterone media solution.
174
5.48 Production of androstreone in stromal and epithelial cells from a hyperplasia 
biopsy over 72 hours after addition of a lOOnM testosterone media solution.
175
5.49 Oestrone production in a hyperplasia sample over 72 hours after addition of a 
lOOnM testosterone media solution.
176
5.50 Production o f oestradiol in stromal and epithelial cells from an endometrial 
hyperplasia biopsy over 72 hours after addition o f a lOOnM testosterone media 
solution.
177
5.51 Production of steroids in an endometrial polyp stromal biopsy over 72 hours after 
addition of a lOOnM testosterone media solution.
178
5.52 Oestrogen production in a stromal biopsy from an endometrial polyp over 72 
hours after addition of a lOOnM testosterone media solution.
179
Chapter Six
6.0 Schematic describing the approach taken to analyse expression o f RNA relating 
to specific steroid converting enzymes in cell lines and biopsies.
189
6.1 Relative basal expression of aromatase in the Ishikawa, HEC-1A, HEC-1B, 
RL95-2 and COV434 established cell lines.
192
6.2 Relative basal expression of 17P-HSD1 in the Ishikawa, HEC-1 A, HEC-1B, 
RL95-2 and COV434 established cell lines.
193
6.3 Relative basal expression of 17P-HSD2 in the Ishikawa, HEC-1 A, HEC-1B, 
RL95-2 and COV434 established cell lines.
194
6.4 Relative basal expression of 17P-HSD4 in the Ishikawa, HEC-1 A, HEC-IB, 
RL95-2 and COV434 established cell lines.
195
6.5 Relative basal expression of 17P-HSD5 in the Ishikawa, HEC-1 A, HEC-IB, 
RL95-2 and COV434 established cell lines.
195
6.6 Relative basal expression of 17P-HSD7 in the Ishikawa, HEC-1 A, HEC-IB, 
RL95-2 and COV434 established cell lines.
196
6.7 Relative basal expression of 17P-HSD8 in the Ishikawa, HEC-1 A, HEC-1B, 
RL95-2 and COV434 established cell lines.
197
6.8 Relative basal expression of 5AR1 in the Ishikawa, HEC-1A, HEC-1B, RL95-2 
and COV434 established cell lines.
198
6.9 Relative basal expression of 5AR2 in the Ishikawa, HEC-1 A, HEC-1B, RL95-2 
and COV434 established cell lines.
199
6.10 Changing enzyme RNA expression levels over 72 hours after addition of 
testosterone to Ishikawa cell media
202
6.11 Changing enzyme RNA expression levels over 72 hours after addition of 
testosterone to RL95-2 cell media.
203
6.12 Changing enzyme RNA expression levels over 72 hours after addition of 
testosterone to HEC-1 A cell media.
204
6.13 Changing enzyme RNA expression levels over 72 hours after addition of 
testosterone to HEC-IB cell media.
204
6.14 Changing enzyme RNA expression levels over 72 hours after addition of 
testosterone to COV434 cell media.
205
6.15 Relative basal expression of aromatase in endometrial biopsies from averaged 
fertile and endometriosis.
208
6.16 Relative basal expression of HSD1 in endometrial biopsies from averaged fertile 
and endometriosis samples..
209
6.17 Relative basal expression of HSD2 in averaged fertile and endometriosis biopsies. 209
6.18 Relative basal expression of HSD4 in averaged fertile and endometriosis biopsies. 210
6.19 Relative basal expression of HSD5 in averaged fertile and endometriosis biopsies. 211
6.20 Relative basal expression of HSD7 in averaged fertile and endometriosis biopsies. 211
6.21 Relative basal expression of HSD8 in averaged fertile and endometriosis biopsies. 212
6.22 Relative basal expression of 5AR1 in endometrial biopsies in comparison to 
averaged fertile biopsies.
212
6.23 Relative basal expression of 5 AR2 in averaged fertile and endometriosis biopsies. 213
xix
6.24 Relative basal expression o f aromatase in averaged fertile and ovarian disorder 
biopsies.
215
6.25 Relative basal expression of HSD1 in averaged fertile and ovarian disorder 
biopsies.
215
6.26 Relative basal expression of HSD2 in averaged fertile and ovarian disorder 
biopsies.
216
6.27 Relative basal expression of HSD4 in averaged fertile and ovarian disorder 
biopsies.
216
6.28 Relative basal expression of HSD5 in averaged fertile (control) and ovarian 
disorder biopsies.
217
6.29 Relative basal expression of HSD7 in averaged fertile (control) and ovarian 
disorder biopsies.
217
6.30 Relative basal expression of HSD8 in averaged fertile and ovarian disorder 
biopsies. .
218
6.31 Relative basal expression of 5AR1 expression in averaged fertile and ovarian 
disorder biopsies.
218
6.32 Relative basal expression of 5AR2 in averaged fertile and ovarian disorder 
biopsies.
219
6.33 Average basal expression of all enzymes in fertile and unexplained infertility 
biopsies.
220
6.34 Comparison of basal expression in averaged (stromal) fertile biopsies and 
epithelial and stromal cells from an endometrial epithelial hyperplasia biopsy.
222
6.35 Comparison o f basal expression in fertile and hyperplasia samples (epithelial and 
stromal).
223
6.36 Comparison o f basal expression of nine steroid converting enzymes in fertile and 
endometrial polyp biopsies.
225
6.37 Changes in enzyme expression levels over 72 hours after testosterone treatment in 
average fertile stromal biopsies.
227
6.38 Changes in enzyme expression levels over 72 hours after testosterone treatment in 
average unexplained infertility biopsies.
228
6.39 Changes in enzyme expression levels over 72 hours after testosterone treatment in 
average endometriosis stromal biopsies.
229
6.40 Changes in enzyme expression levels over 72 hours after testosterone treatment in 
average PCOS stromal biopsy.
229
6.41 Changes in enzyme expression levels over 72 hours after testosterone treatment in 
average ovarian cyst stromal biopsy.
230
6.42 Changes in enzyme expression levels over 72 hours after testosterone treatment of 
an epithelial hyperplasia biopsy.
230
6.43 Changes in enzyme expression levels over 72 hours after testosterone treatment in 
stromal cells from an endometrial hyperplasia biopsy.
231
6.44 Changing expression o f all enzymes over 72 hours after testosterone treatment in 
an endometrial polyp biopsy.
232
Chapter Seven
7.1 Alteration in steroid metabolism from 4 fertile biopsies to 1 epithelial hyperplasia 
biopsy to the established cell lines.
240
7.2 Alteration in steroid metabolism from stromal cells from 4 fertile biopsies to 
biopsies from each pathology (endometriosis (6 biopsies), unexplained infertility 
(2 biopsies), PCOS (2 biopsies) endometrial polyp (1 biopsy), endometrial 
hyperplasia (1 biopsy), and ovarian cyst (1 biopsy).
241
7.3 Plots illustrating the basal expression of HSD2,4, 8 and 5AR1 in endometrial cell 
lines in comparison to fertile endometrial biopsies.
242
7.4 Top plot illustrates the basal expression of HSD2,4, 8, aromatase and 5AR1 in 
endometrial biopsies, bottom plot illustrates the expression of HSD2,4 and 5AR1
243
7.5 Comparison o f basal expression levels of nine steroid converting enzymes in the 
RL95-2 cell line and 4 averaged fertile biopsies.
251
7.6 Alteration in routes of testosterone metabolism from fertile biopsies to RL95-2 
cells.
252
XX
7.7 Alteration in routes of testosterone metabolism from stromal fertile biopsies to 
Ishikawa and HEC-1 A cells.
253
7.8 Alteration in routes of testosterone metabolism from fertile biopsies to HEC-IB 
and COV434 cells.
254
7.9 Comparison o f basal expression of steroid converting enzymes in COV434 and 
HEC-IB cells.
255
7.10 Comparison o f basal expression of steroid converting enzymes in Ishikawa and 
HEC-1 A cells.
256
7.11 Comparison of basal expression of HSD4 (green) and HSD5 (brown) in Ishikawa 
and HEC-1 A cell lines.
258
7.12 Correlation between 5AR1 expression and DHT concentration in Ishikawa cells 
over 72 hours after addition of a lOOnM testosterone media solution.
260
7.13 Correlations between HSD8 expression and androstenedione concentration in 
Ishikawa cells over 72 hours after addition o f a lOOnM testosterone media
260
7.14 Correlations between oestradiol concentration and aromatase expression in 
Ishikawa cells over 72 hours after addition of a lOOnM testosterone media 
solution.
261
7.15 Correlation between testosterone concentration and HSD5 expression in HEC-1 A 
cells over 72 hours after addition of a lOOnM testosterone media solution.
263
7.16 Correlation between oestradiol concentration and aromatase expression in HEC- 
1A cells over 72 hours after addition of a lOOnM testosterone media solution.
264
7.17 Correlations between 5AR1 expression and DHT concentration in HEC-IB cells 
over 72 hours after addition of a lOOnM testosterone media solution.
265
7.18 Correlation between 5AR1 expression and concentration of DHT in COV434 
cells over 72 hours after addition of a lOOnM testosterone media solution.
266
7.19 Steroid metabolism in stromal biopsies from fertile patients over 72 hours after 
addition of a lOOnM testosterone media solution.
267
7.20 Typical metabolism route of testosterone in four fertile biopsies. 267
7.21 Steroid metabolism in stromal cells from unexplained infertility biopsies over 72 
hours after addition of a lOOnM testosterone media solution.
268
7.22 Correlation between SAR2 expression and androsterone concentration in 
unexplained infertility biopsies over 72 hours after addition of a lOOnM 
testosterone media solution.
269
7.23 Alteration in routes of testosterone metabolism from fertile biopsies to 
unexplained infertility biopsies.
270
7.24 Alteration in routes of testosterone metabolism from fertile biopsies to 
endometriosis biopsies.
272
7.25 Alteration in routes of testosterone metabolism from fertile biopsies to 
endometrial biopsies from women with PCOS and ovarian cysts.
275
7.26 Correlation between oestrone and oestradiol concentrations and aromatase 
expression in an epithelial hyperplasia biopsy over 72 hours after addition o f a 
lOOnM testosterone media solution.
276
7.27 Alteration in routes of testosterone metabolism from stromal fertile biopsies to a 
stromal and epithelial hyperplasia biopsy.
277
7.28 Alteration in routes of testosterone metabolism from fertile biopsies to an 
endometrial polyp biopsy.
279
xxi
Abbreviations
5-AR- 5 alpha reductase 
a-alpha (a)
AR-androgen receptor 
b- beta (|3)
DC- Dansyl-chloride 
DHEA- Dehydroepiandrosterone 
DHT- Dihydrotestosterone 
El - Oestrone.
E2- 17P-oestradiol 
E3- Oestriol 
El- Electron Ionisation 
ESI- Electrospray ionisation 
ER-Oestrogen receptor
FCS-Foetal calf serum also (foetal bovine serum)
GC/MS- Gas Chromatography Mass Spectrometry
GC MSD- Agilent Instrument
GC/MS MD800- Fisons Instrument
HPLC- High Performance Liquid Chromatography
HSD- Hydroxy steroid dehydrogenase a number o f different isoforms
IS- Internal Standard
LC- Liquid chromatography
LOD- Limit o f detection
MS/MS- Tandem mass spectrometry
m/z- Mass-to-charge ratio
PR- Progesterone receptor
OH- Hydroxyl
RLA-Radioimmunoassays
RNA-Ribonucleic acid
RSD-Relative standard deviation
RT-PCR- Real time reverse transcription polymerase chain reaction 
SIM-Selected ion monitoring 
SPE- Solid phase extraction 
TMS- Trimethylsiyl
xxii
Acknowledgements
I would firstly like to say a massive thank-you to my supervisors Professor Gareth 
Brenton and Professor John White for their constant guidance, encouragement and 
enthusiasm throughout this project.
I also thank my colleagues at the Institute o f Mass Spectrometry, Institue o f Life 
Sciences, Reproductive Biology Group, Chemistry Department and the EPSRC 
National Mass Spectrometry Service Centre at Swansea University. I would like to 
especially thank Dr Deyarina Gonzalez and Dr Edward Dudley who have been 
invaluable to me regarding their teaching in the labs and assistance with data 
management.
I would like to thank all the patients and staff at Singleton Hospital, who provided 
the endometrial biopsies.
I would also like to thank the Engineering and Physical Sciences Research Council 
(EPSRC) for funding this project.
And finally I would like to thank my family and my fiancd Rhys for supporting my 
ambitions as an eternal student!
xxiii
Chapter One
Steroid Metabolism in the Human Endometrium
Chapte r  One:  Steroid M et ab o l i sm  in the Hu man  1’ndometr ium
1.0 Introduction
This chapter describes steroid structure, metabolism and the roles of specific steroid 
converting enzymes in the normal endometrium and endometrial disorders. The 
techniques required to establish steroid profiles and steroid converting enzyme 
expression are also described.
Steroids are metabolised in a number o f tissues in the human body including the 
liver, endometrium, brain and breast. Significant steroid metabolism takes place in 
the liver, where the majority o f cholesterol is produced which goes on to form the 
wide variety of other steroids described in figure 1.1. The biosynthetic pathways are 
similar in all these organs, however rates o f production, important enzymes involved 
and concentrations of each steroid can vary significantly. The role of each steroid in 
each tissue is varied, for example, oestrogens in the bone protects against progression 
of osteoporosis1 but have been linked to progression o f cancer in the endometrium.2
When steroid metabolism is displaced from a normal pattern a number o f steroid 
related disorders can occur. Examples o f steroid related disorders are;
1. Breast cancer. Localised production of androgens and oestrogens has been 
described in breast cancer development.3
2. Addison’s Disease. Decreased secretion of the adrenal glucocorticoids and 
mineralocorticoids causes a number o f  conditions due to low blood sugar and ultra­
filtration problems.4
3. Endometrial cancer. Localised synthesis o f oestrogens is thought to be 
important in endometrial cancer development.5
2
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1.1 Structure of steroids
Steroids have a four ring system comprising three cyclohexane rings and one 
cyclopentane ring.6 Differences in biological activity are due to differing constituent 
groups and their stereochemistry on the basic ring structure. Steroids are separated 
into five major groups based on their structure and function (Tablet.0).
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Fig 1.0: Numbering o f the steroid skeleton.
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Tablet.0. Steroid grouping, structure, origin and biological function in females.
Group name Typical structure Tissue of origin Major biological function in 
females
Androgen
OR Me j
Cj9
Ovaries 
Adrenal glands
Precursor of oestrogens in gonadal 
sites such as the ovaries and 
extragondal sites such as the brain, 
bone, and adipose tissue
Oestrogen
M* j*
C]8
Placenta 
Ovaries 
Andrenal cortex 
Adipose tissue 
Breast 
Endometrium
Designate female characteristics 
Regulation of menstrual cycle 
Cognitive function 
Bone minerlisation
Progestin
. y -
C21
Ovaries
Important for implantation and 
maintenance of pregnancy 
Regulation of menstrual cycle
M ineralocorticoid Adrenal cortex
Affect the mineral content of the 
blood through ultra-filtration in the 
kidneys (re-absorption of sodium and 
loss of potassium)
Glucocorticoid MmHO^ 1 /  
Me I \ Adrenal cortex
Affect blood sugar levels and 
stimulate gluconeogenesis in the liver, 
also involved in resistance to 
infection (T-cell control) and anti­
inflammatory effects
R= functional group such as alkyl or aryl side chains or hydrogen.
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1.2 Steroid Metabolism
Steroids can be arranged into a bio-pathway based on their metabolism in the body. 
A number o f different enzymes are involved in steroid metabolism, expression and 
activity of individual enzymes within a tissue leads to flux through specific routes of 
the bio-pathway. The metabolism routes, rates, and products can vary due to 
differences in biological phenotype and steroid converting enzyme expression. 
Steroid profiles produced experimentally can indicate metabolism routes, combined 
with steroid converting enzyme expression data this can provide novel information 
concerning normal and altered steroid metabolism in specific tissues, which could 
aid development o f specific enzyme antagonists.
Cholesterol is the precursor of steroid metabolism in the human body. It can be 
metabolised through a number of key rate limiting enzymes to produce all the 
steroids defined in figure 1.1. The initial step is the conversion o f cholesterol to 
pregnenolone which occurs in the adrenal glands or gonads through the P450scc 
enzyme, after this the bio-pathway branches to produce mineralocorticoids or 
glucocorticoids or androgens and oestrogens. This occurs in a number o f organs and 
tissues throughout the human body such as the adrenal glands, liver, ovaries, and 
adipose tissue. Active steroids can also be metabolised from their inactive sulphated 
analogues (usually present at high concentration in the plasma) through the action of 
steroid sulphatase, common circulatory steroid sulphates are 
dehydroepiandrosterone-sulphate (DHEAS) and oestrone (E l) sulphate. The route 
and production o f specific steroids may be important for progression o f androgen and 
oestrogen responsive conditions; the degree of importance is dependent on the 
condition.7
5
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Fig 1.1: M etabo lism  o f  C holestero l.  T he left hand side o f  the diagram  illustrates the 
bio-pathw ays for the p roduction  o f  the m inera locortico id  a ldos terone  and the 
glucorticoid cortisol. T he  right hand side o f  the diagram  illustrates the reversib le  
metabolism o f  the androgens, andros te rone ,  androstanedio l and the non-revers ib le  
metabolism o f  the oestrogens, oestrad io l and oestrone. a =  a lpha b = beta, O H =  
hydroxyl. S teroid converting  enzym es  are coloured. A rom atase  is the rate limiting 
enzyrne in oestrogen  b io -syn thesis  (red). H S D =  hydroxystero id  d ehydrogenase  these  
are e th e r  ox idative  o r reductive  enzym es,  w hich have a n u m b er  o f  d iffe ren t 
isofoims. P450s are a group  o f  enzym es  w hich  act at specific points  in the carbon  
skeleton.
1.2.1 Important steroids in the bio-pathway
There are specific  s teroids in the b io -pa thw ay  that are described as the m ost po ten t or 
biologically active in their  group. T he  m etabolism  o f  these steroids can have  a 
significant effect on a n u m b er  o f  b iological functions, for exam ple ,  D H T  
(d ihy iro tes tos terone)  is described  as the m ost  potent androgen , and is im plica ted  in
developm ent o f  prostate cancer .8 O estrad io l (E2) is described  as the m ost  po ten t
•  •  2 oestrogen and  is h ighlighted  as a key  steroid in endom etr ia l  cancer  deve lopm en t.
C ortho l is the m ost po ten t g lucocortico id , it is secreted from the adrenal g lands  in
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response to stress, an increase cortisol concentration affects a number o f biological 
functions such as gluconeogenesis in the liver and insulin binding in muscles and 
adipose tissue.9 Aldosterone is the most potent mineralocorticoid, its major function 
is involved in maintenance o f blood sodium and potassium levels in the kidney, high 
levels of aldosterone have been recorded in patients with heart failure and 
myocardial fibrosis, suggesting a role in these conditions.10 Accumulation or 
depletion of these steroids may lead to progression of endocrine disorders.
Testosterone is another important steroid present in females, it is a major circulatory 
androgen and is a precursor to oestrogens synthesis in a number of tissues including 
in the normal and proliferative endometrium.11 DHEAS is also an important 
precursor for androgen biosynthesis through steroid sulphatase. Expression of 
steroid sulphatase and the concentration o f plasma DHEAS has been linked to 
tumour growth and progression through conversion to androgens and oestrogens in
1 9steroid responsive cancers such as adrenal tumours.
1.3 Steroid converting enzymes
There are a number of enzymes involved in steroid metabolism represented by the 
coloured boxes in figure 1.1. These all act on specific steroid substrates to oxidise, 
reduce, hydroxylate, aromatise, or sulphate the steroid precursor. The expression 
levels of each enzyme can affect the steroid concentration in that tissue (precursor to 
product ratio). Described here are enzymes involved in the androgenic and 
oestrogenic metabolism, which could be implicated in hormone responsive 
endometrial disorders. Investigations into these enzymes could lead to more specific 
treatments for steroid dependent conditions through steroid bio-pathway intervention.
1.3.1 Cholesterol lyase P450scc
P450scc is a member o f the cytochrome P450 superfamily, P450s are involved in a 
number of biological functions such as oxidation, reduction, aromatisatior, and 
hydroxylation. P450scc is important as it catalyses the initial step in steroid bio­
synthesis. The P450scc enzyme cleaves between C20 and C22 o f the cholesterol 
side chain to produce a ketone group, this is the rate limiting step in the wider 
steroidogenesis pathway.13 P450scc action is dependent on the inclusion of the 
cofactor NADPH.
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Me. Me,
Me Me
P450scc
Me Me
HO- HO*
Cholesterol Pregnenolone
Fig 1.2: Illustration o f the conversion of cholesterol to pregnenolone via the P450scc 
enzyme.
1.3.2 The aromatase enzyme
P450 aromatase is a member o f the P450 superfamily. P450 aromatase comprises of
2 proteins, the first is NADPH-cytochrome P450 reductase and the second is
cytochrome P450 aromatase, which contains a heme molecule and a steroid binding
site.14 P450 aromatase acts on position 3 of the steroid skeleton and converts the
keto group into a hydroxyl group, and converts the 4-ene in the cyclo-hexane ring
into a benzene (tricyclo-hexene) structure (aromatisation).15 Aromatase converts
androgens to oestrogen (testosterone to oestradiol and androstenedione to oestrone)
which is the rate limiting step in oestrogen synthesis.16 Expression o f aromatase has
been studied in many steroid responsive tissues such as the breast and endometrium
and it has been linked to the progression of a number of disorders such as breast
cancer and endometriosis.17 To combat excess aromatase expression a number o f
1 8aromatase inhibitors have been developed such as anastrozole.
MeOH
Aromatase
Me
HO'
Oestradiol
Testosterone
Fig 1.3: Illustration o f the aromatase conversion reaction. Testosterone 
aromatisation to oestradiol.
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1.3.3 The 5 a-Reductases (5AR)
5ARs are from the 3-oxo-5-alpha-steroid 4-dehydrogenase 2 protein superfamily,19 
which are dependent on the inclusion o f the cofactor NADPH.20 The five a- 
reductases act between position 4 and 5 o f the steroid skeleton to reduce the double 
bond to a single bond. There are two isoforms o f 5AR, described as 5AR1 and 
5AR2 which both metabolise testosterone to DHT and/or androstenedione to 
androstane-dione. These isoforms however have different affinities for their 
substrates.
OHOH MeMe
Me Me
5 Alpha Reductase
DHTTestosterone
Fig 1.4: Illustration of a 5-a reductase conversion o f C4-ene group in steroid skeleton 
to the saturated compound. Testosterone to DHT.
1.3.4 The hydroxysteroid dehydrogenases (HSD)
There are two types o f HSDs involved in androgenic steroid conversions under 
investigation in these experiments these are 17p-HSD and 3P-HSD which act 
primarily at position 17 or 3 of the steroid skeleton to convert between a keto and an 
alcohol group (or the reverse). They are all short-chain dehydrogenases/reducatses 
except HSD5 which is an all aldo-keto reductase and can act in a reductive or 
oxidative manner through the inclusion o f NADP(H) or NAD(H) depending on the 
reaction.21
OH
Me Me
Me Me
17b-HSD
17b-HSD
Androstene-dioneTestosterone
Fig 1.5: Illustration o f a 17p-HSD reaction conversion o f a hydroxyl to a ketone 
group at position 17. The oxidative reaction is the conversion of testosterone to 
androstenedione and the reductive reaction is the conversion o f androstenedione to 
testosterone.
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OHOHMe Me
MeMe
3-HSD
HO
Androstane-diolDHT
Fig 1.6: Illustration o f a 3 (3-HSD reductive conversion at the 3 keto group to a 3 
hydroxyl group.
To date fifteen isoforms o f 17P-HSD have been identified which have varying tissue 
and cellular distribution.22 The expressions of a number o f these isoforms are 
investigated in this thesis. The major reactions of each isoform is described below 
each HSD may act on multiple substrates.23
17p-HSDl- along with 17p-HSD2 this is the most widely studied 17P-HSD. 17p- 
HSD1 converts oestrone to oestradiol.24 Specific inhibition of this isoform is being 
developed for the treatment o f endometriosis.
17P-HSD2- this isoform converts oestradiol to oestrone, testosterone to 
androstenedione, DHT to androstane-dione, androstanediol to androsterone, and 20a- 
progesterone to progesterone and is involved in the oxidation of retinols.
17P-HSD3- is involved in testosterone metabolism, exclusively in the testes. 
Specific inhibition o f 17p-HSD3 is being developed for treatment of prostate
25cancer.
17p-HSD4- this isoform converts testosterone to androstenedione, oestradiol to 
oestrone, and is involved in peroxisomal fatty acid metabolism.
17p-HSD5- converts androstenedione to testosterone, androstane-dione to DHT, 
androsterone to androstanediol and oestrone to oestradiol. 17p-HSD5 is a 
multifunctional enzyme which can also convert at the 3a- or 20a steroid position, for 
example converting progesterone to 20a hydroxy-progesterone.26 
17P-HSD6- this isoform converts androstanediol to DHT at position 3, but is still 
classed as a 17p-HSD.
17p-HSD7- converts oestrone to oestradiol, DHT to androstanediol and is involved 
in cholesterol biosynthesis.
17P-HSD8- converts DHT to androstane-dione, oestradiol to oestrone and 
testosterone to androstenedione, and is involved in fatty acid metabolism.
10
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17p-HSD9- converts at the 3 and 17 positions o f the steroid skeleton, identified in 
the rat, no analogue has been positively identified in humans.
17J3-HSD10- this isoform is similar to 17|3-HSD4. It has been found in the human
brain and has been linked to Alzheimer’s disease.27
17p-HSDll-15 are more recently discovered and less widely explored.
1.3.5 Steroid sulphatase and steroid sulphotransferase
Steroid sulphatase is from the animal sulphatase superfamily, which acts through 
inclusion of the co-factor calcium. Steroid sulphatase hydrolyses inactive steroid 
sulphates into their biologically active analogues. Steroid sulphatase converts the 
hydroxyl or phenol group at position 3 into a sulphated analogue, (steroid 
sulphotransferase does the reverse of this reaction).
MeMe
DHEA sulphotransferase
MeMe
DHEA sulphatase
HO SHO
DHEA
DHEA-sulphate
Fig 1.7: Illustration of the steroid sulphatase/sulphotransferase conversion reaction. 
Conversion o f DHEA to DHEA-sulphate (DHEAS) by the steroid sulphatase (DHEA 
sulphatase), and the reverse by the steroid sulphotransferase (DHEA 
sulphotransferase).
The sulphated analogues of steroids such as the abundant circulatory steroids 
oestrone sulphate and DHEAS act as the primary precursors for localised oestrogen 
synthesis in breast cancer patients.28 The production o f oestrogens in breast cancer 
patients through the oestrogen sulphatase pathway has been defined as being 40-500
A
times higher than the aromatase pathway. In endometrial cancers production of  
oestrogens through oestrogen sulphatase is an important pathway, however localised 
production o f oestrogens through androgens and the aromatase enzyme is also 
significantly.29 Steroid sulphatase has also been linked to benign endometrial 
conditions, Purohit and co-workers investigated the role o f steroid sulphatase in 
relation to bio-accumulation o f oestrogens in women with endometriosis, they found 
that the more severe the condition the higher the sulphatase activity, again
11
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suggesting a number o f routes for steroid production may contribute to steroid 
related disorders.
Steroid sulphotransferase is an enzymes which add a sulphate group to steroid 
hydroxyl groups to form the inactive steroid sulphates. They are members of the 
SULT (cytosolic sulphotransferase) superfamily,31 the co-factors required for these 
conversions must supply the sulphate group, for example in the conversion of DHEA 
to DHEAS, 3’-phosphoadenosine-5’-phosphosulphate (PAP) is the cofactor 
supplying the sulphate group.32 Steroid sulphotransferase acts at position 3 to form 
the sulphated steroid analogues (as shown in figure 1.7).
1.4 Steroid metabolism
The quantity o f any steroid in a specific tissue or within the body depends on four 
factors.
1. Secretion. The secretion rate from issuing tissue, such as the ovary, adrenal 
glands or adipose tissue.
2. Uptake. The ability o f the tissue to uptake the steroid. Steroids are lipophillic 
molecules which readily diffuse through cell membranes. The binding o f a steroid to 
its specific receptor determines the retention of that steroid within the cell. When 
steroid-receptor binding occurs the receptor changes configuration and through 
regulation o f receptor interacting factors can influence expression of target genes. 
Expression o f these genes can be involved in normal cell cycle processes or can be 
involved in progression o f steroid related disorders. There are a number of steroid 
receptors such as the androgen, oestrogen, progesterone, mineralocorticoid and 
glucocorticoid receptors (AR, ER, PR, MR and GR). The ER and PR receptors have 
two isoforms known as a and p, the expression o f which is dependent on tissue type 
under investigation. ERa for example is the main isoform expressed in the 
endometrium.33 ER expression has been directly linked to expression of some 
growth factors important in endometrial cancer proliferation.34
3. Metabolism. The rate o f metabolism of the steroid in the tissue under 
investigation through conversion to other steroids or steroid analogues is related to 
the expression and activity o f specific steroid converting enzymes. A steroid within 
a tissue can be converted into a number o f metabolites, all o f which may have 
significant biological effects.
12
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4. Inactivation/Excretion. Circulatory steroids are primarily inactivated by liver 
sulphotransferases to their inactive sulphated analogues. Steroids are subsequently
o r
removed from the body via the urine or faeces, to excrete steroids in the urine they 
must first be metabolised into hydrophilic compounds this is achieved by a number 
of enzymes within the kidneys which reduce, oxidise, hydroxyalte or conjugate the 
steroids.36
1.5 The human endometrium
The endometrium is the inner lining o f the uterus illustrated in figure 1.8. Steroids 
are important in the normal functioning endometrium, and progression of some 
endometrial disorders. The normal cycling endometrium is a dynamic tissue subject 
to monthly changes in multiple steroid concentrations as well as changes in steroid 
receptor status, gene and enzyme expression. These changes are associated with the 
endometrial phases, the proliferative phase (follicular), the secretory phase (luteal) 
and the menstrual phase. The endometrium undergoes depletion and repletion during 
these phases, making it a unique tissue. The steroids generating these changes are 
the ovarian steroids oestradiol and progesterone which cause the morphology o f the 
endometrium to change throughout the cycle. Oestradiol controls the proliferative 
phase by stimulating the endometrial glands stromal cells and epithelial cells to 
proliferate. Oestradiol concentrations increase throughout the proliferative phase and 
the endometrial lining thickens. Directly following the highest oestradiol 
concentration LH (luteinising hormone) and FSH (follicle stimulating hormone) are 
produced by the pituitary gland, these hormones are responsible for ovulation and 
induction o f progesterone secretion in the ovarian follicle. In the secretory phase 
oestradiol concentrations reduce and progesterone concentrations increase inducing 
endometrial glands to secrete glycogen. If implantation does not occur the corpus 
luteum (present in the ovary) degenerates, the levels o f oestradiol and progesterone 
decreases and the menstrual phase begins.37 These changes in morphology make the 
endometrium a difficult organ to study, as the day o f the cycle a biopsy is taken can 
result in a large variation in steroid concentration or enzyme expression levels.
Any dysfunction or change in global, ovarian or localised steroid metabolism can 
result in development of endometrial disorders. The production o f excess oestrogens 
for example without progestins (unopposed oestrogen) has been shown to promote
13
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grow th  factors such as insulin-like grow th  factor and vascular  endothelial growth 
factor w hich are im plicated in d ev e lo p m en t and progression  o f  endom etria l cancer .38
folbpton
lube
Fig 1.8: D iagram  o f  the U terus. T he  endom etr ium  is the inner lining o f  the u terus 
labelled above. D iagram  from the US N ational Institute o f  H e a l th / 9
Body of 
Uterus
Cervix 
Vogma ■
Endometrium 
Myometnum 
Cervical (anal
1.5.1 Structure of endometrium
The uterine wall co m p ro m ises  o f  a n u m b er  o f  layers o f  d ifferent cell types. T hese  
are the perim etr ium , m yo m etr iu m , endom etr ia l  stromal and endom etria l epithelial 
layers (figure 1.9). T he perim etr ium  is the ou ter  layer o f  the uterus, the m yom etrium  
is a th ick  m uscu la r  layer con ta in ing  arteries w hich  supply  blood to the endom etr ium . 
The endom etr ium  itse lf  consis ts  o f  tw o cell types, strom al and epithelial.
Fallopian tube
. ^  /Endometrial epithelium
Perimetrium
Endometrial stroma
Inside
UterusMyometrium
Endometrium
Fig 1.9: S tructure o f  the uterine wall. T he uterus has four distinct sections the 
perim etr ium , m yom etr ium , endom etr ia l  s trom a and endom etr ia l  epithelium .
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1.5.2 The role of stromal cells
Stromal cells make up the connective tissue in the endometrium. Stromal cells are 
found in a number of tissues, and act as a support to surface epithelial cells. 
Endometrial stromal cells (fibroblasts) have been shown to regulate growth and 
differentiation in endometrial epithelial cells via a paracrine relationship. 
Throughout the menstrual cycle oestradiol or progesterone bind to receptors 
expressed in the stromal cells, which can cause responses in the surrounding 
epithelial cells such as promotion o f cell development or differentiation.40
1.5.3 The role of epithelial cells
Epithelial cells cover the surface o f an organ, such as the lungs, gastro-intestinal tract 
and the endometrium. The epithelium itself can contain glands and has a number of 
functions such as secretion (through glands formation) and absorption (of nutrients in 
the intestine). There are a number of types o f epithelial cells, the cell type is 
determined by its shape and how deep the cell layers are, for example squamous cells 
are surface (flat) cells and adenomatous cells are glandular.41
1.6 Current steroid metabolism investigations
Studies which highlight important steroids and steroid converting enzymes involved 
in progression of a number of endometrial disorders such as endometriosis, 
endometrial hyperplasia, and endometrial cancer have been completed.
The major volume o f articles investigating steroid metabolism in the endometrium 
and its disorders are concerned with either measuring the concentration o f a specific 
steroid or the expression o f a specific enzyme such as aromatase. In endometrial 
cancer investigations, for example Berstein and colleagues recorded oestradiol 
concentrations in endometria from normal and cancerous patients.42 Endometriosis 
is the most widely investigated benign endometrial disorder many studies focussing 
on the expression of aromatase or 17P-HSD1 and 17p-HSD2.43 Oestradiol has also 
been recorded at high concentrations at the site of endometriosis and at endometrial 
cancer precursor lesions sites,44 while the circulatory oestrogen concentration 
remains normal. These studies have lead to the conclusion that localised steroid 
synthesis is responsible for the increased tissue steroid concentrations, however the 
wider pathways have not been fully explored. Identification o f steroid bio-pathways
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in these pathologies permits identification of important metabolism routes and 
enzymes allowing future development o f specific ‘targeted’ treatments.
The presence (or absence) o f a specific enzymes alone does not itself provide proof 
of steroid metabolism, to confirm steroid metabolism is occurring a technique which 
combines enzyme expression with steroid identification is required. Conclusions 
drawn from analysis o f a single steroid are restricted, information concerning the 
wider bio-pathway is often more informative, Rauh recently described the increased 
clinical value o f determination a steroid profile in comparison to measurement of a 
single steroid in a number o f endocrine conditions.45 Single enzyme or steroid 
studies highlight important, but small parts o f steroid metabolism our study aims to 
discover the wider picture o f steroid metabolism by production of both steroid and 
enzyme expression profiles following steroid treatments o f endometrial cell lines and 
biopsies from benign endometrial conditions.
1.6.1 Endometrial cancer and endometrial established cell line pathologies
Localised oestrogen metabolism and aromatase expression are described as the key 
steps in the progression o f endometrial cancer. In a healthy endometrium there is 
very little aromatase expression. The roles o f the hydroxy steroid dehydrogenases, 5- 
a reductases, sulphatase, sulphotransferase and other steroid converting enzymes 
could also be important in endometrial cancer progression,2 however localised 
steroid metabolism information in combination with RNA expression data from 
multiple steroid converting enzymes has to our knowledge not been undertaken.
An investigation into steroid metabolism in established endometrial cell lines has 
been undertaken in this study. Epithelial cancer cell lines are excellent models which 
permit investigation into altered steroid metabolism in endometrial cancers.11 The 
use of specific cell lines which are known to metabolise steroids permits 
development o f robust methods for determination o f steroid metabolism routes. Cell 
lines are employed in these experiments as model systems as they have 
homogeneous cell types and can be studied over long time periods (in comparison to 
primary biopsies).46 They were also studied to overcome the problems associated 
with experimental variation between patients and to optimise and assess the methods 
required for determination o f steroid profiles and steroid converting enzyme
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expression (which can be later applied to primary cell biopsies). The endometrial 
cell lines investigated were the endometrial cell lines, Ishikawa, HEC-1A, HEC-1B, 
and RL95-2.
The endometrial cell lines Ishikawa, HEC-1A and HEC-1B are all representative of 
endometrioid (type one) cancers. Type one endometrial cancer is hormone 
dependent, which progresses if  there are increased levels o f oestrogens without 
increased concentrations of progesterone (unopposed oestrogen).47 Development of 
type one endometrial cancers can occur due to a number of gene abnormalities the 
major cause of endometrial cancer is PTEN inactivation (a tumour suppressor gene 
approximately 55% of cancers48), although microsatellite instability (-20%) and 
mutations in other genes are also implicated p53 (-5-10%), p-catenin (-25-38%), K- 
ras (~13-26%).49 Type one cancers have superficial invasion into the myometrium, 
are more common in younger women and have good patient prognosis if detected 
early. RL95-2 is derived from a uterine adenosquamous carcinoma (a tumour from 
both glandular and squamous cells). Once optimised these methods and results were 
applied to and compared with steroid metabolism and enzyme expression in a 
number of endometrial biopsies from fertile and benign conditions.
1.6.2 Benign endometrial disorders
There are a number o f benign endometrial disorders whose development may be 
related to an alteration in global or local steroid metabolism. It is vital to elucidate 
the steroid bio-pathways in these conditions to determine important steroids and 
steroid converting enzymes, before effective treatments can be developed.
1. Poly Cystic Ovary Syndrome (PCOS). The US Department o f Health and 
Human Services estimates that PCOS affects 1 in 10 women o f child bearing age.50 
Women with PCOS are defined as having two o f the following three symptoms;
i) high levels o f the circulatory androgens testosterone and 
androstenedione (hyperandrogenism),
ii) oligo or annovulation and,
iii) polycystic ovaries present on ultrasound.
After treatment for PCOS (ovulation medication, ovarian drilling or surgical 
removal) these women are often sub-fertile and at increased risk o f developing 
further endometrial disorders such as endometrial hyperplasia and endometrial
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cancer.51 Altered endometrial steroid converting enzyme expression- a possible 
cause was identified by Bacallao and co-workers who recorded changes in 
expression of the steroid converting enzymes 17p-HSDl and 17|3-HSD2; (17p-HSDl 
expression increased and expression o f 17P-HSD2 was decreased in the endometria 
of women with PCOS compared to normal females).52
2. Endometriosis. Endometriosis is defined as the presence of endometrial 
tissue outside the uterus it affects from 2 to 22% of women, there is a huge variation 
in symptoms and severity o f the condition, from non-symptomatic to chronic pelvic 
pain and infertility.53 Endometriosis is mostly found in women o f reproductive age, 
before puberty and after menopause the incidence of endometriosis decreases 
suggesting a link between ovarian steroid hormones and progression of the disease. 
Endometriosis lesion sites have been described as aromatase positive with reduced 
17P-HSD2 expression,54 suggesting bio-accumulation o f oestradiol, however most 
studies are limited to RNA expression information for these enzymes only, without 
complimentary steroid metabolism information. Aromatase inhibitors such as 
anastrozole have been used to treat endometriosis with impressive results (patient’s 
conditions improve within 9 months),55 suggesting an important role for oestrogens 
and aromatase in disease progression. There are four stages o f endometriosis stage 
one (minimal) is represented by a few endometriotic implants and can be 
asymptomatic. In stage two (mild) there are more and deeper endometrial implants 
possibly spreading to the ovaries, at stage three (moderate) the number of 
endometrial implants has increased and they are deeper and can affect a number of 
reproductive areas. At stage four (severe) deep endometrial implants are observed 
throughout the pelvic area which can be coupled with chronic pain and infertility.56 
The metabolism of steroids and expression of specific steroid converting enzymes 
may not be identical at each stage o f endometriosis.
3. Endometrial hyperplasia. Endometrial hyperplasia is excessive non-invasive 
proliferation (cell growth) in the endometrium.57 Endometrial hyperplasia is related 
to hormonal in-balances in the endometrium (unopposed oestrogen) and the first 
course of treatment is often a progestin to combat the unopposed oestrogen. There 
are two types o f hyperplasia the first is atypical which is recognised by changes 
(enlargements) in endometrial glands, stomal cells and epithelial cells. Atypical 
hyperplasia is divided into four groups based on the likelihood of progression to 
endometrial cancer. Simple hyperplasia has a ~1% chance of progression to
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endometrial cancer, complex hyperplasia a -3% chance, simple hyperplasia with 
aptypia a - 8% chance and complex hyperplasia with atypia a -29% chance58 if left 
untreated. The second type o f endometrial hyperplasia (non-atypical) does not 
progress to endometrial cancer and is not dependent on oestrogens or progestins.
4. Secondary infertility. The patient has already carried at least one child to 
term but cannot conceive again. There can be a number of causes o f secondary 
infertility in females such as changes in ovulation, formation of endometrial fibroids 
or progression o f tubal disease due to infections such as Chlamydia. Fetal bone 
fragments from the previous child can also cause secondary infertility.59 It is also 
possible that some o f these women are infertile due to altered steroid metabolism in 
their endometrial, although to our knowledge no investigations have been conducted.
5. Unexplained infertility. The tests currently available to these couples do not 
define the reason for their infertility (15% of population who take the tests).60 A 
number of reasons can be hypothesised, such as the inability o f the ovum to implant 
in the endometrium itself, even after in-vitro fertilisation successful pregnancy does 
not always occur. Unexplained infertility in some patients could be due to altered 
endometrial steroid metabolism.
A wider investigation into steroid metabolism in the endometria o f women with 
benign endometrial conditions could further elucidate any altered steroid metabolism 
following steroid treatments, highlighting possible therapeutic targets. Similarities 
between benign endometrial conditions, if observed can also be highlighted by these 
methods.
Fertile patients in this study have none of the endometrial disorders under 
investigation. They were in hospital due to hysterectomy for exploratory 
investigations or sterilisation, and have a normal cycling endometrium. A ‘control’ 
fertile biopsy is difficult to obtain as the endometrium is a dynamic organ, also the 
numbers o f women entering hospital without any underlying endometrial condition 
was low. All biopsies were obtained on the same day o f the cycle to try and 
minimise variation between biopsies, and biopsies were cultured for a number of 
days where the media was changed sequentially this should remove any residual 
steroids. Biopsies from patients with tubal disorders were also collected, tubal 
disease can occur due to previous infections such as Chlamydia,61 or as a result of
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69inflammation caused by past surgery. In the endometria of these patients it is 
expected that normal steroid bio-synthesis should occur if this is confirmed 
experimentally they can be included in the fertile group.
All endometrial cell lines were epithelial cells, and the majority o f biopsy samples 
were stromal cells. In the endometrium there is evidence o f stromal cells directly 
affecting epithelial cells, causing alterations in epithelial cell function. For example 
Pierro and colleagues used a co-culture technique and were able to demonstrate that 
epithelial cell proliferation was induced through oestradiol action in the stromal 
cells.63 It is the altered steroid metabolism in epithelial cells which leads to 
progression and maintenance of epithelial endometrial cancers. This demonstrates 
epithelial/stromal cell interactions are important in the normal endometrium and in 
endometrial disorders such as hyperplasia and endometrial cancer. Determination of 
altered steroid metabolism in epithelial and stromal cells separately should first be 
completed, following this the co-culture of epithelial and stromal cells would further 
elucidate the interactions between the two cell types in the endometrium.
1.7 Detection of steroids
For positive determination of steroid bio-pathways analytical techniques must first be 
validated and optimised. This includes techniques to remove steroids from the cells 
and cell media under investigation, and analysis methods to positively identify 
specific steroids. RNA extraction procedures and quantitative real-time, reverse 
transcription polymerase chain reaction (QRT-PCR) was required to ascertain 
expression levels o f specific steroid converting enzymes.
1.7.1 Steroid extraction techniques
As steroids are lipophillic compounds they should readily move from an aqueous to 
an organic environment. This property allows for simple liquid-liquid extractions, 
addition o f an organic solvent to a cell pellet causes the cell membranes to rupture 
and the steroids to be extracted into the organic phase (although some purification 
may be required).64 With more complex matrices such as plasma or serum there may 
be problems with phase separation causing more sophisticated methods of extraction 
to be developed, such as solid phase extraction, where specific stationary phases 
have been developed to retain steroids while interfering compounds are removed.
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Free steroids can be separated from the sulphated and glucuronide analogues using a 
variety o f techniques. Alousi and colleagues investigated different separation 
methods to achieve this, they compared three separation methods- a Lipidex-5000 
column, Sep-PakC18 cartridges and a Sephadex LH-20 column.65 They found that 
for optimum recovery a methanol/water elution system is needed, and four to six 
Sep-Pak cartridges were ideal for removal of non-steroidal contaminants.
After effective, efficient extraction o f steroids positive identification was required. 
To achieve this a sensitive, reproducible, accurate technique was essential. Steroid 
metabolism has been studied in endometrial cells, by a number o f methods such as
f \ f \  f \ lelectrochemical detection, radioimmunoassay (RIA) and fluorescence detection. 
RLA is widely used for identification o f steroids, and is applied to detect low 
concentrations o f steroids (below parts per million levels) and is a relatively cheap 
and simple technique.69 RLA’s are specific and sensitive, however a single assay is 
required for each steroid under investigation, and therefore calculation of steroid 
profiles by this method is time intensive. Cross-reactivity of steroids which are 
structurally similar such as DHT and testosterone can be problematic in these assays 
leading to false positives.70 Another widely used technique for the identification of 
steroids is mass spectrometry, which is employed for the rapid, specific, sensitive 
detection of steroids.71 Mass spectrometers can be linked to chromatographic 
separation techniques (such as liquid or gas chromatography) to determine a steroid 
profile in a single experiment. Mass spectrometers identify steroids by their 
molecular weight or molecular structure (after fragmentation). Quantitation of a 
steroid(s) within a sample can be achieved by calibration against appropriate 
standards,72 for these reasons mass spectrometry was the chosen analytical method in 
these investigations.
There were two major techniques which can be linked to mass spectrometers to 
separate a steroid mixture into specific steroid fractions, these were liquid 
chromatography and gas chromatography. Mass Spectrometry in combination with 
either o f these chromatographic separation procedures can be used to establish a 
qualitative and quantitative profile o f steroids within a sample. Positive 
identification o f a compound was achieved through the four parameters described
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below, in combination these four parameters permit confident assignment of steroids 
present in a sample.
1. Matching retention time. A direct comparison between the retention times 
of a steroid standard to the same steroid present within a sample. To give 
unambiguous results using this method requires high resolution over a wide range of 
standards, (no co-elution of steroids o f the same mass)
2. Identical molecular weight. The molecular weight is usually measured to 
its nominal mass and sometimes depending on the mass spectrometer to its accurate 
mass. Accurate mass permits determination o f the elemental composition of the 
compound. The molecular species seen in the spectra depends on the technique, for 
example, the [M+H]+ species is present in Cl (chemical ionisation) and ESI 
(electrospray ionisation) and the [M*+] in El (electron ionisation). This alone may 
not be sufficient for positive steroid identification due to many steroids producing the 
same molecular protonated species, for example, DHEA and testosterone.
3. Identical unique fragmentation patterns by MS/MS. Fragmentation 
patterns were obtained using the ion trap, which assisted in determination of 
molecular structure. This can be somewhat limited in steroid analysis due to similar 
fragmentation patterns from the same steroidal groups after the molecular ion, 
however unique ions for some steroids may be observed aiding structure elucidation.
4. Library searches. Databases were utilised to compare mass spectra 
obtained experimentally to mass spectra (and fragmentation patterns) o f steroid 
standards.
1.7.2 Chromatography
There are two chromatography systems investigated in these experiments to 
determine the optimum separation o f steroids, these are liquid chromatography and 
gas chromatography, which separated steroids via different methods as described 
below;
1. Liquid chromatography (LC) permits separation of a mixture of liquid 
analytes into separate analyte fractions. This is achieved with the use of a 
column packed with a stationary phase which retains the analytes. Typical 
stationary phases which act to retain steroids are Cig and phenyl-hexyl, which 
in combination can separate mixtures o f corticosteroids, androgens and
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progestins. Steroids are retained on the column stationary phase at differing 
degrees based on their polarity, increasing the polarity of the mobile phase 
elutes the steroids sequentially. Typical mobile phases used in steroid 
analysis via LC/MS have one aqueous and one organic mobile phase such as 
water/methanol74 or water/acetonitrile.75 The development of high-pressure 
liquid chromatography (HPLC) in the late 1960’s has overcome problems 
associated with mobile phase flow rates which led to poor efficiency, and 
now liquid chromatography is comparable to gas chromatography in 
performance.76
2. Gas chromatography (GC) permits separation of liquid analytes which are 
vaporised in the GC injector. These (now gaseous) steroids travel through the 
heated column and arrive at the mass spectrometer at different times due to 
differences in interactions with the column. GC has been widely used in 
steroid chemistry, usually after chemical derivatisation of the steroids to 
increase the volatility and stability of the steroid which produces optimum 
sensitivity and chromatographic resolution. Typical derivatisation procedures 
involve addition o f a trimethyl-silyl group which adds to any hydroxy group 
present on the steroid skeleton.77 Steroid specific gas chromatography 
columns have been produced that retain the steroids at high temperatures, 
producing excellent chromatographic resolution, examples are the widely 
used (5%-phenyl)-methylpolysiloxane columns such as the DB578 and the
70more specialised dimethylpolysiloxane stationary phase columns.
1.7.3 Mass Spectrometry
After chromatographic separation the steroids sequentially enter the ionisation source 
of the mass spectrometer. The general operating principles o f mass spectrometry are 
similar, the four step procedure is outlined below;
1. Ionisation. The ionisation source vaporises (if needed) and ionises the 
sample to produce gaseous ions. There are many types of ionisation source 
including, electron ionisation (El), chemical ionisation (Cl), electrospray ionisation 
(ESI), and atmospheric pressure chemical ionisation (APCI).
2. Fragmentation. Where there is excess internal energy (i.e. more energy 
than is required to ionise the molecule), the energy can be transferred into vibrational
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energy levels o f the molecule, this can cause molecular bonds to break and so 
fragmentation occurs. Controlled fragmentation, for example, collision induced 
dissociation (CID) in an ion trap allows structural information about a given 
molecule to be obtained.
3. Separation. A mass analyser separates ions accurately according to the m/z 
ratios o f the ions, mass separation is achieved using magnetic or an electrical field or 
a combination of both.
4. Detection. Ions are detected by a variety o f detection devices, the choice 
being dependent on the instrument design, a signal proportional to the ion signal (or 
count) is passed to a data system which processes this raw data into mass spectra and 
ion chromatograms.
1.7.4 Ionisation methods in mass spectrometry 
Electron Ionisation (El)
High energy electrons are created from a tungsten or rhenium filament, these high 
energy electrons (70eV) are ‘fired’ at the sample which causes a molecular ion [M*+] 
(a radical cation) to form. El spectra characteristically show considerable 
fragmentation due to excess internal energy, and the molecular ion signal can be 
small or absent. The excessive fragmentation o f steroids in El mode is regarded as 
an impediment in using El mass spectra for structural elucidation, therefore this 
ionisation method is generally not used in steroids analysis. El has however been 
applied to distinguish between isomers of the same steroid based on the differences 
in their energy levels, for example Mak and co-workers distinguished between the 
two isomers 11a and lip -  estran.80 El was the ionisation source employed in all 
GC/MS applications in these experiments.
Chemical Ionisation (Cl)
This technique is much softer than El producing ions representative of the molecule 
i.e. [M+H]+ or [M+ adduct ion]+. The Cl source is identical to that of El (electrons 
from a filament), however a reagent gas such as ammonia or methane is added at 
higher pressure than the sample gas into the ionisation chamber. The source volume 
is usually more gas tight for Cl operation (than El) with the use of small entrance 
holes. Electrons ionise the reagent gas forming an excess o f reagent gas ions- if 
ammonia is the reagent gas the following reaction occur in the source;
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NH3 + e ->NH3+*
NH3+‘ + NH3 ->NH4+ + NH2'
NH4+ + M NH3 + [M+H]+ + [M+ adduct ion]
Positively charged reagent ions NH4+ react with sample molecules (M) and the 
analyte becomes protonated. The reagent psuedo-molecular ion is identified as the 
adduct, or quasi-molecular ion, the structure o f which is dependent on the reagent gas 
and the sample present.81 Cl steroid analysis has been conducted using a number of 
different reagent gasses such as methane, isobutane, and ammonia, producing spectra 
that provide information concerning molecular weight which may not be possible 
with El.
Electrospray Ionisation (ESI)
ESI permits direct coupling o f a liquid chromatography system to a mass 
spectrometer. [M+H]+ ions are generally produced in ESI spectra, although sodium 
adducts are commonly seen, and if a reagent such as ammonium acetate is added, 
[M+NH4]+ ions. A fine capillary with a drawn needle tip (~10pm tip diameter) 
sprays the liquid which becomes a gaseous ionised species before entering the mass 
spectrometer. The needle tip is metallised and has a high voltage applied typically 1- 
3 kV. The high electric field strength causes the liquid to form a Taylor cone, which 
extends to a tip (or filament) from which a spray of ionised droplets is emitted.83 The 
droplets then move towards the mass spectrometer due to potential (and pressure) 
gradients. A gas counter current is applied to the tip which desolvates the droplets, a 
typical desolvation gas used is dry nitrogen. ESI has been developed to include 
micro and nano-spray techniques. ESI was the source employed in all liquid 
chromatography mass spectrometry (LC/MS) experiments in these investigations 
using the LCQ DECA mass spectrometer.
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Fig 1.10: Illustration o f the electrospray ionization process at the capillary tip. LC 
liquid chromatography MS= mass spectrometry.
There are two main theories about the mechanism by which the analyte becomes 
ionised. In both theories a solvated ion is ejected from the electrospray needle tip 
and the ions are eventually focused and sampled by the mass spectrometer.
The Ion Evaporation Theory. As the droplet moves through the system it loses 
solvent and charge until only a single ion remains surrounded by a solvent shell. 
Nitrogen gas acts to remove the remaining solvent leaving a protonated analyte 
molecule. This model is relevant if the molecule under investigation is relatively 
small (up to a lOOODa), this theory is the probable ionisation mode for steroids.84
The Charge-Residue Theory. The droplets loses solvent until they reach the 
Rayleigh limit, where Coloumbic (repulsive) forces between the ions are greater than 
surface tension forces, which causes the droplet to explode into smaller droplets, 
these explosions continue until there is little or no solvent remaining. Then nitrogen
o r
acts to remove any remaining solvent until only the ionised analyte remains. This 
theory is accepted to be accurate for larger molecules such as globular proteins.
ESI is an ideal technique for steroid analysis due to the likelihood of the molecular 
ion being formed. ESI has been widely applied in the detection of steroids and can 
be switched from positive mode for detection of androgens to negative mode for
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oestrogen  detection , p roduc ing  a full androgen  and oestrogen  profile on one 
in s trum ent.86
1.7.5 Mass Analysers in mass spectrometry 
Magnetic Sector
A m agnetic  separa to r m ass  ana lyser separates ions due to  their  m ass to charge (m /z) 
ratio using a m agnetic  field. T he ions are deflected  in a c ircu lar path with the 
m agnetic  field strength, B. T he  deflection o f  an ion depends  on m ass  (m), charge (z) 
and m agnetic  field strength (B). It can be expressed  in the  equation  below , w here  R 
is the radius o f  the arc o f  deflection  and V is the accelera ting  voltage,
Ions with a heav ie r m ass  are deflected  less than ions o f  lighter m ass  (assum ing  
identical charges).  An electric field is also involved in th is  ins trum ent to com pensa te  
and correct for energy  spread, the electric field is app lied  orthogonally  to the ion 
path. T he m agnetic  field can be varied resulting  in detec tion  o f  d iffe ren t m ass-to- 
charge (m /z) ions. This  techn ique  can be used for both accura te  m ass  studies and full 
scan studies.
m  _  B 2R
z ~  2 V
(equ 1.0)
DETECTION
Faraday
ootactor*
Fig 1.11: D iagram  o f  m agnetic  separator,  courtesy  o f  the US G eologica l S u rvey .87
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Quadrupole mass analysers
A quadrupole mass analyser uses oscillating electric fields to separate ions. It has 
four parallel rods with each opposite pair being linked together. Voltages are applied 
across the pairs o f rods which have a direct current (dc) component, U, and a radio 
frequency (rf) component, V. The voltages U and V are varied so the ratio of U:V is 
constant focusing ions o f different m/z ratio ions through the quadrupole. When only 
the rf voltage, V, is applied the device transmits all masses and acts as a simple ion 
transmission device. The quadrupole allows for continuous monitoring o f ions and 
so can be directly linked to a continuous source, such as gas or liquid 
chromatography system.
Multiple quadrupoles can be aligned in an MS/MS configuration to obtain 
fragmentation data. Three quadrupoles can be set up in series, the central of which 
only operates in rf mode acting as a gas collision cell. The other two act to separate 
ions due to m/z ratios they have rf and dc fields applied either scanning the full mass 
range or set at a given m/z value. The rf only (central) quadrupole acts as a collision 
cell with the introduction o f an inert collision gas such as helium or nitrogen. 
Fragment scans, product ion scans precursor and neutral loss scans can then be 
completed to obtain more information about the sample under investigation. Triple 
quadrupole mass spectrometers using precursor ion scans are used in steroid analysis 
to identify chemically altered designer steroids used illegally in sport as steroids with
oo
similar structures have similar dissociation patterns. Neutral loss scans have been 
employed in the analysis o f sulphated steroid metabolites in urine, the neutral loss of 
the sulphate group was monitored to detect the steroids such as oestradiol sulphate 
and dehydroepiandrosterone sulphate.89
The quadrupole ion trap
The ion trap is a folded quadrupole mass analyser that has a curved central electrode 
(a ring), and two end cap electrodes above and below the ring (figure 1.12). Ions are 
trapped within this system with the aid of a small pressure o f helium to stabilise the 
ions in the trap. Ions are then mass selectively expelled from the trap by variation of 
the applied voltages, the technique is highly sensitive, with unit mass resolution. It 
can be used in MS/MS and MSn mode producing detailed fragmentation patterns and 
assisting in chemical structure elucidation. The ion trap is a robust interface with a
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w ide dynam ic  range ,90 (104) it has been em ployed  for s teroid ana lysis  in num erous 
investigations,91,92 for this reason an ion trap w as em ployed  in these  experim ents  for 
steroid analysis.
Injected ions
Resonance 
AC voltage
Aperture
RF voltage
Vcoc(Ql+D
Fig 1.12: D iagram  o f  Q uadrupo le  Ion T rap  system , reproduced  from  U niversity  o f  
H eide lberg  on-line  resources.
There  are o ther types  o f  m ass  ana lyser  such as tim e-of-fl igh t,  fourie r  transform  ion 
cyclotron resonance (F T IC R ) and orbitrap , as these  were not used in these 
investigations they are not described.
1.7.6 Detection of ions in mass spectrometry
Initially pho tograph ic  plates w ere used to detect ions produced  by the m ass 
spectrom eter,  ions o f  the sam e m /z  ratio reach the plate  at the sam e point. The 
intensity o f  the spot or line (or its darkness)  is associa ted  to the  abundance  o f  that ion 
in the sam ple (calculated  by com parison  to a s tandard). This  techn ique  is not very 
sensitive and lacks d y nam ic  range and is no longer applied  in practice. D evelopm en t 
o f  a num ber o f  sensitive detectors has been achieved  including  the faraday cup, 
electron (and pho ton) m ultip liers  tubes  and m icrochannel plates. T hese  all detect and 
am plify  (by up to 108) the incom ing  ion flux and transfer  them  into electrical signals 
which are passed to a data  system.
1.8 Real-time reverse transcription polymerase chain reaction (RT-PCR) for the 
detection of RNA relating to steroid converting enzyme expression
To calculate the am oun t o f  R N A  related to specif ic  steroid converting  enzym e 
expression  a techn ique  called Q R T -P C R  was em ployed .  T h is  procedure  perm its  
ca lculation o f  d iffe rences  (and sim ilarities) in R N A  re la ting  to steroid converting
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enzyme expression between the endometrial pathologies as well as temporal changes 
in steroid converting enzyme expression after steroid treatments.
1.9 Analysis methods
Mass spectrometry permits identification and quantification of multiple steroids and 
was applied in these experiments in combination with chromatography (LC or GC) 
to obtain and quantify steroid profiles and identify steroid metabolites. Real time 
(reverse-transcription) polymerase chain reaction RT-PCR permits specific, sensitive 
determination of expression o f multiple enzymes involved in steroid biosynthesis. In 
combination these two techniques produced a novel model o f steroid metabolism in 
the endometrium and allowed identification of possible therapeutic targets.
1.10 Project Aims
Production o f a robust method for detection of a mixture o f steroid standards, 
through optimised and validated gas and liquid chromatography (GC and LC) and 
mass spectrometry.
Development o f cell culture for maximum growth to obtain enough cellular material 
for time related steroid treatments, and to assess expression o f RNA relating to 
steroid converting enzymes.
Optimisation and validation of steroid extraction methods from cells and cell media.
Determination o f testosterone metabolism pathways in cell lines, fertile biopsies and 
biopsies from a number o f benign endometrial pathologies.
Determination o f basal and temporal changes (after testosterone treatment) of 
enzyme expression in fertile biopsies, endometrial cancer cell lines and benign 
endometrial pathologies.
The combination of mass spectrometry steroid metabolism profiles with enzyme 
expression profiles to provide novel information concerning testosterone metabolism 
in a number o f endometrial pathologies.
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Chap te r  Two:  Mater ia ls  and Ins trumentat ion
2.0 General laboratory chemicals
Table 2.1: Chemicals required for derivatisation, extraction and analysis of steroids.
Name Description Manufacturer
Triethylamine 99% Alfa Aesar, Heysham, UK.
Anhydrous sodium sulphate laboratory grade Fischer Scientific, 
Loughborough, UK
Sulphuric acid Concentrated
98.07%
Phillic Harris, Novora Group 
Ltd, Ashby de La Zouch, UK
Dansyl chloride >99% purity 
(derivatisation grade)
Fluka Sigma Aldrich, 
Poole, UK
BSFTA + TMCS 
Bis(trimethylsilyl)trifluoroacetamide 
trimethylchlorosilane
99:1
(derivatisation grade)
Supleco at Sigma Aldrich.
Formic acid 90% purity BDH Ltd, Lutterworth, UK
Acetic acid glacial >99% purity 
HPLC grade
Fischer Scientific
Trifluoroacetic acid 99% spectrophotometric grade Sigma Aldrich, UK
Sodium carbonate >98% Sigma Aldrich, UK
Potassium hydroxide Pellets Sigma Aldrich, UK
2.1 Gases
Nitrogen (oxygen free nitrogen) was used as a desolvation/nebuliser gas in the 
electrospray ionisation source.
Helium gas was used to de-gas the mobile phases prior to LC/MS analysis, 
Helium was also used as the carrier gas in the GC system.
All gases were obtained from BOC (Guildford, UK).
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2.2 Solvents
Table 2.2: Table of solvents employed_______________________
Name Description Manufacturer
Methanol HPLC grade
Thermo Fisher Scientific, 
Loughborough, UK
Ethanol Laboratory grade Fisher Scientific.
Hexane Laboratory grade Fisher Scientific.
Ethyl acetate Laboratory grade Fisher Scientific.
2-Butanol Laboratory grade BDH Ltd, Poole, UK
De-ionised water Milli-Q water Milli-Q purification system 
(Millipore, USA)
Acetonitrile Laboratory grade Fischer Scientific.
Dichloromethane (DCM) Laboratory grade Fisher Scientific.
Isooctane 99% purity Sigma Aldrich.
Methyl ter/-butyl ether (MTBE) >99% purity Sigma Aldrich.
Acetone Laboratory grade Fischer Scientific.
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2.3 Steroid standards
Table 2.3: Steroid standards.
Name IUPAC
name
Description Manufacturer
Cholesterol 3 P-hy droxy cholest-5 -ene 
(3 P-cholest-5 -en-3 -ol)
99% purity Sigma Aldrich.
Androgens
Testosterone 17P-hy droxy androst-4-en- 
3-one
>98% purity, Sigma Aldrich.
17-Methyl testosterone 17 P-hy droxy-17-methy 1- 
androst-4-en-3 -one
analytical
standard
Sigma Aldrich.
Dehydroepiandrosterone
(DHEA)
3 p-hy droxy androst-5 -en- 
17-one
98% purity Sigma Aldrich.
Dehydroepiandrosterone 
3-sulphate sodium salt 
dehydrate DHEA-S
17 P(sulfooxy)androst-5 - 
en-17-one
>99% purity Sigma Aldrich.
Dihydrotestosterone 
4-androstene 17 P-ol-3 - 
one (DHT)
17p-hy droxy-5 a- 
an dr os tan-3-one
Sigma Aldrich.
Androsterone 3 a-hy droxy-5 a-androstan- 
17-one
>99% purity Sigma Aldrich.
5a-androstane3 p-17a- 
diol
5a-androst-3P,
17a-diol
Steraloids Inc (Newport, 
Rhode Island, USA),
4-Androstene-3,17-dione 
(Androstenedione)
Androst-4-en-3, 17-dione 98% purity Sigma Aldrich.
Oestrogens
Oestradiol (E2) Estra-1,3,5( 10)-trien- 
3,17p-diol
analytical
standard
Sigma Aldrich.
Oestrone (E l) 3 -hydroxy estra-1,3,5(10)- 
trien-17-one
99% purity Sigma Aldrich.
Oestriol Estra-1,3,5( 10)-trien- 
3,16a,17p-triol
99% purity Sigma Aldrich.
Progestins
Progesterone (4- 
Pregnene-3,20-dione)
Pregn-4-en-3,20-dione
99% purity Sigma Aldrich.
Pregnenolone5 -pregnen- 
3P-ol-20-one 
(Pregnenlone)
3 p-hy droxypreg-5 -en-20- 
one 98% purity, Sigma Aldrich.
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2.4 Cell culture
Established cell lines (see table 2.5)
Sterile cell culture flaks, slides, dishes and pipettes. Cell star tissue culture 
flasks Greiner Bio One, Frichenhausen, Germany.
Table 2.4: Cell culture chemicals
Name Description
Dulbecco’s Modified Eagle Medium 
(DMEM)
Media used for all cell lines unless stated
Basal Medium Eagle (BME) Media for HEC-1B cell line
Foetal Calf Serum (FCS) Normal and charcoal stripped to remove inferring 
substances.
L- Glutamine 200nM (100X solution)
Antimycotic antibiotic 10,000 units/mL penicillin G sodium, 10,000 pg/mL 
streptomycin sulphate 25pg/mL amphotericin B and 
funizone in 0.85% saline
Sodium Pyruvate lOOnM
Sodium Bicarbonate 7.5% solution
Glucose Sigma Aldrich, UK
Penicillin/streptomycin 10,000 units/mL penicillin G sodium and 10,000pg/mL 
streptomycin sulphate in 0.85% saline.
L-asparagine monohydrate >99% Sigma Aldrich, UK
Non-essential amino acids 100X solution
Insulin
HEPES 
(4-(2-hy droxy ethyl)-1 - 
piperazineethanesulfonic acid )
Standard cell culture material
Hank’s Balanced 
Salt Solution (HBSS +CaCl2 +MgCl2) IX solution
HBSS 
(-CaCl2 -MgCl2)
IX solution
Trypsin-EDTA 
(ethylenediaminetetraacetic acid)
0.25% solution
Dimethylsulphoxide (DMSO) For freezing media
All cell culture chemicals were purchased from Invitrogen cell Culture Company 
/GIBCO Paisley, UK. All chemicals are specific for use in cell culture.
39
Chapter T w o: Materials and 
Table 2.5: G row th  conditions  and descrip tions ol
Instrumentation  
five hum an cell lines.
N am e o f cell 
line
D escrip tion R ecep to r S ta tu s O rig in M edia constituen ts
Ishikawa Human 
endometrial cancer
PR +
AR + 
ER +
Imperial College 
London, UK,
DMEM, 10% FCS, l.OmM 
sodium pyruvate, 1.5g/L sodiun 
bicarbonate, 5ml antimycotic 
antibiotic, 2mM glutamine.
HEC-1B Human
endometrial
adenocarcinoma
PR -
AR + 
ER -
Imperial College 
London, UK
BME (Eagles media), 1.5g/L 
sodium bicarbonate,0.1mM not 
essential amino acids, l.OmM 
sodium pyruvate, 10% FCS, 5n 
antimycotic antibiotic, 2mM L 
glutamine.
HEC-1A Human
endometrial
adenocarcinoma
PR +
AR + 
ER +
Imperial College 
London, UK
DMEM, 10% FCS, l.OmM i 
sodium pyruvate, 1.5g/L sodiui 
bicarbonate, 5ml antimycotic 
antibiotic, 2mM glutamine. 
OR
DMEM-F12, 10% FCS, 5ml 
sodium pyruvate, 5ml 
antimycotic antibiotic, 1.5mM 
glutamine.
R L 9 5 2 Human uterine 
epithelial
PR (very low) 
AR +
ER -
Imperial College 
London, UK
DMEM hans F I 2, 10% FCS, 
5mL HEPES, 1.5g/L sodium 
bicarbonate (100X), 250pl ' 
insulin.
COV434 Human
immortalised
granulosa
PR (not known) 
AR (not known) 
ER +
Imperial College, 
London, UK
DMEM media 10% FCS, 
50pg/mL penicillin/streptomyci 
3mmol/L glutamine, lmmol/L ] 
asparagine.
2.4.1 Biopsy samples
B iopsy  sam ples  w ere  obta ined  from the endom etr ia  o f  patients  with;
- norm al fertility,
- tubal disorders,
- endom etr iosis ,
- P C O S (polycystic  ovary  syndrom e),
- unexplained  infertility,
- endom etr ia l hyperp lasia ,
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-ovarian cyst,
-endometrial polyp.
All biopsies were cultured in DMEM-F12, 10% FCS, 5ml sodium pyruvate, 5ml 
antimycotic antibiotic, 1.5mM glutamine. Biopsy samples were provided by 
Singleton Hospital Obstetrics and Gynaecology department by Dr L Joels and her 
surgical team (ethical approval has been obtained).
2.S Real time Reverse Transcription-Polymerase Chain Reaction materials (RT- 
PCR)
RNAeasy (Qiagen, Crawley, UK) RNA extraction kit,
RNA-cDNA Ambion reteroscript kit (Ambion, Warrington, UK),
RT-PCR (AB gene, Epsom, UK) RT-PCR SYBR green protocol kit.
Sense and antisense primers for the detection of a number o f steroid converting 
enzymes were all purchased from Sigma Genosys, (Cambridge, UK). Primers were 
selected for their efficiency, cross binding between primers was low, calculated using 
Beacon primer design software. The primer sequences and other primer information 
are outlined in table 2.6.
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Table 2.6: Primer sequences for a number o f steroid conversion enzymes.
Gene 
/Steroid 
. converting 
enzyme 
name
Melt 
temperature 
Tm (°C)
Annealing 
temperature 
Ta (°C)
Calculated 
Sense sequence
Calculated Anti-sense 
sequence
GADPH 90.0 55 5’-GTCCACTGGCG
TCTTCAC
5 ’-CTTC AGGCTGTTGTC 
ATACTTC
Aromatase 87.0 53 5’-TGCACAGGTTG
GAGGAGGTG
5 ’-TCAAGAAG AGCGT 
GTTAGAGGTG
WT1 89.0 55 5’-CTATTCGCAA 
TCAGGGTT ACAG
5 ’-C ATGCTTG AATGA 
GTGGTTGG
17p-HSDl 89.0 54.7 5’-TTCCACCGCTT 
CT ACCAATACC
5’-CCTCCGCCACCT
CCTCAG
17p-HSD2 89.2 54.6 5’-TCGTTAGCCAG
CAAGACTTC
5 ’-TGAGC AAGGC AG A 
TCCACAAG
17P-HSD4 86.5 52.8 5 ’-GG ATCACGG 
ATGACTCAGACAG
5’-AGCCACCATTCT
CCTCACAAC
17p-HSD5 82.6 49.1 5 ’-TCCGCCATA 
TAGATTCTGCTC
5 ’-TCTCTTCACACT 
GCCATCTG
17P-HSD7 86.0 52.7 5 ’-AGG A AC ATG AG 
CAAGGCAGAAG
5 ’-GAC AATGGTGAC 
CTCAGCAGTG
17p-HSD8 88.4 54.2 5 ’-G ATCCGCTGT 
AACTCTGTCCTC
5 ’-CG ACC AC ATCTG 
CCACATCC
5AR1 84.8 51.4 5 ’ -TCTGATGCG A 
GGAGGAAAGC
5’-ATACACTGCACAA
TGGCTCAAG
5AR2 89.6 55.1 5 ’-CACTTTGGTCG 
CCCTTGGG
5 ’-AGGCTCTCCGTGTG 
CTTCC
For optimal performance the region spanned by the primers was between 75 and 150 
base pairs in length as SYBR was used in the PCR reaction.
2.6 Steroid extractions
Solid Phase Extraction (SPE) lOOmg Cig cartridges. Varian, Yamton, UK.
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2.7 Chromatography columns
Table 2.7: Type of columns used in liquid and gas chromatography experiments.
Name Description Manufacturer
Liquid Chromatography
C]8 column 15cm x 300pM internal 
diameter
Dionex, Camberley, UK.
C]8 column 25cm x 300pM internal 
diameter
Dionex.
Cig column Prepared and packed in lab 
15cm
Luna phenyl-hexyl 15cm x 1000mm Phenomenex, 
Macclesfield, UK
Hypersil BDS Phenyl 15cm x 1000mm Hypersil 
(Thermo scientific)
Gas Chromatography
HP-1 Dimethylpolysiloxane Agilent (previously Hewlet 
Packard), Stockport, UK.
Supelco SLB-5ms Silphenylene polymer filled 
column
Supleco, Dorset, UK.
2.8 Instrumentation
2.8.1 HPLC linked to the mass spectrometer
Dionex/LC Packings HPLC (Packing’s Ultimate HPLC pump and Famos injection 
system). Auto sampler unit and Ultimate gradient pumping system.
Quadrupole ion trap mass spectrometer (linked to LC) LCQ DECA XP plus (ion trap 
mass spectrometer) Thermo Finnigan Ltd, Hemel Hempstead, UK.
2.8.2 Typical conditions for full scan mass spectrometry (LCQ DECA)
The HPLC was linked to the mass spectrometer and run in capillary mode at a flow 
rate o f 4 pL/minute using the CAP300 calibrator cartridge for androgen and progestin 
analysis. The LC system was also run at a flow rate o f 40pL/minute using the 
MIC 1000 calibrator cartridge for analysis o f dansyl chloride (DC) oestrogen 
derivatives. The LCQ was used in these experiments with an ESI source in positive
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mode. The gradient systems pump parameters and injection programmes (i.e. loop 
size, additives, solvents) were optimised as described in chapter four.
2.8.3 GC/MS linked to the mass spectrometer
There are two GC/MS systems analysed in these experiments the Fisons GC MD800 
and an Agilent GC MSD.
2.8.4 Typical conditions for full scan mass spectrometry (GC/MS MD800)
The GC/MS was run in with an El source in positive mode. The GC oven can be 
operated to give a gradient system that ranges in temperature o f over 400°C. Oven 
and injector temperature and column type were analysed and optimised for steroid 
separation as outlined in chapters three and four.
2.8.5 Typical conditions for full scan mass spectrometry GC MSD
The GC MSD has two ionisation sources available Cl and EL The El source was 
employed for all steroid investigations in these experiments. The GC MSD has 2 
injection ports which offer seven injection procedures, these are hot and cold split 
and splitless, solvent vent, solvent vent-stop flow and on column injections. The GC 
oven again had a range o f 400°C. Again this technique was optimised for steroid 
analysis as described in chapter four.
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2.8.6 Laboratory equipment
Table 2.8: Laboratory equipment
Laboratory equipment Version Supplier
RT-PCR machine 1 Icycler with iQ, 
(version 3.1)
Bio-rad laboratories Inc, 
California, USA
RT-PCR machine 2 Mycycler with iQ5 
(version 2.0)
Bio-rad laboratories Inc.
PCR machine Used for reverse transcription 
processes
Bio-rad laboratories Inc.
Nano-drop ND100 Spectrophotometer Labtech International Ltd, 
Lewes, UK
Vortex Vortex Genie 2 mixer Scientific Industries Bohemia, 
NY, USA
Cell incubator Auto flow C 0 2 jacketed cell 
incubator
NU-AIRE Caerphilly, UK
Centrifuge 1 RT-PCR Heraeus Labofuge 400 Kendro, Hanau, Germany
Centrifuge 2 cell culture Sanyo MSE Centaur 2 MSE, London, UK
Cell culture air filter sterile 
fume hoods
Mars Scanlaf cell culture hoods Scanlaf Lynge, Denmark
PCR fume hoods Labconco Purifier PCR 
enclosure
Labconco, Kansas, USA
Water bath 20-90°C Grant Instruments Ltd, 
Cambridge, UK.
Freezers Excel -16 to -32°C (frost free) Bosch, UK
Air displacement pipettes 1000, 100, and lOpL HTL LabMate Warsaw, Poland
Eppendorf pipettes and tips 1000, 100 and lOpL Eppendorf UK Ltd, 
Cambridge, UK
Glass scintillation vials 20mL ThermoFisher Scientific 
Waltham, MA, USA
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2.9 Software
Beacon primer design software (version 3.0)
Bioworks RT-PCR data browsers,
-iCycler iQ optical system software (version 3.1)
-iQ5 optical system software (version 2.0)
Chromeleon (LC)
Xcalibur (versionl.3) (LC/MS)
Mass Lynx (version 4.0) (GC/MS) MD800 and mass lab software 
Microsoft office suite 2003 and 2007.
Chem Station Agilent Productivity (Revision E.01.00, 2007) Agilent 5975C. 
Minitab 15 statistics software (2007).
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Chapter Three 
Experimental methods
Methods for cell culture and steroid converting enzyme (RNA) 
expression analysis through real time (reverse transcription) 
polymerase chain reaction (RT-PCR).
Methods for positive identification of steroids via gas and liquid 
chromatography mass spectrometry.
Methods of steroid extraction procedures via solid phase extractions
(SPE).
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3.0 Introduction
This chapter describes the experimental methods required for optimum cell growth 
through cell culture in order to obtain sufficient RNA for reverse transcription and 
real-time polymerase chain reaction (RT-PCR). Also described are the methods 
required for detection o f steroid standards by gas and liquid chromatography mass 
spectrometry which were optimised in chapter four and applied to biological 
samples.
Extractions of steroids from simple and complex liquids and cells are described in 
this chapter using a number o f extraction techniques to determine the most efficient 
method in terms of the range and concentration o f steroids that can be extracted.
3.1 Cell culture methods and reverse transcription (real-time) polymerase chain 
reaction (RT-PCR) methodologies
Cells were grown and maintained until there was sufficient cellular material available 
for steroid treatments, extractions and RT-PCR. Cell culture was conducted in a 
controlled environment that was representative of the human body, at body 
temperature 37°C, and with the correct amount of carbon dioxide and oxygen gasses 
as well as the appropriate nutrients provided for growth.
Growing o f established cell lines has been extensively optimised to achieve 
maximum cellular growth through changes in media conditions. Established cell 
lines were used in these experiments due to their immortality and robustness,1 and 
because they are excellent models o f cancerous tissue. The Ishikawa cell line for 
example is a model for type 1 human endometrial cancer.2
3.2 Cell culture methodologies; growth and maintenance of cell lines through 
cell culture methodologies
Both analysis methods (mass spectrometry and real time PCR) require the same 
initial cell culture steps.
A variety o f established cell lines and endometrial biopsies were cultured. The cell 
lines were chosen as they are less variable than clinical samples, the endometrial 
cancer cell lines Ishikawa, HEC-1B, HEC-1A and RL95-2 were investigated to
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provide understanding of the metabolic processes occurring in the endometrium and 
as model systems to optimise steroid treatments and extraction methods. The cell 
line COV434 was chosen as it highly expresses the steroid converting enzyme 
aromatase, and acts as a positive control in respect to the primers used in RT-PCR.
3.2.1 General cell culture methodologies
The cells were stored under liquid nitrogen until required, after which they were 
warmed in a 37 C water bath. Each cell line may require different media constituents 
for optimum growth these are outlined in chapter 2.4. All cell culture media and 
media additives such as sodium pyruvate, foetal calf serum (FCS), and trypsin EDTA 
(chapter 2.4) were warmed to 37°C before addition to the cells. The cells were 
centrifuged to form a pellet and the freezing media removed. The cells then added to 
a 10cm3 sterile plastic cell culture vessel with lOmL of media (plus nutrients) and 
placed in a 37 C incubator, half the media was changed the following day and 
thereafter periodically until the cells were 80% confluent. Following this the cells 
can be subjected to a number of experimental conditions or split into other vessels to 
produce more cells.
After steroid(s) treatment the cell media was removed (for analysis) and the cells 
were washed with 5ml of the salt solution HBSS (-CaCh -M gCb)+ to remove any 
remaining media. The cells were treated with 2mL o f trypsin EDTA, causing them 
to detach from the culture dishes (assuming 10cm3 cell culture flasks, volumes 
increase with larger culture vessels). Media was then added to the flasks to 
neutralise the trypsin and the cells were removed into a centrifuge tube which was 
spun at 1500 rpm for 5 minutes to form a pellet. The pellet was either re-suspended 
into more culture vessels or manipulated via steroid or RNA extractions. RNA was 
extracted using the QIAGEN RNeasy mini kit according to the manufacturer’s 
instructions. Steroids can be extracted from cells and cell media via a number of 
methods (optimised in chapter 4), the extracted steroids from the cells or cell media 
were subjected to analysis by LC/MS, LC/MS/MS or GC/MS.
3.3 Procedures relating to culturing of endometrial biopsies
Biopsies were obtained from Singleton Hospital (Swansea NHS Trust) and the blood 
removed. The tissue was washed a number o f times with HBSS and finely minced
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using two scalpels, after which 200pL of collagenase and 200pL of DNase type 1 
was added. The cells were then placed in the incubator for one hour and were re­
suspended every 15 minutes. They were then centrifuged at 400xg for 4 minutes, 
following this the pellet was re-suspended in media and incubated at 37°C, 24 hours 
later the stromal cells (attached to dish) and epithelial cells (in suspension) were 
separated by decanting the media into another cell culture vessel. The epithelial cells 
were placed in separate cell culture vessels where over time they become attached. 
The media was again changed periodically as with established cell lines. Stromal 
cells can be grown and split into larger vessels through the same methods as 
established cell lines outlined in chapter 3.2. Manipulations or steroid treatments of 
the biopsies can then proceed followed by RNA and steroid extractions.
3.4 RT-PCR methodologies: RNA extraction, reverse transcription and real­
time PCR
RT-PCR was employed to establish expression levels o f specific enzymes relating to 
steroid metabolism these were the steroid converting enzymes; aromatase, 5AR1, 
5AR2, 17J3-HSD1, 170-HSD2, 17|3-HSD4, 170-HSD5, 170-HSD7 and 170-HSD8. 
Expression o f GADPH (glyceraldehyde-3-phosphate-dehydrogenase) was also 
recorded in each experiment, and steroid converting enzyme expression was 
calculated relative to GADPH expression which corrected for any experimental 
errors. This produced steroid converting enzyme expression values normalised to 
GADPH for each steroid converting enzyme.
The biopsies or cell lines were grown until confluent and then removed by trypsin- 
EDTA as a pellet. From these pellets RNA was extracted using the Quigen 
RNAeasy kit (Qiagen, Crawley, UK following the manufacturer’s instructions) and 
the RNA concentration measured using the Nanodrop ND100 Spectrophotometer. 
The RNA was diluted into a lOpL solution of lOOng/pL and converted to cDNA 
using the RETROscript reverse transcription for RT-PCR kit, according to the 
manufacturer’s instructions. The cDNA was then diluted to produce a calibration 
series of concentrations 20ng/pL, 10ng/pL, Ing/pL, O.lng/pL and O.Olng/pL 
(assuming full conversion). A unique genetic sequence for each enzyme was 
determined and primers were designed which only bind to these specific sequences 
(described in chapter 3.4.1). 10pL SYBR green supermix, 2.5pL sense and 2.5pL
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anti-sense primers (for each enzyme) and 5pL of each cDNA dilution was pipetted 
into wells on a 96 well real time PCR plate and subjected to QRT-PCR. The 
fluorescent marker (SYBR green) fluoresces when bound to double strand DNA. 
The icycler RT-PCR instrument then undergoes a number of cyclic temperature 
fluctuations which causes double strand DNA (dsDNA) to be produced and 
denatured until enough dsDNA was present to produce a detectable signal. Through 
a number of calculations it was then possible to calculate the relative amounts of 
cDNA present which is related to the concentrations o f RNA for specific steroid 
converting enzymes in the original cells.
Relative expression levels o f each steroid converting enzyme in each cell line (and 
biopsy pathology) were determined. To complete this lOOng/pL o f RNA from each 
of the five cell lines (under basal conditions) was converted to cDNA, combined 
together and diluted to produce a standard curve. Onto this curve expression of each 
enzyme under basal conditions was applied, which allowed comparison between 
different cell lines with significantly different gene expression.
3.4.1 Primer design for specific gene expression detection in cells and biopsies
Primers were designed to bind to specific genetic base sequences o f DNA unique to 
the steroid converting enzyme o f interest. The genomic sequence of the gene was 
calculated from a number o f sources including the National Centre for Biotechnology 
and Information (NCBI, http://www.ncbi.nlm.nih.gov/ database). Sense (forward) 
and anti-sense (reverse) primers were designed to bind directly to a unique amino- 
acid sequence o f the steroid converting enzyme of interest. These primers were 
designed using Beacon primer design programme (version 3.0), which calculates 
primer efficiency and produces efficient primers. Beacon software can be 
programmed to produce primers that have amplicon lengths o f between 75 and 120 
base pairs, which produce efficient primer interactions and amplification o f the RNA 
of interest. Primer efficiency was defined by the software as being >85%.
3.5 Mass Spectrometry: Methodology for identification, and detection of a 
variety of steroid standards using LC/MS, LC/MS/MS and GC/MS 
A number of steroid standards were initially analysed by direct infusion into the mass 
spectrometer in positive mode using an ESI source for LC/MS and LC/MS/MS and
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an El source for GC/MS. This was completed to obtain individual mass spectra and 
fragmentation patterns (where available) for each steroid. A variety o f androgens, 
oestrogens and progestins were chosen for initial analysis, as they were 
representative o f steroids which could be synthesised in the female body (chapter 1, 
figure 1.1).
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Table 3.1: Structure, molecular weight and nomenclature o f nine steroids standards 
which were studied and considered to be relevant in this study of endometrial tissues.
Name Molecular weight Molecular formula Structure
Testosterone 288 C19H28O2
OHrK
Dihydrotestosterone
(DHT)
290 C]9 H30O2
OH 
M e m
X iX
4-Androstene-3,17-dione 286 C19H26O2
Dehydroepiandrosterone
(DHEA)
288 C19H28O2 Xf? 5
Androsterone 290 C19H30O2 x C 5
Pregnen-3-ol-
20-one
316 C2]H3202
Progesterone 314 C2]H3o02
°v
M .'V "
Oestradiol
(E2)
272 C18H24O2
im7
—(
OX
Oestrone
(El)
270 C]8H2202
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3.6 General set-up of LCQ DECA mass spectrometer
There have been many different liquid chromatography methods developed (column 
types, solvents) for the detection of steroids from a number of matricies, such as 
blood, urine, hair,3 tissues, and cells.4 The main solvent gradient systems utilised 
were acetonitrile/water5,6 and methanol/water,7,8 chosen because o f the solubility of 
steroids in organic solvents. The main liquid chromatography columns used for 
androgen and progestin analysis are Cjg reversed phase columns,9 however there are 
many other columns used for LC/MS analysis of steroids such as the 5p-ultrasphere 
ODS10 and the spherisorb column.11 A number of Cis columns were used in these 
experiments; two Dionex columns, a 25cm x 5p x 100A and a 15cm x 3p x 100 A 
also a number o f columns were packed under high pressure in the laboratory using a 
Cig slurry.
The steroid standards were initially analysed individually by direct infusion into the 
mass spectrometer to obtain mass spectra and fragmentation (MS/MS) data. The 
steroids were dissolved in methanol at concentrations of approx 3pM and infused 
directly into the LCQ DECA mass spectrometer, in positive mode using an 
electrospray ionisation source. The major ions such as the [M+H]+ and [M-H20+H]+ 
were then fragmented using collision energies o f between 30 and 45eV to obtain 
MS/MS data allowing any unique fragments o f each steroid standard to be identified. 
The standard operating parameters for the LCQ DECA are described in table 3.2 
(below).
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Table 3.2: Standard operating parameters for LCQ DECA full scan analysis of
steroid standards, using an ESI source in positive mode._________________________
Parameter Value
General
Run time 30-120 minutes
Scan events 1.0
Scan event details Full MS Scan (jn/z 50-500)
Mobile phases Methanol
Water
(each 0.1% acidic additive)
ESI source
Spray voltage 3.51 kV
Spray current (typ.) 0.58fiA
Sheath gas flow rate 29.3
Capillary voltage 15.2 V
Capillary temperature 200 °C
Vacuum
Ion gauge 2.5 xlO'5 Torr
Ion Optics
Multipole 1 offset -5.93 V
Lens voltage -15.96 V
Multipole 2 offset -9.59 V
Multipole Rf Amp 400 Vp-p, sp
Entrance lens voltage -58.7 V
Coarse Trap DC Offset -10.10 V
Main RF
Main Rf detected -0.01 V
RF Detector temperature 38.87 °C
Main RF modulation 0.03 V
Main RF Amplifier 8.26 Vp-p
RF generator temperature 34.1°C
Ion detection system
Dynode voltage -14.94 kV
Multiplier voltage -1125 V
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3.7 Additives for improved resolution in liquid chromatography mass 
spectrometry
Additives were incorporated into the solvents in liquid chromatography systems to 
improve the resolution o f peaks in the chromatograms. The optimum additive for 
each steroid should produce a high intensity well resolved peak with no peak 
tailing.12
The acidic mobile phase additive required for optimum resolution o f steroids was 
investigated. A mixture o f steroids (each 2pM) were injected into the mass 
spectrometer via a 15cm Cig column. The effect o f various liquid additives was 
systematically investigated, these were the acidic additives trifluoroacetic acid, 
formic acid, acetic acid and propionic acid, which are appropriate for positive mode. 
Each additive was incorporated into the mobile phase at a concentration of 0.1% 
(0.1% in methanol and 0.1% in water), a 50/50 methanol/water 0.1% additive 
solution was also used to prepare the steroid mixtures themselves.
3.8 Procedure for statistical analyses from calibration graphs in both GC/MS 
and LC/MS using standard reference materials
Experiments with standard reference materials were essential for quantitation of a 
known steroid in a biological sample, this was conducted via calibration methods. 
An internal standard is commonly used to improve quantitation statistics, these are 
usually structurally similar compounds such as deuterated steroids or a steroid 
derivative.
When completing a calibration series at least six concentrations of each steroid were 
prepared spanning the concentration range around which the experimental data was 
estimated to lie within. These results were plotted as a calibration graph o f signal (in 
this case peak area) against concentration (when using an internal standard a ratio of 
sample peak area/internal standard peak area was used on the y-axis). The internal 
standard used in these experiments was methyl-testosterone (a testosterone 
derivative), which was added at the same concentration to each sample (the internal 
standard was added at a concentration o f -40% o f the calibration range). Although 
this was not ideal (a deuterated analogue o f each steroid would be the ideal) methyl- 
testosterone was useful as it eluted mid-way through the chromatographic run and
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was not present in the biological samples. In the absence o f deuterated standards 
methyl-testosterone has been shown to be a good alternative internal standard for 
steroid analysis.13 Previous studies have also used other (un-involved) steroids as 
internal standards, for example Cheng and co-workers used progesterone as the 
internal standard when studying oestrogens in negative ionisation mode LC/MS.14
Linear regression from calibration graphs permitted calculation of the limit of 
detection and quantitation of each steroid using each instrument. The R2 value is the 
coefficient of the linear position of the calibration line, which should be 0.98 or 
higher for the results to be analytically significant. Regression calculations and 
accurate quantitative results can only be obtained over the linear region. The same 
method for quantitative calibration was used in LC/MS and GC/MS.
3.8.1 Calculation of R2 and limit of detection (LOD)
If a linear relationship was observed between concentration and instrument response 
(peak area or peak area ratio), the limit o f detection can be calculated using the 
equations below as described by Miller and Miller.15 
First the standard error o f the data series (Sy/X) was calculated using,
c  — i n  n
where Sy/X is the standard error, n is the number o f data points and y i -  y i are the y
residuals which are related to points on the regression line (calculated using the 
regression function in Excel 2007).
The limit of detection (LOD) was then calculated as three times the standard error 
divided by the slope o f the linear regression line.
3 x.S
L.O.D (concentration) = ------—  (3.2)
b
Nine steroid standards were studied to determine the limits o f detection for each in 
each mass spectrometry system (GC/MS and LC/MS). A description of these 
steroids and their structure is found in table 3.1.
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3.8.2 Statistical analysis methods for quantitative calibration by LC/MS 
For each steroid standard a minimum o f six dilutions (and a blank) were produced 
ranging from 2pM-10nM. A Cjg column was prepared by a number o f washing steps 
from 100% water to 100% methanol and subsequently for 20 minutes at the starting 
gradient. Each dilution for each steroid (plus internal standard) was passed through 
the column in triplicate (to provide statistical improvement) into the mass 
spectrometer using methanol/water gradient system (0.1% acetic acid). The results 
were compiled and calculations concerning R2 and limit of detection were 
completed.
3.9 Gas chromatography mass spectrometry for detection of steroids
GC/MS can provide unrivalled chromatographic performance for certain classes of 
compounds. Steroid analysis by GC/MS is widely utilised, however the majority of 
procedures involve a derivatisation step. There are limited examples o f steroid 
analysis using GC/MS without derivatisation, due to increased sensitivity and 
stability upon derivatisation. Derivatisation has been undertaken, in many steroid 
applications, for example, Leyssens and co-workers used a TMS derivatisation 
procedure while investigating the illegal use o f steroids within the cattle industry.16
There were two gas chromatography mass spectrometry systems used in these 
experiments these were the Fisons GC/MS MD800 and the Agilent 5975C GC/MSD 
ChemStation linked to a Gerstel auto-sampler. Initial experiments were undertaken 
prior to derivatisation.
3.9.1 Gas chromatography GC/MS MD800 set-up
Non-derivatised standard steroids o f a concentration o f lOOng/pL in methanol were 
prepared, these were then subjected to analysis using the GC/MS MD800 with an 
electron ionisation (El) source in positive mode. A range of temperature gradient 
programmes and settings of the GC were optimised to obtain an intense and well 
resolved peak for each steroid. Retention times and standard mass spectra for each 
steroid were obtained. Two columns were used for these investigations a HP-1 
dimethylpolysiloxane column and a more specific steroid column a Supelco SLB- 
5ms silphenylene polymer column. The GC/MS MD800 standard parameters for 
steroid analysis prior to derivatisation are defined in table 3.3.
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Table 3.3: Standard operating parameters for GC/MS MD800 full scan analysis of
steroid standards using an El source in positive mode.___________________________
Parameter Value
General
Run time 10-20 minutes
Scan events 1.0
Scan event details Full MS Scan (m/z 50-500)
Temperature range (GC oven) 20-300°C
Ionisation mode Positive
El source
Source temperature 200°C
Source current 975 pA
e‘ Energy 70 eV
Ion Optics
Repeller 4.6
Interface temperature 300°C
Detector
Detector 300
Analyser Pressure -4 (Vac)
Filament current 4.2 A
Trap current 158 pA
3.9.2 Gas chromatography Agilent GC MSD set-up
The Agilent GC MSD with ChemStation was also used in these experiments. This 
was a newer instrument than the GC/MS MD800 with a greater variety o f injection 
and auto-sampler systems. These improvements included the capacity o f online 
derivatisation, cooled sample trays and a number o f different injection methods such 
as hot and cold spilt, splitless and on-column injections. Again the steroid standards 
(lOOng/pL) were individually infused into the GC/MSD and a full scan mass 
spectrum obtained for each. The technique was optimised for detection, and later 
separation of each o f the steroids described in table 3:1.
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Table 3.4: Standard operating parameters for GC MSD full scan analysis of steroid
standards using an El source in positive mode._________________________________
Parameter Value
General
Run time 10-20 minutes
Scan events 1.0
Scan event details Full MS Scan (m/z 50-500)
Temperature range (GC oven) 20-300°C
Ionisation mode Positive
El source
Source temperature 200°C
e' energy 70 eV
Ion Optics
Repeller 28.28
Interface temperature 300°C
Detector
Analyser Pressure 7.67 xlO*6 mbar
3.9.3 Statistical analyses from GC/MS calibration graphs using standard 
reference materials
The methodology for GC/MS quantitation was similar to that for LC/MS. The 
samples were made up in methanol and a calibration graph constructed using six 
different concentrations 20-1 pM plus internal standard (and a blank) spanning the 
region around which the experimental data was expected to lie within. These 
samples (lpL) were analysed in triplicate. The R2 value and limit o f detection were 
calculated for each as outlined in chapter 3.8.1.
3.10 Derivatisation of steroids for analysis by GC/MS and LC/MS 
Derivatisation agents react with certain functional group(s) to make a substituted 
molecule which has an improved signal in the mass spectrometer. Derivatisation was 
applied to;
1. increase (or decrease) volatility o f a compound,
2. increase a compound’s ionisation efficiency,
3. avoid thermal decomposition of a compound,
4. improve sensitivity and/or,
5. improve chromatographic separation.
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In steroid analysis the hydroxyl groups are generally the site o f derivatisation. Two
17derivatisation procedures were investigated utilising the well known reagents, TMS
1 Xand dansyl chloride.
3.10.1 Trimethyl-silyl (TMS) derivatisation procedure
TMS derivatisation occurs at any hydroxyl groups in the steroid skeleton, through 
addition of a trimethyl-silyl group (figure 3.1). Some of the steroids within the 
expected profiles do not have hydroxyl groups, these should not undergo 
derivatisation, also if  multiple hydroxyl groups are present di- or tri-derivatised 
steroids should be produced.
TMS derivatisation is probably the most widely used derivatisation procedure for 
GC/MS analysis. The mass shift for a steroid with a hydroxyl group which 
undergoes TMS derivatisation is +73 mass units for each TMS molecule 
incorporated into the derivatisation end product. The TMS derivatisation procedure 
proceeds as follows; the dry steroid extract was obtained and reacted with 30pL of a 
BSTFA/TMS mixture (Bis(trimethylsilyl)trifluoroacetamide/trimethylchlorosilane) 
(BSTFA +1%  TMS). The solution was heated at 70°C for 60 minutes and dried 
under nitrogen before being reconstituted for analysis.19,20 This procedure was 
investigated using the steroids testosterone, pregnenolone, oestradiol and oestrone. 
Solutions o f these steroids were prepared at concentrations of 10pM in methanol and 
dried before derivatisation. The derivatised steroids were reconstituted in methanol 
and analysed on the GC/MS MD800 using the optimised operating system.
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Testosterone TMS derivatisation CH a
OHMe
Me
-CHa
Me
TMS-X
Me
CHa
+ HX
X= Cl or CF3C(0)=NSi(CH3)3
Pregnenolone TMS derivatisation "s.
C H 3
Fig 3.1: Diagram illustrating the TMS derivatisation reactions for testosterone and 
pregnenolone both products produce a mass shift of +73.
CH:
OHMe
Me
CH3
TMS-X
HX
HO'
OHTMS-X HO' Me
TMS-X
CH3•CHa
HX
X= Cl or CF3C(0)=NSi(CH3)3
+ 2(HX)
'CHaH3C'
CH3
Fig 3.2: Diagram illustrating the TMS derivatisation of oestradiol, two products 
produce a mass shift o f +73, these are mono-derivatised compounds. One product 
(bottom) has a mass shift o f +146 this was the di-derivatised compound.
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3.10.2 Dansyl chloride derivatisation procedure
Dansyl chloride derivatisation is another widely used procedure which adds a highly 
ionisable group to the steroid skeleton. Dansyl chloride derivatises the phenolic 
hydroxyl group of the steroid skeleton which are unique to oestrogens. Androgens 
and progestins do not have the required group and should not undergo any 
derivatisation. Following dansyl chloride derivatisation oestrogens can be readily
91analysed in positive mode LC/MS. Dansyl chloride derivatisation has also been
99applied in GC/MS analysis o f urinary amphetamines.
To complete dansyl-chloride derivatisation the steroid extract was dissolved in 
lOOpL of 0.1 M Na2CC>3 buffer (pH 10.5) and lOOpL of l.Omg/mL of dansyl chloride 
in acetone was added. The mixture was vortexed and heated for 3 minutes at 60°C, 
after which the acetone was evaporated and MTBE (methyl terf-butyl ether) was 
used as an extraction solvent. MTBE was used (at least twice) to extract the steroids 
from the aqueous into the organic layer, the organic layers were then removed and 
combined. The organic layer was evaporated to dryness before being reconstituted 
for LC/MS and GC/MS analysis.23,24 The mass shift for dansyl-chloride 
derivatisation was +234. This procedure was investigated using the oestrogens 
oestrone and oestradiol. The androgen testosterone and progestin pregnenolone were 
also analysed to ascertain if any derivatisation occurs at their hydroxyl groups.
63
C hap te r  Three:  Exper imenta l  Methods
OHMe
OHMe
Dansyl Chloride derivatisation O '
HO- 0 = S = 0
Me
Me
Dansyl Chloride derivatisation O'
HO
Fig 3.3: Diagram illustrating the dansyl-chloride derivatisation of oestradiol and 
oestrone. Top diagram illustrates the derivatisation o f oestradiol by dansyl chloride. 
Oestradiol-DC has a mass shift o f +234 from the neutral steroid of mass 272 to make 
a reaction end product of mass 505. Bottom diagram illustrates the derivatisation of 
oestrone by dansyl chloride. Oestrone-DC has a mass shift of +234 from the neutral 
steroid of mass 272 to make a reaction end product o f mass 503.
3.11 Separation of a mixture of steroids by GC/MS and LC/MS 
A mixture o f steroids was impossible to analyse using mass spectrometry alone due 
to their isobaric nature (similar molecular weights and fragmentation patterns), 
therefore prior chromatographic separation was an essential requirement. There were 
two separation techniques investigated here, high-performance liquid 
chromatography (HPLC or LC) and gas chromatography (GC), described previously.
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Both GC and HPLC systems can be directly linked to the mass spectrometer thereby 
combining chemical separation with mass analysis. When optimised these 
techniques permit excellent detection, resolution and separation o f a mixture of 
steroids.
Separation o f a mixture o f steroids by chromatography allows another method for 
identification of steroids-retention time. Positive identification of a steroid in real 
sample will have identical mass spectra, fragmentation data and a corresponding 
retention time to that o f the steroid standard. Both GC/MS and LC/MS standard 
steroid separation techniques were optimised, (reported in chapter four, part 1), these 
techniques were later applied to biological samples. Confidence in the results was 
further improved by validation of the mass spectrometry methods providing 
information about the reproducibility o f the technique in terms o f retention time and 
instrument response (peak area) (determined in chapter 4.4).
The steroids standards were combined for optimisation of separation procedures. 
This was completed using LC/MS by changing the mixture o f organic and aqueous 
mobile phases to sequentially elute steroids from an analytical column. Optimisation 
of the separation of steroid standards was completed using GC/MS by changing the 
temperature o f the column which causes the steroids to sequentially enter the mass 
spectrometer.
3.12 Steroid extractions
A wide range o f steroid extraction procedures from a number o f different matrices 
have been developed. These range from simple liquid-liquid extractions to multiple 
stage solid phase extractions depending on the matrix from which the steroids are 
extracted and the type o f steroid under investigation.25 An experiment to determine 
the solubility o f steroids in different mixtures o f methanol and water was described 
also described were a series o f simple extraction techniques which were further 
developed and optimised in chapter four, part 2.
3.12.1 Solubility of steroids in methanol and water
Techniques such as LC/MS and GC/MS require the steroid solutions to be prepared 
in solvents and results may differ due to the solubility o f that steroid in each solvent.
65
Chap te r  Three:  Exper imenta l  Methods
Therefore the solubility o f a steroid in the solvent o f interest was important, if a 
steroid was insoluble in that solvent then the experiment cannot proceed, also if the 
steroid crystallises in the solution the concentration o f dissolved steroid will be 
reduced. In these experiments methanol and water were used as the primary 
solvents, an experiment was designed to determine the optimum procedure for 
steroid analysis using these solvents.
lpM  solutions o f testosterone and pregnenolone were dissolved in methanol, this 
was then split into three samples and evaporated to dryness under nitrogen. The 
samples were then dissolved in water, methanol and 50/50 methanol/water, 
respectively. Following this the solutions were filtered to remove any particulates, 
transferred to a clean glass 2mL vial and evaporated to dryness. The samples were 
then dissolved into a 50/50 methanol/water (0.1% acetic acid) solution and analysed 
by LC/MS (outlined in figure 3.4). The peak areas (proportional to concentration) of 
each steroid was directly compared for each sample (methanol, methanol/water 50/50 
and water) and so the solubility of the steroids in each o f the three conditions was 
calculated. This provides valuable information concerning the solubility of each 
steroid in water and so in the cell culture media which was mainly water.
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Sam ple  1
lu M  so lu tion  of te s to s te r o n e  and  
p r e g n e n o lo n e  in m eth a n o l
Sam ple  2 Sam ple  3
Evaporate sa m p les  to  dryness
Dissolve in 
w ater
______________
Dissolve in 
50% w ater  
50% m eth a n o l
Filter
Dissolve in 
m eth a n o l
Evaporate each  sam p le  to  dryness and recon st itu te  in 
m eth a n o l/w a tc r 0 .1 %  acetic  acid for LC/MS analysis
Fig 3.4: F low chart i llustrating the m ethod  for determ ina tion  o f  the solubility  o f  
testosterone and p regneno lone  in m ethanol,  w a te r  and a 50/50 m ixture  o f  m ethanol 
and water.
3.12.2 Simple liquid-liquid extractions of steroids
Steroids are extracted  from sim ple m atrices such as w ate r by o rgan ic /aqueous  liquid- 
liquid ex tractions using an organic solvent. A difference in the polarity  betw een  the 
tw o phases causes the steroids in an aqueous  en v iro n m en t to readily m ove to the 
organic env ironm ent.
3.12.3 Determination of the ideal solvent for liquid-liquid extraction of steroid 
standards
T he optim um  solvent(s) for steroid ex tractions w ere  calculated  by investigating a 
n u m b er  o f  so lvents  o f  d iffe ring  polarities. So lvents  are given a polarity  index (PI) 
value o f  betw een  0 and 10, 10 being the m ost po lar  and 0 being non-polar .  W ate r is 
po lar  and has a PI o f  9.5, hexane is non-po lar  w ith  a PI o f  0. The larger the 
d iffe rence in polarity  betw een  the tw o phases  the m ore  readily  the steroids m ove 
from the aqueous to the organic  env ironm ent.
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Table 3.5: Solvents investigated and their polarity indices.
Solvent Polarity Index (PI)
Hexane 0
MTBE 2.2
Chloroform 4.0
Ethyl acetate 4.4
Methanol 5.1
Acetonitrile 5.8
The solvents investigated were chloroform, ethyl acetate, MTBE and hexane (table 
3.5). Methanol and acetonitrile were not investigated further because they are both 
miscible with water and do not form the two separate layers required to extract 
steroids from the aqueous to the organic environment.
Testosterone and pregnenolone were chosen for this experiment as they elute in 
different concentrations o f methanol. To investigate which solvent was most 
effective for steroid extractions lmg o f testosterone and lmg of pregnenolone were 
dissolved in 40mL of water. This solution was extracted by a number of simple 
liquid-liquid extractions. 200pL aliquots of the steroid solution were decanted and 
500pL of the solvent under investigation was added and vortexed after which the 
organic layer was removed, and the extraction repeated. The organic layers were 
combined and evaporated to dryness, these were then reconstituted in 50/50 
methanol/water (0.1% acetic acid) and analysed by LC/MS.
3.13 Solid Phase Extractions (SPE) of steroids
Solid phase extractions using Cig solid phase extraction cartridges lOOmg (Varian, 
Yamton, UK) were investigated. The Varian solid phase extraction cartridges used 
in these experiments were essentially mini LC reverse-phase Cig columns. Steroids
Ofswere retained on the Cig columns due to non-polar and Van Der Waals interactions. 
Steroids were subsequently eluted from the column with an organic solvent such as 
methanol.27,28,29 Optimisation and validation o f these SPE methods is defined further 
in chapter 4, part 2.
SPE is essential for steroid removal from aqueous based complex liquids such as 
plasma, urine or cell media as it removes interfering substances such as proteins and
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FCS which hinder simple liquid-liquid extractions. SPE also overcomes any phase 
separation problems producing a steroid fraction with a high percentage recovery.
3.13.1 Trial method for solid phase extractions with steroid standards
Steroid solutions o f a concentration o f lpM were made up in a lmL solution of 
methanol, lmL of water was added to this solution and the mixture was vortexed for 
5 minutes. The Cig SPE cartridges were treated with 2mL volumes of 
dichloromethane/methanol (50/50), methanol, water and methanol/water (50/50), 
respectively. The steroid solutions were then allowed to flow through the cartridge 
(0.5ml/min) and the effluent was collected and diluted to 30% methanol 70% water, 
before being applied again to the SPE cartridge. The effluent was once again 
collected and diluted to a 10% methanol solution, 90% water and applied to the 
cartridge. The cartridges were then washed with 2mL of water before polar steroids 
were eluted with a 2mL of 40% methanol, 60% water and neutral steroids were 
eluted with 2mL of an 85% methanol 15% water solution. This standard method was 
efficient for simple liquids such as water, however it was adapted for complex 
matrices such as cells and cell media.
3.13.2 Solid phase extractions of steroids from established cell lines
The method for SPE of steroids from cells proceeds as follows. Cell pellets were 
collected for analysis with all cell media removed, and they were suspended in 5mL 
of ethanol, and heated for 5 minutes at 64°C, the solution was next centrifuged and 
diluted to a 50% ethanol solution by addition o f 5mL of water. The Cig Varian 
cartridge was treated with 2mL of dichloromethane/methanol (50/50), 2mL methanol 
and 2mL of ethanol/water (50/50) respectively. The cell solution was then passed 
through the cartridge at a rate o f 0.5mL/min. The effluent was collected and diluted 
to a 30% ethanol solution by addition o f water and re-applied to the cartridge. The 
effluent was again collected diluted to a 10% ethanol solution and again allowed to 
flow through the cartridge. After a 2mL water wash the steroids were eluted with 
2mL of 40% methanol solution followed by 2mL of 85% methanol solution prior to 
being evaporated to dryness and reconstituted for mass spectrometric analysis.
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3.13.3 Solid phase extractions from cell media
SPE of steroids from cell media proceeds as follows. The SPE cartridges were 
prepared by washing with 2mL dichloromethane/methanol (50/50), 2mL methanol 
and 2mL of water. lOmL of media was separated from the cells and heated with 
2mL of 2M triethylamine sulphate at 64°C for 5 minutes, the media solution was then 
passed through the SPE cartridge (0.5mL/min) and the effluent discarded. The 
cartridge was washed with 2mL of water before the steroids were eluted with a 40% 
methanol (60% water) solution followed by an 85% methanol (15% water) solution. 
These solutions were then evaporated under nitrogen and reconstituted in 200pL of 
methanol/water 50/50 0.1% acetic acid ready for LC/MS analysis or 200pL of 100% 
methanol for GC/MS analysis. This procedure was adapted and optimised through 
changes in elution solvents to achieve efficient steroid extraction.
To optimise steroid extraction from Cis SPE cartridges, the 85% methanol wash step 
was investigated using the elution solvents methanol, 2-butanol and ethyl-acetate as 
outlined in the flow chart below (figure 3.5). The steroids investigated were DHEA, 
androsterone, DHT, oestrone, androstenedione, oestradiol, pregnenolone, 
testosterone and progesterone which were prepared in a water solution 
(representative of cell media) at a concentration o f lpM. The control (100%) sample 
was a steroid sample prepared in methanol and analysed directly by mass 
spectrometry (no sample loss due to experimental procedures).
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100%
solution
Steroid 
solution 1
Steroid 
solution 2
V.  iL
Steroid 
solution 3
No extraction 2-butanol m ethanol Ethyl-
acetate
Elution
S o lv en t
Evaporate 
to dryness
Evaporate 
to dryness
Evaporate 
to dryness
Reconstitute for LC/MS and GC/MS analysis
Fig 3.5: Flow chart illustrating the m ethod  for de term ination  o f  the op tim um  solvent 
for steroid ex tractions from SPE cartridges. S teroid so lutions 1, 2 and 3 and the 
100% steroid solution all contain  1 pM  solutions o f  D H E A , androsterone, DHT, 
oestrone, androstened ione, oestradiol, p regneno lone ,  testosterone and progesterone. 
Elution solvents were 2-butanol,  m ethano l and ethyl-acetate .
Follow ing  determ ination  o f  op tim um  extraction  so lvent tw o lOmL sam ples  o f  cell 
m ed ia  (one con ta in ing  foetal c a lf  serum ) were spiked with steroids (androsterone, 
testosterone, D H E A , DH T, oestrone, oestradiol, androstenedione, m ethyl- 
testosterone, p regneno lone  and progesterone) each at a concentra tion  o f  50nM  (in 
lOmL o f  cell m edia). T hese  steroids w ere  then ex tracted  to investigate the effect the 
cell m edia  and m ed ia  consti tuents  have on the effic iency  o f  the SPE extraction 
procedure .
3.14 Method for steroid treatments of cell lines and biopsies
Follow ing  optim isation  o f  m ass  spec trom etry  and steroid ex tractions m ethods  steroid 
trea tm ents  o f  cell lines and biopsies can be com ple ted . Initially each cell line was 
grow n until 80%  confluen t in a 25m L  flask, after this the m ed ia  w as changed  and the 
cells incubated for 48 hours, the m ed ia  w as  then rem oved  and any  steroids extracted, 
w hich  permitted  determ ination  o f  the basal steroid profile. F o llow ing  this trea tm ents  
with a steroid from each o f  the steroid groups under investigation w ere com ple ted ,  a 
progestin -p regneno lone, an androgen-testosterone , and an oestrogen-oestrad io l.
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Initially pregnenolone, testosterone and oestradiol were added (individually) to 
20mL of media to make lOOnM solutions as a dried solid, however after solubility 
experiments outlined in chapter 3.12 (and optimised in chapters 4.11 and 5.8) 
steroids were subsequently added as a solution in a minimal volume of methanol. 
The cell lines Ishikawa and HEC-1B were grown as outlined in chapter 3.2, once 
80% confluent the cell media was changed and the steroids (pregnenolone, 
testosterone, oestradiol) were added at a concentration o f lOOnM. The cells were 
incubated for 48 hours (Ishikawa) or 72 hours (HEC-1B) and the steroids extracted 
from the cells and cell media by optimised SPE. This allowed analysis o f any 
metabolism products from the added steroids and determination o f further 
experiments. Steroid profiles from cells were uninformative in comparison to cell 
media due to the lower concentration of steroids present in the cells (some below the 
instrument limit o f detection). This was advantageous as cells and cell media from 
the same time point can be analysed in parallel to produce a picture o f both enzyme 
expression information and steroid profiles.
As a result o f these initial experiments testosterone treatments were extended, the 
Ishikawa and COV434 cell lines were split into eight 75cm2 flasks and grown until 
80% confluent. The media was removed and 20mL of fresh media was added with 
the addition of testosterone to make lOOnM solutions. After which every 8 hours for 
48 hours (and at 72 hours) the cell media was removed and any steroids were 
extracted (optimised Cis). 72 hours was chosen as the treatment time for a number 
of reasons;
1. after 72 hours the majority o f testosterone was metabolised to other steroids 
by each cell line,
2. at 72 hours the majority o f nutrients provided by the cell media were used,
3. due to reduced nutrients the cells may become stressed which could alter 
steroid metabolism after 72 hours and,
4. at 72 hours the cells were 100% confluent, after this time the cells become 
overpopulated, possibly causing mutations and growth o f multiple layers.
At each 8 hour time point the cell pellets were also removed, RNA extracted and 
converted to cDNA, following this real time analysis was performed to calculate 
steroid converting enzyme expression providing information on any temporal 
changes in enzyme expression over 72 hours after testosterone treatments relative to
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basal conditions, (chapter 6). The other three cell lines HEC-1A, HEC-1B and 
RL95-2 were analysed through a similar method with steroid and RNA extractions at 
every 12 hours over a 72 hour period.
After mass spectrometry analysis it was possible to combine the steroid profiles from 
each time point and produce a picture of testosterone metabolism in each cell line, or 
endometrial biopsy. This allows comparisons o f testosterone metabolism bio­
pathways in all cell types under investigation.
3.14.1 Testosterone treatment of biopsies
Biopsy samples were separated into epithelial and stromal components. Due to the 
time taken to reach confluency only 4 time points were analysed for each biopsy 
sample these were 0, 24, 48 and 72 hours. These times were chosen as they were 
comparable to time points produced with the established cell lines. The biopsy 
samples were split into four 75cm2 flasks (stromal cells) or four 10cm diameter petri 
dishes (epithelial cells) and treated with a lOOnM solution of testosterone, the 
steroids were extracted from the cell media via the previously optimised SPE 
procedure and RNA was extracted at each time point.
Together the mass spectrometry and enzyme expression profiles produced at basal 
level and after testosterone treatment provides important, novel information about 
steroid metabolism in the endometrium and its disorders. The combination of mass 
spectrometry and enzyme expression information will highlight any relationships 
between specific steroid concentrations and specific enzyme expression. This will 
emphasize steroids or enzymes which can be targeted for development of novel 
treatments for steroid responsive endometrial disorders.
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Chapter four
Optimisation of analytical procedures for the detection and
extraction of steroids
Chapter Four: O ptim isation  o f  E xperim ental Procedures
4.0 Introduction
This chapter presents the optimisation o f mass spectrometry methods for the 
identification o f steroid profiles (part one) and optimisation of steroid extraction 
methods from biological samples (part two).
4.0.1 Chapter 4 Part One: Optimisation and Validation of Mass Spectrometry 
Methods
The first part o f this chapter details the optimisation o f both gas and liquid 
chromatography linked to mass spectrometry techniques for detection of a number of 
steroid standards. Calibration data is included to determine which technique 
provides the lowest limit o f detection for each steroid and to quantify steroids in 
biological samples.
Statistics concerning the reproducibility o f the mass spectrometry techniques are 
presented in this chapter, providing information about confidence in the results. Also 
investigated and compared were a number o f derivatisation procedures which act to 
improve the sensitivity o f mass detection for certain steroids.
4.0.2 Chapter 4 Part Two: Extraction of steroids from biological samples
After steroid analysis methods were developed and optimised the extraction of 
steroids from biological samples was investigated.
Optimisation and validation o f steroid extraction procedures (liquid-liquid and solid 
phase extraction SPE) was completed. This data allows determination of the most 
effective steroid extraction method(s) from solutions o f steroid standards and 
biological samples.
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Part One: Detection and separation of steroid standards by mass spectrometry
4.1 Optimisation of liquid chromatography mass spectrometry for detection of 
steroids; solvents, mobile phase additives, and quantitative calibrations
A Dionex/LC Packings HPLC system fitted with a Cig column was linked to the 
LCQ DEC A XP Plus mass spectrometer. A number o f different Cis column lengths 
were investigated (chapter 2 table 2.7). Various solvents, gradient systems, trap 
columns, mobile phase additives, injection volumes and ionisation methods were 
investigated to optimise the chromatographic resolution, separation and detection of 
each steroid defined in table 3.1.
4.1.1 Steroid analysis by LC/MS
The steroids were infused directly into the mass spectrometer in positive mode with 
an electrospray ionisation source and full scan mass spectra obtained over an m/z 
ratio range of 50-500 Da. Each steroid protonated molecular ion [M+H]+ if present, 
was then fragmented at a collision energy >30eV to obtain fragmentation data. The 
major ions produced were subsequently fragmented at similar collision energies to 
produce further fragmentation information.
4.1.2 Androgen mass spectra and fragmentation data in LC/MS and MS/MS 
All androgens (ESI source in positive mode) produced spectra with [M+H]+ clearly 
visible and abundant. Fragmentation information was subsequently obtained in 
LC/MS/MS mode. For all the androgens analysed (table 4.1) an initial neutral loss of 
18 mass units was observed due to a loss of water from the steroid, a subsequent 
second water molecule was lost from all the androgens following the first. 
Structurally characteristic fragments were noted to help aid steroid determination in 
biological samples (table 4.1). All androgen mass spectra were comparable to 
database steroid mass spectra.1
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Table 4.1: LC/MS/MS fragmentation data o f androgens analysed on the LCQ DECA 
mass spectrometer with an ESI source in positive mode.__________________________
Steroid m/z Assignment
289 [M +H f
271 [M+H]+-H20
Testosterone 253 [M+H]+-2H20
169 Fragment
303 [M+H]+
17a-methyl testosterone 285 [M+H]+-H20
267 [M+H]+-2H20
211 Fragment
DHEA 289 [M+H]+
271 [M+H]+-H20
253 [M+H]+-2H20
223,148 Fragments
Androsterone 291 [M+H]+
273 [M+H]+-H20
255 [M+H]+-2H20
199 Fragment
4-Androstene-3,17-dione 287 [M+H]+
269 [M+H]+-H20
251 [M+H]+-2H20
Androstane 3,17-diol 293 [M+H]+ not present
275 [M+H]+ -H20
257 [M+H]+ -2HzO
DHT 291 [M+H]+
273 TM+H]+-H20
4.1.3 Progestin mass spectra and fragmentation data in LC/MS and LC/MS/MS 
Progesterone and pregnenolone both demonstrated abundant protonated molecular 
ion [M+H]+ peaks when analysed by LC/MS using an ESI source in positive mode. 
The results were similar to those produced by androgens, with two neutral losses of  
H2O observed in MS/MS mode. Fragmentation data was recorded in table 4.2.
Table 4.2: LC/MS/MS fragmentation data o f progestins analysed on the LCQ DECA 
mass spectrometer with an ESI source in positive mode. ________________________
Steroid m/z Assignment
315 [M +Hf
Progesterone 297 [M+H]+ -H20
279 [M+H]+ -2H20
255, 239,215 Fragments
317 [M+H]+
Pregnenolone 299 [M+H]+ -H20
281 [M+H]+ -2H20
180 Fragment
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4.1.4 Mass spectra and fragmentation data of oestrogens in LC/MS and 
LC/MS/MS
The protonated molecular species [M+H]+ for oestrogens were less abundant than 
those produced from androgen or progestin analysis (for the same concentration of 
steroid). Some weak fragmentation patterns were observed table 4.3, again as with 
the androgen and progestin series an initial loss o f water was observed in MS/MS 
mode. A subsequent water loss was seen with oestriol, but with oestradiol and 
oestrone the -2H2O signals were not present possible due to a lack of sensitivity for 
oestrogens in the mass spectrometer. A more sensitive technique was required for 
oestrogen analysis such as GC/MS analysis, or negative mode ionisation LC/MS, or 
adoption o f a derivatisation procedure.
Table 4.3: Fragmentation data LC/MS/MS of oestrogens analysed on the LCQ 
DECA mass spectrometer with an ESI source in positive mode.___________________
Steroid m/z Assignment
273 [M+H]+
Oestradiol 255 [M +H f -H20
158 Fragment
289 [M+H]+
Oestriol 271 [M+H]+ -H20
253 [M+HT -2H20
271 [M+H]+
Oestrone 253 [M+H]+ -H20
197 Fragment
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Fig 4.1: M ass  spectra o f  a s tandard  androgen  top (testosterone), progestin  m iddle  
(p regneno lone)  and an oestrogen  bottom (oestriol).  Sam ples  were analysed using the 
L C Q  D E C A  m ass spec trom eter  with an ESI source in positive m ode by direct 
infusion using  3 pM  solutions in 50/50 m eth an o l/w ate r  (0 .1%  formic acid).
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4.2 Separation of steroid standards by LC/MS
For optimum separation the steroids should be fully resolved (well separated no peak 
overlap), and have clear mass spectra containing abundant signals for the molecular 
ions [M+H]+ in ESI positive mode. A number of different gradient systems of  
methanol and water were investigated to obtain an optimised steroid separation.
A mixture o f androgens, oestrogens and progestins were prepared in 50/50 
methanol/water and a number o f methanol/water gradient programmes were analysed 
to determine optimum separation and resolution. The elution order o f steroids was 
determined by running each steroid standard separately, using the same gradient 
system, and comparing this to the chromatogram produced from the mixture o f 
steroids. The optimised separation was method 4 in the table below which was a 
summation o f a number of method development steps.
Table 4.4: Method development steps for optimisation o f separation o f a mixture o f  
steroid standards by LC/MS with an ESI source in positive mode using a 
methanol/water gradient system with 0.1% acetic acid.______ _____________ _______
Method
Starting 
concentration 
% methanol
Time
(min)
Concentration 
% methanol
Time
(min)
Finishing 
concentration 
% methanol
Time
(min)
1 70 10 80 55 100 60
2 70 10 90 55 100 60
3 50 10 75 55 100 70
4 70 10 - - 100 70
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Fig 4.2: O ptim ised  separation o f  e igh t steroids on the LC Q  D E C A  m ass spec trom eter 
via a Cig co lum n with an ESI source  in positive m ode using a m ethano l/w ater  0 .1%  
acetic acid grad ien t system . Selected ion ch ro m ato g ram s o f  androstenedione, 
testosterone, D H E A , m ethyl-tes tosterone, androstane-3 ,17d io l,  androsterone, 
p rogesterone and p regneno lone  selected m olecu lar  ions [M + H ]+ were m /z 287, 289, 
289, 303, 257, 291, 315, and 317 respectively .
F igure 4.2 illustrates the op tim ised  separation  o f  and rogens  and progestins using a
m ethano l/w ate r  elution system  on a 25cm  D ionex  Cig co lum n. This  optim ised
separation  system w as transferred  to biological sam ples , a l low ing  positive
identification o f  steroids th rough  re tention t im e and m ass  spectra com parisons. 
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Steroids which co-elute (same retention time) can be distinguished on the basis of 
their mass spectra and fragmentation patterns, although quantitation is not possible 
for co-eluting peaks and so a technique which separates these compounds is required 
for quantitation. Oestrogen separations were not shown here due to the lack of 
sensitivity in this LC/MS procedure.
4.3 Effect of mobile phase additives on resolution of steroid peaks
Additives were incorporated into the LC/MS solvents to aid ionisation, improve 
sensitivity and reduce peak tailing by altering the pH of the mobile phase.3 The 
optimum additive for each steroid will produce high intensity well resolved peaks. 
The choice of additive depends on the ionisation source (ESI, APCI or Cl) and the 
compound of interest. There are three types of mobile phase additives;
1. acids- aid detection o f compounds mainly in positive mode,
2 . salts- aid detection o f compounds in both positive and negative mode,
3. bases- aid detection o f compounds in mainly negative mode.4
4.3.1 Optimum additives
A number of acidic mobile phase additives (formic, acetic and trifluoroacetic acid) 
were investigated to improve the resolution of the androgens and progestins in 
LC/MS with an ESI source in positive mode. These were added to both mobile 
phases and all samples at a concentration o f 0.1%.
Table 4.5: Acidic additives producing optimum resolution and signal intensity for a 
series o f steroids. The percentage o f each acid additive was 0.1% in all solvents and 
steroid solvent solutions. ______________________
Name Optimum additive
Androstenedione Formic acid
Testosterone Trifluoroacetic acid
DHEA Acetic acid
DHT Acetic acid
Androsterone Acetic acid
Progesterone Formic acid
Pregnenolone Formic acid
It was concluded that acetic acid was the overall optimum additive, as it increased 
resolution and signal intensity for the majority of steroids. Subsequently acetic acid
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was added to mobile phase solvents and samples at a concentration o f 0.1% for all 
positive mode LC/MS analyses. Chang and co-workers studied steroid analysis 
using a methanol/water elution system and concluded that the additives formic or 
acetic acid produce optimum responses for androgen analysis, agreeing with the 
work outlined above.5
4.4 Optimum separation by GC/MS
As stated in chapter 3 (section 3.9) and in the literature most GC/MS steroid analysis 
has occurred after derivatisation.6 However, initial experiments here were 
undertaken without derivatisation.
4.4.1 GC/MS MD800 analysis of steroid standards
Different column temperatures were investigated (table 4.12) and an optimum 
procedure established to obtain high resolution peaks.
The molecular ion [M]+* for androgens and oestrogens were abundant when analysed 
by GC/MS (figure 4.3). The [M]+' molecular ions o f the progestin series were less 
abundant, however the chromatographic peak representative o f progesterone and 
pregnenolone were still clearly visible in the total ion chromatograms. The 
molecular ion indicative o f cholesterol was also abundant in GC/MS analysis ([M]+ 
observed at m/z 386). Following this the steroids were combined and a temperature 
gradient system was developed to determine the optimum separation conditions for 
steroids using the GC/MS MD800.
Table 4.6: Major ions present for a series o f androgens using the GC/MS MD800 
with an electron ionisation source (El) in positive mode. ________________________
Steroid m/z Rationalisation
Testosterone 288 [Ml+
DHT 290 [M f
17a-methyl testosterone 302 TM r
DHEA 288 fMl+
Androsterone 290 fMl+
4-Androstene-3,17-dione 286 [M]+
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Table 4.7: Major ions present for progestins and cholesterol using the GC/MS
MD800 with an electron ionisation source (El) in positive mode.
Steroid m/z Rationalisation
Pregnenolone 316 [M]+
Progesterone 314 imt
Cholesterol 386
Table 4.8: Major ions present for a oestrogens using the GC/MS MD800 with an
electron ionisation source (El) in positive mode.
Steroid m/z Rationalisation
Oestrone 270 [M]+
Oestradiol 272 [Ml+
Oestriol 288 [M]+
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Fig 4.3: R epresen ta tive  m ass spectra  ob ta ined  on the M D 8 0 0  G C /M S  using an El source in 
positive m ode, sam ples  were a concen tra tion  o f  lOpM in m ethanol.  Top  m ass spectra w as 
a progestin  (p regneno lone)  m iddle  w as an androgen  (androsterone),  and bottom was an 
oestrogen  (oestradiol).  T he m olecu lar  species w as  c learly  observed  for each steroid.
Table 4.9: G C /M S  M D 8 0 0  T em p era tu re  p rog ram m es to optim ise  the
ch rom atograph ic  perfo rm ance (separating  steroid s tandards as a function o f  oven 
tem perature) ._______________________ _________________________ _____________ __________
Method
Injector
temperature
(°C)
Start
temperature
(°C)
Hold
time
(min)
Gradient
(°C/min)
Finish
temperature
(°C)
Final hold 
time (min)
I 220 40 l 20 290 10
2 220 200 1 20 290 15
3 220 220 1 20 290 15
4 220 250 1 20 290 15
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Injection num bers  1 to 4 w ere com ple ted  to establish a tem pera tu re  grad ien t system 
using a variety of steroids. M ethod  4 produced  an op tim um  separation (figure 4.4) 
with well resolved steroid peaks in a short t im e period (less than 15 minutes).
loo-. 8y
Androsterone
Androstene-dione
Oestradiol
Testosterone
CH3Testosterone
Y Progesterone 
Pregnenolone
Oestrone
DHEA
Time
7 00  7 60  8 0 0  8  60 9  00  9  50 10 0 0  10 60  1 1 0 0  1 1 5 0  12 00  12 SO 13 0 0  1 3 5 0  14 00  14 SO f i l l i n ' )
Fig 4.4: Separation o f  10 steroids by G C /M S  M D 8 0 0  with an El source in positive 
m ode. Som e steroids co-elute  but can be d is t inguished  from their  unique peaks in 
the m ass spectra, for exam ple  the peak on the left o f  the chrom atogram  was the c o ­
elution o f  a m ix ture  o f  D H E A  and androsterone.
4.4.2 GC MSD analysis of steroid standards
T he GC M SD  w as linked to the Gerstel au to-sam pler,  w hich  perm its  pre-colum n 
sam ple  preparation m ethods  such as ex tractions and on-line derivatisa tion . The 
increased sensitiv ity  o f  the GC M S D  should  im prove standard steroid results in 
com parison  to the G C /M S  M D 800  in te rm s o f  sensitiv ity  and resolution. The steroid 
s tandards w ere subjected  to analysis  using the G C  M S D  to de term ine  op tim um  
separation  param eters  and the limit o f  detection for each steroid.
T he  steroid standards  w ere  infused directly  into the G C  M S D  in positive m ode using 
an electron ionisation source and spec tra  obta ined  for each steroid. The full scan 
m ass  spectra  gave the [M ]+‘ for each steroid standard com parab le  to those produced 
by direct infusion to the G C /M S  M D 800  see tables 4.9, 4 .10 and 4.11.
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Fig 4.5: M ass  spec tra  p roduced  by the G C  M S D  with an El source in posit ive  m ode 
for oestradiol (top), D H E A  (m idd le)  and progesterone (bottom). T he m o lecu la r  ion 
[M +] were abundan t  for each steroid.
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Cholesterol 386
M*
3 6 3  .
v l
m/z
Fig 4.6: C holestero l GC M SD  m ass spec trum  with an El source in positive m ode. 
The m olecu la r  ion [M +] was abundan t for cholestero l observed  at m /z 386.
Cholestero l can be easily  detected using both the G C /M S  M D 800  and GC M SD . In 
figure 4 .6 the M f m olecu lar  species w as abundan t.  T he LC Q  D E C A  m ass 
spec trom eter  was not sensitive to cholestero l,  (possib ly  due to poor ionisation 
effic iency  using ESI) and G C /M S  offers a v iable  alternative  for cholesterol analysis.
T he ten steroids (table 3.1 and cho les te ro l)  were subsequen tly  com bined  and 
analysed  to develop a separation technique. T he op tim um  steroid separation was 
achieved  using a short co lum n HP1 and the rear p rog ram m able  tem peratu re  
vaporisa tion  (PT V ) injection port at 1 5 0 C ,  w hich  w as held for 1 m inute , fo llow ed by 
a tem pera tu re  increase o f  20°C/min to 250  C, w hich  w as held for 2 m inutes. T here  
w as still som e co-elution o f  s teroids using  this tem pera tu re  gradient system , for 
exam ple  testosterone and oestradiol co-elu te  (f igure 4.7). Separation  o f  these two 
co m p o u n d s  was possible but at the expense  o f  good ch ro m atog raphy  as a grad ien t o f
O .fC /m in  w as required which caused s ign ificant peak  b roaden ing  and tailing. 
Positive identification o f  co-elu ting  co m p o u n d s  can be de term ined  from m ass spectra  
generated  at these t im es as the co-elu ting  stero ids  generate  d iffe ren t M + ions, such as 
D H E A  and androsterone w hich have the d iffe ren t M + ions o f  288 and 290, 
respectively .
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Fig 4.7: Optimised separation of ten steroids by GC MSD using an HP-1 1 metre 
column in positive mode with an El source.
Time
(min)
When comparing the GC MSD separation (figure 4.7) to that o f the GC/MS MD800 
(figure 4.4) it was possible to determine that the steroids can be separated in a shorter 
time using the GC MSD. Separation 14 minutes (GC/MS MD800) whereas 
separation of the same steroids using the GC MSD required just 8 minutes. The 
elution orders o f the steroids were the same for both techniques, but the GC MSD 
instrument exhibited improved resolution. This was due to a combination o f factors 
such as the improved chromatography and injection procedures on the GC MSD.
4.5 Reproducibility of steroid retention times and peak areas: variation in 
results with use of an internal standard
The reproducibility o f each technique was measured by subjecting the same 
concentration and volume o f a steroid solution to analysis a number o f times and 
over many days (inter variation) and calculating the variation in the instrument 
response (peak area and/or retention time).
Mass spectrometers are subjected to a number of day-to-day (intra-variation) 
variations, such as variation in the source, instability of the mass scale, and changes 
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in capillary temperatures. There are also daily variations (inter-variation) associated 
with the LC systems, such as changes in column pressure, flow rate and column 
temperature. GC variations can be due to problems within the GC interface to the 
mass spectrometer (the transfer line from the GC oven to the ion source) or 
temperature variations in the GC oven which affects pressure and temperature on the 
column and so resolution of the compounds.
There are many techniques employed to reduce these errors through accurate 
measurements and optimisation o f analytical techniques and apparatus. The use o f a 
standard compound, similar to those under investigation to which the compound 
under investigation can be compared is applied to reduce errors associated with intra 
experimental variations o f the instrument.7 This standard compound can be added at 
two time points each o f which are given a different name;
1. Surrogate internal standard- standard compound is added at the start o f the 
experiment before extraction and undergoes all processes with the compound of 
interest. This includes the whole analytical procedure i.e. derivatisation and 
extraction. This method allows calculation of the analyte concentration present in 
the original sample and overcomes errors associated with experimental sample losses 
as well as errors associated with the analytical technique.
2. Internal standard (IS)- A standard compound is added after extraction 
and/or derivatisation, prior to analysis. The internal standard is added in the same 
concentration to each sample and a ratio of the instrument response for the analyte to 
the instrument response for the internal standard is calculated. The internal standard 
is added at a concentration of -40% of the expected concentration range. In these 
experiments the IS methyl-testosterone was added after steroid extractions, prior to 
mass spectrometry analysis.
Instrument response reproducibility was calculated by measuring the peak area 
produced by a steroid over 10 infusions. The peak area recorded should be the same 
for each injected volume of sample and the variance o f this represents the 
reproducibility of the technique. The variance o f the ratio of peak area/internal 
standard peak area over a number of injections gives an error value related to
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instrument reproducibility, this is expressed as the relative standard deviation (RSD) 
defined in equation 4.1.
Retention time reproducibility was calculated as actual retention time (Rt) and as 
relative retention time to the internal standard. The retention times should be the 
same for each steroid in every injection (same temperature/gradients). The retention 
time was noted for each steroid for 10 injections over 2 days, and the relative 
retention time to the internal standard’s retention time was calculated. The variance 
over 10 injections and relative standard deviation (RSD) were calculated, producing 
an error relating to retention time reproducibility.
4.5.1 Reproducibility of instrument response (peak area) produced by analysis 
of androstenedione and androsterone
A mixture o f androsterone and androstenedione was infused into the GC/MS 
MD800, GC MSD and the LCQ DECA, ten times over two days. The instrument 
response (peak area and retention time) was determined for each steroid in each 
injection. The peak area ratio, and the retention time relative to the internal standard
o
were also calculated. The standard deviation and relative standard deviation (RSD) 
were calculated as defined in equation 4.1.
RSD = standard deviation x 100 (equ4.1)
average
RSD= relative standard deviation, average is the average peak area (or retention 
time) for 10 infusions into the mass spectrometer.
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Fig 4.8: R eproducib il i ty  instrum ent response  (peak area) for andros tened ione  and 
andros te rone  analysed  by G C /M S  M D 800  in positive m ode using an El source. 
G raph  on the left dem onstra ted  variation w ithou t an IS and the graph on the left 
dem onstra tes  varia tion with an IS.
Figure 4.8 illustrates the im portance o f  an internal s tandard (IS). T he R SD  o f  10 
m easu rem en ts  o f  peak  area w as reduced from the initial error o f  > ± 4 0 %  to only 
~ ± 6 %  with the use o f  an internal s tandard for both steroids. Use o f  an internal 
s tandard  in G C /M S  M D 800  analysis  increased the confidence in quantitation  o f  
s teroids in biological sam ples.
Reproducibil ity of  peak  area  in
GC/MSD for t w o  s tero ids
A n d  f a s t e n e d  i A n d r o s t e r o n e
Fig 4.9: R eproducib il i ty  o f  peak  area rela ting  to andros tened ione  (m /z  286) and 
andros te rone  (m /z  290) when analysed  by G C  M S D  in positive m ode using an El 
source with an internal s tandard (m ethyl-tes tosterone).
T he R SD  with use o f  an internal standard  w ere  ~ ± 8 %  for both o f  the steroids 
ana lysed  on the G C  M S D  (this w as  com parab le  to those  generated  by the G C /M S  
M D 800).  W ithou t an internal standard  the percen tage varia tion  for both steroids was 
~ ± 1 0 % , therefore the GC M S D  m ass  spec trom eter was less susceptib le  to day-to-day  
instrum ent varia tions than the G C /M S  M D 800.
93
Chap te r  Four:  Opt imisa t ion  o f  Exper imenta l  Procedures
LC/MS rep ro d u c ib ility  d a ta  no  in te rn a l s ta n d a rd
10000
9000
8000
7000
6000
5000
4000
3000
2000
1000
LC/MS re p ro d u c ib ility  d a ta  w ith  in te rn a l  s ta n d a r d
18 
1.6 
(0 14
|  1.2
I 18. 0.8
£ 0.6 
0.4 
0.2 
0
Fig 4.10: Reproducib il i ty  o f  instrum ent response  (peak are) relating to
androstened ione (m /z  287) and androste rone  (m /z  2 9 1) w hen analysed  by LC /M S on 
the LC Q  D E C A  m ass spec trom eter  ana lysed  in posit ive  m ode using an ESI source. 
Left plot illustrates reproducib il ity  w ithou t an internal s tandard right plot illustrates 
reproducibility  with an internal standard variance was calculated  as RSD .
The RSD  produced  with and w ithou t use o f  an internal standard on the L C Q  D EC A  
were sim ilar  ~ ±1 0 % . From this small error it was conc luded  that there was little 
variation in the L C Q  D E C A  m ass spec trom eter in term s o f  peak area (the technique 
was reproducible).
Reproducibility of retention tim es of two stero ids in GC/MS 
MD800
Reproducibility in term s of reten tio n  t im es in 
GC/MSD.
S 40
3.35
3.3
3.25
3.2
3.15
3.1
3.05
3
Andorstene-<l»one A ndrosterone Androstene-dione
Fig 4.11: R eproducib il i ty  o f  retention tim es o f  and ros tened ione  and androsterone. 
Left hand graph show s re tention tim e reproducib il ity  ana lysed  on the G C /M S  
M D 800, with an El source in positive m ode. T he right hand graph show s relative 
retention t im es  o f  andros tened ione  and andros te rone  analysed using the G C  M S D  in 
positive m ode  with an E l source. The scale on the y-axis  are d ifferent due to d ifferent 
retention t im es o f  the steroids in the d ifferent m ass  spec trom eters  (d ifferen t co lum ns 
and tem perature  grad ien t system s G C /M S  M D 8 0 0  y-axis  is seconds and G C  M SD  is 
m inutes).
F igure 4.11 dem onstra tes  the high reproducib il ity  o f  the retention times o f  
androsterone and andros tened ione  in gas ch ro m atography  m ass  spec trom etry  
(G C /M S  M D 8 0 0  and G C  M SD ). Retention t im es  w ere h ighly  reproducib le  with or
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w ithou t use o f  an internal s tandard. V ariation  in the re tention tim e and relative 
standard devia tion  o f  the retention t im e with both gas ch ro m ato g rap h y  m ass 
spec trom eters  was com parab le  (table 4.11).
Fig 4.12: Plot show ing  the reproducib ility  o f  retention tim es o f  and ros tened ione  and 
androste rone. T hese  w ere analysed on the L C Q  D EC A  in positive m ode using an 
ESI source.
From the results presented above (figure 4 .12) it was conc luded  that retention time 
w as reproducib le  with a relative standard  devia tion  o f  ± 1 2 .5 %  in LC /M S. There  w as 
som e variation in retention tim es w ithou t an internal s tandard (~ ±20%  data not 
show n) this could  be due to incom plete  initial co lum n condition ing , pressure 
changes, flow rate changes  or d iffe rences  in ch ro m atog raphy  causing  polarity  to be 
low er or h igher than expected . C alcu la tions  o f  re lative retention t im es to an internal 
standard  reduce these  errors  (table 4.11 below).
4.5.2 Comparison of reproducibility for GC/MS MD800, GC MSD and LC/MS 
LCQ DECA
A com parison  betw een  the tw o G C /M S  techn iques  and L C /M S w as com ple ted . This 
p rov ides  in form ation concern ing  how  reliable each instrum ent was, and which 
m ethod  was superior in te rm s o f  rep roducib il ity  o f  peak area  and retention time.
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Table 4.10: Reproducibility comparison o f instrument response (peak areas) 
produced in GC/MS (GC/MS MD800 and GC MSD) and LC/MS (LCQ DECA): A 
comparison of RSD variations (calculated variation of 10 measurements recorded on 
2 separate days).________________ __________________________________ _________
Steroid
GC/MS
(MD800)
GC MSD LC/MS
± RSD % variation ± RSD % variation ± RSD % variation
Without an internal 
standard
Androstenedione 43.38 10.4 8.86
Androsterone 45.59 10.3 10.39
With an internal 
standard
Androstenedione 6.20 7.57 10.98
Androsterone 6.21 7.59 10.68
The RSD associated with peak area for the GC/MS MD800 was very large when an 
internal standard was not incorporated (the average RSD for these two androgens 
was ±44%). This error was significantly reduced with addition o f an internal 
standard to an average RSD error o f ±6.2%. This showed a significant run-to-run 
variation within the GC/MS MD800 system, the reason for this large variation could 
be due to the manual injection procedure, instrument parameter variation, or the GC 
itself. The GC MSD has much reduced errors without the internal standard in 
comparison to the GC/MS MD800, probably due to the automated injection system 
and superior heating and cooling system of the oven. RSD were ~±10% without an 
internal standard for the GC MSD, this was comparable with results generated by 
Van Renterghem9 and co-workers who investigated the reproducibility of a number 
of steroids using a GC MSD they calculated RDS values of between ±5.02 and 
21.9% for androsterone and ±5.70 to 35.5% for androstenedione (placing the values 
in table 4.10 at the lower end of their results). The LC/MS system (LCQ DECA) 
shows small variations in the RSD for peak areas due to day-to-day instrument 
variation. The LCQ DECA and GC MSD were comparable in terms o f RSD of peak 
area. This research highlights the importance o f use o f an internal standard for 
quantitative analysis. It should still be noted that even though the LCQ and GC 
MSD demonstrated comparable reproducibility values that the GC MSD was less 
sensitive than the LCQ and so cannot be used for low concentration analysis.
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Table 4.11: Comparison o f retention time reproducibility in GC/MS and LC/MS. A 
comparison of RSD variations (calculated variation of 10 measurements recorded on 
2 separate days).____________________________________________________________
Steroid
GC/MS
MD800
GC MSD LC/MS
± RSD % variation ± RSD % variation ± % RSD variation
Without an internal Androstenedione 0.17 0.02 19.9
standard Androsterone 0.17 0.27 5.15
With an internal Androstenedione 1.14 0.05 9.98
standard Androsterone 0.65 0.11 3.53
Percentage RSD variation o f retention time in GC/MS was low, both techniques were 
highly reproducible. Table 4.11 demonstrates that retention times in the GC/MS 
systems were more reproducible than the LC/MS system. The RSD retention times 
in LC/MS were as much as ±20%, which was reduced by approximately half with 
addition of an internal standard. Shifts in retention times can vary throughout a 
chromatographic run, the percentage variation is generally reduced at longer 
retention times.
LC/MS and GC MSD were more reproducible in terms of peak areas than the 
GC/MS MD800 (no internal standard). The GC/MS techniques were significantly 
more reproducible in terms of retention time than the LC/MS system, however the 
LCQ was more sensitive for androgens and progestins in positive mode (chapter 4.5) 
and has the capability of MS/MS. A dual procedure for complete positive 
identification and quantitation of a mixture o f steroids from a biological sample may 
be required. It was reasonable to assume that the errors associated with peak area 
and retention times for the other androgens, progestins and oestrogens will be 
comparable to those generated above.
4.6 Statistical analyses from calibration graphs using standard reference 
materials
The method required to obtain calibration graphs were described in chapter three 
(3.8). The results presented in this chapter represent the limit of detection calculated 
for a number o f steroids obtained through calibration series via LC/MS. From 
calibration graphs the concentration of a specific steroid in a biological sample was 
determined.
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Calibration graph for DHT0.25
y = 0.002x+ 0.004 
R2 = 0.994
0 20 40i 60 80
Concentration nM 100 120
Fig 4.13: Representative calibration graph for a series o f concentrations o f DHT. 
Instrument response (peak area ratio to IS) was plotted against concentration. 
Analysed on the LCQ DECA mass spectrometer in positive mode using an ESI 
source.
Table 4.12: Limit o f detection and R2 values for 8 steroids analysed on the LCQ 
DECA using a Ci8 reversed-phase column ESI source in positive mode. Methyl-
testosterone was the interna standard.
Steroid Limit of detection 
nM
R2
Testosterone 184 0.976
DHT 87.0 0.994
Androstenedione 36.1 0.987
DHEA 92.4 0.975
Androsterone 95.5 0.993
Androstanediol 80.5 0.969
Pregnenolone 211.7 0.998
Progesterone 83.5 0.991
The calibration graphs generated for each o f the eight steroids, with the use of an 
internal standard were statistically significant as the R2 values were all >0.98. 
Oestradiol and oestrone cannot be detected below a concentration of ~500nM, as 
when a steroid mixture was infused into the LC/MS system the protonated molecular 
ions [M+H]+ were indistinguishable from background. This may be because other 
steroids were ionised preferentially, therefore a more sensitive method was required 
for oestrogen analysis.
These limits o f detection were higher than the required performance limits for 
androgens as outlined in the WAD A (World Anti-Doping Agency) 2004 for doping 
laboratories, which are -lOng/mL10,11 the limits o f detection recorded here could be
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reduced by at least an order of magnitude by the use o f selected ion monitoring 
(SIM) which would produce comparable results to the WADA values. Physiological 
levels o f steroids present in biological samples may be higher than the calculated 
limits above, for example DHEA-S (a steroid precursor) has been recorded at a 
concentration o f lpM in postmenopausal women.12 In these experiments it was 
steroid metabolism under investigation, specific steroids were added at 
concentrations higher than the limit o f detection, so they and their major metabolites 
can be detected. Also after experiments steroids were concentrated by extractions 
from large volumes o f cell media and so were present at high concentration(s) in 
comparison to the limit o f detection of each steroid. For these reasons SIM was not 
required in these experiments.
4.7 Statistics for GC/MS calibration graphs using the GC/MS MD800 and GC 
MSD
Through calibration methods and a number of calculations it was possible to 
calculate the R2 value and the limit o f detection for each steroid using the GC/MS 
MD800 and GC MSD.
Table 4.13: Limit of detection and R2 values for nine steroids analysed by GC/MS
MD800 (without an interna standard).
Steroid Limit of detection 
jiM
R2
Testosterone 3.09 0.982
DHT 4.47 0.964
Androstenedione 3.04 0.983
DHEA 7.33 0.908
Androsterone 7.66 0.901
Pregnenolone 4.74 0.960
Progesterone 2.99 0.984
Oestradiol 2.25 0.989
Oestrone 9.96 0.843
These R2 values vary significantly, this was due to errors associated with the manual 
injection procedure (use o f an internal standard would increase the R2 value and 
lower the limit o f detection). To our knowledge there were no current examples of 
analysis of these steroids by GC/MS without prior derivatisation methods to improve 
the sensitivity o f the technique.
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Table 4.14: Limit o f detection and R2 values for nine steroids analysed by GC MSD 
(with an internal standard). _________________________________________________
Steroid Limit of detection 
pM
R2
Testosterone 1.40 0.995
DHT 1.65 0.996
Androstenedione 1.10 0.998
DHEA 2.03 0.990
Androsterone 1.50 0.996
Pregnenolone 2.56 0.983
Progesterone 2.56 0.990
Oestradiol 3.32 0.983
Oestrone 1.31 0.997
Addition o f an internal standard increases the R2 value for each of the steroids 
analysed. All the calibrations were statistically significant now as they all have an R 
value o f over >0.98. The limit o f detection was also reduced with the addition o f an 
internal standard by an average o f 1 .77pM for the GC MSD.
After analysis of these steroids by the GC/MS MD800 and GC MSD it was 
concluded that the R2 values were more statistically significant when using the GC 
MSD. The limit o f detection for each steroid was reduced when using the GC MSD 
in comparison to the GC/MS MD800 (whether an internal standard was used or not). 
These conclusions along with the auto-sampler availability and improved resolution 
confirm that the GC MSD was a superior instrument to the GC/MS MD800. The 
limit of detection for each steroid can conceivably be reduced following 
derivatisation and/or SIM experiments.
4.8 Comparison of GC/MS and LC/MS for determination of ideal technique for 
analysis of standard steroids
A comparison of LC/MS and GC/MS provides information concerning the optimum 
analysis technique for each steroid in terms o f the limit of detection. This was 
important because, neither LC/MS nor GC/MS is universal for low level steroid 
analysis. It was concluded that a dual method which includes both LC/MS and 
GC/MS was required to generate full steroid profiles (from cholesterol to oestradiol) 
in biological samples.
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Table 4.15: Comparison o f the limit o f detection (LOD) for GC MSD and LC/MS 
with internal standard.
Steroid
GC MSD LC/MS
LOD
tiM
R2 LOD
nM
Rz
Testosterone 1.40 0.995 184 0.976
DHT 1.65 0.996 87.0 0.994
Androstenedione 1.10 0.998 36.1 0.987
DHEA 2.03 0.990 92.4 0.975
Androsterone 1.50 0.996 95.5 0.993
Pregnenolone 2.56 0.983 21.2 0.998
Progesterone 2.56 0.990 83.5 0.991
Oestradiol 3.32 0.983 n/a n/a
Oestrone 1.31 0.997 n/a n/a
These results (table 4.15) demonstrated that the limit o f detection for each steroid 
generated by GC/MS (GC MSD) were higher than those generated by LC/MS (with 
an internal standard). LC/MS was an average o f ~20 times more sensitive than 
GC/MS. The R2 values for both were >0.98 showing that both sets o f data were 
statistically significant.
When a mixture o f steroids were analysed by LC/MS oestradiol was almost 
undetectable due to ionisation suppression. The signal produced when oestradiol 
was infused into the GC MSD as a mixture was much improved in comparison to 
LC/MS. Therefore for real sample analysis both LC/MS and GC MSD were 
required, or a derivatisation method may be employed for single instrument full 
steroid analysis.
4.9 Derivatisation for improved signal in GC/MS and LC/MS 
Derivatisation changes the molecule by adding a functional group which increases 
the ionisation efficiency o f the molecule. The two derivatisation procedures 
investigated have been previously described (chapter 3). The first was TMS 
derivatisation which aids GC/MS steroid identification by derivatising the hydroxyl 
groups present in some, but not all steroids.13 The second derivatisation procedure 
was aimed solely at increasing the mass spectrometers sensitivity to oestrogens, this 
was dansyl-chloride derivatisation.14 Dansyl-chloride derivatises the phenolic 
hydroxyl group present in oestrogens, this procedure permits identification of 
oestrogens in positive mode LC/MS and GC/MS.
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4.9.1 TMS derivatisation
T M S  derivatisa tion  was investigated  using testosterone, oestradiol,  p regneno lone  and 
oestrone solutions all o f  lOpM  in m ethanol.  Each steroid w as derivatised as outlined 
in chap te r  3.10. T he steroids w ere  then analysed  by direct infusion into the G C /M S 
M D 800  in positive m ode using an El source.
T E S T O S T E R O N E  TM S
TMS4 6 57  (13  952) S can  El*
Fig 4 . 14: T estosterone T M S  derivatisa tion  analysed on the G C /M S  M D 800 in 
positive m ode with an El source. T es tos te rone -T M S  deriva tive  and som e rem aining 
testosterone w ere observed  at 16 m inutes ,  the derivatisa tion  w as not 100% efficient.
Scan Eli- 
416 
3 27e4
13.75
Scan El* 
345 
1 68e5
STERTMS
1<Xh 1132
Scan El* 
272 
3 67e5
STERTf.'S
10th
Tine
14.50 1475 1500 1525 15.50
Fig 4.15: C h ro m ato g ram s show ing  the four peaks produced  after oestradiol TM S 
derivatisa tion . T hese ch ro m a to g ram s w ere  p roduced  on the G C /M S  M D 800 in 
positive ionisation m ode using an El source. T he top peak is representa tive o f  di- 
derivatised oestradiol m /z  416, the m iddle  peaks o f  selected m ass  m /z  345 were due 
to the tw o m ono-derva tised  co m p o u n d s  w hich can be produced  with oestrad io l-TM S 
derivatisa tion  (O H  groups at position  3 and position 17). T he final peak o f  selected 
m ass m /z  272 is un-derivatised oestradiol indicating  that the derivatisation was not 
100% efficient.
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Fig 4.16: C h ro m ato g ram s  and m ass  spec tra  show ing  incom plete  derivatisa tion  o f
pregnenolone. T w o  peaks w ere  seen in the total ion chrom atogram  representa tive  o f  
p regneno lone-T M S  and un-derivatised pregneno lone .  T hese  sam ples  w ere  analysed 
in positive m ode  using the G C /M S  M D 8 0 0  with an El source.
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Fig 4.17: T he  ch rom atogram  at the top  show s tw o  peaks af te r  T M S  derivatisa tion  o f  
oestrone. T he top ch rom atogram  and top m ass  spectrum  is the derivatised  oestrone 
m /z  342 the second chrom atog ram  and the low er m ass  spectrum prove that 
incom ple te  derivatisa tion  o f  oestrone has occurred  as the derivatised m olecu lar  ion 
m /z  270 is observed. A nalysed  on the G C /M S  M D 8 0 0  using an El source.
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Figures 4.14 to 4.17 demonstrated that TMS derivatisation of the hydroxyl groups 
occurred with testosterone, oestradiol, pregnenolone and oestrone as the derivatised 
molecular ion peaks were observed with all four compounds. Testosterone 
conversion was the most efficient o f these with little remaining underivatised 
testosterone present. Oestradiol-TMS chromatograms and spectra were complex 
because of the two mono, and one di-derivatised reaction end products (figure 4.15). 
The mono-derivatised compounds produced a molecular ion peak at m/z 345, and the 
di-derivatised compound produced a molecular ion peak of m/z 416. This leads to 
multiple peaks in the chromatograms representative o f one compound. This new 
level o f complexity will occur in any steroid with multiple OH groups such as 
androstene-diol, oestriol and 5a-androstane-3,17 diol. The complexity o f multiple 
derivatisation sites combined with incomplete derivatisation lead to an alternative 
derivatisation procedure being adopted.
4.9.2 Dansyl-chloride derivatisation
This procedure was initially investigated using oestradiol, oestrone, testosterone, and 
pregnenolone. It has been previously shown that derivatisation of oestrogens can 
lead to a large decrease in their limit o f detection by LC/MS.15 Dansyl-chloride 
derivatisation acts only at phenolic hydroxyl groups however testosterone and 
pregnenolone were also studied to ascertain if any derivatisation occurs at their 
hydroxyl sites. ~0.1mg of each steroid were derivatised as outlined in chapter 3.10, 
the end products o f these reactions were extracted and reconstituted in lmL of 
methanol. From these stock solutions 2pL was taken and diluted in lOOpL of 50/50 
methanol/water 0.1% acetic acid which was directly infused into the LC/MS.
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Fig 4 . 18: Full scan m ass  spectra  o f  dansy l-ch lo r ide-oes trone  (top spectra), the protonated 
m olecu la r  spec ies can clearly  be seen at [M +  deriva tive  + H ]+ = m /z 504. This  w as produced 
from direct infusion into the L C Q  D E C A  with an ESI source in posit ive  m ode. The 
L C /M S /M S  generated  fragm entation  pattern o f  the pro tonated m olecu la r  ion (m /z 504 
spectra) show ing  fragm ents  w h ich  further aid identification using selected reaction 
m onito r ing  (S R M ).
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Fig 4 . 19: Full scan m ass  spectra  o f  dansy l-ch lo ride-oestrad io l (top spectra), the protonated
m o lecu la r  ion can clearly  be seen at [M + deriva tive  + H ]+ =  m /z  506. This  w as p roduced  from 
direct infusion into the L C Q  D E C A  with an ESI source in positive m ode. T he L C /M S /M S  
generated  fragm entation  pattern o f  the pro tonated  m olecu la r  ion (m /z 506-bottom  spectra) 
sho w in g  fragm ents which further aid identification w hen using SRM .
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The mass spectra (figure 4.18 and 4.19) illustrated dansyl-chloride derivatisation of 
oestrone and oestradiol. Both full scan mass spectra display peaks which were 
indicative of the derivatised oestrogens. There were no abundant peaks in either 
spectrum which showed underivatised oestrogens, this shows the technique was 
efficient, although the lack of sensitivity towards the un-derivatised oestrogens 
should also be noted. Development of a new separation technique was also required 
for unequivocal identification o f the oestrogen derivatives. Dansyl chloride- 
oestradiol and dansyl chloride-oestrone were distinguishable due to a mass difference 
of 2Da, due to the 2 extra hydrogens which are present in oestradiol in comparison to 
oestrone.
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Fig 4 .20: Full scan m ass  spectra o f  dansy l-ch lo r ide  derivatised  tes tosterone and 
dansyl chloride derivatised p regnenolone. A na lysed  on the L C Q  D E C A  m ass 
spec trom eter  with an ESI source in positive m ode. N o derivatisa tion has occurred  as 
the calcu la ted  dansyl-ch loride  representa tive  peaks  at m /z 523 for testosterone and 
m /z 551 for pregneno lone w ere not present.
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Figure 4.20 illustrates no hydroxyl group dansyl chloride derivatisation of 
testosterone or pregnenolone, as there were no peaks at the predicted derivatisation 
m/z values. In both spectra the protonated molecular ion o f the underivatised steroid 
was abundant. The pregnenolone protonated molecular ion (figure 4.20) was less 
abundant than in the other spectra, this could be due to the reduced extraction 
efficiency o f pregnenolone from the aqueous to the organic phase in the 
derivatisation procedure, this theory was further supported by the steroid extraction 
data described later in this chapter (4.14). Androgen and progestin analysis should 
therefore be completed prior to oestrogen derivatisation.
4.9.3 Separation of Oestrogen dansyl-chloride derivatives
The polarity o f the derivatised oestrogens is now different from the free steroid and a 
new separation protocol was required. The separation of oestrogen dansyl chloride 
derivatives was described by Tai using an LC/MS system.16 The LCQ DECA system 
was optimised for the separation o f the oestrogen dansyl-chloride derivatives in 
positive mode using an ESI source.
A number o f elution programmes were investigated and an optimised gradient 
system o f methanol and water with 0.1% formic acid was required to elute oestrogen 
dansyl-chloride derivatives from a 150x1mm 3pm luna phenyl-hexyl column using a 
flow rate o f 40pL/min with an electrospray ionisation source in positive mode. The 
optimum elution was achieved at a starting concentration of 70% methanol which 
was maintained for 20 minutes, after which the methanol was increased to 100% at 
25 minutes (this 100% methanol was subsequently maintained until the experiment 
end at 60 minutes). The sample was first run in full scan mode and later for 
increased sensitivity using SRM for the fragments o f oestradiol-DC [M+H]+ 506 —► 
171 and oestrone-DC [M+H]+ 504 —►171. A method to confidently determine 
oestradiol and oestrone, due to their unique molecular ions and retention times using 
SRM was developed. Unique protonated molecular ions and fragmentation patterns 
were observed for each DC-oestrogen, which in combination with unique retention 
times (figure 4.21) allowed positive, more sensitive identification o f oestrogens by 
LC/MS in positive mode using an ESI source.
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Fig 4 . 2 1: Separation  o f  D C -oestradiol and D C -oestrone  (2 p M  solutions) on the LCQ  
D E C A  m ass spec trom eter  with an ESI source in positive m ode using a 
m ethano l/w ate r  0 .1%  formic acid using a l 5 0 x l m m  3p Luna phenyl hexyl co lum n. 
O estrad io l-D C  SR M  m /z 50 6 —>171 (top), and oes trone-D C  SR M  m /z 5 0 4 —>171 
(bottom ).
4.9.4 Optimisation of dansyl-chloride derivatisation
A n u m b er  o f  ex p e rim en ts  w ere devised with the aim o f  im prov ing  the effic iency  o f  
the derivatisa tion  procedure . This was com ple ted  by adapting  the deriva tisa tion  
m ethod  described  in chap te r  3.10. Four 2 p M  sam ples  o f  oestradiol and oestrone 
w ere prepared  each w as derivatised  using dansy l-ch lo ride  with a different m ethod  
adapta tion;
1. (all) the w hole  derivatisa tion  m ixture  w as dried and ana lysed-w ithou t an 
ex traction  step
2. (2-butanol)  2-butanol w as used as the extraction so lvent (2-butanol w as  
chosen  as it w as  calculated  as the op tim um  extraction so lvent for solid phase  
ex tractions chap te r 4.14),
3. (cen trifuged) the derivatised  m ix tu re  was cen tr ifuged  before analysis  and,
1 1 1
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4. (no buffer) der iva tisa tion  w as  undertaken without the sodium  ca rbonate  
buffer.
T hese  sam ples  w ere  then dried and reconstituted for LC/M S analysis. T hey  w ere 
ana lysed  using the op tim ised  L C /M S  separation procedure outlined previously.
12 Dansyl chloride derivatisation  
m eth od s.
O e s tra d io l
J J
a ll 2 -b u ta n o l  c e n tr ifu g ed
M ethod
Fig 4 .22: O ptim isa tion  o f  the dansyl-ch loride  derivatisation procedure  by chang ing  
reaction conditions. Peak areas w ere  proportional to concentration the largest peak 
area equa tes  to the largest percen tage conversion o f  oestrogen to the dansy l-ch lo ride  
oestrogen  species analysed on the L C /M S  LCQ  DECA in positive m ode using an ESI 
source. O estrone  is represented  in blue and oestradiol in red.
F igure 4.22 illustrated that the first derivatiastion procedure (all) w as the m ost 
effective- this w as analysis  o f  the w hole  derivatisation m ixture by L C /M S, h o w ever  
use o f  a guard co lum n was needed to protect the analytical co lum n from blocking. 
This m ethod  w as adopted for all future derivatisations.
4.9.5 Limit of detection for dansyl-chloride oestrogens
The in s tru m en t’s limit o f  detection  for derivatised oestrogens was ca lcu lated  by 
preparing  a calibration series o f  oestradiol and oestrone, derivatised  as described 
prev iously  (4.9.4). Six sam ples  ranging  in concentration from 2 0 p M  to 500nM  were 
analysed.
Table  4.16: L im it o f  detection and R2 values for dansyl-chloride derivatised 
oestrogens. A na lysed  on the L C Q  D EC A  m ass spectrometer with an ESI source  in 
posit ive  m ode._____________ _____________________________ _______________ ____________
Steroid LOD
nM
R2
Oestradiol 316 0.9899
Oestrone 516 0.9806
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These results significantly improve the oestrogen limits o f detection using an LC/MS 
system. Previously Lin and colleagues determined that the use o f dansyl chloride 
derivatisation increased LC/MS sensitivity to oestrogens by 1 or 2 orders o f  
magnitude compared to the un-derivatised steroids.17 A single instrument (LC/MS) 
can now be applied for full steroid analysis though Ci8 analysis o f the androgens and 
Luna phenyl hexyl analysis of dansyl-chloride derivatised oestrogens.
4.10 Optimal steroid analysis methods
Table 4.17 outlines the optimum analysis methods for nine steroids and cholesterol. 
The optimum methods were determined through combination of a number of  
parameters, such as sensitivity o f the mass spectrometer (limit of detection), 
complete separation and resolution o f steroid standards. GC/MS analysis was 
required for cholesterol analysis all other steroids can be identified and quantified 
using the LC/MS system.
Table 4.17: Optimal analysis method for ten steroids. This table represents the ideal 
method for analysis in terms o f sensitivity and resolution.________________________
Steroid Method Requirements
Testosterone LC/MS ESI positive mode
DHT LC/MS ESI positive mode
Androstenedione LC/MS ESI positive mode
DHEA LC/MS ESI positive mode
Androsterone LC/MS ESI positive mode
Pregnenolone LC/MS ESI positive mode
Progesterone LC/MS ESI positive mode
Oestradiol LC/MS Dansyl chloride derivatisation 
ESI positive mode
Oestrone LC/MS Dansyl chloride derivatisation 
ESI positive mode
Cholesterol GC/MS El positive mode
The results generated above were linked to recent literature via a number o f sources, 
for example Leinonen and co-workers concluded that ESI was the ideal method for
anabolic steroid analysis using a methanol/water elution system with acetic acid
•  •  •  18 •mobile phase additive, in comparison to other LC/MS ionisation methods, agreeing
with the results accumulated for androgen analysis.
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A study by Diaz-Cruz and colleagues confirms the results regarding progesterone 
analysis, LC/MS (ESI) was superior in terms of limit o f detection to GC/MS,2 (it was 
conceivable that the same can be assumed for the chemically similar pregnenolone).
Anari and co-workers concluded that dansyl chloride derivatisation significantly 
improves LC/MS sensitivity to oestrogens, this was confirmed in these 
experiments.14
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Part Two
Optimisation of extraction of steroids from biological samples
4.11 Optimisation of extraction procedures of steroids from biological samples
A nu m b er  o f  extraction m ethods  w ere investigated to de term ine  w hich  m ethod 
ex tracts  the w idest variety  o f  steroids m ost effec tively  as described  in chap te r  3.12. 
Initially an investigation into the solubility  o f  the steroids in d ifferent so lvents  was 
com pleted .
4.12 Solubility of testosterone and pregnenolone in water and methanol
T he solubility  o f  testosterone and p regneno lone  in m ethanol and w ate r  was 
determ ined  as described  in chap te r  3.12.
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Fig 4.23: Top graph illustrates the solubility  o f  testosterone in w ater, m ethano l/w ater  
(50 /50) and m ethanol.  L ow er graph illustrates the solubility  o f  p regneno lone  in 
w ater, m ethano l/w ate r  50/50 and m ethanol.  Tes tos terone  w as  m ore  so luble  in 
m ethanol than in water, with 50/50 solution having a m id-range  value. P regneno lone  
w as m ore  soluble in m ethano l than w ate r  with  the h a l f  and h a l f  solution produc ing  a 
m id-po in t  value. All errors w ere  calculated  from the standard  deviation  o f  tw o 
experim ents .
The percentage o f  organ ic  so lvent (com pared  to w ater) that steroids w ere  d issolved 
in affects  the concentra tion  o f  the d isso lved  steroid. The h igher  the percen tage  of 
m ethanol in the m ix tu re  the h igher  the concentra tion  o f  d isso lved  steroid. Tw ice  as
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much testosterone dissolved in methanol when compared to water, and 
approximately ten times the amount o f pregnenolone was dissolved in methanol in 
comparison to water alone (figure 4.23). In the 50/50 methanol/water samples both 
steroids produced a mid-point concentration between the high dissolved 
concentrations recorded in methanol and the lower dissolved concentrations in water.
From figure 4.23 it was concluded that addition of steroids to cells (via cell media) 
should not be completed with the steroid as a solid or in a water solution. The ideal 
method was to dissolve the steroid in methanol (or other organic solvent) and add a 
minimal volume to the cell media. A concentration o f less than 0.1% methanol in the 
cell media should have no negative effect on the cells, (a high methanol 
concentration would kill the cells).
After experiments were completed and steroids extracted solutions should be 
prepared in 50/50 methanol/water for LC/MS analysis. This was to reduce 
evaporation effects from the auto-sampler tray, and to ensure chromatographic 
performance was not affected which may occur with a 100% methanol solution.
4.13 Cell media extractions- simple steroid extraction methods
The optimum solvent for a wide range o f steroids will remove all steroids, 
(androgens, oestrogens and progestins) from an aqueous solution with the highest 
possible percentage recovery o f each. This extraction procedure can then be applied 
to extract steroids from cell media.
To calculate the optimum extraction solvent for simple liquid-liquid steroid 
extractions two steroids which widely differed in the elution sequence were chosen 
(testosterone and pregnenolone). The method for determination o f optimum steroid 
extraction solvent was outlined in chapter 3.12.
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Extraction of Testosterone and Pregnenolone by 
a number of solvents.0.25
0.2
□  T estosteron e
□  Pregnenolone0.15
0 . 1
0.05
C h lo ro fo rm  E th y l-a c e ta te H e x a n e
Fig 4.24: Relative extraction  efficiencies o f  d iffe ren t so lvents  for testosterone and 
pregneno lone  extraction from a w ate r  solution. A verage  peak area to an internal 
standard  was plotted aga inst  the so lvent used for extraction  (ch loroform , ethyl- 
acetate, hexane and M T B E ),  ana lysed  by L C /M S  in positive m ode using an ESI 
source. Tes tos terone  is represented  in blue and p regneno lone  in purple.
E thyl-acetate  w as the m ost effective ex traction  so lvent for testosterone, 
pregneno lone was extracted  m ost effectively  by M T B E . M T B E  was the least 
effective so lvent for tes tosterone ex tractions a lthough it has been w idely  used 
p rev io u s ly .19 T he errors assoc ia ted  with p regneno lone  w ere very high because  o f  the 
lack o f  so lubility  and poor extraction  o f  p regneno lone  from the aqueous  to the 
organic  phase. As a co m p ro m ise  e thy l-aceta te  extracts  both p regneno lone  and 
testosterone in re latively high am oun ts  and is therefore  the so lvent o f  choice for 
steroid ex tractions from w ater based sam ples.
This  investigation w as deve loped  to ana lyse  the cell m edia  as cell m ed ia  was m ainly 
water, h o w ev er  m any  other substances  w ere added to the m edia, including 
antibiotics, g lu tam ine , nutrients , foetal c a lf  serum , and o ther m inor  com ponen ts .  A 
n u m b er  o f  steroids w ere  added  to the Ish ikaw a cell m ed ia  (5m L  o f  D M E M , w ithout 
any added constituents),  and 5m L  o f  D M E M  with full additions (antibiotic, 
g lu tam ine , sodium  bicarbonate, sodium  pyruva te  and 10% foetal c a lf  serum as 
described  in table  2.5). The sam ples  were then ex tracted at least tw ice with ethyl- 
acetate  evaporated  to dryness  and reconstitu ted  in m ethano l/w a te r  50/50 0 .1%  acetic 
acid for analysis  by L C /M S.
Extraction o f  steroids from the D M E M  sam ple  (w ithou t additives) proved effective, 
but extraction  was not possib le  from the m ed ia  with additives. This  w as probably  
due to foetal c a lf  serum in the m edia  causing  a suspension  to form in the ethyl-
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acetate, causing incomplete separation o f the organic and aqueous layers, 
centrifuging the sample reduced this but the extraction was still ineffective. Steroids 
cannot be extracted effectively from media containing these additives by liquid- 
liquid extractions, a solid phase extraction method was developed to overcome this 
problem.
4.14 Development of solid phase extraction for the extraction of steroids from 
liquids
Solid phase extraction (SPE) was adopted as the method to extract steroids from cell 
media which contained interfering substances such as foetal calf serum. SPE has 
been widely used in steroid chemistry for a number o f applications from the drug 
abuse detection industry in cattle and athletes to oxy-steroid concentrations in neural 
human biology.20 The solid phase acts as a barrier to the interfering substances and 
so they were no longer problematic to the extraction procedure. The SPE procedure 
itself was initially investigated followed by its application to cells and cell media.
4.14.1 Solid phase extraction method validation
The SPE procedure was investigated using a lmL solution of a lpM mixture of 
pregnenolone and testosterone in water/methanol (50/50). This was completed using 
the SPE procedure outlined in chapter 3.13. The extracts were evaporated to dryness 
and re-constituted in 50/50 methanol/water 0.1% acetic acid for LC/MS analysis in 
positive mode using an electrospray ionisation source.
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Testosterone
Pregnenolone
Fig 4.25: Separation  o f  tes tosterone and  p regneno lone  after solid phase ex tractions 
from 1 pM  solutions, using the L C Q  D E C A  with an ESI source in positive mode.
lp M  to 50nM  solutions o f  tes tosterone and p regneno lone  in w ate r  w ere effectively  
extracted  from w ate r based so lutions by SPE  and detected  by L C /M S. Further 
op tim isation  o f  the techn ique  w as conduc ted  to de term ine  the percentage recovery  o f  
these steroids and the op tim um  elution solvent.
4.14.2 Solid phase extractions of steroids from cells
Steroid ex tractions from cells did not yield high steroid concen tra tions  after 
pregnenolone, tes tosterone and oestradiol additions  (lOOnM concentra tions).  It was 
concluded  that steroids w ere not present in the cells them selves  in high 
concentra tions , p robab ly  due to their lipophillic  nature therefo re  this p rocedure  w as 
not op tim ised.
4.14.3 Optimisation of solid phase extractions of steroids from cell media
Solid phase ex tractions o f  steroids from cell m edia  sam ples  w ere optim ised  from the 
original p rocedure  outl ined  in chap te r 3.13 using diffe ren t polarity  w ash  so lvents  for
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the final SPE steroid elution step. The elution wash was investigated to improve 
extraction efficiency of steroids from cell media, previously Cho and co-workers 
improved the recovery o f urinary steroids by changing the elution solvent when 
using an Oasis HLB column.21
To optimise steroid extraction using Cig SPE cartridges, the 85% methanol wash step 
was investigated as described in chapter 3.13. The use o f a number of solvents with 
a range of polarities were investigated, these were methanol, 2-butanol and ethyl- 
acetate with polarity indices o f 5.1, 4 and 5.8, respectively. The SPE procedure was 
completed as previously defined with the 40% methanol wash extended to remove all 
traces of phenol-red after which 2mL of methanol, 2-butanol or ethyl-acetate was 
used to elute the steroids. The eluted steroid solutions were then evaporated to 
dryness and reconstituted for mass spectrometry analysis. A number o f steroids were 
investigated to define which solvent produced the optimum recovery for a range o f  
steroids. These were DHEA, androsterone, DHT, oestrone, androstenedione, 
oestradiol, pregnenolone, testosterone and progesterone. The control sample was a 
steroid sample prepared in methanol and analysed directly (no sample loss due to 
experimental procedures).
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Extraction o f  9 s te r o id s  by SPE a n a ly se d  by GC/MS.
c o n tr o l
7
■ m e th a n o l
2 -B u ta n o l
Steroid ex tracted
Fig 4.26: Extraction effic iency o f  nine steroids by SPE using three d iffe ren t solvents 
m ethanol,  2-butanol and ethyl-acetate . T he control w as a non -S P E  100% steroid 
solution. T he peak area (proportional to concen tra tion) was expressed  as a ratio to 
the internal s tandard methyl testosterone. These  results w ere from the G C /M S  
M D 800 in positive m ode using an El source. E rrors  w ere produced  from the 
standard deviation o f  the peak area ratio to an internal standard  o f  tw o experim ents .
Table 4.18: Percentage recovery  o f  steroids when extracted  by SPE using three 
different elution so lvents analysed on the G C /M S  M D 8 0 0  with an El source. 
Percentage recovery  was calculated  by assum ing  the control sam ple  steroids produce 
a peak area representa tive  o f  100% recovery. T he percentage recovery  for the o ther 
steroids w as relative to the contol sample.____________________________________________
Solvent
Recovery o f  s teroids from  SPE. 
(% )
DHEA A ndro
sterone
DHT El A ndros tene
dione
E2 Testosterone Pregnenolone Progester
one
M ethano l 78.7 60.3 67.4 59.4 89.4 90.7 91.6 189 36.6
2-bu tano l 90.7 89.8 101 68.4 77.7 110 103 91.9 101
Ethyl-
aceta te 84.3 69.0 73.3 58.0 94.6 92.5 92.3 78.0 149
From the figure 4.26 and table  4 .18 it w as possib le  to de term ine  the ex traction 
effic iency (%  recovery) for all the steroids investigated w hen analysed  by G C /M S  
M D 800. It can be concluded  that 2-butanol was the op tim um  elution so lvent as a 
range o f  percentage recoveries  w ere  ob ta ined  w hich  were all o v e r  68%  with an 
average recovery  value o f  92 .7%  com pared  to 84 .9%  for m ethano l and 87 .8%  for 
ethyl-acetate.
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The sam e sam ples  w ere  also subjected  to L C /M S analysis. The L C /M S  results 
(figure 4 .27 and table 4 .19) agree  with the G C /M S  results, confirm ing  that 2-butanol 
w as the op tim um  solvent for m ax im u m  steroid elution from the SPE cartridges (as 
this w as non-derivatised L C /M S  techn ique  oestradiol w as not included).
3.5 Extraction of 8 steroids by SPE analysed by LC/MS
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Fig 4.27: Extraction effic iency  o f  e ight steroids by SPE  using three d ifferent solvents 
m ethanol,  2 -butanol and e thyl-acetate .  C ontro l is a n on-S P E  100% steroid solution. 
T he peak area (proportional to concen tra tion)  w as expressed  as a ratio to the internal 
standard  m ethyl testosterone. T h ese  steroids w ere detec ted  on the LC Q  D E C A  with 
an ESI source in positive m ode. Errors w ere  produced  form the standard deviation o f  
the peak area ratio to an internal standard  o f  tw o experim ents .
Table  4.19: Percentage recovery  o f  steroids from SPE cartridges  using m ethanol,  2- 
butanol and ethyl-aceta te  ana lysed  on the L C Q  D E C A  m ass  spec trom eter  using an 
ESI source in positive m ode. P ercen tage recovery  w as  calculated  by a ssum ing  the 
control sam ple  steroids p roduce a peak area representa tive  o f  100% recovery . The
Solvent
Recovery of steroids from  SPE.
(% )
DHEA DHT A ndro
sterone
E l Androstene
dione
Testosterone Pregnenolone Progester
one
M ethano l 72.2 63.7 69.0 65.6 93.4 83.3 115.0 107
2-butanol 87.9 86.4 85.0 103 100.1 92.5 87.1 97.9
Ethyl-
aceta te 36.6 68.0 67.8 68.1 90.1 82.8 71.4 112
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The percentage recoveries vary compared to those calculated for GC/MS, this was 
because o f the differing sensitivities o f each technique to different steroids. 
Oestradiol (E2), for example, was not detectable in LC/MS, and LC/MS analysis was 
more sensitive to progesterone. The overall average recoveries were similar for both 
techniques, the methanol average percentage recovery was 83.7%, 2-butanol was 
92.5% and ethyl-acetate was 74.6% in LC/MS compared to 84.9, 92.7 and 87.8% for 
methanol, 2-butanol and ethyl-acetate respectively via GC/MS MD800. Both data 
sets conclude that 2-butanol was most effective solvent for multiple steroid 
extractions, as a result o f this 2-butanol was employed as the steroid elution solvent 
for all SPE processes in these experiments.
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4.15 Conclusions
The detection, extraction and derivatisation o f steroids has been fully optimised and 
validated. These optimised methods were subsequently applied to biological samples 
to determine the steroid profiles and concentrations of each steroid in that profile.
The optimisation o f steroid standard mass spectrometry techniques and determination 
of limit of detection of each steroid in each mass spectrometer permits the confident, 
positive, identification o f steroids in water, cells and cell media. Quantitative 
determination of androgens and progestins in biological samples can now be 
assigned through calibration methods. Derivatisation o f oestrone and oestradiol was 
completed and optimised allowing for identification and quantitation o f oestrogens in 
biological samples.
The extraction methods o f steroids from cell media has been adapted and optimised. 
The percentage recovery o f steroids from media with foetal calf serum was now 
increased from virtually zero (liquid-liquid method) to an average recovery of more 
than 92% for a mixture o f androgens, oestrogens and progestins (SPE method), 
producing an effective extraction procedure. The SPE method produced high 
recovery, clean extracts and should be routinely used in steroid extractions from 
complex matrices such as cell media.
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Chapter Five
Steroid metabolism by endometrial cancer established cell lines, and
endometrial biopsies
Chapte r  Five: Steroid Metabol ism in Endometrial  Cell Lines and Biopsies
5.0 Introduction
This chapter describes the metabolism of testosterone by the endometrial cancer cell 
lines Ishikawa, HEC-1A, HEC-1B, and RL95-2 as well as the ovarian granulosa cell 
line COV434. These cell lines were used to determine the optimum methods for 
analysis of steroid profiles through mass spectrometry. Steroid concentrations were 
determined from the optimised calibration experiments outlined in chapter 4.2, using 
the internal standard methy 1-testosterone.
These experimental methods were subsequently applied to endometrial biopsy 
samples to determine steroid profiles (and enzyme expression-chapter 6) from 
women with endometriosis, PCOS and ovarian cysts, unexplained infertility, 
endometrial polyps, and moderate atypical hyperplasia, a fertile group was also 
analysed.
This chapter will present cell line and biopsy experiments principally focussing on 
the utilisation o f testosterone. The data is presented as follows;
Cell lines;
- Preliminary experiments to investigate the metabolism of pregnenolone, 
testosterone and oestradiol.
- Experiments regarding the utilisation of testosterone in established cell
lines.
- Androgen and oestrogen production in established cell lines following 
testosterone treatment.
- Kinetics relating to production/metabolism of specific steroids.
- Conclusions (cell lines).
Biopsies;
- Experiments regarding the utilisation o f testosterone in biopsies from fertile, 
endometriosis, PCOS, ovarian cyst and unexplained infertility.
- Androgen and oestrogen production in fertile biopsies (and a tubual disorder 
biopsy) following testosterone treatment.
- Androgen production in endometriosis, PCOS, ovarian cyst and unexplained 
infertility biopsies following testosterone treatment.
- Oestrogen production in endometriosis, PCOS, ovarian cyst and 
unexplained infertility biopsies following testosterone treatment.
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- Testosterone utilisation in an endometrial hyperplasia biopsy.
- Androgen and oestrogen production in an endometrial hyperplasia biopsy 
following testosterone treatment.
- Testosterone utilisation in an endometrial polyp biopsy.
- Androgen and oestrogen production in an endometrial polyp biopsy 
following testosterone treatment.
- Conclusions biopsies.
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5.1 Steroid Metabolism
Evidence suggests  that  the p recursors  to oestrogen  synthesis  in the endom etr ium  are 
the androgens tes tos terone  and andros tened ione ,  which are present in norm al and 
proliferative en d o m e tr iu m .1 T he  m ajority  o f  testosterone and andros tened ione  are 
synthesised outs ide  the en d om etr ium , for exam ple  in the ovary, adrenal glands or 
ad ipose  tissue w hich en ter  the endom etr ium  via the c irculatory  system . The 
conversion  o f  these  steroids to o ther  and rogens  and oestrogens is described  in figure
5.1.
17b-HSD5
17b-HSDZ 4
5AR1.25AR1.2
lAndrostane-dione
17b- HSD6
3-HSD1
»ndrostan©-clolAndrosterone
I7b-H S D 1. 5, 7
Fig 5.1: Suggested  pa th w ay  o f  tes tosterone and and ros tened ione  m etabolism  through 
steroid converting  en zy m es  into androgens  and oestrogens (the m ajo r  reactions were 
determ ined  from a literature search references 2, and 13-31 chap te r  1). 17b-HSD  = 
hydroxy  steroid d eh y d ro g en ase  which acts on position 17 o f  the steroid ring 3 -H SD  
acts at position 3 (the n u m b er  after the nam e donates  the isoform ). 5A R  = five a lpha 
reductase  tw o iso fo rm s 1 and  2. A rom atase  is the rate lim iting enzym e in the 
conversion  o f  and rogens  to oestrogens.
All the H S D ’s m en tioned  in th is  chap te r  and th roughou t this thesis are isoform s o f  
17(3-HSD, how ever to s im plify  the in form ation  they are expressed  as H SD 1, H SD 2 
etc.
5.2 Established cell lines: an introduction
E ndom etria l  es tab lished  cell lines have  been w idely  used as m odels  for s tudying 
steroid m etabolism  and gene  expression  in hum an  en d o m etr iu m .2 All endom etria l
130
Chap ter  Five: Steroid Metabo l i sm in Endometrial  Cell Lines and Biopsies
cell lines investigated in these experiments were representative o f type one cancers 
which typically develop from endometrial hyperplasia associated with oestrogen 
exposure.3 The ovarian cell line COV434 was incorporated as it has been previously 
demonstrated to highly express aromatase and was employed as a positive control.4
5.2.1 Ishikawa cells
Ishikawa cells are a model o f type one endometrial cancer derived from an 
endometrial adenocarcinoma in a 39 year old woman. Ishikawa cells have been 
widely used by numerous groups over the last twenty years.5
5.2.2 RL95-2 cells
RL95-2 are uterine epithelial adenosquamous cells, isolated from a 65 year old 
woman with grade 2 (moderately differentiated) cancer in the early 1980’s.6 These 
endometrioid cells grow quickly upwards in island-like formations.
5.2.3 HEC-1A and HEC-1B cells
HEC-1A and HEC-1B are similar endometrial epithelial adenocarcinoma cell lines 
isolated in 1968 from a grade two, endometrial carcinoma in a 71 year old woman. 
HEC-1B is a sub-strain of HEC-1A, the cells in the HEC-1B strain are flatter and 
more ‘pavement’ like than HEC-1A which tend to grow upwards in islands.7 The 
metabolism of steroids in these cell lines may not be identical due to differences in 
steroid converting enzyme expression.
5.2.4 COV434 cells
The COV434 established cell line was established in 1984 from a 27 year old woman 
with primary ovarian granulosa cell tumour. These cells grow quickly upwards in 
islands. Ovarian granulosa cells are involved in the formation o f the ovarian follicle, 
as well as conversion o f androgens to oestrogens and progesterone production 4
5.3 Endometrial biopsies
Biopsy samples were analysed using optimised experimental procedures developed 
using the cell lines to produce quantitative steroid (and enzyme expression) profiles. 
As many patient biopsies as possible from each o f the groups described in chapter 
one were collected (fertile and tubual disorders, PCOS, endometriosis, unexplained
131
C hap te r  Five: Steroid Metabol ism in Endometr ial  Cell  Lines and Biopsies
infertility). W here  this was not possib le  case studies were investigated (endom etrial 
hyperplasia , endom etr ia l polyp, ovarian  cyst). All endom etr ia l  b iopsies investigated 
w ere strom al cells (excep t one epithelial endom etr ia l  hyperp lasia  biopsy).
5.4 Steroid profiles of established cell lines
Each cell line w as initially ana lysed  to de term ine  the steroid profile under  basal 
cond itions  as described  in chap te r  3.14. This  was com ple ted  through optim ised 
ex tractions (S P E -chap te r  4 .14) o f  the culture  m edium  fo llow ing  exposure  to cells for 
48 hours w hich w as subsequen tly  ana lysed  by op tim ised  liquid ch rom atography  and 
gas ch rom atography  m ass  spec trom etry  (chap ter  4).
HEC-1B control
hfcCldC . ,
^  A n d r o s te r o n c
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Fig 5.2: Illustrative ch rom atog ram  show ing  the detection  o f  s teroids in H E C -1B  cell 
m edia. A ndroste rone, oestrone, tes tosterone and cholesterol w ere observed  in H EC - 
1B cell m ed ia  w ithou t addition  o f  steroid precursor. A nalysed  using optim ised  
p rocedures  on the G C /M S  M D 8 0 0  m ass  spec trom eter in positive m ode using an El 
source, (the num bers  o f  the chrom atog ram  refer to the retention time (seconds) o f  
each peak).
Table  5.1: Steroid present in cell m ed ia  o f  the estab lished  cell lines under basal 
conditions.
Cell line Steroids detected
Ishikawa
Testosterone, DHT, Androsterone, Androstenedione 
Oestradiol, Oestrone
HEC-1A
Testosterone, DHT, Androstenedione, Androsterone 
Oestradiol,Oestrone
HEC-1B
Testosterone, Androsterone 
Oestrone 
Cholesterol
RL95-2
Androsterone, Testosterone 
Oestradiol, Oestrone
COV434
Testosterone, Androstenedione, DHT 
Oestradiol, Oestrone
T he steroid profiles ca lculated  in table  5.1 (no added steroids) represent steroids 
present under  basal conditions , the presence o f  som e o f  these steroids is due to foetal
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calf serum (FCS) which was added to cell media as it is essential for optimum cell 
growth. These steroids can be removed by charcoal stripping the serum, however 
this process does not remove 100% of all steroids and it also removes growth factors 
which aid cell growth (which were important for growth o f endometrial biopsies). 
Addition o f steroids to the cell media were completed to determined the routes of 
steroid metabolism, three steroids were chosen for initial analysis these were 
pregnenolone, testosterone and oestradiol.
The metabolism of pregnenolone, testosterone and oestradiol by endometrial cell 
lines was investigated because,
1. pregnenolone is the precursor to androgen and oestrogen synthesis and 
production,8
2. testosterone is a major circulatory androgen,9
- increased testosterone concentration has been recorded in the ovarian veins 
of women with endometrial cancer,10
- testosterone is present at higher concentrations in endometrial tumours than 
in the circulatory system,11
- increased circulatory testosterone concentration is associated with increased
12risk o f developing endometrial cancer in postmenopausal women,
- testosterone is present at increased concentrations in the circulatory system 
of women with PCOS,13
- testosterone is a precursor to oestrogens in the normal and proliferative 
endometrium and,1
3. oestradiol is the most potent oestrogen responsible for proliferation and 
progression o f endometrial cancer,14 and is implicated in benign endometrial 
conditions such as endometriosis.15
5.5 Treatment of Ishikawa and HEC-1B cells with pregnenolone, testosterone 
and oestradiol
The HEC-1B and Ishikawa cell lines were treated with lOOnM solutions o f  
pregnenolone, testosterone and oestradiol and the metabolites recorded as described 
in chapter 3.14. lOOnM of each steroid (above biological concentration) was added 
to allow for low concentration products to be detected using the mass spectrometer.
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Table 5.2: Steroids produced after treatments of HEC-1B and Ishikawa cells with 
20mL 1 OOnM media solutions o f oestradiol, testosterone and pregnenolone.________
Cell line
Steroid added 
(lOOnM concentration) Steroids Detected
Ishikawa Pregnenolone Pregnenolone
HEC-1B Pregnenolone Pregnenolone
Ishikawa Testosterone
Testosterone, Androstenedione, 
DHT, Androsterone
HEC-1B Testosterone
Testosterone, Androstenedione, 
DHT, Androsterone
Ishikawa Oestradiol Oestrone, Oestradiol
HEC-1B Oestradiol Oestrone, Oestradiol
Pregnenolone was not metabolised into any other steroids when added to Ishikawa or 
HEC-1B cells. This suggests that the enzymes responsible for pregnenolone 
metabolism, P450cl7 is absent in Ishikawa and HEC-1B cells. There is some
literature which describes expression o f P450cl7 in the placental cell line JEG-3, but
to our knowledge there is no evidence o f expression in Ishikawa or HEC-1B cells or 
in the endometria,16 therefore any steroid production in the endometrium would 
require a precursor distal to pregnenolone in the metabolic pathway, circulatory 
testosterone and androstenedione have been suggested as such precursors.11
Addition of oestradiol to Ishikawa and HEC-1B cells resulted in an increase in
oestrone concentration. Previous studies by Chetrite and colleagues with the
Ishikawa cell line determined that the majority of added oestradiol was metabolised 
into the sulphated (excretion) product via the enzyme oestrogen sulphotransferase.5 
However, at high oestrogen concentration the sulphotransferases become saturated 
and instead oestradiol was converted to oestrone by the oxidative HSDs (17P-HSD2, 
4, 8) observed in figure 5.3. This was not pursued as the major objective was to 
explore utilisation o f testosterone by endometrial cells, however this would be an 
ideal experiment for future work.
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Fig 5.3: C h ro m ato g ram s o f  H E C -1B  cell lines before (top) and 72 hours after 
trea tm ent with oestradiol (be low ) using the G C /M S  M D 8 0 0  m ass  spec trom eter with 
an El source in positive m ode. T he top chrom atog ram  show s androsterone and 
cholesterol present in cell m edia  prior to steroid trea tm ent,  the low er ch rom atogram  
has tw o m ajor  peaks these  were due to oestradiol and oes trone  (ch rom atog ram s are 
scaled to the m ost abundan t  peak=  100).
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Fig 5.4: C h ro m ato g ram s for Ish ikaw a cell lines before  (top) and 48 hours after 
trea tm ent with tes tosterone (be low ) using the G C /M S  M D 8 0 0  m ass  spec trom eter 
with an El source in positive m ode. T he top ch rom atog ram  show s testosterone 
before addition to the cells and the low er ch ro m ato g ram  show s production o f  
androsterone, D H T  and androstened ione.
T hese  initial experim ents  revealed that testosterone p roduced  the m ost in form ative 
steroid profile (the m etabo lites  androstened ione ,  andros te rone ,  and D H T  were 
recorded figure 5.4). This  expe rim en t w as ex tended  to include m ore data points  over
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the 72 hour period permitting calculation o f time dependent steroid production. The 
experiments were also adapted to include testosterone treatments o f the established 
cell lines HEC-1A, RL95-2 and COV434.
5.6 Metabolism of testosterone in endometrial established cell lines
lOOnM solutions o f testosterone were added to the cell lines Ishikawa, RL95-2, 
HEC-1A, HEC-1B and COV434. The androgens and oestrogens produced were 
recorded at 8 hour intervals (Ishikawa and COV434) and 12 hour intervals (HEC-1A, 
HEC-1B and RL95-2) over a 72 hour period.
5.6.1 Enzyme Kinetics
The rate o f production o f each steroid and its subsequent conversion rate (if 
observed) was calculated by analysing the change in steroid concentration over time.
If a reaction is first order the rate o f reaction is dependent on the concentration and 
all time points and concentrations will fit the equation,
Ln = kt (equ 5.1)
C,
where Co is the concentration at time zero and Ct is the concentration at time t. t is 
time and k is the rate constant. A plot o f Ln(Co/Ct) against time will produce a linear 
line if the reaction was first order as demonstrated in figure 5.5.
T esto s te ro n e  d e a c y  in HEC-1B celts
3
2.5
2
1.5
1 r 2 =  0.9844
0.5
OO 12 24 36 48 60 72
Fig 5.5: Illustration o f a model first order decay o f testosterone by the HEC-1B cell 
line.
Graphs similar to figure 5.5 were produced for each cell line, where possible, 
permitting calculation of kinetic data for testosterone utilisation. Co is not always set
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at 0 hours, this is due to som e steroids not being present at the start o f  the reaction 
and so C 0 has to be adjusted , in o rder  to fit the equation.
5.7 Testosterone utilisation in established cell lines
Testosterone utilisation in each cell line w as com pared  to p rov ide  inform ation about 
differential utilisation o f  tes tosterone during  the 72 hour t rea tm en t period.
T e s to s te r o n e  u tilisa tion  in 5 e s ta b lis h e d  ce ll lin e s
C CAM 34 
Ishikawa 
RL95-2
HEC-1A 
HEC-1 B
0 8
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Fig 5.6: T he reduction in testosterone concentra tion  in Ish ikaw a (pink), C O V 4 3 4  
(dark blue), R L95-2 (yellow ), HEC-1 A (light blue) and HEC-1 B (purple) cell lines 
over  72 hours after addition o f  a lOOnM testosterone m ed ia  solution. S tero ids  were 
extracted from lOmL o f  cell m edia  at each tim e point. C oncen tra t ions  o f  
testosterone w ere  ob ta ined  by L C /M S  using the ESI sou rce  on  the LC Q  D E C  A m ass 
spec trom eter in positive m ode using m ethy l-tes tos terone  as an internal standard .
T estosterone concen tra tions  decreased  o ver  t im e in all cell lines, suggesting  it was 
m etabolised  to o ther products  (these products  are defined in the next section). The 
percentage converted  af te r  72 hours w as s im ilar  in Ish ikaw a 57%  and HEC-1 A 67%  
cells. 75%  o f  the tes tosterone has been converted  af te r  72 hours  in the C O V 4 3 4  cell 
line. The HEC-1 B cell line converts  88%  o f  the tes tos terone  to o ther p roduc ts  in the 
72 hour t im e period. T he cell line R L 95-2  m etabo lises  the largest am o u n t  o f  
testosterone 96%  conversion  to o ther p roducts  w ith in  the first 12 hours. To 
determ ine  the nature o f  these products  L C /M S  and L C /M S /M S  expe rim en ts  were 
com pleted  (described in chap ter  4.2).
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The d iagram  below  (figure 5.7) illustrates positive identification o f  testosterone in 
R L95-2 cells due to co m p ara t iv e  re tention t im es to tes tosterone and identical mass 
spectra.
Testosterone present in RL95-2
t r i o ‘J u n e  i ron  i i t f l i i n i u  u h c  a « » « i f t  h o o •  m i i a o i u  « « i u  u i  u  rui w i o e  b i l b
i Testosterone standard
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>3
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|  *■ RL95-2 mass spectra
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Testosterone mass spectra
Fig 5.7: T op  chrom atogram  and spec tra  show s positive determ ination  o f  testosterone 
in R L95-2 cells via m atch ing  ch rom atogram  and m ass spectra. Obtained  on the LCQ 
D E C A  m ass spec trom eter  using an ESI source  in positive m ode with a Cig colum n 
and m ethano l/w ate r  0 .1%  acetic acid elution system .
5.8 Steroid metabolism by established cell lines
To aid com parison  betw een  cell lines androgen  concentra tions  have been expressed 
as an average  ratio to the internal s tandard  at each t im e point analysed via LC/M S, 
and oestrogen  concen tra tions  as the peak  areas produced from the L C /M S /M S  
transitions (S R M ) o f  5 0 6 —> 171 (oestrad io l) and 504 —>171 (oestrone).
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Table  5.3: Steroid nom encla tu re  and co lours on graphics (observed  th roughou t this 
chapter).________________________________________________________________________
Steroid Colour on graphic
Testosterone Red
Androstenedione Blue
DHT
Androsterone
Androstanediol Green
Oestradiol
Oestrone Black
5.8.1 Steroid metabolism by the Ishikawa cell line
T he concentra tion  o f  tes tosterone decreased  after addition to the Ish ikaw a cell m edia  
from lOOnM at t im e zero  to ~43nM  after 72 hours. F igure 5.8 suggests  that the rate 
o f  decay  o f  tes tosterone is not a first o rder  process, as there is deviation  from the 
linear (a linear re la tionship  is not show n) and R 2 is low (the graph m ay  be linear over  
the first 24 hours h o w ever  there are not enough  data  points  to confirm  this).
A v e r a g e  r a te  o f  T e s t o s t e r o n e  r e d u c t io n  in  I s h ik a w a  c e l l s
1. 2
0 8
y = 0.01 38x  
R2 = 0.6421
0.2
726048362412
-0 2
Time (hours)
Fig 5.8: Rate o f  decay  o f  testosterone in Ish ikaw a cells  over  72 hours  after addition  
o f  a lOOnM testosterone m edia  solution. L n(C 0/C ) is plotted versus t im e to 
de term ine  the rate o f  reaction  and reaction o rder  in Ish ikaw a cells.
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Androgen production by Ishikawa cells a f te r  
t e s t o s t e r o n e  trea tm en t! .
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Fig 5.9: Steroid profiles o f  four and rogens  over  72 hours in Ishikaw a cells after 
addition  o f  a lOOnM testosterone  solution in 20m l o f  culture m edium . C oncentra tion  
w as calculated  as a ratio  to the internal s tandard  m ethyl-testosterone, analysed using 
an ESI source in positive m ode on the L C Q  D E C A  m ass spec trom eter with a Cjg 
reversed phase co lum n  and an optim ised  m ethano l/w ate r  0 .1%  acetic acid elution 
system. T he errors  bars  are produced  from  the standard deviation  o f  3 experim ents.
F igure 5.9 illustrates the production  o f  and rogens  in Ishikaw a cells over  72 hours 
after tes tosterone treatm ent.  It was possib le  to detect four androgens in the steroid 
bio-pathw ay, andros tened ione ,  DH T, andros te rone  and androstanedio l.  The 
concentra tion  o f  D H T  increased from 0 hours  to a m axim um  concentration  o f  
27.6nM  at 40  hours after w hich the concentration rem ained  constant. 
A ndros tened ione  concentra tion  increased steadily  from 8 hours until it reached a 
plateau at 48 hours (concentra tion  o f  8 .6nM ). The presence o f  D H T  and 
andros tened ione  suggests  that both sides o f  the androgen  bio-synthetic  pa thw ay were 
active in Ish ikaw a cells. T he  concen tra tion  o f  androsterone increased to a m axim um  
at 72 hours (10 .5nM ), suggesting  that this w as  a reaction end product.
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O estrogen production in Ishikawa ce lls  after testo steron e
treatm ent300000
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Fig 5.10: O estrogen  production  in Ishikaw a cells  af te r  addition  o f  a lOOnM m edia  
solution o f  testosterone over  72 hours. D ansy l-ch lo ride  deriva tives  ana lysed  using 
an ESI source in positive m ode on the L C Q  D E C A  m ass  spec trom eter  using a phenyl 
hexyl co lum n and an op tim ised  m ethano l/w a te r  0 .1%  form ic acid e lu tion  system . 
C oncen tra tion  is expressed  as peak area.
In the Ish ikaw a cell line there w ere high initial concen tra tions  o f  both oestrogens 
(due to FCS), the concentra tion  o f  oestradiol w as  high at t im e zero but o v e r  t im e 
concentra tion  decreases  (figure 5.10). O estrone  concen tra tion  d ec reases  af te r  t im e 
zero until 24 hours, oestrone concentra tion  then increased at 32 hours ,  (as the 
p recursor and ros tened ione  was readily  ava ilab le  at th is  time). It is possib le  that in 
Ishikaw a cells  and ros tened ione  w as converted  to oes trone  at 32 hours.
The initial concen tra tions  o f  oestrone and oestrad io l (tim e zero) de term ined  for all 
cell lines and biopsies were representa tive  o f  oes trogens  present in the cell m edia  
w ithou t any interactions with the cells. A n y  oes trone  or oestradiol de tec ted  at this 
t ime w ere  due to FCS and not due to conversion  o f  added  tes tosterone to oestrogens. 
R em oval o f  oestrogens via charcoal s tripp ing  o f  the FCS reduce the oes trogens  
present, h o w ev er  due to the variability  in rem ova l o f  androgens,  and p roges te rones  
coup led  with rem oval o f  grow th  factors w hich  aid cell g row th  th is  w as not 
perform ed.
T herefore  production  o f  oestrogens from added  tes tos terone  in cell lines and biopsies 
w as only  confirm ed if,
1. testosterone (or andros tened ione) co n cen tra t ions  decreased  in correlation with 
increased oestradiol (or oestrone) concen tra t ion  after t im e zero and,
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2. the change  in oestrad io l (or oestrone) concentra tion  w as significantly  
different from the p rev ious data  po int(s) (m ore  than the erro r  bars).
No oestradiol (or oes trone) w as being p roduced  if,
1. despite  tes tosterone (or andros tened ione)  being readily  ava ilab le  the 
concen tra tions  o f  oestrad io l and oes trone  rem ain  constan t or,
2. despite  tes tosterone (or and ros tened ione)  being readily  ava ilab le the 
concen tra tions  o f  oestrad io l and  oestrone decreased. T hese  rules w ere 
applied  th roughou t  this chapter.
5.8.2 Steroid production by RL95-2 cells after testosterone treatment
A ndrogen p roduction  in RL95-2 ce lls a fter te s to s te ro n e  trea tm en t
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Fig 5.11: A ndrogens  detec ted  over  72 hours  by RL95-2 cells after addition o f  a 
testosterone solution o f  lOOnM. C oncen tra t ion  was ca lcu lated  as a ratio to the 
internal s tandard m ethyl-tes tosterone, ana lysed  using an ESI source  in positive m ode 
on the L C Q  D E C  A m ass  spec trom eter  using a Cjg reversed phase  co lum n and an 
o p tim ised  m e thano l/w ate r  0 .1%  acetic acid elu tion  system.
The m ajority  o f  tes tosterone w as m etabo lised  by R L95-2  cells within the first 12 
hours. All tes tosterone appeared  to be converted  to the m ajo r  end product 
androste rone  v ia  the in term ediate  and ros tened ione ,  this was com ple ted  in the first 48 
hours o f  the experim ent.  There  w as  no D H T  or androstaned io l produced  after 
tes tosterone trea tm ent sugges ting  that on ly  one  side o f  the b io -pa thw ay  w as active 
(f igure 5.12). The m ax im u m  concen tra tion  o f  androstened ione  w as  46 .7nM  at 12 
hours, and the m ax im um  concen tra tion  o f  andros te rone  w as 74.8nM  at 36 hours.
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Fig 5 . 12: D iagram  illustrating the active pa thw ay  (h ighligh ted  yellow ) o f  androgen  
synthesis  in R L95-2 cells.
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Fig 5.13: A ndros tened ione  is p roduced  from tes tos terone  in R L 95-2  cells over  72 
hours after addition  o f  a lOOnM testosterone m ed ia  solution. A nd ro s ten ed io n e  decay  
appears  to be a first o rder  process  as a linear re la tionship  w as observed  w hen 
Ln(C o/C ) is plotted aga inst  time. Co has been ad justed  to 12 hours.
T he rate o f  the reaction w as ca lcu lated  with the concen tra tion  o f  and ros tened ione  at 
12 hours  being  defined as C 0 as before 12 hours  there w as no p recursor p resen t for 
this reaction ( testosterone w as converted  to andros tened ione  in the first 12 hours). 
T he  m etabolism  o f  and ros tened ione  to its end p roduc ts  w as a first o rder reaction  as a 
l inear rela tionship  is observed  w hen concen tra t ions  is plotted against Ln(CO/C) and 
R 2 is 0.9913 (figure 5.13).
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Production of oestrogens in RL95-2 cells after testosterone  
treatment
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Fig 5 . 14: O estrogen  produc tion  in R L 95-2  cells o ver  72 hours after addition o f  a 
lOOnM testosterone m ed ia  solution . D ansy l-ch lo ride  derivatives analysed using an 
ESI source in positive m ode on the L C Q  D E C A  m ass  spec trom eter using a phenyl 
hexyl co lum n  and an op tim ised  m e th an o l/w a te r  0 .1%  formic acid elution system .
The concen tra tions  o f  oestradiol and oes trone  rem ained  constan t th roughout the 
experim ent,  in R L95-2 cells  this sugges ts  that there was no arom atisa tion  o f  
testosterone (or and ros tened ione)  to o es trogens  af te r  testosterone treatment.
5.8.3 Steroid metabolism by HEC-1 A cells after testosterone treatment
Production of androgens in HEC-1 A cells  after testosterone  
treatm ent
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Fig 5.15: A ndrogen  p roduction  in HEC-1 A cells over  72 hours after addition  o f  a 
lOOnM testosterone m ed ia  solution. C oncen tra t ion  was calculated as a ratio to the 
internal s tandard  m ethyl-tes tosterone, ana lysed  using an ESI source in positive m ode 
on the L C Q  D E C A  m ass  spec trom eter  using  a Cig reversed phase co lum n and an 
op tim ised  m ethano l/w a te r  0 .1%  acetic ac id  elution system.
Four andro g en s  were detec ted  as m etab o li tes  o f  testosterone in HEC-1 A cells, these 
were and ros tened ione ,  D H T, andros te rone  and androstanedio l.  The concen tra tions
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o f  and ros tened ione  and androste rone  increased to a m ax im um  o f  15.0 and 17.0nM 
respectively  at 60 hours. The concen tra tion  o f  D H T  reaches a m axim um  
concentra tion  o f  11.6nM at 24 hours. The reaction end product androstanedio l was 
produced  after 24 hours and reaches a m ax im u m  at 60 hours.
Both sides o f  the steroid b iosynthetic  pa thw ay  w ere  active in this cell line, confirm ed 
by the presence o f  D H T  and androstened ione .
Testosterone decay in HEC-1A cells
0.0133x 
0.8896
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Fig 5.16: D ecay o f  testosterone is HEC-1 A cells  o ver  72 hours after addition o f  a 
lOOnM testosterone m edia  solution. T es tos terone  decay  appears  to be a first order 
process as a linear re la tionship  was observed  w hen  Ln(Co/C) is plotted aga inst time.
The m etabolism  o f  tes tosterone in HEC-1 A cells  w as  probably  a first o rder reaction, 
ho w ev er  there w as som e d ivergence p robab ly  due to the production  o f  two 
testosterone m etabo lites  (andros tened ione  and D H T ) o r p roduction  o f  testosterone 
itself. T he result  o f  this is the R 2 value  is low er than expected  for a first o rder 
reaction.
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P ro d u c tio n  o f  o e s t ro g e n s  in  H E C -1  A  c e l ls  a f te r  te s to s te r o n e  
t r e a tm e n t
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Fig 5 .17: O estrogen  p roduction  in H E C -IA  cells over  72 hours after addition  o f  a 
lOOnM/pL testosterone m ed ia  solution. D ansyl-ch loride  deriva tives  analysed using 
an ESI source in positive m ode  on the L C Q  D E C A  m ass  spec trom eter using a phenyl 
hexyl co lum n and an op tim ised  m ethano l/w ate r  0 .1%  form ic acid elution system.
A gain  there w ere oestrogens present at t im e zero  ( low er than in the o ther cell line 
m edia) thought to be due to oes trogens  present in foetal c a l f  serum . The 
concentra tions  o f  oestradiol and oestrone increased after this t im e suggesting  that in 
these cells utilisation o f  testosterone (and andros tened ione)  possibly  via the 
a rom atase  enzym e w as occurring. T here  w ere f luctuations in the oestrogen 
concentra tions  this could  be due to in ter-conversion  betw een  oestradiol and oestrone 
possibly th rough the 17(3-HSDs.
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5.8.4 Steroid metabolism by HEC-1 B cells after testosterone treatment
Production of androgens in HEC-1 B cells  after testosterone  
treatm ent
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Fig 5.18: P roduction o f  and rogens  in F1EC-1B cells o ver  72 hours after addition  o f  a 
lOOnM testosterone m edia  solution. C oncen tra tion  w as calculated  as a ratio to the 
internal s tandard m ethyl-tes tosterone, analysed using an ESI source in positive m ode 
on the L C Q  D E C A  m ass  spec trom eter using a Cig reversed phase co lum n  and an 
optim ised  m ethano l/w ate r  0 .1%  acetic acid elution system .
A fter addition o f  tes tosterone to the cell m edia  o f  HEC-1 B cells, again four 
androgens  w ere detected , DH T, andros tened ione ,  and ros te rone  and androstanedio l 
observed  in figure 5.18. A m ax im um  concentration  o f  D H T  o f  47 .6nM  w as  detected 
at 12 hours, the concen tra tion  o f  D H T  then dec lined th roughou t the rem a inder  o f  the 
experim en t with the appearance  o f  androsterone. T he concentra tion  o f  
androstanedio l increased from 12 hours o nw ards  to a m ax im um  concentra tion  o f  
7 .87nM  at 36 hours. In HEC-1 B cells the m ajor  tes tosterone m etabolism  route 
appeared  to be via p roduction  o f  D H T  in preference to andros tened ione  (figure 5.19).
147
C h ap te r  Five: Steroid M etabo lism  in Endom etrial Cell Lines and B iopsies
A n d r o s t e n e - d i o n e
I7b-HSD2. 17gHSD4
T  e s t o s t e r o n e
5A R 1
5A R 2 I5AR15A R 2
[ A n d r o s t a n e - d i  o n e 1 7 b -H S D  2 .5 ,8 .1 0 D H T
3a-HSD
3b-HSD
3a-l kSD 
3 b -H S D
a
A n d r o s t e r o n e ¥ A n d r o s t a n e - d i o l
O e s t r o n e
17b-HSD2 17b-HSD4 17b-HSDB 
17b-H Sni '7i>HSD5__________ O e s t r a d i o l
Fig 5.19: M ajo r  tes tosterone m etabo lic  route in HEC-1 B cells.
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Fig 5.20: D ecay  o f  tes tos terone  in H E C -IB  cells over  72 hours after addition  o f  a 
lOOnM testosterone m ed ia  solution . T es tos terone  decays appears  to be first o rder 
processes  as a linear re la tionship  w as observed  w hen Ln (Co/Ct) w as plotted against 
time.
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Fig 5.21: D ecay  o f  D H T  in HEC-1 B cells over  72 hours after addition o f  a lOOnM 
testosterone m edia  solution. D H T  decays appears  to be first o rder p rocesses a a 
linear re la tionship  w as observed  w hen  Ln (Co/C) was plotted aga inst time. Co has to 
be altered to 12 hours  as before this t im e no D H T  is present.
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F igure 5.20 illustrates that testosterone utilisation in HEC-1 B cells was a first o rder  
decay. T here  w as one m ajor  in term ediate  produc t o f  this reaction D H T, the highest 
concentra tion  o f  which w as p roduced  at 12 hours and was m etabolised  via the 5A R  
enzym es.  A fte r  this t im e D H T  w as converted  into its m etabolites  again as a first 
o rder  reaction (f igure 5.21). T estosterone  w as also  m etabolised  to the m in o r  
products  androstened ione ,  oestrone and oestradiol.
80
Fig 5.22: D ecay  o f  andros tened ione  in HEC-1 B cells over  72 hours after addition  o f  
a lOOnM testosterone m ed ia  solution . A ndros tened ione  m etabolism  appears  to be a 
first o rder process as a linear re la tionship  w as  observed  w hen Ln (Co/C) was plotted 
aga inst  time.
T he decay  o f  andros tened ione  in HEC-1 B cells  w as also a first o rder  process, 
possibly  th rough the production  o f  oestrone o r o ther androgens. This  w as the m inor 
produc t o f  testosterone b iosynthesis ,  the concen tra tions  o f  which w ere  close to the 
limit o f  detection  (36 .1nM ).
A n d ro sten e-d io n e  d eca y  in HEC-1 B c e lls
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Production of oestrogens in HEC-1 B cells after testosterone  
treatm ent1 4 0 0 0 0 0 0
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Fig 5.23: P roduction  o f  oes trogens  in HEC-1 B cells  over  72 hours after addition o f  a 
lOOnM testosterone  m ed ia  solution. D ansy l-ch lo ride  derivatives analysed using an 
ESI source in positive m o d e  on the L C Q  D E C A  m ass spec trom eter using a phenyl 
hexyl co lum n and an op tim ised  m e thano l/w ate r  0 .1%  formic acid elution system.
T he am o u n t  o f  oes trogens  present at t im e zero  w ere  m uch reduced in this cell line in 
com parison  to the o ther cell lines h ighligh ting  the variation between batches o f  foetal 
c a lf  serum  com posit ion .  There  w as a large increase in the concentra tions  o f  
oestradiol and oestrone at 12 hours suggesting  that testosterone and androstenedione 
w ere being  converted  to oestradiol and oes trone  in HEC-1 B cells possib ly  via the 
a rom atase  enzym e . T he  concentra tion  o f  oestrone then decreased to an a lm ost 
constan t value  after 24 hours  until the end o f  the experim ent.  The concentration  o f  
oestrad io l ho w ev er  increased again at 48 hours, this suggests  that testosterone has 
been m etabo lised  to oes trogens  in this cell line e ither th rough direct arom atisa tion  or 
v ia the in term ediate  andros tened ione  (via H S D s)  fo llow ed by arom atisa tion.
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5.8.5 Steroid metabolism by COV434 cells after testosterone treatment
Androgens produced in COV434 cells after 
testosterone treatment.0.3
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Fig 5.24: A ndrogen  produc tion  in C O V 4 3 4  cells  over  72 hours after add it ion  o f  a 
lOOnM testosterone m ed ia  solution. C oncen tra tion  is calculated as a ratio to the 
internal standard m ethyl-tes tosterone, ana lysed  an ESI source in positive m o d e  on 
the L C Q  D E C A  m ass spec trom eter  using a Cig reversed phase co lum n and an 
op tim ised  m ethano l/w ate r  0 .1%  acetic acid elution system .
Four androgens  w ere detec ted  after addition  o f  tes tosterone to the C O V 4 3 4  cell 
m edia  (androstened ione, D H T, andros te rone  and androstanedio l) .  T hese  results 
suggest the m ajo r  testosterone m etabolism  route in this cell line occurs th rough  D H T  
to the end product and ros te rone  (the route outlined in figure 5.19). The 
concentra tion  o f  D H T  increased after addition o f  testosterone to a m ax im u m  o f  
94 .7nM  at 48 hours. T he  androgen ic  end produc t w as  andros te rone  with a m ax im um  
concen tra tion  o f  12.3nM recorded at 48 hours. A m axim um  concen tra tion  o f  
androstanedio l w as detected as a reaction end p roduc t at 48 hours (12 .6nM ).
T esto stero n e  d ecay  in COV434 cells
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Fig 5.25: T es tos terone  decay  in C O V 4 3 4  cells  o v e r  72 hours af te r  add it ion  o f  a 
lOOnM testosterone m edia  solution. A plot o f  L n (C 0/C) aga inst t im e dem onstra te s  
that testosterone m etabolism  in C O V 4 3 4  w as  a first o rder process.
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T he m etabolism  o f  tes tosterone was a first o rder  process in C O V 4 3 4  cells. There 
w as an error produced at 32 hours, w hich  w as  correlated with the variation in D H T 
concen tra tions  at this t im e (figure 5 .24). T he explanation  for this large error could 
be because  the p roduction  rate o f  D H T  at 32 hours was different in one experim ent 
(possib ly  due  to d ifferent expression  o f  specif ic  enzym es),  or due to testosterone 
production .
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Fig 5.26: O estrogen  production in C O V 4 3 4  cells over 72 hours after addition o f  a 
lOOnM testosterone m ed ia  solution. D ansy l-ch lo ride  derivatives analysed using an 
ESI source in positive m ode on the L C Q  D E C A  m ass spec trom eter using a phenyl 
hexyl co lum n  and an op tim ised  m e th an o l/w a te r  0 .1%  formic acid elution system.
C oncen tra t ions  o f  oestradiol and oestrone w ere  high in the cell m ed ia  (observed at 
t im e zero) probably  due  to their  p resence in the FCS, after the first 8 hours the 
concen tra t ions  o f  oestradiol and oes trone  decreased. T he concentra tions  o f  
oestradiol and oestrone then essentially  rem ain constan t suggesting  that testosterone 
w as not be ing  m etabolised  to oestradiol o r  oestrone in C O V 4 3 4  cells.
5.8.6 Conclusions- cell lines
A n d ro g en s  and oestrogens w ere detec ted  after testosterone trea tm ents  o f  the cell 
lines, and the m etabolism  o f  tes tosterone w as  different in each cell line.
T he detec tion  o f  tes tosterone m etabo lites  has been studied for m any  years, primarily  
in and rogen  responsive  t issues. In 1973 D orring ton  and co-w orkers  recorded the 
p resence o f  androgens (andros tened ione ,  androsterone, D H T  and androstanediol) 
after tes tos terone  trea tm ent o f  the sem in iferous  tubules isolated from m ale rats. They
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observed localised steroid metabolism routes in this androgen responsive tissue 
comparable to that observed in the oestrogen responsive cell lines above,17 
suggesting that while the roles o f  a specific steroid in each tissue may be different the 
metabolism routes are similar. There is also metabolism data available for the breast 
cancer cell line ZR75-1, which is comparable to the data outlined above, after 
androgen treatment o f  this cell line androgen metabolism readily occurs with no 
detectable aromatisation to oestrogens.18 Information about androgen metabolism in 
endometrial cancer cell lines is less widely available, a recent paper however 
described the metabolism o f  androstenedione in the established cell lines Ishikawa, 
HEC-1A, HEC-1B, and RL95-2. In the article Fournier and colleagues described 
metabolism o f  DHT, testosterone, androsterone, and androstanediol after 
androstenedione treatment with no reported conversions to oestrogens19 (GC/CI-MS 
technique) which was directly correlated to the data recorded in these experiments.
Table 5.4 Times and maximum concentrations o f  androstenedione and DHT in 
established cell lines. Detected on the LCQ DECA mass spectrometer using a Ci8 
column, with an ESI source in positive mode using an optimised methanol/water 
elution system with 0.1% acetic acid. Concentrations were calculated via
Cell Line Maximum concentration 
nM
Time
hours after testosterone 
treatment
Androstenedione
Ishikawa 8.6 48
RL95-2 46.7 12
HEC-1A 15.1 60
HEC-1B Below LOD (36.1) 24
COV434 5.3 16
DHT
Ishikawa 27.6 32
RL95-2 n/a n/a
HEC-1A 11.6 24
HEC-1B 47.6 24
COV434 94.7 48
The highest concentration o f  androstenedione was recorded in the RL95-2 cell line at 
48 hours, DHT was not detected in this cell line. The COV434 and HEC-1B cell 
lines produced the highest concentrations o f  DHT and the lowest concentrations o f  
androstenedione. From these results it was possible to ascertain the principal route 
o f  testosterone metabolism in each cell line. In the RL95-2 cell line testosterone
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metabolism was through androstenedione in the COV434 and HEC-1B cell lines 
testosterone metabolism occurred mainly through DHT. In the Ishikawa and HEC- 
1A cell lines testosterone metabolism occurred through both DHT and 
androstenedione, suggesting that both sides o f the bio-pathway were active. 
Information concerning the expression o f  5AR1, 5AR2 and a number o f  170-HSDs 
may explain differences in the metabolic pathways favoured in each cell line 
(chapters 6 and 7).
Table 5.5 Table o f  maximum concentrations o f  androsterone and androstanediol in 
all established cell lines. Detected on the LCQ DEC A mass spectrometer using a Cig 
column, with an ESI source in positive mode using an optimised methanol/water 
elution system with 0.1% acetic acid. Concentrations were calculated via 
comparison to a calibration series for each steroid as described in chapter 4._________
Cell Line Maximum concentration 
nM
Time
hour
Androsterone
Ishikawa 10.5 72
RL95-2 74.9 36
HEC-1A 17.0 60
HEC-1B 8.1 72
COV434 12.3 48
Androstanediol
Ishikawa 40.9 72
RL95-2 n/a n/a
HEC-1 A 13.0 60
HEC-1B 7.9 36
COV434 12.6 48
The highest concentration o f  androsterone was recorded in RL95-2 cells, again due 
to the simplicity o f  testosterone metabolism in these cells. The lowest concentration 
o f androsterone was detected in the HEC-1B cell line. The highest concentration o f  
androstanediol was detected in the Ishikawa cell line at 72 hours. There were similar 
maximum amounts o f  androstanediol detected in HEC-1A (60 hours) and COV434 
(48 hours).
Androsterone and androstanediol were the major androgenic end products. It is 
conceivable that whichever way testosterone was metabolised (via DHT or 
androstenedione) that androsterone and androstanediol was produced due to inter­
conversions through HSD enzymes.
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Table 5.6 Table o f  maximum concentrations o f  oestradiol and oestrone in all 
established cell lines (concentrations at time zero were not included). Detected on the 
LCQ DECA mass spectrometer using a luna phenyl hexyl column, with an ESI 
source in positive mode using an optimised methanol/water elution system with 0.1% 
formic acid. Concentrations were calculated via comparison to a calibration series 
for each steroid as described in chapter 4.________________________________________
Cell Line Maximum concentration 
(nM)
Time
hour
Oestradiol
Ishikawa 1.55 16
RL95-2 1.45 72
HEC-1 A 1.77 60
HEC-1B 7.59 12
COV434 1.87 48
Oestrone
Ishikawa 2.53 32
RL95-2 1.95 72
HEC-1 A 4.88 36
HEC-1B 2.91 12
COV434 1.01 16
The highest concentration o f  oestradiol was produced in the HEC-1 B cell line at 12 
hours and the lowest in RL95-2 cells at 72 hours. The highest concentration o f  
oestrone was detected in the HEC-1A cell line (36 hours), and the lowest 
concentration was detected in COV434 cells (16 hours). These results demonstrate 
some oestrogen production was occurring after testosterone treatment however in 
comparison to androgen synthesis this was a reduced pathway. It should also be 
noted that there were oestrogens in the FCS under basal conditions and insensitivity 
to oestrogens compared to androgens in the mass spectrometer may lead to reduced 
sensitivity to oestrogens.
These experiments provide quantitative information concerning the metabolism o f  
testosterone in endometrial established cell lines. The results generated determine 
the route o f  testosterone metabolism in the endometrial epithelial cancer cell lines. 
At high testosterone concentration androgen synthesis occurred readily, and the 
production o f  oestrogens was minor in all cell lines investigated. Oestrogen 
production was not a major metabolism pathway in these oestrogen responsive cell 
lines irrespective o f  aromatase expression. This unexpected result could be due to a 
number o f factors such as saturation o f  the aromatase enzyme in high androgen 
environments, or due to the correct co-factors for the aromatisation not being present.
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The mRNA expression and aromatase activity may not be directly linked which 
could further explain the disparities between high aromatase expression and no 
oestrogen production. This is further discussed in chapter 7.
5.8.7 Conclusions testosterone utilisation (reaction kinetics)
The utilisation o f  testosterone was investigated in the established cell lines (figures 
5.8, 5.16, 5.20, and 5.25).
Table 5.7: Reaction kinetics for testosterone metabolism in established cell lines.
Cell
line
Rate
equation R2
Rate
constant
k
Reaction
Order
Final
testosterone
cone
nM
Half life 
hours
HEC-1B 0.0298x 0.9944 0.0301 1 12 23.26
COV434 0.0176x 0.9402 0.0168 1 15 39.38
RL95-2 - - - - 4 -
Ishikawa 0.0138x 0.6421 0.0192 9 43 50.23
HEC-1 A 0.0133x 0.8896 0.0129 ~1 33 52.12
First order reactions were observed for testosterone decay in HEC-1 B and COV434 
cells (figures 5.20 and 5.25). The rate o f  conversion is directly proportional to the 
concentration o f  testosterone, this was observed because there was only one major 
product for both reactions, testosterone —> DHT.
The kinetics o f  testosterone metabolism in RL95-2 cells was not possible to 
determine as more than 96% o f  the testosterone was utilised in the first 12 hours.
The decay o f  testosterone in Ishikawa cells is not a first order process no linear 
relationship was observed (figure 5.8). The other two cell lines, Ishikawa and HEC- 
1A produced two products when testosterone was added (DHT and androstenedione), 
which makes the kinetics more complex, simple relationships between reaction rate 
and concentration were not observed (relationships were not linear and R2 <0.90).
An increase in testosterone concentration would cause the rate o f  reaction to appear 
to decrease, causing divergences from the linear as observed in HEC-1 A cells at 24 
and 60 hours (figure 5.16), (a calculated decrease in the rate o f  reaction and R2 
values). If these data points were removed the data set becomes more linear (R 
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increases to 0.975) demonstrating the decay o f testosterone was probably a first order 
and that a secondary process also could have been occurring in this cell line which 
produced testosterone. This could be attributed to expression o f  specific enzymes 
such as 17J3-HSD5 (androstenedione —► testosterone).
Table 5.8: Reactions kinetics for the decay o f  DHT and androstenedione in HEC-1 B 
and RL95-2 cells.
Cell
Line
Steroid
Decay
Rate
equation
R2 Rate
constant
k
Reaction
Order
Half
Life
hours
HEC-1 B DHT 0.0343x-
0.5088
0.992 0.02886 1 20.21
HEC-1B Androstenedione 0 .0365x-
0.4644
0.9733 0.03568 1 18.99
RL95-2 Androstenedione 0.061 4 x -  
0.6561
0.9913 0.04605 1 15.05
First order decays o f  the testosterone products DHT and androstenedione were 
observed in the HEC-1B and RL95-2 cell lines (figures 5.21, 5.22 and 5.13). These 
relationships were observed due to the simplicity o f  the reactions;
DHT —► —► androsterone (HEC-1B)
androstenedione —► —► androsterone (HEC-1B and RL95-2).
In the HEC-1B cell line the conversion rates o f  DHT and androstenedione to their 
reaction products were similar to the utilisation o f testosterone, half lives o f 20.21 
hours (DHT) and 18.99 hours (androstenedione) in comparison to 23.26 hours 
(testosterone). This allows us to determine that none o f these decays were rate 
limiting in the production o f  androgens in the HEC-1B cell line. These decays were 
concentration dependent this suggests all conditions and co-factors required for the 
conversion were present.
These fully optimised and analytically validated methods were subsequently applied 
to biopsies from women with benign endometrial conditions and fertile women to 
evaluate the utilisation o f testosterone in this setting.
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5.9 Analysis of endometrial biopsies from women with benign endometrial 
disorders
The endometrial biopsies used in this study are summarised in table 5.9. These 
disorders were chosen as there is evidence o f  altered localised endometrial steroid 
metabolism in these conditions which may influence the course o f  the disorder;
1. Kitawaki and co-workers presented evidence o f  bio-accumulation o f  
oestradiol in endometrial biopsies from women with endometriosis.20 The 
role o f  androgens in progression o f  endometriosis is unknown.
2. Kaku and colleagues demonstrated high levels o f  oestradiol within 
endometrial lesions sites o f  women with endometrial hyperplasia21 and this 
may contribute to progression to endometrial cancer. Current knowledge o f  
steroid metabolism in endometrial hyperplasia is limited and the potential 
roles o f  androgens unknown.
3. Leon and co-workers demonstrated increased expression o f 17p-HSDl and 
sulphatase and decreased expression o f  sulphotransferase in the endometria o f
women with PCOS in comparison to normal endometria, which could result
00in altered steroid metabolism. The analysis o f  a full steroid profile and the 
inclusion o f analysis o f  more steroid converting enzymes would further 
elucidate altered steroid metabolism in the endometria o f  women with PCOS.
4. Pienkowski and colleagues discussed hormone production by ovarian cysts in
O'!
prepubescent girls causing the early onset o f  puberty. It is possible that 
steroid metabolism in the endometria o f  women with ovarian cysts is altered 
due to increased production o f steroids by the cyst. Investigations into 
whether there is altered steroid metabolism in the endometria o f  women with 
ovarian cysts to our knowledge have not been completed.
5. Endometrial polyps can progress to hyperplasia and eventually endometrial 
cancer, suggesting an alteration from normal steroid metabolism may occur. 
Endometrial polyps are found in 12-34% o f  endometria o f  women with 
endometrial cancer suggesting progression may be hormone dependent.24 
Investigations into steroid metabolism in endometrial polyps are limited.
6. The unexplained infertility biopsies came from women who were unable to 
conceive, the reason could not be elucidated, but could be due to altered 
endometrial steroid metabolism.
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The purpose o f  these experiments was to determine alterations in steroid metabolism 
routes in fertile and benign endometrial biopsies. Endometriosis biopsies were first 
considered (4 biopsies) followed by analysis o f  a smaller number o f  endometrial 
biopsies from other benign endometrial conditions. These biopsies were investigated 
focusing on the utilisation o f  testosterone and the production o f  the testosterone 
metabolites DHT, androstenedione, androsterone, androstanediol, oestradiol, and 
oestrone.
Testosterone treatments over 72 hours were conducted for the stromal cells from 
each biopsy and androgen, oestrogen and enzyme expression recorded at each time 
point, the epithelial and stromal cells from a epithelial endometrial hyperplasia 
biopsy were also treated with testosterone. A comparison o f  changes in enzyme 
expression to changes in steroid profile was then completed to ascertain any 
relationships between enzyme expression and steroid concentrations (chapters 6, 7).
Table 5.9: Biopsy histology showing the number o f  biopsies in each category and the 
average age and age range within each group. These biopsies were analysed by mass
Histology Number of 
patients
Average age 
(years)
Age range 
(years)
Fertile 3 35.8 23-43
Endometriosis 4 (plus 2 
RT-PCR only)
33.9 26-37
PCOS 2 32.5 25-38
Unexplained
infertility
2 36 33-37
Tubual disorder 1 41 -
Endometrial
polyp
1 43
Ovarian cyst 1 34 -
Atypical
hyperplasia
1 55
Table 5.9 shows that the four major groups under investigation (fertile, 
endometriosis, unexplained infertility and PCOS) had similar average ages and age 
ranges. The groups with only one biopsy were investigated as case studies from 
which interesting preliminary data was compiled and an initial comparison o f  benign 
conditions was completed.
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5.9.1 Testosterone utilisation by endometrial biopsies
Testosterone utilisation in endometrial stromal cells
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Fig 5.27: T estosterone utilisation in strom al cells  from endom etr ia l  pathologies
m onitored  over  72 hours after addition o f  a lOOnM testosterone m edia  solution. 
C oncentra tion  is ca lcu la ted  as a ratio to the internal s tandard m ethyl-tes tosterone, 
analysed using an ESI source in positive m ode on the L C Q  D E C A  m ass spec trom eter 
with a Cig reversed phase co lum n and an optim ised  m e thano l/w ate r  0 .1%  acetic acid 
elution system.
All strom al b iopsies investigated m etabolised  > 9 0 %  o f  the testosterone within the 
first 24 hours (figure 5.27). T he  concentra tion  o f  tes tosterone w as reduced in all 
b iopsies to less than 3%  o f  the original concentra tion  after 48 hours. Testosterone 
consum ption  in these cells does not seem to be related to the nature o f  the benign 
d iso rder under clinical investigation.
5.9.2 Production of steroids following testosterone treatment by fertile biopsies.
There  was no a de tec tab le  D H T  at any t im e in any o f  the fertile sam ples  (3 biopsies) 
or the tubual d iso rder sam ple  (1 biopsy). A s described later (5.9.3) the production  o f  
D H T  w as recorded in all endom etr ia l  d isorders  (excep t unexp la ined  infertility), this 
w as the m ajo r  d iffe rence in tes tosterone m etabolism  in fertile b iopsies relative to 
biopsies from all o ther endom etr ia l  pathologies  investigated  ( including  cell lines).
160
C hap ter  l ive: S tero id  M etabo lism  in E ndom etria l  Cell Lines and B iopsies
Production ot androstenedioen in lertile stromal biopsies following testosterone treatment
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Fig 5.28: A ndros tened ione  production  in fertile biopsies o v e r  72 hours af te r  addition 
o f  a lOOnM testosterone m edia  solution. C oncen tra tion  is calculated  as a ratio to the 
internal s tandard m ethy l-tes tosterone, ana lysed  using an ESI source  in positive m ode 
on the L C Q  D EC A m ass  spec trom eter  with a Cjg reversed  phase  co lum n and an 
op tim ised  m ethano l/w a te r  0 .1%  acetic acid elution system .
E ndom etrial b iopsies from w om en  with norm al cyc ling  en d o m etr ia  (fertile w o m en )  
and from a w om an  with tubual d iso rder produced  an d ros tened ione  24 hours after 
tes tosterone trea tm ent w hich  w as m etabo lised  to o ther p roduc ts  over  the next 48 
hours. T he m ax im um  andros tened ione  concen tra tions  produced  by each fertile 
b iopsy at 24 hours w ere com parab le  0 .103, 0 .122 and 0 .1 5 7pM .
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Fig 5.29: P roduction o f  andros te rone  in fertile b iopsy  sam ples  o ver  72 hours after 
addition o f  a lOOnM testosterone  m ed ia  solution. C oncen tra t ion  is ca lcu lated  as a 
ratio to the internal s tandard  m ethyl-tes tosterone, ana lysed  using  an ESI source in 
positive m ode on the L C Q  D EC A m ass  spec trom eter  using a C |g reversed phase 
co lum n and an optim ised  m ethano l/w ate r  0 .1%  acetic acid e lu tion  system .
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T w o o f  the fertile b iopsies and the tubual b iopsy  show ed sim ilar  androsterone 
production as illustrated in figure 5.29. T he concentra tion  o f  androste rone  increased 
throughout the expe rim en t for th ree  o f  the biopsies. The end concentration  o f  
androsterone w as  s im ilar  in all b iopsies  ana lysed  an average value o f  7 .9nM . In one 
fertile sam ple  there was different p roduc tion  o f  androste rone  at 24 hours, how ever  at 
the end o f  the expe rim en t and ros te rone  concen tra tions  were sim ilar  in all fertile
sam ples.
Production o f  oestrone by fertile samples alter testosterone treatment
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Fig 5.30: Production  o f  oestrone in endom etr ia l strom al cells  over  72 hours after
addition o f  a lOOnM testosterone m ed ia  solution. D ansyl-ch loride  derivative 
analysed using an ESI source in positive m ode  on the L C Q  D E C A  m ass spec trom eter 
using a phenyl hexyl co lum n and an op tim ised  m e thano l/w ate r  0 .1%  form ic acid 
elution system .
T he production o f  oestrone w as  s im ilar  in all fertile sam ples  (and the tubual d isorder 
biopsy, figure 5.30) fo llow ing  tes tos terone  trea tm ent.  T w en ty  four hours after 
tes tosterone trea tm ent oes trone  w as p roduced  from added tes tosterone in the fertile 
sam ples  with a m axim um  concentra tion  at 48 hours (observed  in 3 o f  the 4 biopsies). 
O ne  fertile b iopsy  exhib its  a larger oestrone concentra tion  at t im e zero  in com parison  
to the others, h o w ever  the co n to u r  o f  this profile is s im ilar  to that o f  2 o ther fertile 
biopsies (m ax im u m  concentra tions  at 48 hours).
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Fig 5.31: Production o f  oestradiol in endom etr ia l  strom al cells o ver  72 hours  after 
addition o f  a lOOnM testosterone m ed ia  solution. D ansy l-ch lo ride  deriva tive  
ana lysed  using an ESI source in positive m ode on the L C Q  D E C A  m ass sp ec trom ete r  
using a phenyl hexyl co lum n  and an op tim ised  m ethano l/w ate r  0 .1%  form ic  acid 
elution system.
There w as a large increase in oestradiol concen tra tion  in one fertile b iopsy, at 24 and 
48 hours. O estradiol concen tra tions  also increased in the first 24 hours to p roduce 
m ax im a at 48 hours for tw o o ther fertile b iopsies fo llow ing tes tosterone trea tm ent 
(figure 5.31). The tubual d iso rder  b iopsy  show ed an increase in oestradiol 
concentra tion  over  time, but this w as not as large as the o ther fertile b iopsies .  The 
low am o u n ts  o f  oestradiol p resent at t im e zero in conjunction  with the oestrone 
inform ation (figure 5 .30) suggests  that oestrogen  production  w as occurr ing  in fertile 
sam ples  fo llow ing  tes tosterone trea tm ent.  O estrogen  concen tra tions  have been 
m easured  for com ple tion ,  h o w ever  because  the FCS is not charcoal stripped there is 
som e variability  in these results. As with the cell lines it should  be noted  with all 
b iopsy sam ples  that any  oestrogens detec ted  at the zero t im e poin t are represen ta tive  
o f  oestrogens present due to FCS in the m ed ia  and not from testosterone m etabo lism . 
T he conversion  o f  tes tosterone to oestradiol (or oestrone) w as  only  con f irm ed  i f  the 
cond itions outlined in chap te r  5.8.1 w ere fulfilled.
F igure 5.28 to 5.31 illustrated sim ilar  u tilisation o f  tes tosterone and p roduc tion  o f  
androstenedione, androsterone, oestradiol and oes trone  in fertile b iopsies  to the 
patient with tubual d isorder, also there w as  no production  o f  D H T  by any  o f  these 
biopsies. Tubual d iso rder  is the prim ary  reason for infertility in th is  w o m an  with her 
clinical notes indicating tw o  prev ious full term p regnancies ,  production  o f  steroids
Production of oestradiol in endometrial stromal cells after 
testosterone treatment
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s im ilar to the fertile biopsies suggests  that there w as no endom etr ia l dysfunction as 
m ight be expected  from her clinical history, therefore the tubual d iso rder b iopsy was 
included in the fertile group. T h ese  four b iopsies were subsequen tly  com bined  
together  to produce  an average profile  for production  o f  each steroid, which was 
com pared  to production  o f  steroids in each benign endom etr ia l  pa thology  following 
tes tosterone treatm ent.  (The average  fertile value for each steroid was represented on 
figures 5.34 to 5.52 by a bold line.)
5.9.3 Production of DHT by endometrial biopsies after testosterone treatment
There  w as  no detec tab le  D H T  at any  tim e in the unexplained  infertility biopsies 
fo llow ing  testosterone trea tm ent,  th is  w as  identical to the fertile biopsies, how ever 
D H T  w as p roduced  in endom etr ia l  b iopsies from patients  with endom etriosis ,  
ovarian  d isorders,  endom etr ia l  hyperp lasia  and an endom etr ia l polyp.
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Fig 5.32: P roduction o f  D H T  in endom etr ia l  s trom al cells from patients  with 
endom etr io s is  o ver  72 hours  after addit ion  o f  a lOOnM testosterone m ed ia  solution. 
C oncen tra t ion  is calculated  as a ratio to the internal s tandard m ethyl-tes tosterone, 
ana lysed  using an ESI source in positive m o d e  on the L C Q  D E C A  m ass spec trom eter 
with a Ci8 reversed phase co lum n and an op tim ised  m ethano l/w ate r  0 .1%  acetic acid 
elution system .
Figure 5.32 show s that D H T  w as p roduced  by endom etr ia l  strom al cells o f  patients 
w ith endom etr io s is  fo llow ing tes tosterone trea tm ent suggesting  altered testosterone 
m etabolism  com pared  with the fertile endom etr ium  w here  there w as no detectable 
D H T . T he highest concentra tion  for each b iopsy was observed  after 72 hours but 
there w as  variability  betw een  sam ples.  T herefore  m etabolism  o f  testosterone to
Production of DHT in stromal biopsies from patients with 
endom etriosis after testosterone treatment
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D H T  is a feature o f  endom etr ios is ,  the variation o f  w hich  can be attributed to the 
d isease  having  a com plex  phenotype.
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Fig 5.33: Production o f  D H T  in endom etr ia l  s trom al cells  from w o m en  with ovarian  
d isorders  over  72 hours after addition  o f  a lOOnM testosterone m ed ia  solution. 
C oncen tra tion  is calculated  as a ratio to the internal standard  m ethyl-tes tosterone, 
ana lysed  using an ESI source in positive m ode  on the L C Q  D E C A  m ass spec trom ete r  
with a Cig reversed phase co lum n and an optim ised  m e th an o l/w a te r  0 .1%  acetic acid 
elution system.
D H T  w as detected  in all endom etr ia l  b iopsies from patients  with ovarian disorders, 
suggesting  altered tes tosterone m etabolism  com pared  with fertile endom etr ia  w here  
there w as no detec tab le  D HT. T he concentra tion  o f  D H T  increased th roughou t the 
ex pe rim en t with a m ax im um  concentration  o f  D H T  recorded  in all ovarian  d isorders  
b iopsies 72 hours after tes tosterone treatm ent.
5.9.3 Production of androstenedione by endometrial biopsies after testosterone 
treatment
Production of androstene-d ione in strom al endom etrial b iopsies 
from patients with unexplained infertility after te s to s te ro n e  
treatm ent
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Fig 5.34: P roduction o f  andros tened ione  in patients  with unexplained  infertility after 
addition  o f  a lOOnM testosterone m edia  solution. C oncen tra tion  is ca lculated  as a 
ratio to the internal s tandard m ethyl-tes tosterone, ana lysed  using  an ESI source  in 
positive m ode  on the L C Q  D E C A  m ass spec trom ete r  w ith a C]g reversed phase 
co lum n  and an optim ised  m ethano l/w a te r  0 .1%  acetic acid elution system .
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T he tw o sam ples  from patients  w ith unexp la ined  infertility had low er am ounts  o f  
and ros tened ione  present at 24 hours  in com parison  to the average fertile biopsies. 
This suggests  m etabolism  o f  tes tos terone  to andros tened ione  was less rapid than in 
fertile biopsies, h o w ever  the end po in t concen tra t ions  were s im ilar in all samples.
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Fig 5.35: C om parison  o f  endom etr io s is  andros tened ione  production and fertile 
and ros tened ione  production in endom etr ia l  strom al cells over 72 hours after addition 
o f  a lOOnM testosterone m edia  so lu tion . C oncen tra tion  is calculated  as a ratio to the 
internal standard  m ethyl-tes tosterone, ana lysed  using an ESI source in positive m ode 
on the LC Q  D E C A  m ass  spec trom eter  with a C|g reversed phase co lum n and an 
optim ised  m ethano l/w ate r  0 .1%  acetic acid elution system.
Figure 5.35 illustrates that the m etabo lism  o f  androstened ione  in w om en  with 
endom etr io s is  w as s im ilar  to that o f  w o m en  from the fertile group.
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Fig 5.36: P roduction o f  andros tened ione  com parison  betw een patients with ovarian 
abnorm alit ies  and fertile endom etr ia l  b iopsies  over 72 hours after addition  o f  a 
lOOnM testosterone m ed ia  solution. C oncen tra tion  is ca lculated as a ratio to the 
internal standard  m ethyl-tes tosterone, ana lysed  using an ESI source in positive m ode 
on the L C Q  D E C A  m ass  spec trom eter  with  a Cig reversed phase co lum n and an 
op tim ised  m ethano l/w ate r  0 .1%  acetic ac id  elution system.
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T he m etabolism  o f  andros tened ione  was s im ilar in b iopsies from patients  with 
ovarian  d isorders to the average fertile biopsies. A fter 72 hours  the am o u n t o f  
rem ain ing  andros tened ione  in the PCO S and ovarian  cyst b iopsies w ere  s im ilar  to 
that o f  the average fertile sam ple.
5.9.4 Production o f androsterone by endometrial biopsies after testosterone 
treatment
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Fig 5.37: C om parison  o f  androsterone production in endom etr ia l  s tromal cells from 
b iopsy sam ples  from fertile and unexplained  infertility patients  o ver  72 hours after 
addition  o f  a lOOnM testosterone m edia  solution. C oncen tra tion  is ca lcu lated  as a 
ratio to the internal standard  m ethyl-tes tosterone, analysed using an ESI source in 
positive m ode on the L C Q  D E C A  m ass spec trom eter with a Cig reversed phase 
co lum n and an op tim ised  m ethano l/w ater  0 .1%  acetic acid elu tion  system .
T he production o f  andros te rone  in b iopsy  sam ples  with unexplained  infertility was 
s im liar  in both sam ples  with an average  end concentra tion  o f  ~4 .0nM  fo llow ing 
testosterone treatm ent. The am oun t o f  andros teone  increased th roughou t the 
experim en t over the 72 hours. T he final concentra tion  o f  andros te rone  in b iopsies 
from patients with  unexplained  infertility w as  lower than in fertile sam ples.
P roduction  of an d roste rone  in endom etrial strom al cells from  p atien ts with unexplained 
infertility after te s to s te ro n e  treatm en t
♦ Unexplained
» unex planed
a Average 
fertile T
X
10 20 30 40 50 60
■
70
Time (hours)
167
C hap te r  Five: Steroid M etabo lism  in Endometrial Cell Lines and B iopsies
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Fig 5.38: P roduction  o f  androste rone  in stromal cells from patients  with 
endom etr ios is  o ver  72 hours af te r  addition o f  a lOOnM testosterone m ed ia  solution. 
C oncen tra tion  is calculated  as a ratio to the internal standard m ethy l-tes tos terone ,  
analysed using an ESI source in positive mode on the LC Q  D E C A  m ass  spec trom eter  
with a C 18 reversed phase co lum n and an optimised m ethano l/w ater  0 .1%  acetic acid 
elution system .
Production o f  andros te rone  in endom etr iosis  sam ples w as s im ilar  to that o f  the 
averaged  fertile sam ple  fo llow ing  testosterone treatment. T hree  out o f  the four 
b iopsies dem onstra ted  a h igher concentration  at 72 hours (figure 5.38).
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Fig 5.39: Production  o f  andros te rone  in patients with ovarian d iso rders  over  72 hours 
after addition  o f  a lOOnM testosterone  m edia solution. C oncen tra tion  is ca lcu lated  as 
a ratio to the internal s tandard  m ethyl-testosterone, ana lysed  using an ESI source  in 
positive m ode  on the L C Q  D E C A  m ass spec trom eter with a Cig reversed  phase 
co lum n and an op tim ised  m ethano l/w ate r  0 .1% acetic acid elution system .
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T he production  o f  andros te rone  in patients  w ith ovarian d isorders was s im ilar  to the 
average  fertile sam ple  fo llow ing  tes tosterone treatm ent.  All the ovarian d isorder 
biopsy sam ples  produced  a m ax im um  concen tra tion  o f  androste rone  at 72 hours.
5.9.5 Production of androstanediol by endometrial biopsies after testosterone 
treatment
Production  o f  andros taned io l w as not recorded  in any o f  the biopsy sam ples  
fo llow ing  tes tosterone trea tm ent.  This  could  be related to the concen tra tions  
produced  be ing  below  the limit o f  detection o f  the m ass spec trom eter  (80.5nM ). 
Detection o f  and ros taned io l m ay be possib le  w ith  the inclusion o f  m ore  t im e points 
as it is an in term ediate  steroid form ed as the equilibrium  betw een  D H T  (or 
and ros te rone)  w as  achieved.
5.9.6 Production of oestrogens by endometrial biopsies after testosterone 
treatment
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Fig 5.40: O estrone  produc tion  in unexp la ined  infertility o v e r  72 hours  af te r  addition  
o f  a lOOnM testosterone m ed ia  solution. D ansyl-ch loride  deriva tive  analysed using 
an ESI source in positive m ode on the L C Q  D E C A  m ass spec trom eter  using a phenyl 
hexyl co lum n and an op tim ised  m eth an o l/w a te r  0 .1%  form ic acid elution system .
T he tw o  unexplained  infertility b iopsies p roduced  oestrone from testosterone within 
the first 24 hours  o f  the experim ent.  O estrone  production  in unexplained  infertility 
b iopsies  w as similar, w ith  decreased  concen tra tion  o f  oestrone at 48 hours and 
increased  oes trone  concen tra tion  at 72 hours in com parison  to the average fertile 
b iopsies .  This  m ay be due to d iffe ren t expression  o f  17[3-HSDs in unexplained  
infertility  b iopsies w hich in ter-convert  oes trone  and oestradiol.
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Fig 5.41: O estrone  p roduction  in endom etr io s is  sam ples  over  72 hours after addition 
o f  a lOOnM testosterone m ed ia  solution . D ansyl-ch loride  deriva tive  analysed using 
an ESI source in positive m ode on the L C Q  D E C A  m ass  spec trom eter using a phenyl 
hexyl co lum n and an op tim ised  m e thano l/w ate r  0 .1%  formic acid elution system.
All endom etr ios is  b iopsies p roduced  oestrone after addition  o f  testosterone, 
suggesting  the a rom atase  en zy m e  was active in these cells. A fter the first 24 hours 
the concen tra tions  o f  oestrone fluctuates in the sam ples, possib ly  due to the 
p roduction o f  oestrone in endom etr io s is  biopsies via a n u m b er  o f  pathw ays, 
( tes tosterone — *  oestradiol —> oestrone, o r  tes tosterone —► andros tened ione  —> 
oestrone). A decrease  in oestrone concen tra tion  in 2 o f  3 endom etr ios is  sam ples 
occurs at 48 hours.
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Fig 5.42: O estrone  p roduc tion  in ovarian  d iso rders  over  72 hours  after addition  o f  a 
lOOnM testosterone m ed ia  solution. D ansy l-ch lo ride  deriva tive  ana lysed  using an 
ESI source in positive m ode on the L C Q  D E C A  m ass  spec trom eter  using a phenyl 
hexyl co lum n and an op tim ised  m ethano l/w ate r  0 .1%  form ic acid elution system. 
T op  graph show s all ovarian  disorders, bo ttom  graph show s ovarian  d isorders 
w ithou t the ovarian  cyst sam ple.
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A high am oun t o f  oestrone w as detected  at the start o f  the experim ent (due to FCS 
concentra tions) in the ovarian  cyst sam ple  (figure 5.42). In both PC O S b iopsies the 
am o u n t o f  oestrone decreased  after t im e zero to a m in im um  at 72 hours. O estrone  
concen tra tions w ere  m uch h igher in these sam ples  than in the average  fertile 
b iopsies, how ever  due to the very  high initial concentra tions  any oes trone  detected  
canno t be linked to tes tosterone m etabo lism .
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Fig 5.43: Oestradiol p roduction  in unexplained  infertility biopsies o ver  72 hours  after 
addition o f  a lOOnM testosterone m edia  solution. D ansyl-ch loride  deriva tive  
analysed using an ESI source in positive m ode on the LCQ DECA m ass  spec trom eter  
using a phenyl hexyl co lum n and an op tim ised  m ethanol/w ater  0 .1%  form ic acid 
elution system.
The production o f  oestradiol w as s ignificantly  h igher in one o f  the unexplained  
infertility sam ples  (dotted line) in com parison  to the average fertile sam ple  fo llow ing  
testosterone trea tm ent (figure 5.43). T he o ther  unexplained infertitlity b iopsy 
(sm ooth  line) had a sim ilar  oestradiol profile to the fertile th roughou t (assum ing  
initial oestradiol concen tra tion  is d iscounted).
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P ro d u c tio n  o f  o e s tra d io l in s tro m a l c e lls  fro m  p a tie n ts  w ith  
e n d o m e tr io s is  a fte r  te s to s te ro n e  tre a tm e n t
70000
^  60000
50000
40000
A v e r a g e  F e r t i l e
30000
.2 10000
10 20 30 50 60 70
Time (hours)
Fig 5.44: O estrad io l p roduction  in endom etr ios is  sam ples  over  72 hours after 
addition  o f  a lOOnM testosterone m ed ia  solution. D ansyl-ch loride  derivative 
ana lysed  using an ESI source in posit ive  ionisation m ode on the L C Q  D E C A  mass 
spec trom ete r  using a phenyl hexyl co lu m n  and an optim ised  m ethano l/w ate r  0 .1%  
form ic acid elution system .
All the endom etr ios is  b iopsies investigated dem onstra ted  increases in oestradiol 
concen tra tions  after tes tosterone trea tm ent.  T he initial low concentration  o f  
oestradiol in these experim en ts  indicates little interference from oestrogens in the 
foetal c a l f  serum . O estrad io l detec ted  af te r  48 and 72 hours w as either due to 
tes tosterone m etabolism  through the a rom atase  enzym e or via the interm ediates 
andros tened ione  and oestrone. T he  concen tra tion  o f  oestradiol in endom etr iosis  
sam ples  w as lower than the average  fertiles at all t im e points, this was in part due to 
the h igher  initial oestradiol concen tra tion  in the fertile biopsies at t im e zero, how ever 
the m etabo lism  con tour  is s im ilar  w ith  a m ax im um  oestradiol concentra tion  in 2 o f  3 
endom etr io s is  sam ples  at 48 hours.
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Fig 5.45: P roduction o f  oestradiol in patients  with ovarian  d isorders over  72 hours 
after addition o f  a lOOnM testosterone m ed ia  solution. Dansyl-ch loride  derivative 
ana lysed  using an ESI source  in posit ive  m o d e  on the LC Q  D E C A  m ass spec trom eter 
using a phenyl hexyl co lum n  and  an op tim ised  m ethano l/w ater  0 .1%  formic acid 
elu tion  system .
Production of oestradiol in endometrial stromal cells from patients w ith  
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Oestradiol was detected in an endometrial biopsy from a woman with an ovarian cyst 
and in endometrial biopsies from two women with PCOS (figure 5.45). The 
concentrations o f oestradiol in these samples was higher than the average fertile 
throughout the experiments for the ovarian cyst and one PCOS biopsy, oestradiol 
metabolism in these samples was different from the fertile. After 24 hours the PCOS 
plus tubual disorder biopsy produced oestradiol in a similar manner to the fertile 
biopsies.
Case Studies
5.10 Testosterone metabolism by a stromal and epithelial endometrial atypical 
hyperplasia biopsy
Atypical endometrial hyperplasia is an oestrogen responsive condition, which can 
progress to endometrial cancer.25 Atypical endometrial hyperplasia is defined by the 
elongation o f the epithelial cells and glands, while stromal cell appearance 
essentially remains normal.26 Throughout this thesis this biopsy is referred to as 
epithelial hyperplasia and stromal hyperplasia, however it is only in the epithelial 
cells that hyperplasia occurs.
In the endometrium stromal cells have been shown to directly affect steroid 
production in the epithelial cells,27 however if cultured together stromal cells grow 
faster and steroid metabolism information regarding only the stromal cells is 
observed. In the endometrial hyperplasia biopsy all stromal cells were removed from 
the epithelial cells prior to steroid treatments to prevent this. This permitted analysis 
of variations in testosterone utilisation by the stromal and epithelial cells from an 
endometrial hyperplasia biopsy.
A biopsy was collected from a 55 year old patient with moderate atypical 
endometrial hyperplasia who suffered from post menopausal bleeding. This biopsy 
was split into 4 flasks o f epithelial and 4 flasks o f stromal cells and steroid profiles 
were determined after treatment with lOOnM of testosterone.
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Fig 5.46: C om parison  o f  D H T  production in strom al and epithelial cells from a 
hyperp lasia  b iopsy  o ver  72 hours  after addition o f  a lOOnM testosterone m edia 
solution. C oncen tra tion  is ca lcu la ted  as a ratio to the internal s tandard m ethyl- 
testosterone, ana lysed  using an ESI source in positive m ode  on the L C Q  D E C A  mass 
spec trom eter using a Cig reversed phase co lum n and an op tim ised  m ethano l/w ater  
0 .1%  acetic acid elution system .
There  w as a d iffe rence in the p roduction  o f  D H T  in the strom al and epithelial cells o f  
the above hyperp lasia  b iopsy  fo llow ing  testosterone trea tm ent (figure 5.46). The 
final concen tra tions  w ere 10.3 and 22.6nM  in the strom al and epithelial cells, 
respectively. P roduction o f  D H T  occurred in this hyperp lasia  b iopsy, no D H T  was 
detected  in any  fertile sam ples  fo llowing tes tosterone trea tm ent,  dem onstra ting  an 
altered androgen ic  profile af te r  testosterone trea tm ent o f  this hyperp lasia  biopsy in 
com parison  to the fertile biopsies.
Production of androstene-dione in endometrial stromal and 
epithelial cells from a patient with epithelial hyperplasia after 
testosterone treatm ent
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Fig 5.47: P roduction o f  andros tened ione  com parisons  betw een  s trom a and epithelia  
from an endom etr ia l hyperp las ia  b iopsy  and fertile strom al cells over  72 hours after 
addition o f  a lOOnM tes tos terone  m edia  solution. C oncen tra tion  is ca lculated  as a 
ratio to the internal standard  m ethyl-tes tosterone, analysed using an ESI source in 
positive m ode on the L C Q  D E C A  m ass spec trom eter  using a Cig reversed phase 
co lum n and an op tim ised  m ethano l/w ate r  0 .1%  acetic acid elution system .
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The stromal hyperp lasia  biopsy investigated produced  andros tened ione  in a sim ilar 
pattern to the fertile b iopsies but at low er concen tra tions  (until 72 hours) following 
tes tosterone trea tm ent.  The epithelial p roduction o f  and ros tened ione  after 
testosterone trea tm ent has a m ax im um  at 48 hours  w here a m in im um  is observed  in 
the strom al cells (figure 5.47).
Production o f an d rosteron e  in endom etria l strom al and epithelial c e lls  
from an epithelial hyperplasia b iop sy  after te s to ste r o n e  treatm ent
o 1
0 09
008
- 0  07 
o
| o ° 6
—0 05 c o
= 004
1 0 03
oO 02 o
0 01 
0
T
I
T
1
T
X
*A
0 10 20 30 4 0 50 60 70
Time (hours)
♦ Hyperplasia (stroma)
» Hyperplasia i ep tn esa  i
»  Average Fertile
Fig 5.48: Production o f  androstreone  in stromal and epithelial cells from a 
hyperp lasia  b iopsy o ver  72 hours after addition  o f  a lOOnM testosterone m edia  
solution . C oncen tra tion  is calculated  as a ratio to the internal s tandard m ethyl- 
testosterone, analysed using an ESI source in positive m ode on the L C Q  D E C A  m ass 
spec trom eter  using a Ci8 reversed phase co lum n  and an optim ised  m ethano l/w ate r
0 .1%  acetic acid elution system .
T he strom al hyperp lasia  sam ple  dem onstra ted  altered production  o f  androsterone 
com pared  to the fertiles, with h igher concen tra tions  p roduced  at 72 hours  (figure 
5.48). The epithelial hyperp lasia  cells p roduced  h igher concen tra tions  o f  
andros te rone  than the strom al cells at 48 hours 16.5nM , but at 72 hours the 
concentra tion  o f  andros te rone  w as  h igher in the strom al cells 24 .1nM .
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P io d u c tio n  o f o e s tr o n e  in strom al and ep ithelia l c e l ls  from  a p a tien ts  
with ep ithelia l en d om etr ia l h yp erp lasia  after te s to s te r o n e  treatm en t
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Fig 5.49: O estrone  production  in a hyperp lasia  sam ple  over  72 hours after addition o f  
a lOOnM testosterone m ed ia  solution. D ansy l-ch lo ride  deriva tive  ana lysed  using an 
ESI source in positive m ode  on the L C Q  D E C A  m ass spec trom eter  using a phenyl 
hexyl co lum n and an op tim ised  m eth an o l/w a te r  0 .1%  form ic acid elution system.
O estrone was present at a h igher concen tra tion  in the hyperp las ia  s trom al cells than 
fertile biopsies with a m ax im um  concentra tion  observed  at 24 hours (figure 5.49). 
A fter 72 hours the concen tra tion  o f  oestrone w as  s im ilar  in both the epithelial and 
stromal cells. T he production o f  oestrone was significantly  d ifferent from the 
averaged fertile b iopsies for strom al cells th roughou t  the experim ent,  with a h igher 
concentra tion  observed  in the hyperp las ia  s trom al cells  af te r  24 hours. O estrone  was 
produced by the epithelial cells after tes tosterone trea tm ent with a m ax im um  at 72 
hours. O estrone production  from testosterone by both the epithelial and stromal cells 
from the hyperp lasia  b iopsy m ay  occur  via oestradiol (a rom atisa tion) followed by 
conversion  to oestrone by the H SD s, o r from testosterone to andros tened ione  (via 
H SD s) and to oestrone by arom atase , (R T -P C R  is required  to confirm  expression  o f  
these enzym es in these biopsies).
176
C hapter Five: S tero id  M etabolism  in Endom etria l  Cell Lines and  B iopsies
P ro d u c t io n  o f o e s tra d io l in s tro m a l a n d  e p ith e l ia l  c e l ls  fro m  an  
e n d o m e tr ia l  h y p e rp la s ia  b io p s y  a f te r  te s to s te r o n e  t r e a tm e n t
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Fig 5.50: Production o f  oestradiol in strom al and epithelial cells from an endom etr ia l  
hyperp lasia  b iopsy  o ver  72 hours after addition o f  a lOOnM testosterone m edia  
solution. D ansyl-ch loride  deriva tive  ana lysed  using  an ESI source in positive m ode 
on the LCQ  D E C A  m ass  spec trom eter  using a phenyl hexyl co lum n and an optim ised  
m ethano l/w ater  0 .1%  form ic acid elution system .
There  were d iffe rences  in the production o f  oestradiol in the strom al and epithelial 
cells from the hyperp lasia  sam ple  fo llow ing  tes tosterone trea tm ent (figure 5.50). In 
the first 24 hours the h ighest  concentra tion  o f  oestradiol w as  observed  in the stromal 
cells, at 72 hours the h ighest  oestradiol concen tra tion  w as  observed  in the epithelial 
cells. The concen tra tion  o f  oestradiol in the s trom al cells  from the endom etr ia l 
hyperp lasia  b iopsy w as  h igher th roughou t the ex p e r im en t  than the averaged  stromal 
fertile biopsies. O estrad io l m ay  be p roduced  from added testosterone (or 
andros tened ione) in both hyperp lasia  cell types v ia  the a rom atase  enzym e, this can 
occur via tw o pathw ays;
testosterone —► andros tened ione  —► oestrone  —» oestradiol, 
tes tosterone —► oestradiol.
T he strom al hyperp las ia  cells produced  differen t steroid produc tion  o f  androsterone, 
D H T, oestrone and oestradiol com pared  to the fertile s trom al biopsies. Despite  these 
observations being for only one exam ple  o f  th is  patho logy , changes  in all o f  the 
testosterone m etabo lites  investigated excep t and ros tened ione  (com pared  to the 
fertile) is consis ten t with altered tes tosterone utilisation. It w as expected  that 
hyperp lasia  sam ples  will p roduce m ore  oes trogens  th rough  highly  expressed  
a rom atase28 in com parison  to fertile sam ples, this w as  confirm ed  here by high 
oestrogen concentra tions. P roduction o f  D H T  w as  also significantly  d ifferent 
com pared  to the fertile, suggesting  a possib le  role for D H T  in endom etr ia l  
hyperp lasia  progression.
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It w as conc luded  that there  w ere  d iffe ren t rates o f  steroid m etabolism  in stromal and 
epithelial cells from the sam e endom etr ia l  hyperp lasia  biopsy. In -v itro  the 
d iffe rences  in the u tilisation o f  tes tos terone  in the strom al and epithelial cells m ay 
result in an paracrine re la tionship  betw een  the tw o  cell types  in a s im ilar m anner  to 
the breast. This  re la tionship  is w idely  investigated in the breast for exam ple  previous 
w ork  by W ilson and co lleagues dem onstra ted  that stromal cells can alter steroid 
m etabo lism  in su rround ing  epithelial cells. The inclusion o f  a co-cu lture  technique 
w ould  confirm  this re la tionship  in the endom etr ium .
5.11 Testosterone metabolism by an endometrial polyp biopsy
A biopsy  w as  co llec ted  from a 43 year old patient with an endom etr ia l  polyp. 
Steroid profiles were calculated  af te r  trea tm ent o f  the stromal cells with lOOnM 
m ed ia  so lu tions o f  testosterone.
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Fig 5 .5 1: Production  o f  steroids in an endom etr ia l  polyp stromal b iopsy over 72 
hours  af te r  addition  o f  a lOOnM tes tos terone  m ed ia  solution. T op  graph com pares  
the tes tos terone  m etabo li tes  p roduced  by the average fertile b iopsies to the 
endom etr ia l  polyp, bo ttom  graph has a reduced  scale and illustrates production o f  
and ros tened ione ,  D H T  and andros te rone  in an endom etr ia l  polyp w ithou t the 
inclusion o f  the fertile b iopsies.  C oncen tra tion  is ca lculated  as a ratio to the internal 
s tandard  m ethy l-tes tosterone, ana lysed  using an ESI source in positive m ode on the 
LC Q  D EC A m ass sp ec tro m e te r  with a C]8 reversed phase co lum n and an optim ised 
m e th an o l/w a te r  0 .1%  acetic  acid elution system .
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The endom etr ia l  polyp b iopsy dem onstra ted  a s ignificantly  different tes tosterone 
m etbolism  profile in com parison  to the fertile b iopsies (figures 5.51 and 5.52). There 
was a small concentra tion  o f  and ros tened ione  detected  at 24 hours in the endom etr ia l 
polyp b iopsy (bottom figure 5.51). The initial route o f  tes tosterone m etabolism  is 
th rough D H T  (m ax concentra tion  24 hours 31 .8nM ), this does  not occu r  in fertile 
b iopsies (no D H T  detected). A fter  48 hours there w as no detectable D H T  or 
and ros tened ione  by the endom etr ia l  polyp biopsy. A ndros te rone  was then produced  
as an androgen ic  end produc t (m ax im um  concentra tion  o f  65.0nM  at 48 hours) at 
h igher concen tra tions  than observed  in the fertile biopsies.
Oestrogen production in stromal cells from an endometrial 
polyp biopsy after testosterone treatment
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Fig 5.52: O estrogen  p roduction  in a strom al biopsy from an endom etr ia l  polyp over 
72 hours after addition o f  a lOOnM testosterone m ed ia  solution. A verage  fertile 
concen tra tions  are presented  as the w ider  lines. O estrad io l in black and oestrone in 
orange. D ansyl-ch loride  deriva tives  analysed using an ESI source in positive m ode 
on the L C Q  D E C A  m ass  spec trom eter using a phenyl hexyl co lum n and an optim ised  
m ethano l/w ate r  0 .1%  form ic acid elution system .
O estrogen  production  w as occurring  in this endom etr ia l  polyp sam ple  fo llow ing 
tes tosterone treatm ent,  w ith  an increase in concentra tion  o f  both oestrone and 
oestradiol observed  at 48 hours. T he  concentra tion  o f  oes trone  was h igher at all time 
points  than in the fertile b iopsies, and the concentra tion  o f  oestradiol was reduced at 
all t im e points  relative to the fertile biopsies. O estrad io l can be produced  in the 
endom etr ia l  polyp biopsy  via tw o pathw ays;
testosterone —> oestradiol,
testosterone —> andros tened ione  —► oestrone —► oestradiol.
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Despite these observations being for only one example o f this pathology, changes in 
all o f the testosterone metabolites investigated was consistent with an altered 
testosterone utilisation in this endometrial polyp biopsy (compared to the fertile).
5.12 Conclusions biopsy steroid metabolism
Testosterone was metabolised rapidly in all endometrial biopsies irrespective o f the 
pathology. The role o f testosterone only as a precursor to oestrogen synthesis is 
restricted. Testosterone is involved in regulation o f a number o f transcription 
factors, genes and proteins in the endometrium such as the metalloproteinase MMP-1 
which is involved in implantation and menstruation. Testosterone has been defined 
as being important in normal endometrial function and may also be involved in 
progression o f some endometrial disorders.
The major difference in testosterone metabolism between biopsy samples was the 
synthesis o f DHT. DHT was not detected in any o f the fertile (4 biopsies) or 
unexplained infertility (2 biopsies) samples, but was present in endometrial biopsies 
from patients with endometriosis (4 biopsies), ovarian disorders (3 biopsies), 
endometrial hyperplasia (1 biopsy), and an endometrial polyp (1 biopsy). Although 
the numbers o f biopsies in the hyperplasia, endometrial polyp and unexplained 
infertility groups were small, it was concluded that DHT production was associated 
with benign endometrial pathologies following testosterone treatment. The role DHT 
plays in progression o f these disorders has not been confirmed, although it has been 
described by Ito and colleagues to be involved in regulation o f androgen action and 
cellular proliferation in normal and cancerous endometria.31 The role of DHT in 
androgen dependent tumours is important, it is described at the most potent 
androgen, important in proliferation in steroid responsive prostate cancer.32 It is 
possible that DHT also plays a vital role in the progression o f proliferative 
endometrial disorders and alteration o f the differentiation function in this tissue.
A previous investigation by Lovely and co-workers defined the presence o f DHT in 
the endometria o f women with PCOS due to high circulatory androgen levels which 
induced endometrial AR expression.33 However it was concluded that any DHT 
recorded in the experiments reported here was due to localised (cellular) steroid 
metabolism as the biopsies investigated have been through at least 3 passages to 
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obtain enough cells for experimentation, any residual DHT from the circulatory 
system will have been removed in this process. In agreement with this Leon and 
colleagues determined that localised steroid biosynthesis occurs in the endometria of 
women with PCOS independently of circulatory steroid concentration.34 It is 
probable that increased DHT concentrations recorded in endometria o f women with 
PCOS were due to increases in both circulatory and localised DHT production.
The metabolism o f androstenedione in all endometrial disorders was not significantly 
altered from the fertiles to differentiate between pathologies. The end concentrations 
o f androstenedione were similar in all samples (except endometrial polyp).
The metabolism of testosterone to androsterone in all endometrial disorders was not 
significantly altered from the fertiles to differentiate between pathologies. A similar 
increase in concentration was observed in all samples with a maximum at 72 hours, 
this is because androsterone is an androgenic end product produced irrespective of 
which side o f the bio-pathway was active.
5.12.1 Conclusions oestrogens
Both oestrone and oestradiol were produced in the fertile biopsies probably via the 
aromatase enzyme. The biopsies here were taken at the early proliferative stage and 
it is possible that the production of oestradiol and oestrone could be due to aromatase 
expression at this stage o f the menstrual cycle, RT-PCR experiments will permit the 
determination of aromatase expression in these fertile biopsies and correlations with 
oestrogen production if observed.
Oestrone concentration decreased in both PCOS samples from the high initial 
concentration observed at time zero. Oestradiol profiles for both PCOS biopsies 
differ significantly, again a high concentration o f oestradiol due to FCS makes trends 
difficult to determine.
In the ovarian cyst biopsy a similar contour was observed for oestradiol and oestrone 
concentrations after testosterone treatment. There was a very high initial 
concentration of both present at time zero, this high concentration was metabolised to 
other products over the next 48 hours possibly through conversion via either 17p-
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HSDs or oestrogen sulphotransferases. At 72 hours the concentration of both 
oestradiol and oestrone increased again, probably due to the aromatisation of 
testosterone and/or androstenedione.
5.12.2 Conclusions endometriosis
The production o f androstenedione and androsterone in stromal cells derived from 
the endometria o f women with endometriosis was similar to the fertile biopsies 
following testosterone treatment. The metabolism o f DHT, oestrone and oestradiol 
in all endometriosis biopsies was different from the fertile biopsies, inclusion of 
enzyme expression information may be able to explain these differences.
There was no uniformity in the profiles for the significantly altered steroids (DHT, 
oestrone, oestradiol) in the endometriosis biopsies probably due to differences in 
stage or severity of the endometriosis in each individual (as described in chapter 
1.6.2). It was also expected that large variations in enzyme expression between 
biopsies may therefore occur.
Production o f DHT may be important in endometriosis patients as duel treatments 
may be required for these women to conceive, the first to combat the ovarian 
dysfunction and the second to alter steroid metabolism in their endometrium. This 
altered androgen metabolism in the endometria o f women with ovarian disorders 
may cause problems with uterine receptivity.
5.12.3 Conclusions Unexplained Infertility
Steroid metabolism by the two biopsies from patients with unexplained infertility 
demonstrated similar steroid profiles to the fertile biopsies for testosterone, 
androstenedione, oestrone and produced no DHT.
There was a significantly lower concentration o f androsterone recorded at 72 hours 
in the first unexplained infertility biopsy (2.55 compared to 7.88nM average fertile) 
and the concentration o f oestradiol was similar to the fertile. The second 
unexplained infertility biopsy had a similar profile for androsterone and an increased 
concentration o f oestradiol relative to the fertile. The altered steroid profile whether 
androgen or oestrogen related could be significant enough to cause infertility in these 
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women, however the similarities in production o f all other steroids after testosterone 
treatment (especially no production of DHT) provides no positive conclusion. It is 
possible that another reason for infertility in these women such as quality o f the 
ovum or foetal bone fragments could be the main reason for their infertility.35
5.13 Conclusions Chapter Five
Initial investigations into steroid metabolism in cell lines permitted optimisation of 
experimental procedures which were applied to endometrial biopsy samples from 
women with endometriosis, as there was previous evidence o f altered steroid 
metabolism. This was extended to include a smaller number o f benign endometrial 
pathologies. Pregnenolone, testosterone and oestradiol treatments o f the cell lines 
indicated that pregnenolone was not metabolised to any other steroids suggesting the 
enzymes responsible for pregnenolone metabolism were not active in these 
endometrial cell lines, and that a steroid below pregnenolone in the bio-pathway is 
responsible for oestrogen production in the endometria. Oestradiol was metabolised 
to oestrone probably through conversion via specific 17p-HSDs, addition of 
oestradiol did not provide any new information about steroid metabolism in the 
endometria.
Steroid treatments with the bio-available androgen, testosterone provided novel 
information about steroid synthesis in established cell lines and benign endometrial 
conditions. Steroid metabolism varied in the cell lines and biopsies under 
investigation. Testosterone metabolism in all conditions occurs via the initial 
metabolites;
1. DHT,
2. androstenedione,
3. oestradiol or,
4. DHT and androstenedione depending on the cell line or pathology. 
Production o f these steroids may occur via a number o f enzymes (5AR1, 5AR2, 17p- 
HSD2, 4, 8, and aromatase), the significance the expression of each of these enzymes 
has on the steroid profile was determined in chapters 6 and 7.
Testosterone metabolism in fertile biopsies was representative o f testosterone 
metabolism by the RL95-2 cell line: testosterone to androstenedione to androsterone
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(no DHT). When analysing androgen metabolism in healthy samples this cell line 
could be recommended as a model. Ishikawa and HEC-1A metabolise testosterone 
into both androstenedione and DHT which was comparable to biopsies from patients 
with endometriosis and ovarian disorders. The endometrial polyp biopsy metabolises 
testosterone primarily to DHT this was representative o f androgen metabolism in the 
HEC-1B and COV434 cell lines. This highlights the importance o f selecting the 
correct cell line for investigations into steroid metabolism in endometrial disorders. 
Production o f oestrogens by the cell lines was minimal, however a number of  
biopsies produced oestradiol or oestrone after testosterone treatment (PCOS, 
hyperplasia), it is therefore expected that these biopsies express the aromatase 
enzyme and actively convert androgens to oestrogens.
The production o f androgens in preference to oestrogens was unexpected especially 
in the cell line COV434 which highly expressed the aromatase enzyme. It is possible 
that the aromatase enzyme has become saturated in the high androgen environment. 
This phenomenon has been described previously by Havelock and Thompson who 
both saw saturation o f the aromatase enzyme in ovarian granulosa cells in high 
androgen environments with the result o f DHT being produced in preference to 
oestrogens.36,37 This is similar to the results obtained for the COV434 cell line in 
these experiments.
The inclusion o f steroid converting enzyme expression data should provide 
additional information on the routes to the altered steroid metabolism in these 
conditions in comparison to fertile biopsies. This was conducted and the results were 
recorded in chapter 6, following this a comparison o f steroid profiles and steroid 
converting enzyme expression was completed to determine any correlations between 
the two as described in chapter seven.
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Chapter six
Real time polymerase reaction (RT-PCR) for analysis of steroid 
converting enzyme expression in established endometrial cell lines
and biopsies
Chapte r  Six: R T -P CR  anal} sis o f  endometr ia l  cell lines and biopsies
6.0 Introduction
This chapter describes basal expression data for the enzymes aromatase, 17p-HSDl, 
17P-HSD2, 17P-HSD4, 17P-HSD5, 17P-HSD7, 17P-HSD8, 5AR1 and 5AR2 
(described in chapter 1.3 and table 6.0) in the endometrial epithelial cell lines 
Ishikawa, HEC-1A, HEC-1B, RL95-2 and the ovarian granulosa cell line COV434 
(aromatase positive). In order to access expression o f these enzymes analysis o f their 
RNA was determined by quantitative real-time, reverse transcriptase PCR (QRT- 
PCR). RNA expression o f steroid converting enzymes in the established cell lines 
under basal conditions (starting quantity no steroid treatment) provided information 
from which an estimated steroid profile was determined. The mass spectrometry 
data obtained after steroid treatments o f these cell lines permitted a comparison of 
metabolic profiles to enzyme expression which could validate the original hypothesis 
(chapter 7).
Following optimisation of techniques and methodologies using established cell lines 
the same experimental methods to determine enzyme expression were applied to 
endometrial biopsy samples obtained from fertile, endometriosis, PCOS patients and 
patients diagnosed with unexplained infertility, an endometrial polyp or ovarian cyst.
Basal enzyme expression profiles were compared to highlight similarities and 
differences in RNA expression in a number o f endometrial pathologies. The 
differences in enzyme expression between fertile biopsies and endometrial cancer 
cell lines (or endometrial disorders) could be essential to understanding altered 
steroid metabolism in these pathologies. This could highlight specific previously 
unrecognised enzyme targets, antagonism of which could lead to novel treatments for 
specific endometrial disorders.
Temporal changes in RNA expression after testosterone treatments were recorded in 
all samples. Testosterone treatments of biopsies and cell lines were conducted over 
72 hours and enzyme expression was measured throughout this time. This permitted 
analysis o f changing RNA expression after testosterone treatment in each cell line or 
biopsy. Again the different pathologies were compared to highlight differences and 
similarities in enzyme expression profiles over 72 hours after testosterone treatment.
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A flow chart ou tl in ing  the experim en ts  undertaken  to ana lyse  R N A  en zy m e 
expression  if  the steroid converting  en zy m es  is described  in figure 6.0.
T able  6.0: Steroid converting  enzym es  nom encla tu re  and suggested  reactions under 
investigation in these experim ents ,  (the m ajo r  reactions w ere de term ined  from a 
literature search references  2, and 13-31 chap te r  1). All the H S D ’s here are isoform s 
o f  17p-H SD, h o w ever  to sim plify  the inform ation  they  are expressed  as H SD 1, 
H S D 2 etc.
Steroid converting 
enzyme
Major reactions in 
androgen/oestrogen synthesis
Other reactions
A rom atase
T esto s te rone  —*■ O estrad io l 
A ndrostened ione  —> O estrone
HSD1 O estrone  —► O estrad io l D H EA  —►Androstene-diol
H SD 2
O estrad io l — *  O estrone 
T esto s te rone  —* A ndrostened ione  
D H T — *■ A ndrostane-d ione  
A ndrostaned io l —► A ndrosterone
20a-p rogeste rone
—►Progesterone
H SD 4
T estosterone  —* A ndrostened ione  
O estrad io l —* O estrone
Peroxisom al fatty acid 
m etabolism
HSD5
A ndrostened ione  —► T esto s te rone  
A ndrostane-d ione  —> DHT 
A ndrosterone  —> A ndrostanedio l 
O estrone  —► O estrad io l
P rogesterone—► 2 0 a- 
hydroxyl p rogesterone
H SD 7
O estrone  —» O estrad io l 
D H T —► A ndrostanedio l C holestero l b iosyn thesis
H SD 8
D H T  — *  A ndrostane-d ione  
T estosterone  —► A ndrostened ione  
O estrad io l —» O estrone
Fatty acid m etabolism
5AR1
T esto s te rone  —► D H T 
A ndrostened ione  —► A ndrostane-d ione _
5A R2
T esto s te rone  —► D H T 
A ndrostened ione  —* A ndrostane-d ione -
Cell Lines Biopsies
—---J V*---
M easure  levels of arom atase, HSD1, HSD2, HSD4, 
HSD5, HSD7, HSD8, 5AR1, 5AR2
1. No stim ulation
2. Testosterone stim ulation
Q RT-PCR
Fig 6.0: Schem atic  describ ing  the approach  taken to analyse expression  o f  R N A  
relating to specific steroid converting  en zy m es  in cell lines and b iopsies.  1. 
C orresponds  to basal R N A  expression  and 2 co rresponds  to changes  in expression  
after tes tosterone trea tm ent,  th is w as determ ined  for a n u m b er  o f  tim e points  over  72 
hours for each experim ent.
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Information concerning the expression levels o f some o f these enzymes was 
available in the literature, allowing comparisons o f the results obtained here to 
previously described observations. There was not however one study which 
encompasses the range o f steroid converting enzymes or the number of endometrial 
pathologies investigated here, and there are no examples o f a comparative study 
which incorporates multiple enzyme expression data with testosterone metabolism 
mass spectrometry information (chapter 7).
This chapter will present cell line and biopsy experiments principally focussing on 
the expression o f specific steroid converting enzymes. The data is presented as 
follows;
-Primer design.
Cell lines;
- Relative basal expression o f aromatase, 17P-HSD1, 2, 4, 5, 7, 8 and 5AR1
and 2.
- Changing enzyme expression following testosterone treatment (72 hours) in 
each cell line.
- Conclusions (cell lines).
Biopsies;
- Comparison o f basal expression o f aromatase, 17P-HSD1, 2, 4, 5, 7, 8, 
5AR1 and 2 in stromal cells from fertile endometrial biopsies (four samples) to;
a) endometriosis biopsies (six samples),
b) endometrial biopsies from women with PCOS (2 samples) and an 
endometrial biopsy from a woman with an ovarian cyst (1 sample),
c) unexplained infertility biopsies (2 samples),
d) an endometrial hyperplasia biopsy (stromal and epithelial cells 
from 1 sample) and,
e) an endometrial polyp biopsy (1 sample)
- Changing enzyme expression following testosterone treatment (72 hours) in 
all endometrial biopsies.
- Conclusions (cell lines).
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6.1 Primer design and housekeeping genes for quantitative real-time reverse 
transcription polymerase chain reaction (RT-PCR)
QRT-PCR was employed in these experiments to determine RNA expression o f the 
steroid converting enzymes as described in chapter 3.4. The quality o f the primer 
pair was important; all specific primer pairs were designed using Beacon Design 2.0 
software (Premier Biosoft, USA) to ensure the reaction was as efficient as possible.
All primers were between 15 and 30 base pairs in length, and were tested for primer 
dimer formation or for annealing non-specifically. A blast search on all primers was 
run in the Beacon Design software to make sure the primers would not anneal to 
other targets. In addition analysis o f the melting curves was completed in all 
experiments and the presence o f a single homogeneous melt curve peak for all 
reactions was confirmed (this was indicative o f a single PCR product being amplified 
in each reaction). In order to generate meaningful data that can be compared from 
sample to sample it was important to quantify as well as normalise the data with the 
inclusion o f a normalising gene. The normalising gene is typically a ‘housekeeping 
gene’ whose expression should be constant under the experimental conditions under 
investigation. The housekeeping gene in these experiments was GADPH 
(glyceraldehyde-3-phosphate-dehydrogenase) which has been well characterised and 
widely used.1 As expression o f the housekeeping gene was constant any variation in 
the threshold cycle (Ct) o f the housekeeping gene can be attributed to other sources 
of variation such as efficiency o f the reverse transcription reaction, yield o f RNA 
purification and variation in the number o f cells from which RNA was purified. The 
standard curves and the samples were run in triplicate to provide statistical 
improvement.
6.2 Relative enzyme expression in cell lines
To compare basal RNA expression levels for each steroid converting enzyme 
between cell lines a number o f RT-PCR experiments were devised. lOOng/pL of 
RNA from each o f the five cell lines was converted to cDNA combined together and 
diluted to make a standard curve. Onto this curve the expression o f each steroid 
converting enzyme for each cell line under basal conditions was applied. This 
provides comparative starting quantity expression information for each enzyme in 
each o f the cell lines, for example we observed which cell line has the highest (and
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lowest) a rom atase  expression . E n zy m e  expression  in biopsy sam ples  was also 
applied  to this ca libration series to d e te rm in e  enzym e expression profiles in a num ber 
o f  endom etr ia l  pathologies.  E xpress ion  o f  each enzym e under basal conditions was 
com pared  betw een  cell lines to d e te rm in e  s ign ifican tly  sim ilar  expression . Statistical 
analysis  was perfo rm ed  using the M in itab  1.5 softw are  package. For every  set o f  
data  an unpaired  t-test w as p e rfo rm ed  for the norm ally  distributed R T -P C R  data 
ob tained for the basal expression  o f  steroid  converting  enzym es in endom etr ia l cell 
lines. Statistical ana lysis  o f  the ch an g es  in fold expression relative to basal 
expression  after testosterone t rea tm en t w ere  also calculated  by this m ethod (6.3 
onw ards).  A calculated  s ign ificance P value  <0.05 w as considered  statistically 
significant.
6.2.1 Aromatase expression
Aromatase expression in established cell lines
COV434Ishikawa l l [ (  IB RL95 2NEC 1A
2 2.5
Eo
c 1.5
Aromatase expression in established cell lines.
Ishikawa HCC-1A ItEC IB COV4J4
Fig 6.1: Relative basal express ion  o f  a rom atase  in the Ishikawa, H E C -1A , H EC-1B, 
RL95-2  and C O V 4 3 4  established cell lines. Each cell line was grown in specific 
m ed ium  (chapter  2.4) harvested  and R N A  extracted. E xper im ents  were com pleted  in 
trip licate  and representative im ages are  show n. Specific prim ers  outlined in table 2.6 
w ere  used to establish a rom atase  express ion  levels through R T -P C R . G raph  on the 
right is a reproduction  o f  the graph on  the left with a reduced scale.
The a rom atase  enzym e ca ta lyses the  conversion  o f  testosterone to oestradiol and 
and ros tened ione  to oestrone. E xpress ion  levels o f  arom atase  de term ined  by Q R T - 
PC R  w ere high in C O V 4 3 4  cells  in ag reem en t with w ork  by H avelock  and 
co lleagues .2 Expression  levels o f  a ro m a tase  in H E C -1A , H E C -1B  and R L95-2  were 
similar, (the d ifference in expression  o f  a rom atase  in these cell lines was not 
s ign ificantly  d ifferent P> 0.05). Ish ikaw a  expression  o f  a rom atase  w as lower than
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C O V 4 3 4  but w as statistically  s ignificantly  h igher than that found in H E C -1 A , HEC- 
1B, and R L 95-2  cells (All P< 0.041).
6.2.2 17J3-HSD1 expression
HSD1 expression in established cell 
? lines.
m i i l
Fig 6.2: Relative basal express ion  o f  17(3-HSD1 in the Ishikaw a, H E C -1 A , H E C -IB ,  
R L95-2  and C O V 4 3 4  established cell lines. Each cell line w as grow n in specific 
m ed ium  (chapter  2 .4) harvested  and R N A  extracted . E xper im en ts  w ere com ple ted  in 
trip licate  and representa tive  results are show n. Specific prim ers  outlined in table  2.6 
w ere used to establish HSD1 expression  levels th rough R T -P C R .
T he en zy m e HSD1 ca ta lyses  the conversion  o f  oestrone to oestradiol. Expression  
levels o f  HSD1 determ ined  by Q R T -P C R  were h ighest in R L 95-2  and C O V 4 3 4  cells, 
the d iffe rences  in expression  o f  HSD1 betw een  RL95-2  and C O V 4 3 4  w ere not 
s tatis tically  s ignificant (P> 0.05). H E C -1A  and H E C -IB w ere de term ined  to have 
s im ilar  expression  levels o f  HSD1 (which w ere not s ign ifican tly  d ifferent P> 0.05). 
H E C -1 A  and H E C - IB expression  o f  HSD1 w as low er than R L 95-2  and C O V 4 3 4  but 
h igher than that found in Ishikaw a. Ish ikaw a cells had statistically  s ignificantly  
(low er) expression  o f  HSD1 in com par ison  to C O V 4 3 4  cells (P=  0.014)
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6.2.3 17p-HSD2 expression
Expression of HSD2 in established cell 
£ 2 lines.OC TKDO
~  1.5
1
O S
n ■ i t i r
mptSam
Ishikawa HCC-1A HEC IB RLD5-2 COV434
Fig 6.3: Relative basal expression  o f  17p-H SD 2 in the Ishikaw a, H E C -1A , H E C -I B ,  
R L95-2  and C O V 4 3 4  estab lished  cell lines. Each cell line was grown in specific 
m edium  (chap ter 2.4) harvested  and R N A  extracted. E xperim ents  were com ple ted  in 
trip licate  and representative results are show n. Specific prim ers outlined in table  2.6 
w ere used to establish H S D 2 expression  levels through R T -PC R .
T he en zy m e  H SD 2 cata lyses the convers ion  o f  tes tosterone to androstened ione ,  D H T  
to androstane-d ione, androstaned io l to androsterone and oestradiol to oestrone . 
E xpression  levels o f  H SD 2 determ ined  by Q R T -P C R  was significantly  h igher  in 
R L95-2 cells  in com parison  to all o ther  cell lines (P< 0.05 for all com parisons) .  
C O V 4 3 4  and H E C -1B  cells have s im ilar  low expression levels o f  H SD 2. The 
diffe rences in expression o f  H S D 2 in H E C -1B  and C O V 4 3 4  cells was determ ined  
not to be statistically  s ignifican t P= 0.78. Ito and co lleagues analysed a n u m b er  o f  
cell lines for  H SD 2 expression  these  w ere  H E C -1A , H E C -1B , R L95-2, Ish ikaw a and 
KLE. T h e ir  results produced  by northern  blot analysis  dem onstra ted  no expression  
o f  H SD 2 in Ish ikaw a and H E C -1B  cells and low expression  in H E C -1A  cells. The 
RL95-2  cell line was show n to express  H SD 2 over  100 fold h igher than in H E C -1A  
ce lls .3 T he  starting quantities  in figure 6.3 illustrated higher H SD 2 expression  in 
RL 95-2  cells  w hich w as com parab le  to Ito’s results. It w as probable that in our 
investigations H SD 2 expression  w as  detected  in Ishikawa, HEC-1 B and HEC-1 A 
cells  because  o f  the use o f  the m ore  sensitive techn ique  o f  R T -P C R  w hich  canno t be 
detected th rough  northern  blot analysis , Q R T -P C R  has been described  as being  m ore  
sensitive than northern blot; ~ 8ng  o f  R N A  can be detected by northern blo t4, w hereas  
~ l f g  can be detected  by Q R T -P C R  (although around lOfg is required for re liable 
de tec tion) .5
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6.2.4 17P-HSD4 expression
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Fig 6.4: Relative basal expression  o f  17p-H SD 4 in the Ishikaw a, HEC-1 A, HEC-1 B, 
R L95-2 and C O V 4 3 4  estab lished  cell lines. Each cell line w as grown in specific 
m edium  (chapter  2.4) harvested and RN A  extracted . E xper im en ts  were com ple ted  in 
trip licate  and representa tive  results are show n. Specific  p r im ers  outlined in table  2.6 
w ere used to establish H S D 4 expression  levels th rough R T -P C R .
T he en zy m e  H SD 4 ca ta lyses the conversion  o f  tes tosterone to andros tened ione ,  and 
oestradiol to oestrone. Expression levels o f  H S D 4 determ ined  by Q R T -P C R  were 
sign ifican tly  h igher in HEC-1 A cells in com parison  to all o ther  cell lines (P<  0.05). 
HEC-1 B and Ishikaw a and RL95-2 exhib ited  sim ilar  starting  quantity  expression  o f  
H SD 4. T he d iffe rences  in expression  o f  H S D 4 in HEC-1 B, Ish ikaw a and RL95-2  
w ere determ ined  not to be statistically  s ign ifican t P> 0.05. In the cell lines C O V 4 3 4  
expression  o f  H S D 4 w as s ignificantly  low er than HEC-1 A (P =  0 .044) but h igher 
than that recorded in R L 95-2  cells.
6.2.5 17P-HSD5 expression
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Fig 6.5: Relative basal express ion  o f  17(3-HSD5 in the Ish ikaw a, HEC-1 A, HEC-1 B, 
R L95-2  and C O V 4 3 4  estab lished  cell lines. Each cell line w as grown in specific 
m edium  (chapter 2.4) harvested  and R N A  extracted . E xper im en ts  were com ple ted  in 
trip licate  and representa tive  results are show n. Specific  p r im ers  outlined in table  2.6 
w ere  used to establish H SD 5 expression  levels th rough R T -P C R .
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The enzym e H SD 5 ca ta lyses the conversion  o f  androstened ione  to testosterone, 
androstane-d ione  to D H T , andros te rone  to androstaned io l and oestrone to oestradiol. 
Expression levels o f  H SD 5 determ ined  by Q R T -P C R  were highest in Ishikaw a cells. 
The expression  o f  H SD 5 in C O V 4 3 4  and HEC-1 A w as negligible. HSD5 expression  
in HEC-1 B and RL95-2 w as low er than in Ish ikaw a and h igher than in C O V 4 3 4  or 
HEC-1 A cell lines.
6.2.6 17P-HSD7 expression
HSD7 express ion  in es tab l ished  cell
I
2 .5 lines.o2 2
|  15
oc
1cra
Z  05
<5 _
u n  O
Fig 6.6: Relative basal exp ress ion  o f  17p-H SD 7 in the Ishikawa, HEC-1 A, HEC-1 B, 
R L95-2 and C O V 4 3 4  estab lished  cell lines. Each cell line was grown in specific 
m edium  (chap ter  2.4) harvested  and R N A  extracted . E xperim ents  were com ple ted  in 
triplicate and representa tive  results are show n. Specific prim ers outlined in table 2.6 
were used to establish H S D 7 expression  levels through R T -PC R .
T he enzym e H S D 7 ca ta lyses  the conversion  o f  oestrone to oestradiol. Expression  
levels o f  H S D 7 determ ined  by Q R T -P C R  w ere  highest in R L95-2 and H E C -IB  cells  
and lowest in C O V 4 3 4  cells. T he expression  o f  H S D 7 was s im ilar in the HEC-1 B 
and RL95-2  cell lines (the d iffe rence in expression  o f  H SD 7 betw een  HEC-1 B and 
R L95-2 cells w as de term ined  not to be statistically  significant P =  0.41). HEC-1 A 
and Ish ikaw a also dem onstra ted  s im ilar  H S D 7 expression (the d iffe rence in 
expression  o f  H S D 7 in Ish ikaw a and HEC-1 A cells was determ ined  not to be 
statistically significant P= 0.50).
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6.2.7 17p-HSD8 expression
HSD8 expression in established cell
25 lines.
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Fig 6.7: Relative basal expression  o f  17f3-HSD8 in the Ishikaw a, HEC-1 A, HEC-1 B, 
R L95-2 and C O V 4 3 4  established cell lines. Each cell line w as grow n in specific 
m edium  (chapter 2.4) harvested  and R N A  extracted . E xper im en ts  were com ple ted  in 
trip licate  and representa tive  results are show n. Specific  prim ers  outlined in table  2.6 
w ere  used to establish H S D 8 expression  levels th rough R T -PC R .
T he enzym e H S D 8 ca ta lyses the conversion  o f  oestradiol to oestrone and androstane- 
d ione  to DH T. Expression  levels o f  H S D 8 determ ined  by Q R T -P C R  w ere h ighest in 
C O V 4 3 4  cells. Expression  o f  H S D 8 in C O V 4 3 4  w as s ign ifican tly  h igher than in 
R L 95-2  cells (P=  0 .006), (R L 95-2  dem onstra ted  the lowest expression  o f  H SD 8). 
Expression  o f  H S D 8 was s im ilar in Ishikaw a, HEC-1 A, and HEC-1 B cells. The 
diffe rence in expression  o f  H SD 8 in Ishikaw a, HEC-1 A, and HEC-1 B cells was 
determ ined  not to be statistically  s ign ifican t P>0 .24  for all com parisons.
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6.2.8 5AR1 expression
5AR1 expression in established cell 
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Fig 6.8: Relative basal express ion  o f  5AR1 in the Ishikawa, HEC-1 A, HEC-1 B, 
RL95-2 and C O V 4 3 4  estab lished  cell lines. Each cell line w as grow n in specific 
m edium  (chapter 2.4) harvested  and R N A  extracted . E xper im en ts  were com ple ted  in 
triplicate and representa tive  results are show n. Specific  prim ers  outlined in table 2.6 
w ere used to establish 5AR1 expression  levels th rough R T -P C R .
The enzym e 5AR1 ca ta lyses  the conversion  o f  testosterone to D H T  and 
androstened ione  to andros tane-d ione .  Expression  levels o f  5AR1 determ ined  by 
Q R T -P C R  were highest in HEC-1 B and C O V 4 3 4  cells. The d iffe rence in expression  
o f  5AR1 betw een HEC-1 B and C O V 4 3 4  cells were determ ined  not to be statistically 
significant (P= 0.73). T he lowest expression  level o f  5AR1 w as detected  in the 
R L95-2 cell line w hich  w as s ign ifican tly  low er than recorded in HEC-1 B (P= 0 .029) 
or C O V 4 3 4  (P< 0 .0001) cells. Expression  o f  5AR1 in Ish ikaw a and HEC-1 A w as 
h igher than in R L95-2  and low er than in HEC-1 B and C O V 4 3 4  cells, ( these 
diffe rences w ere found to be not statistically  significant).
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6.2.9 5AR2 expression
I
5AR2 expression in established cell 
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Fig 6.9: Relative basal expression  o f  5A R 2 in the Ishikawa, HEC-1 A, HEC-1 B, 
R L95-2 and C O V 4 3 4  estab lished  cell lines. Each cell line w as grown in specific 
m edium  (chapter  2.4) harvested  and R N A  extracted . E xper im en ts  w ere  com ple ted  in 
triplicate and representa tive  results are show n. Specific  prim ers  outlined in table 2.6 
w ere used to establish 5A R 2 expression  levels th rough R T -P C R . The graphs above 
are identical h o w ever  the graph on the right has a reduced  scale  to a llow  observations 
o f  low level expression  o f  5A R 2.
The enzym e 5A R 2 ca ta lyses  the conversion  o f  tes tosterone to D H T  and 
andros tened ione  to andros tane-d ione .  Expression  level o f  5A R 2 determ ined  by 
Q R T -P C R  were s ign ificantly  h igher in R L95-2  cells  in com par ison  to all o ther cell 
lines investigated (P= 0.002 for all com parisons) .  W hen the scale was reduced it was 
revealed that Ishikawa, HEC-1 A and C O V 4 3 4  had s im ilar  expression  o f  5A R 2 and 
HEC-1 B dem onstra ted  the low est expression  value. T he  d iffe rences in expression  o f  
5A R 2 in Ishikaw a, HEC-1 A, and C O V 4 3 4  cells w ere  determ ined  not to be 
statistically  s ign ifican t P> 0.17. HEC-1 A, Ish ikaw a and C O V 4 3 4  expression  o f  
5A R 2 was low er than R L 95-2  but h igher than that found in HEC-1 B cells.
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6.2.10 Summary of basal enzyme expression in established cell lines
Table 6.1: Relative expression  o f  en zy m es  investigated in es tablished cell lines. 
E nzym e expression  (high, m edium  o r  low) w as re lative to expression in the o ther cell 
lines ca lcu la ted  from a m ixed  calibration  series. Cell lines indicated in red show  the 
highest re lative expression  and those  indicated in blue show  the lowest expression o f  
that specific  enzym e._________________________________________________________________
Enzyme Cell Line
High expression Medium
expression
Low expression
A rom atase C O V 434 Ishikaw a, R L95-2, 
, HEC-1 B
HSD1 R L 95-2, C O V 434 HEC-1 A, HEC-1 B Ishikaw a
HSD2 RL95-2 C O V 434 Ishikaw a, \ ,  
HEC-1 B
HSD4 HEC-1 A Ishikaw a, HEC-1 B, 
C O V 434
R L 95-2
HSD5 Ishikaw a, HEC-1 B R L95-2 C O V 434,
HSD7 R L 95-2 , HEC-1 B Ishikaw a, HEC-1 A C O V 434
HSD8 C O V 434. H E C -IB Ishikaw a, HEC-1 A RL95-2
5AR1 HEC-1 B .C O V 4 3 4 Ishikaw a, HEC-1 A RL95-2
5AR2 RL95-2 Ishikaw a, HEC-1 A, 
C O V 434
H E C -IB
Each cell line expressed  the specific  steroid converting  enzym es under investigation 
at d iffe ren t quantit ies  under basal conditions, from these relative expression  values it 
w as possib le  to hypothesise  a variety o f  m etabo lic  pathw ays m ay be active after 
addition  o f  testosterone. T he d iffe rences  in basal expression  o f  specific enzym es was 
corre la ted  to the initial m etabolites  o f  tes tosterone as described in chap ter  7.
Ish ikaw a cells exhibited  the h ighest re lative expression o f  H SD 5, this enzym e 
ca ta lyses  the conversion  o f  and ros tened ione  to testosterone and oestrone to 
oestradiol, after addition  o f  tes tosterone to Ish ikaw a cells it w as postulated that the 
m etabo lite  andros tened ione  m ay  be converted  back  into testosterone via the highly 
expressed  H S D 5 enzym e.
HEC-1 A cells exhib ited  high expression  o f  H S D 4, after testosterone trea tm ent o f  this 
cell line andros tened ione  is a p robable  m etabo lite  due to conversion  via the highly 
expressed  H SD 4.
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HEC-1 B cells exhibited high expression o f 5AR1 and HSD7, after testosterone 
treatment it was expected that these cells will produce the metabolite DHT (through 
5AR1).
RL95-2 cells exhibited high expression o f HSD1, HSD2, HSD7 and 5AR2, the 
significantly high expression o f HSD2 in comparison to the other cell lines suggested 
that after testosterone treatments that the major initial metabolite will be 
androstenedione (via HSD2) following this metabolism of androstenedione is 
expected to occur via the highly expressed 5AR2 enzyme (to androstanediol).
COV434 cells expressed aromatase, HSD1, HSD8 and 5AR1 in the highest amount 
relative to the other cell lines, it was expected from these results that after addition of 
testosterone, DHT will be metabolised via 5AR1, androstenedione via HSD8 and 
oestradiol via aromatase.
This represents a simplistic view o f steroid metabolism (simple substrate-product 
relationships), it is probable that generated experimental data will be more complex 
due to the different reactions possible. For example an enzyme may bind a number 
of substrates to produce a number o f products. Enzyme affinity for each substrate 
may differ (some enzymes may have a higher affinity for a specific substrate at low 
expression levels than others).
6.3 Changes in gene expression after Testosterone treatment in established cell 
lines
Following determination o f basal starting quantity expression o f mRNA for each 
enzyme testosterone treatments o f the cell lines were conducted as described in 
chapter 3.14 and changes in expression were recorded at specific time intervals. 
Significant changes in enzyme expression were determined relative to basal enzyme 
expression using the unpaired t-test as described previously, (the times any 
significant changes occur and P values are summarised in table 6.3)
For ease o f comparison the same enzymes are represented by the same colours 
throughout this chapter and chapter 7.
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Table 6.2: Enzym e nomenclature and corresponding colours in chapters 6 and 7.
Enzyme Colour
Aromatase
HSD1 Red
HSD2 Pink
HSD4 G reen
HSD5 Brown
HSD7
HSD8 O ra n g e
5AR1 Black
5AR2 P u rp le
The changes in RNA expression levels for all enzym es assessed throughout the 
experim ents were expressed as fold expression relative to the housekeeping gene 
G ADPH  (expression divided by expression amount o f  G ADPH  in each sam ple). The 
expression o f  each enzym e was then normalised to 1 at tim e zero (under control 
conditions) changes in fold expression relative to this tim e throughout the 72 hours 
were observed.
6.3.1 Changes in enzyme expression in the Ishikawa cell line
Changes in steroid mRNA expression in Ishikawa
Aromatase HSD1
0 8 16 24 32 40  48  56 64 72
Time (hours)
Fig 6.10: Changing enzym e R NA  expression levels over 72 hours after addition o f  
testosterone to Ishikawa cell m edia. Ishikawa ce lls were grown in specific medium  
(chapter 2 .4) harvested and RN A extracted. Specific primers outlined in table 2.6  
were used to establish expression o f  each enzym e through RT-PCR.
Highest fold expression changes were observed for the enzym es H SD 8 (48hours) and 
5AR1 (40 hours). 5AR1 converts testosterone to DHT and androstenedione to 
androstane-dione with this increased expression at 40 hours it w as expected that an
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increase in the reaction product concentration w ill be observed this was confirm ed in 
chapter 7.
6.3.2 Changes in enzyme expression in the RL95-2 cell line
Fig 6.11: Changing enzym e RNA expression levels over 72 hours after addition o f  
testosterone to RL95-2 cell m edia. R L95-2 ce lls were grown in specific medium  
(chapter 2 .4) harvested and RNA extracted. Specific primers outlined in table 2.6  
were used to establish expression o f  each enzym e through RT-PCR.
Expression o f  all enzym es (except 5A R 2, H SD 8 and arom atase) w as reduced at all 
tim e points relative to tim e zero. Expression o f  5A R 2 w as high at 12, 48, and 60 
hours. 5A R 2 catalyses the conversion o f  testosterone to DHT and androstenedione 
to the end product androsterone through androstane-dione. Corresponding mass 
spectral steroid profiles were com bined to determine any steroid-enzym e  
relationships. Arom atase expression increased at 60 hours (figure 6 .11), this could  
be linked to an increase in the reaction products oestrone and/or oestradiol if  the 
reaction substrate (testosterone or androstenedione) w ere available, how ever in these 
experim ents this is not recorded as all testosterone w as converted to androsterone 
(through androstenedione) before 60 hours as described in chapter 5 .8 .2)
5AR1
C h a n g e s  in  s t e r o i d  m R N A  e x p r e s s i o n  in  R L 9 5 - 2  c e l l s
3 6  48
Time (hours)
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6.3.3 Changes in enzyme expression in the HEC-1A cell line
— HS D1  
—— H S D 4 
H S D 7 
— —  5AR1
C h a n g e s  in s t e r o i d  m R N A  e x p r e s s i o n  in HEC-1A
24 36
Time (hours)
A io m ata se
H0D2
HCD5
HCDo
5AR2
Fig 6.12: Changing enzym e RNA expression levels over 72 hours after addition o f  
testosterone to HEC-1 A cell m edia. HEC-1 A ce lls were grown in specific medium  
(chapter 2 .4) harvested and RNA extracted. Specific primers outlined in table 2.6  
were used to establish expression o f  each enzym e through RT-PCR
The fold expression changes in HEC-1 A ce lls  were sm aller than for all other cell 
lines. Figure 6.12 illustrates that expression o f  all enzym es (except H SD 5 and 
5A R 2) decreased after testosterone treatment. S ignificant changes in fold expression  
were observed with the enzym es 5A R 2 and H SD 5 relative to basal expression (P=  
0.025 and 0.033 respectively) both at 24 hours. Correlation between these results 
and changes in steroid profiles are defined in chapter 7.
6.3.4 Changes in enzyme expression in the HEC-1 B cell line
10
Changes in steroid mRNA expression in HEC-1B cells
A r o m a t a s e
H S D 1
H S D 2
H S D 4
- H S D 5
H S D 7
H S D 8
-5 A R 1
5 A R 2
Time (hours)
Fig 6.13: Changing enzym e RNA  expression levels over 72 hours after addition o f  
testosterone to HEC-1 B cell m edia. HEC-1 B ce lls were grown in specific medium  
(chapter 2 .4) harvested and RN A extracted. Specific primers outlined in table 2.6  
were used to establish expression o f  each enzym e through RT-PCR.
Expression o f  m ost o f  the enzym es increased at 12 hours after which expression  
levels were essentially  constant throughout the experim ent. Figure 6.13 illustrates
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that only H SD 8 demonstrated significant changes in fold expression relative to time 
zero in HEC-1 B ce lls at 36 hours (P = 0.005) and 72 hours (P= 0 .003). H SD 8  
converts testosterone to androstenedione, increased expression at 36 and 72 hours 
should correlate with increased androstenedione concentration at these time.
6.3.5 Changes in enzyme expression in the COV434 cell line
C h anges  steroid mRNA exp ress ion  in COV434
A r o m a t a s e
H S D 4
H S D 8
HSD1
H S D 5
5AR1
H S D 2  
H S D 7  
 5 A R 2I
Q
7232  4 0
T im e (h ou rs)
56 6416 24 48
Fig 6.14: Changing enzym e RNA expression levels over 72 hours after addition o f  
testosterone to C O V 434 cell media. C O V 434 ce lls  were grown in specific medium  
(chapter 2 .4) harvested and RNA extracted. Specific primers outlined in table 2 .6  
were used to establish expression o f  each enzym e through RT-PCR.
C hanges in expression levels o f  all steroid converting enzym es (except 5A R 1) were 
neglig ib le compared to tim e zero. Fold expression o f  5AR1 relative to tim e zero 
increased significantly in C O V 434 cells, at 12, 32 and 72 hours (P= 0 .043 , 0 .006  and 
0 .047  respectively). It w as expected that at these tim e points the concentration o f  the 
steroid produced by 5AR1 (D H T) w ill increase; this was confirm ed in chapter 7.
6.3.6 Conclusions established cell lines
Basal enzym e starting quantities provided information concerning the likely route o f  
steroid bio-synthesis. Changes in expression levels o f  each enzym e through the 72 
hours after testosterone treatment highlighted enzym es which expression levels  
changed significantly (relative to basal expression) in each cell line. Further 
investigation into each o f  these com bined with the mass spectrometry generated  
steroid profiles were com pleted in chapter 7. This a llow s any trends in enzym e  
expression and/or relationships between enzym e expression and changes in steroid 
concentration to be observed.
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Table 6.3: Significant enzyme expression changes (relative to basal expression) over 
72 hours after testosterone treatment o f the cell lines Ishikawa, RL95-2, HEC-1 A,
HEC-1B, anc COV434.
Cell Line Enzyme
changing
Time change 
rel to zero 
(hours)
P values Steroid conversion 
reaction
HSD8 40 0.035 Androstane-dione —>DHT
Ishikawa 48 0.038 Oestrone—►Oestradiol
5AR1 40 0.041 Testosterone —► DHT
RL95-2
5AR2 12
48
60
0.029
0.037
0.029
A ndrostenedione —► Androstane- 
dione (—►Androsterone)
Arom atase 60 <0.001 A ndrogens —►Oestrogens
5AR2 24 0.025 Androstenedione —► Androstane- 
dione (—►Androsterone)
HEC-1A HSD5 24 0.033
A ndrostenedione —►Testosterone
HEC-1B HSD8 36
72
0.005
0.003
Androstane-dione —►DHT 
Oestrone—►Oestradiol
COV434
5AR1 0
16
72
0.043
0.006
0.047
Testosterone —► DHT
From the table 6.3 and table 6.1 it was possible to observe the enzymes which were 
important in all the cell lines in terms o f high relative starting quantity expression or 
significant fold expression changes were aromatase, 5AR1, 5AR2, HSD2, HSD5 and 
HSD8. Specific inhibition o f one o f these enzymes may change the steroid profile 
significantly, resulting in normal steroid metabolism being re-established, and halting 
progression o f proliferation. For example finasteride a 5AR inhibitor alters steroid 
metabolism, and has been used for treatment o f benign prostatic hyperplasia and 
androgenetic alopecia.6
A sensitive, reproducible method was determined for the analysis o f enzyme 
expression in endometrial established cell lines. These experimental methods were 
applied to biopsy samples to obtain information about basal enzyme expression and 
temporal changes in enzyme expression following testosterone treatment in benign 
endometrial conditions.
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6.4 Relative expression of steroid converting enzymes in a number of 
endometrial pathologies (biopsies)
Studies o f basal enzyme expression relative to the averaged fertile biopsies in the 
biopsy groups under investigation (endometriosis, PCOS and unexplained infertility) 
were completed. Studies into basal enzyme expression (relative to the averaged 
fertile biopsies) in biopsies from a patient with an endometrial polyp, a patient with 
an ovarian cyst and in stromal and epithelial cells from a patient with endometrial 
hyperplasia were also conducted. The number o f biopsies in each endometrial 
disorder group was described in chapter 5 (table 5.9).
Biopsies from each o f the groups were obtained as there is evidence o f altered 
enzyme expression relating to steroid metabolism in these conditions. This altered 
expression is thought to cause bio-accumulation o f steroids which aid progression 
and proliferation of the disorders. For example in endometriosis biopsies from both 
the eutopic and ectopic endometrium there is evidence o f increased aromatase and 
sulphatase activity7, and increased HSD1 and reduced HSD2 expression which leads
o
to bio-accumulation o f oestradiol.
In biopsies from the endometria o f women with PCOS it has been shown that there 
was increased expression of HSD1 and decreased expression of HSD2 in comparison 
to healthy endometrial tissue again causing bio-accumulation o f oestradiol. 9
The unexplained infertility biopsies come from women who are unable to conceive, 
but the reason cannot be explained by any o f the tests available today, this was an 
interesting group to study as one o f the factors contributing towards their infertility 
could be an altered steroid metabolism due to abnormal expression o f specific steroid 
converting enzymes in their endometria.
Women who have endometrial hyperplasia (or non-invasive proliferation) have been 
recorded as having altered enzyme endometrial expression of HSD2, 5AR1 5AR2 
(all decreased) and HSD5, (increased) relative to fertile biopsies (discussed further in 
6.5.5).10
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To confirm these results the expression o f  these enzym es was investigated in fertile 
biopsies and in b iopsies from the specific endometrial disorders. The work was also 
extended to include all steroid converting enzym es described in table 6 .0  to produce 
a wider enzym e expression profiles with the aim o f  elucidating important enzym es  
which have been previously overlooked.
6.4.1 Comparison of basal starting quantity expression of steroid converting 
enzymes in stromal cells isolated from fertile and endometriosis endometrial 
biopsies
The similarity in basal steroid converting enzym e expression in fertile b iopsies (4 
sam ples) allow ed averaged data to be obtained with relatively small standard 
deviations. Endom etriosis b iopsies cannot be grouped by this method as RNA  
enzym e expression can vary considerably betw een sam ples, possib ly due to the stage 
or severity o f  the endom etriosis in each individual (described in chapter 1.6.3). It 
was hypothesised that as the condition progresses enzym e expression w ill alter. 
Unfortunately the severity o f  endom etriosis in each biopsy w as not recorded in these 
experim ents and so this hypothesis cannot be validated. S ix endom etriosis biopsies  
were investigated, three o f  the w om en were described as having secondary  
endom etriosis (2 nd endom etriosis), these wom en had previously conceived  and had 
developed endom etriosis since their pregnancies.
A r o m a t a s e  e x p r e s s io n  in e n d o m e t r i o s i s  b io p s ie s
Fig 6.15: R elative basal expression o f  aromatase in endometrial b iopsies from  
averaged fertile and endom etriosis. A ll b iopsy ce lls were grown in specific medium  
(chapter 2 .4) harvested and RNA extracted. Specific primers outlined in table 2.6  
were used to establish aromatase expression through RT-PCR.
Figure 6.15 illustrated aromatase expression in four o f  the six  endom etriosis sam ples 
was higher than the average fertile b iopsies. Increased aromatase expression in 
endom etriosis b iopsies relative to fertile sam ples agrees with observations by Attar
208
C hapter Six: R I -P C R  analys is  of endomet r ia l  cell l ines and biopsies
and co-w orkers.11 There were tw o sam ples which have lower aromatase expression  
than the fertile sam ple this could be due to the disease being at an early stage in these 
w om en.
HSD1 expression in endometriosis biopsies
14
Fig 6.16: Relative basal expression o f  HSD1 in endometrial b iopsies from averaged  
fertile and endom etriosis sam ples. Endom etriosis b iopsy cells were grown in specific  
medium (chapter 2 .4) harvested and RNA extracted. Specific primers outlined in 
table 2.6 were used to establish HSD1 expression through RT-PCR.
All endom etriosis b iopsies investigated demonstrated lower or com parable HSD1 
expression relative to the average fertile sam ple (figure 6 .16). HSD1 expression was 
found to be increased at deep-invasive endom etriosis sites by D assen 12 and 
colleagues, the disparity in these results compared to those in figure 6 .16 may be due 
to the biopsies in D assen’s study being taken directly from the ectopic endometrium  
(lesion sites) and not the endometrium itself, (the endom etriotic lesion sites are 
inflammation sites and it was expected that at these sites there w ill be an increase in 
m ultiple enzym e expression and steroid concentrations).
HSD2 expression in endometriosis biopsies
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Fig 6.17: Relative basal expression o f  H SD 2 in averaged fertile and endom etriosis 
biopsies. Endom etriosis biopsy ce lls were grown in specific medium (chapter 2.4) 
harvested and RNA extracted. Specific primers outlined in table 2 .6  were used to 
establish H SD 2 expression through RT-PCR.
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Bulun and colleagues recorded a decrease in expression o f  H SD 2 in endom etriosis 
biopsies relative to fertile b iopsies resulting in bioaccum ulation o f  oestradiol.13 
H SD 2 expression was decreased in three o f  the six  endom etriosis sam ples 
investigated in these experim ents in com parison to the fertile as illustrated by figure 
6.17. Three o f  the sam ples have increased H SD 2 expression relative to the fertile 
this difference in expression levels could again be attributed to severity o f  the 
disease, how ever there is som e variation in the literature concerning the down  
regulation o f  H SD 2 from fertile to endom etriosis sam ples, Day and colleagues 
reported som e studies demonstrating an increase in H SD 2 expression, although the 
majority o f  experim ents record decreased expression o f  H SD 2 in endom etriosis 
b iop sies.14’1516
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Fig 6.18: Relative basal expression o f  H SD 4 in averaged fertile and endom etriosis 
biopsies. Endom etriosis biopsy ce lls were grown in specific medium (chapter 2.4) 
harvested and RNA extracted. Specific primers outlined in table 2 .6 were used to 
establish H SD 4 expression through RT-PCR.
Expression o f  H SD 4 in four o f  six  endom etriosis sam ples was less than the fertile
group (figure 6 .18). T w o biopsies were recorded as having com parable H SD 4
expression to the fertile sam ples. This agrees with work by Dassen and co-workers
w ho recorded decreased expression o f  H SD 4 in endom etriosis b iopsies in
• 12com parison to fertile b iopsies.
HSD4 expression in endometriosis biopsies
l i i I I i
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HSD5 expression in endometriosis biopsies
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Fig 6.19: Relative basal expression o f  H SD 5 in averaged fertile and endom etriosis 
biopsies. Endom etriosis b iopsy ce lls were grown in specific medium (chapter 2.4) 
harvested and RNA extracted. Specific primers outlined in table 2 .6  were used to 
establish H SD 5 expression through RT-PCR.
Three o f  the six endom etriosis b iopsies illustrated in figure 6 .19  demonstrated higher 
expression o f  H SD5 than the fertile group. Sim ilarly high H SD 5 expression has 
recently been recorded in endom etriosis sam ples by Sm uc and co llea g u es.17 The 
other three sam ples have H SD 5 expression com parable to the fertile, again variation 
was attributed to severity.
HSD7 expression in endometriosis biopsies
3.5
Fig 6.20: R elative basal expression o f  H SD 7 in averaged fertile and endom etriosis 
biopsies. E ndom etriosis b iopsy ce lls were grown in specific  medium (chapter 2.4) 
harvested and RNA extracted. Specific primers outlined in table 2 .6  were used to 
establish H SD 7 expression through RT-PCR
H SD 7 expression in endom etriosis b iopsies was either higher or com parable to the 
averaged fertile sam ple as illustrated by figure 6 .20 . Sm uc and co-w orkers recorded
increased H SD 7 expression in endom etriosis sam ples relative to fertile sam ples,
1 8confirm ing these results.
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Fig 6.21: Relative basal expression o f  H SD 8 in averaged fertile and endom etriosis 
biopsies. Endom etriosis biopsy ce lls  were grown in specific medium (chapter 2 .4) 
harvested and RNA extracted. Specific primers outlined in table 2 .6  were used to 
establish H SD 8 expression through RT-PCR.
H SD 8 w as expressed at levels sim ilar to or less than expression levels o f  the fertile 
sam ple in four endom etriosis b iopsies (figure 6 .21). This agrees with previous work 
from Sm uc and co-workers stating oxidative H SD s (H SD 2, 4, 6 and 8) have sim ilar 
or reduced expression levels relative to the fertile sam p les.19 H SD 8 was how ever  
highly expressed in tw o endom etriosis sam ples, again this was probably due to the 
progression o f  the d isease in these patients.
5ARl expression in endometriosis biopsies
0.6
Fig 6.22: R elative basal expression o f  5A R l in endometrial b iopsies in com parison  
to averaged fertile biopsies. Endom etriosis biopsy ce lls were grown in specific  
medium (chapter 2.4) harvested and RN A extracted. Specific primers outlined in 
table 2.6 were used to establish 5A R l expression through RT-PCR.
5A R l expression w as increased in four o f  the six endom etriosis sam ples relative to 
the fertile group (figure 6 .22). 5A R l expression has been detected in endom etriosis
sam ples in previous studies, Cam eiro and co-w orkers detected 5A R l expression in
2083% o f  endometria from endom etriosis suffers, agreeing with the above results.
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5AR2 expression in endometriosis biopsies
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Fig 6.23: R elative basal expression o f  5A R 2 in averaged fertile and endom etriosis 
biopsies. Endom etriosis biopsy ce lls  were grown in specific medium (chapter 2.4) 
harvested and RNA extracted. Specific primers outlined in table 2 .6  were used to 
establish 5A R 2 expression through RT-PCR.
Expression o f  5A R 2 was reduced relative to the fertile group in four o f  the six 
endom etriosis b iopsies (figure 6 .23). 5A R 2 expression was detected in tw o o f  six  
endom etriosis b iopsies a study by Carneiro and colleagues, this correlates with the 
results recorded in the experim ents described in figure 6 .2 3 .20
6.4.2 Conclusions Endometriosis samples
Endom etriosis b iopsies were d ifficult to investigate due to the variation between  
sam ples. If the b iopsies were grouped according to the stage o f  endom etriosis  
(m inim al, m ild, moderate, severe) changes in basal enzym e expression through the 
different stages o f  endom etriosis may be apparent. This made any data analysis 
difficult to determine for the group as a w hole (expression w as not determined to be 
significantly different from the fertiles for all endom etriosis b iopsies for each  
enzym e investigated).
The general trends recorded in these experim ents were high aromatase, 5A R 1, 
H SD 7, and H SD 5 starting quantity expression, and low  expression o f  5A R 2, H SD 4, 
and HSD1 relative to the average fertile sam ple. Sm uc and co lleagues demonstrated  
expression o f  the reductive H SD s ( 1 , 5  and 7) was up-regulated in endometria from 
endom etriosis sam ples (relative to fertile b iopsies), leading to bio-accum ulation o f  
the potent oestrogen oestradiol which is essential o f  progression o f  endom etriosis, in 
the same study by Sm uc expression o f  the oxidative FISDs (2, 4 and 8) w as found to 
be comparable to or lower than fertile sam p les.19 The majority o f  endom etriosis 
sam ples investigated in these experim ents agreed with these observations (except
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HSD1). Cameiro and colleagues observed increased expression o f 5ARl and 
decreased expression o f 5AR2 in the majority o f endometriosis biopsies under 
investigation, the results accumulated in these experiments confirm Cameiro’s 
results.20 The altered enzyme expression profiles produced by the endometriosis 
samples relative to the fertile biopsies indicated that a number o f steroid metabolism 
pathways were active in this pathology, furthermore a different steroid pathway 
should be observed between the two groups after testosterone treatment. This agrees 
with the experimentally obtained steroid profiles described in chapter 5.9.
6.4.3 Comparison of average starting quantity expression of steroid converting enzyme 
RNA in ovarian disorder biopsies to fertile biopsies
The endometria o f women with ovarian disorders were investigated. The two 
ovarian disorders under investigation were PCOS (2 biopsies) and ovarian cyst (1 
biopsy). One patient with PCOS was also described as having tubual disorder, in 
chapter five it was recorded that testosterone metabolism in a woman with only 
tubual disorder was similar to the fertile biopsies. It was therefore probable that in 
the biopsy from the woman with PCOS and tubual disorder any recorded alterations 
in testosterone metabolism or enzyme expression would be influenced by the PCOS 
condition and not tubual disorder. In all the graphs below this biopsy was described 
as PCOS plus tubual disorder to permit observations between the two PCOS 
biopsies.
Ovarian cysts and PCOS while both ovarian conditions are different disorders 
determined by different clinical pathologies. PCOS patients have 2 o f these 3 
symptoms, circulatory hyperandrogenism, oligo-ovulation (or annovulation), and a 
number o f cysts on the ovary (chapter 1.6). These factors may cause altered steroid 
metabolism in the endometrium of women with PCOS.
Presence o f cysts in the ovaries can affect the menstrual cycle and cause pelvic pain. 
Cunat and colleagues demonstrated ovarian cysts (themselves) expressing aromatase 
which could lead to an increase in circulatory oestrogens, which could in turn affect 
steroid metabolism and proliferation in the endometrium.21 The patient investigated 
in this thesis was described as having chronic pelvic pain which may suggest the cyst 
was proliferating and expressing aromatase and oestradiol. The expression o f steroid
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converting enzym es in endometrial tissue from w om en with ovarian cysts is not 
w idely  investigated (in com parison to PCO S), as the cyst is generally removed  
elim inating the problem.
Aromatase expression in endometria  
from patients with ovarian disorders
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Fig 6.24: Relative basal expression o f  aromatase in averaged fertile and ovarian 
disorder biopsies. Ovarian disorder b iopsies were grown in specific medium  
(chapter 2 .4) harvested and RNA extracted. Specific primers outlined in table 2.6  
were used to establish aromatase expression through RT-PCR.
Figure 6.24 illustrates basal aromatase expression in the endometria from w om en  
with ovarian disorders relative to fertile b iopsies. There w as little aromatase 
expression in the PCOS (plus tubual d isease) sam ple or the fertile b iopsies. This 
agrees with work by Bacallao who detected no aromatase expression in endometrial 
tissue from fertile w om en and wom en with PCO S.9 The other PCOS biopsy and the 
ovarian cyst biopsy disagree with this both recording higher aromatase expression in 
com parison to the fertile sam ple (figure 6 .24).
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Fig 6.25: R elative basal expression o f  HSD1 in averaged fertile and ovarian disorder 
biopsies. Ovarian disorder b iopsies were grown in specific medium (chapter 2 .4) 
harvested and RNA extracted. Specific primers outlined in table 2.6 were used to 
establish HSD1 expression through RT-PCR.
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Figure 6.25 illustrates that HSD1 expression w as reduced in all ovarian disorder 
sam ples relative to the average fertile b iopsies. HSD1 expression w as com parable in 
all ovarian disorders.
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Fig 6.26: Relative basal expression o f  H SD 2 in averaged fertile and ovarian disorder 
biopsies. Ovarian disorder b iopsies were grown in specific medium (chapter 2.4) 
harvested and RNA extracted. Specific primers outlined in table 2.6 were used to 
establish H SD 2 expression through RT-PCR.
Figure 6 .26 illustrates H SD 2 expression was reduced in all ovarian disorder sam ples 
relative to the averaged fertile sam ple. This reduced expression o f  H SD 2 in the 
PCOS biopsies did not agree with m RNA enzym e expression information recorded 
by Leon and co-workers in 2 008 , who found sim ilar H SD 2 expression in fertile and 
endom etriosis b iopsies, the reason for this disparity could be because Leon obtained
his b iopsies from the mid secretary phase whereas in these experim ents they were
22taken from the proliferative phase.
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Fig 6.27: R elative basal expression o f  FISD4 in averaged fertile and ovarian disorder 
biopsies. Ovarian disorder b iopsies were grown in specific medium (chapter 2 .4) 
harvested and R N A  extracted. Specific primers outlined in table 2 .6  were used to 
establish H SD 4 expression through RT-PCR.
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Figure 6.27 illustrates expression o f  H SD 4 was reduced in all ovarian disorder 
biopsies relative to the averaged fertile sam ple.
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Fig 6.28: R elative basal expression o f  H SD5 in averaged fertile (control) and ovarian 
disorder biopsies. Ovarian disorder b iopsies were grown in specific medium  
(chapter 2.4) harvested and RNA extracted. Specific primers outlined in table 2 .6  
were used to establish H SD 5 expression through RT-PCR.
Figure 6.28 illustrates that HSD5 expression was low  in all ovarian disorder b iopsies  
relative to the fertile sam ples. The expression levels o f  H SD 5 were com parable in 
the ovarian cyst and both PCOS biopsies.
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Fig 6.29: Relative basal expression o f  FISD7 in averaged fertile (control) and ovarian  
disorder biopsies. Ovarian disorder b iopsies were grown in specific medium  
(chapter 2 .4) harvested and RNA extracted. Specific primers outlined in table 2.6  
were used to establish H SD 7 expression through RT-PCR.
Figure 6 .29 illustrates the PCOS biopsy and the ovarian cyst b iopsy exhibited high 
com parable starting quantity expression o f  H SD 7 relative to the fertile (and the 
PCOS plus tubual disorder biopsy).
217
C hap te r  Six: R F-PCR analysis o f  endometr ia l  cell lines and biopsies
6 HSD8 e x p r e s s io n  in e n d o m e t r ia  from  p at ien ts  
x w ith  ovarian d isord ers
Q 5 T
<
PCOS * tu b u a l  d is  PCOS O v a r ia n  C yst
Fig 6.30: R elative basal expression o f  H SD 8 in averaged fertile and ovarian disorder 
biopsies. Ovarian disorder biopsies were grown in specific medium (chapter 2.4) 
harvested and RNA extracted. Specific primers outlined in table 2 .6 were used to 
establish H SD 8 expression through RT-PCR.
Figure 6 .30 illustrates low  H SD 8 expression in all ovarian disorder biopsies in 
com parison to the fertile biopsies.
5AR1 expression in endom etria  from patients  
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Fig 6.31: Relative basal expression o f  5 A R l expression in averaged fertile and 
ovarian disorder biopsies. Ovarian disorder b iopsies were grown in specific medium  
(chapter 2 .4) harvested and RNA extracted. Specific primers outlined in table 2.6  
were used to establish 5AR1 expression through RT-PCR.
Figure 6.31 illustrates low  expression o f  5AR1 in all ovarian disorder biopsies in 
com parison to the average fertile sample.
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Fig 6.32: R elative basal expression o f  5A R 2 in averaged fertile and ovarian disorder 
biopsies. Ovarian disorder biopsies were grown in specific  medium (chapter 2.4) 
harvested and RNA extracted. Specific primers outlined in table 2 .6 were used to 
establish 5A R 2 expression through RT-PCR.
Figure 6.32 illustrated that 5A R 2 expression in all ovarian disorder b iopsies was 
lower than the fertile sam ple.
6.4.4 Conclusions ovarian disorders
Basal enzym e expression in PCOS b iopsies a llow s confirm ation o f  altered enzym e  
expression o f  previously investigated enzym es. The majority o f  previous work has 
been centred specifically  on oestrogen m etabolism  and the bio-accum ulation o f  
oestradiol2' via increased expression o f  arom atase and HSD1 or decreased  
expression o f  H SD 2. To our know ledge com parative investigations into the 
expression levels o f  H SD  4, 5, 7, 8, 5 A R l or 5A R 2 in the endometria o f  w om en with 
PCOS or ovarian cysts has not been com pleted.
There is less information about steroid m etabolism  in the endom etria o f  w om en with 
ovarian cysts. The data described in this thesis suggested  that ovarian cysts can 
affect endometrial steroid m etabolism  as there w as altered enzym e expression under 
basal conditions and altered steroid profiles fo llow in g  testosterone treatment relative 
to the fertile b iopsies (chapter 5).
There were sim ilarities between the starting quantity expression for both PCOS 
sam ples and the ovarian cyst biopsy (low er expression o f  H SD  1, 2, 4, 5, 8, 5A R 1, 2, 
and significantly higher expression o f  aromatase and com parable H SD 7 expression  
relative to the fertile group). Altered endometrial enzym e expression in patients with  
ovarian disorder suggests that ovarian cysts and PCOS affect steroid m etabolism  in
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the endometrium in a sim ilar manner. This could contribute towards infertility  
described in these w om en since horm one changes regulate endometrial receptivity. 
It could also lead to progression o f  an endom etrial disorder such as hyperplasia or 
endometrial cancer. It is probable there were significant roles for these enzym es and 
the steroids they produce in the progression o f  endometrial disorders in w om en with  
PCOS. G iudice stated that unopposed oestrogen and increased androgens aid the 
progression to endometrial hyperplasia and endometrial cancer in w om en with  
PCOS. It is possib le that this progression occurs through altered endometrial enzym e  
expression .24
6.4.5 Comparison of basal starting quantities of enzymes in averaged fertile 
biopsies to biopsies from patients with unexplained infertility
T w o b iopsies from wom en with unexplained infertility were analysed and compared  
to the average fertile b iopsies to determine relative expression o f  nine steroid 
converting enzym es outlined in table 6.0.
C o m p a r is o n  o f  e n z y m e  e x p r e s s io n  in fert ile  (F) an d
u n e x p la i n e d  in fertil ity  (U) b io p s i e s  
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Fig 6.33: A verage basal expression  o f  all enzym es in fertile and unexplained  
infertility b iopsies. T w o unexplained infertility (U ) and four fertile b iopsies (F) were 
grown in specific m edium  (chapter 2 .4 ) harvested and the RNA extracted. Specific  
primers described in table 2 .6  were used to establish expression levels o f  steroid 
converting enzym es through RT-PCR.
A ll enzym es analysed in the unexplained infertility group (2 b iopsies) and the fertile 
group (4 b iopsies) demonstrated sim ilar basal enzym e expression values for all 
steroid converting en zym es (figure 6 .33). T hese results suggest that in the 
endometria o f  these tw o w om en, steroid m etabolising enzym e expression w as not a 
factor contributing towards infertility. This correlates with the steroid profiles
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described in chapter 5.8 which showed similar metabolism of testosterone, and 
production o f androstenedione, androsterone, oestradiol and oestrone in comparison 
to the fertile biopsies. The unexplained infertility biopsies also produced no DHT 
which was identical to the fertile biopsies (further discussed in chapter 7.2). More 
samples are required to confirm these preliminary results described in this thesis.
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6.4.6 Case Reports
Statistical analysis o f  the data sets cannot be confidently assigned to groups with low  
number o f  sam ples. C ase studies were described for biopsies from a wom an with 
endometrial hyperplasia and a wom an with an endometrial polyp. Initial 
observations were recorded, how ever the numbers in each group limit any 
conclusions regarding that condition due to variation between patients, how ever 
these were interesting to study and the observations recorded show ed som e  
interesting preliminary data. Progression o f  this work to include analysis o f  more 
biopsies from these groups via these optim ised methods would be an ideal 
continuation o f  this project.
6.4.7 Basal starting quantities of steroid converting enzymes in stromal and 
epithelial cells from a patient with endometrial hyperplasia compared to fertile 
biopsies
A hyperplasia biopsy w as obtained from a 55 year old woman with moderate atypical 
hyperplasia and post m enopausal bleeding, this was split into epithelial and stromal 
cells. Starting quantity expression o f  the enzym es outlined in table 6.0 were 
recorded under basal conditions.
Fig 6.34: Comparison o f  basal expression in averaged (stromal) fertile b iopsies and 
epithelial and stromal ce lls  from an endometrial epithelial hyperplasia biopsy. All 
biopsies were grown in specific medium (chapter 2.4) harvested and the RNA  
extracted. Specific primers described in table 2 .6  were used to establish expression  
levels o f  steroid converting enzym es through RT-PCR. EH= endometrial epithelial 
hyperplasia, SH = stromal ce lls  from a patient with endometrial epithelial 
hyperplasia, F= averaged fertile stromal b iopsies (4 sam ples).
C o m p a r i s o n  o f  e n z y m e  s t a r t i n g  q u a n t i t i e s  fo r  f e r t i l e s  (F) 
e n d o m e t r i a l  e p i t h e l i a l  h y p e r p l a s i a  (EH) a n d  s t r o m a l  
h y p e r p l a s i a  (SH) b i o p s i e s
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Figure 6.34 illustrated that aromatase expression was significantly increased in the 
stromal cells from the hyperplasia biopsy in com parison to the fertile b iopsies 
(P = 0.004). Increased aromatase expression in endometrial hyperplasia has been 
reported by Li and co lleagues, and the treatment o f  endometrial hyperplasia with 
aromatase inhibitors is often adm inistered25 (although som e inhibitors reduce global 
oestrogen synthesis). There w as low  expression o f  HSD1 in both hyperplasia 
sam ples in com parison to the fertile b iopsies, Utsunom iya and co lleagues confirm ed  
these results (no expression o f  HSD1 in hyperplasia using an im m unoreactivity  
m ethod). U tsunom iya also recorded decreased H SD 2 expression lower in 25% o f  
hyperplasia biopsies. H SD 2 expression recorded in this investigation was decreased  
in both the stromal and epithelial hyperplasia b iopsies in com parison to the fertile 
(figure 6 .35), agreeing with som e o f  U tsunom iya’s results. Further experim ents with 
more sam ples w ill be required to confirm the initial observations described in this 
thesis.
C o m p a r i s o n  o f  e n z y m e  s t a r t i n g  q u a n t i t i e s  f o r  f e r t i i e s  (F), e n d o m e t r i a l  e p i t h e l i a l  
h y p e r p l a s i a  (EH) a n d  s t r o m a l  h y p e r p l a s i a  (SH) b i o p s i e s
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Q
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Fig 6.35: Com parison o f  basal expression in fertile and hyperplasia sam ples 
(epithelial and stromal). Endometrial epithelial hyperplasia, endometrial stromal cells  
from a patient with endometrial hyperplasia and fertile b iopsies were grown in 
specific medium (chapter 2 .4) harvested and the RNA extracted. Specific primers 
described in table 2 .6  were used to establish expression levels o f  steroid converting  
enzym es through RT-PCR. EH= endometrial epithelial hyperplasia, SH = stromal 
ce lls  from a patient with endometrial epithelial hyperplasia, F= averaged fertile 
stromal b iopsies.
FISD5 expression w as higher in the hyperplasia epithelial ce lls  than the hyperplasia  
stromal cells. Ito and colleagues show ed increased expression o f  H SD 5 in 
endom etrioid cancer b iopsies relative to the hyperplasia and fertile sam ples. In these  
experim ents both hyperplasia b iopsies have lower H SD 5 expression than the fertile
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biopsy (this was contradictory to Ito’s second conclusion).10 Expression o f 5AR1 and 
5AR2 in the hyperplasia (epithelial and stromal) biopsy was reduced in comparison 
to the fertile sample. This agrees with another study by Ito and co-workers who 
recorded low expression o f both 5AR isoforms in hyperplasia biopsies.27 To our 
knowledge comparative investigations into the expression levels o f HSD4, HSD7, 
and HSD8 in endometrial hyperplasia biopsies have not been completed.
PCOS patients are at a higher risk o f developing endometrial hyperplasia (and 
possibly endometrial cancer) due to increased androgens and unopposed 
oestrogens.28 It is possible that the endometria from women with PCOS are 
progressing towards hyperplasia. A comparison o f the expression levels of each 
steroid converting enzyme in the endometria o f the ovarian cyst and PCOS biopsies 
to the stromal hyperplasia biopsy demonstrated similar trends for all enzymes (a 
decrease in HSD1, 2, 4, 5, 8 and 5AR2, an increase in aromatase, and comparable 
expression o f HSD7 and 5ARl relative to the average fertile biopsies), suggesting 
progression in these biopsies to endometrial hyperplasia.
6.4.8 Comparison of basal starting quantities of steroid converting enzymes in 
an endometrial polyp biopsy to fertile biopsies
Starting quantity expression under basal conditions for the enzymes outlined in table 
6.0 were analysed in an endometrial polyp biopsy from a 43 year old woman. An 
endometrial polyp is a benign growth in which steroid metabolism is thought to be 
similar to the normal endometrium, if this was true enzyme expression in the average 
fertile and the endometrial polyp sample should be identical. However in chapter 
5.11 this biopsy demonstrated altered steroid metabolism (compared to fertile 
biopsies) and so altered enzyme expression was expected.
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Comparison to enzyme starting quantities for fertile biopsies to 
an endometrial polyp biopsy
i  i
Fig 6.36: Com parison o f  basal expression o f  nine steroid converting enzym es in 
fertile and endometrial polyp b iopsies. An endometrial polyp biopsy (EP) and the 
fertile b iopsies (F) w ere grown in specific medium (chapter 2 .4) harvested and the 
RNA extracted. S pecific primers described in table 2 .6 were used to establish  
expression levels o f  steroid converting enzym es through RT-PCR.
Figure 6.36 illustrated a decrease in the starting quantity expression o f  H SD  1, H SD 2, 
H SD 4, 5ARI  and 5A R 2 in the endometrial polyp biopsy compared to the average 
fertile b iopsies. There w as increased expression o f  aromatase, H SD 5, H SD 7 and 
H SD 8 (figure 6 .36). Arom atase expression in the biopsy from an endometrial polyp  
was higher than the basal expression levels in the average fertile sam ple, this did not 
agree with expression information from Pal and co-workers w ho observed aromatase
29expression to be sim ilar in endometrial polyps and fertile sam ples. Further 
experim ents with more sam ples w ill be required to confirm the initial observations 
described in this thesis.
The com bination o f  enzym e expression profile for the endometrial stromal 
hyperplasia and the m ass spectrometry information from chapter 5 this suggests that 
this endometrial polyp biopsy could be progressing towards hyperplasia. This was 
supported by the sim ilar trends in expression o f  a number o f  enzym es in both 
pathologies relative to the fertile b iopsies, (increased expression o f  aromatase and 
H SD 7, and decreased expression o f  H SD  1, H SD 2, H SD 4 and 5A R 2).
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6.4.9 Summary of enzyme expression in fertile biopsies and benign endometrial 
disorders
A direct comparison between basal expression o f each enzyme in each condition 
relative to the fertile biopsies was completed (table 6.4).
Table 6.4: Basal enzyme expression in benign endometrial pathologies relative to the 
averaged fertile biopsies. H was higher expression than the 95th percentile o f the 
average fertiles, L was lower expression than the 95th percentile o f the averaged 
fertiles and, -  was comparable expression to the averaged fertiles. Expression o f  
specific enzymes was determined by RT-PCR with specific primers as outlined in 
table 2.6 (arom= aromatase).
Pathology arom HSD1 HSD2 HSD4 HSD5 HSD7 HSD8 5AR1 5AR2
Unexplained
Infertility _ _ _ - . . _ _ _
Endom etriosis H L * L H * * H *
PCOS - L L L L L L L L
Ovarian Cyst H L L L L L L L L
H yperplasia
Epithelial H L L L L L L L L
Hyperplasia
Stromal H L L L L H L «. L
Endometrial
polyp H L L L H H H L H
* basal expression varied significantly between endometriosis biopsies making 
comparison by 95th percentile method not possible.
The results quoted for endometriosis samples in table 6.4 demonstrate increased (or 
decreased) expression in the majority o f endometriosis biopsies relative to the fertile 
biopsies, (this was not possible with HSD2 or HSD8 expression due to the large 
variation in basal expression of endometriosis enzymes also half exhibited increased 
and half decreased expression o f each enzyme relative to the fertile biopsies). 
Unexplained infertility biopsies were observed to exhibit similar enzyme expression 
and steroid profiles to fertile biopsies, again confirming the hypothesis that 
endometrial steroid metabolism was not altered in these women suggesting steroid 
metabolism was not contributing towards infertility. There was variation in 
expression o f a number o f enzymes in all other benign conditions relative to the 
fertile biopsies. This could explain the variation in testosterone utilisation and 
production o f the specific steroids determined in chapter 5. Relative to the fertile 
biopsies, one PCOS biopsy demonstrated higher aromatase expression the other 
exhibited lower aromatase expression, this highlights the variation between 
biological samples, an expansion o f this investigation to include further PCOS
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biopsies would determine the relationship between aromatase expression in PCOS  
endometria relative to the fertile group.
6.5 Changes in enzyme expression after testosterone treatment over 72 hours in 
endometrial biopsies
Testosterone treatment o f  b iopsies was com pleted over four tim e points over 72 
hours (0, 24, 48 and 72 hours) as described in chapter 3 .14. Changes in enzym e  
expression throughout the experim ent for each endometrial pathology were 
determined (expressed as fold expression relative to G A D PH ). The expression o f  
each enzym e was then norm alised to 1 at tim e zero (under basal conditions) changes 
in expression relative to this tim e throughout the 72 hours were calculated. This 
highlights the enzym es w hich demonstrated the largest changes in fold expression  
throughout the experim ents after testosterone treatment. F ollow ing determination o f  
changes in enzym e expression after testosterone treatment correlations between  
changing steroid concentrations and enzym e expression were determined (chapter 7).
6.5.1 Changes in enzyme expression in fertile biopsies
Changing mRNA e n z y m e  express ion  in fertile  
biopsies
^  •  a io m a f a s e  — ■ HSI>1 __
n  a — HSD2 — *—  HSD4
O  —m — HSD5 HSD7
O  „  H S D 8  --------- ^ A R l
o  /  \“  ----—  SAR2
O
O 12 2 4  36 48 60 7 2
T im e  ( h o u r s )
Fig 6.37: C hanges in enzym e expression  levels over 72 hours after testosterone  
treatment in average fertile stromal b iopsies. Fertile b iopsies were grown in specific  
medium (chapter 2 .4) harvested and RNA extracted. S pecific primers described in 
table 2 .6 were used to establish expression levels o f  steroid converting enzym es  
through RT-PCR.
There were significant changes in expression levels o f  the 5A R 2 enzym e produced  
from averaged data from four fertile b iopsies (figure 6 .37). The expression was 
significantly increased at 24 hours relative to zero (P= 0 .016) a maxim um  fold
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increase w as observed at 48 hours. The expression o f  all other enzym es remains 
essentially constant throughout the experim ent. It w as postulated that at 24 and 48  
hours there would be an increase in the reaction product androsterone and a decrease 
in the reaction precursor androstenedione this was confirm ed in chapter 7.
6.5.2 Changes in enzyme expression in unexplained infertility biopsies
C h a n g e s  in e n z y m e  e x p r e s s i o n  in u n e x p l a i n e d  
in f e r t i l i t y6
ai om atase HSOlS
HSC>2 HS£I4
~  4 HSD5 HSD7<L>
HSD8 SARI
0  12  2 4  3 6  4 8  6 0  72
Time (hours)
Fig 6.38: Changes in enzym e expression levels over 72 hours after testosterone 
treatment in average unexplained infertility b iopsies. U nexplained infertility b iopsies 
were grown in specific medium (chapter 2 .4) harvested and RN A extracted. Specific  
primers described in table 2 .6 were used to establish expression levels o f  steroid 
converting enzym es through RT-PCR.
5A R 2 expression increased at 48 and 72 hours relative to tim e zero in the 
unexplained infertility b iopsies, as illustrated in figure 6 .38 . A s with the fertile 
biopsies expression o f  all other enzym es remained constant throughout the 
experim ent. A change in 5A R 2 expression was com parable to the fertile b iopsies 
(although observed later in the unexplained infertility b iopsies).
6.5.3 Changes in enzyme expression in endometriosis biopsies
The endom etriosis b iopsies were grouped together to determine changes in enzym e  
expression after testosterone treatment this w as possib le as at tim e zero all enzym e  
expression was norm alised to one. This a llow s investigation into changes in enzym e  
expression irrespective o f  basal enzym e expression.
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C h a n g e s  in e n z y m e  e x p r e s s i o n  in e n d o m e t r i o s i s  
b i o p s i e s
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Tim e (h o u rs)
Fig 6.39: C hanges in enzym e expression levels over 72 hours after testosterone  
treatment in average endom etriosis stromal b iopsies. Endom etriosis b iopsies were 
grown in specific medium (chapter 2 .4) harvested and RNA extracted. Specific  
primers described in table 2 .6 were used to establish expression levels o f  steroid 
converting enzym es through RT-PCR.
Figure 6.39 illustrates a change in expression o f  the enzym e H SD 2 at 48 and 72 
hours in the endom etriosis biopsies.
6.5.4 Changes in enzyme expression in endometrial biopsies from patients with 
PCOS
Avg changing enzyme expression in
io
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Fig 6.40: C hanges in enzym e expression levels over 72 hours after testosterone 
treatment in average PCOS stromal biopsy. PCOS b iopsies were grown in specific  
medium (chapter 2 .4 ) harvested and RNA extracted. Specific primers described in 
table 2 .6  were used to establish expression levels o f  steroid converting enzym es  
through RT-PCR.
Figure 6 .40 illustrates a change in H SD 7 enzym e expression at 48 and 72 hours in 
the PCOS biopsy. H SD 8 expression w as increased at 48 hours and any correlations 
between enzym e expression and steroid concentrations were outlined in chapter 7. 
Expression o f  all the other enzym es remains essentially  constant after tim e zero.
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Case Reports
6.5.5 Changes in enzyme expression in an endometrial biopsy from an ovarian 
cyst
Changes in enzym e expression in Ovarian 
40 cyst biopsy
^  arom
30 - * - HSD1
HSD2
^  HSD4
, 0 HSD8
 SARIIS 
10 
S
0 : ' “ ’
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Fig 6.41: Changes in enzym e expression levels over 72 hours after testosterone 
treatment in average ovarian cyst stromal biopsy. An ovarian cyst biopsy was grown 
in specific medium (chapter 2 .4 ) harvested and RNA extracted. Specific primers 
described in table 2 .6 were used to establish expression levels o f  steroid converting  
enzym es through RT-PCR (tw o separate graphs are shown as the increase in 
expression was larger for H SD 5, 7 and 5A R 2 in com parison to the other enzym es).
There were large changes in the expression levels o f  a number o f  enzym es in the 
stromal biopsy from a patient with an ovarian cyst (figure 6 .41). At 48 hours the 
expression levels o f  aromatase, H SD 8 and 5A R 2 were increased in relation to basal 
expression. These large changes were all recorded at the sam e tim e point which may 
be indicative o f  a m isleading result.
6.5.6 Changes in enzyme expression in endometrial biopsy from an endometrial 
hyperplasia biopsy
Thf l f |h0UrS) 40
C hanging  e n z y m e  e x p r e s s io n  in an
e p i th e l ia l  h yp erp la s ia  b iopsy
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Fig 6.42: Changes in enzym e expression levels over 72 hours after testosterone 
treatment o f  an epithelial hyperplasia biopsy. An endometrial hyperplasia biopsy  
was grown in specific m edium  (chapter 2.4) harvested and RNA extracted. Specific  
primers described in table 2 .6  were used to establish expression levels o f  steroid  
converting enzym es through RT-PCR.
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Significant changes in enzym e expression relative to tim e zero were recorded in the 
enzym es H SD 5, H SD 7, 5AR1 and 5A R 2 in the epithelial hyperplasia biopsy. H SD 7  
increases at 24 and 72 hours relative to tim e zero. H SD5 expression was increased at 
48 and 72 hours, and expression o f  5AR1 and 5AR2 was increased at 72 hours 
relative to tim e zero (figure 6 .42). Expression o f  all other enzym es w as constant 
throughout the experim ent.
Changing enzyme expression in a 
stromal hyperplasia biopsy
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Fig 6.43: Changes in enzym e expression  levels over 72 hours after testosterone 
treatment in stromal ce lls from an endometrial hyperplasia biopsy. An endometrial 
stromal biopsy was grown in specific  medium (chapter 2 .4) harvested and RNA  
extracted. Specific primers described in table 2 .6 were used to establish expression  
levels o f  steroid converting enzym es through RT-PCR.
Figure 6.43 illustrates increased expression o f  three enzym es in the hyperplasia 
stromal biopsy. These changes were higher than recorded in the epithelial ce lls, but 
were recorded with the sam e enzym es H SD 5, 5AR1 and 5A R 2 all o f  which show ed  
increased expression at 72 hours. Expression o f  H SD 2, H SD 4 and aromatase 
increased 48 hours after testosterone treatment, all other enzym e expression  
remained essentially  constant throughout the experim ent.
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6.5.7 Changes in enzyme expression in an endometrial sample from a patient 
with an endometrial polyp
Changing enzyme expression in 
endometrial polyp A r o m o t j s o
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Fig 6.44: Changing expression o f  all enzym es over 72 hours after testosterone  
treatment in an endometrial polyp biopsy. An endometrial polyp biopsy was grown 
in specific medium (chapter 2 .4) harvested and RNA extracted. Specific primers 
described in table 2 .6 were used to establish expression levels o f  steroid converting  
enzym es through RT-PCR.
At 24 hours all enzym es (except arom atase) were reduced in com parison to time 
zero, another decrease in expression o f  all enzym es was observed after 48 hours in 
the endometrial polyp sam ple as illustrated in figure 6 .44 . Aromatase expression  
increased after 24 hours and decreased after this time.
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6.5.8 Conclusions biopsies
A table of temporal changes in enzyme expression levels for each endometrial 
pathology was compiled. This was directly compared to steroid metabolism profiles 
in chapter 7.
Table 6.5: Temporal changes in enzyme expression in seven endometrial pathologies 
relative to basal expression after testosterone treatment (72 hours).________________
Endometrial
pathology
Enzymes which exhibit 
large fold expression 
changes rel to time zero
Steroid conversion reaction
Fertile 5AR2 (P= 0.016) Androstenedione —► Androstane-dione 
Testosterone —► DHT
Unexplained Infertility 5AR2 Androstenedione —► Androstane-dione 
Testosterone —► DHT
Endometriosis HSD2 Testosterone —► Androstenedione 
Oestradiol —► Oestrone
Ovarian Cyst Aromatase
HSD5
HSD7
HSD8
5AR1/5AR2
Androgens —►Oestrogens 
Androstenedione —►Testosterone 
Oestrone —► Oestradiol 
Oestradiol —►Oestrone 
DHT—►Androstane-dione 
Testosterone —> DHT 
Androstenedione —► Androstane-dione
PCOS HSD7
HSD8
Oestrone —► Oestradiol 
Oestradiol —►Oestrone 
DHT-> Androstane-dione
Hyperplasia Epithelial HSD7
HSD5
5AR1/5AR2
Oestrone —► Oestradiol 
Androstenedione —►Testosterone 
Testosterone —► DHT 
Androstenedione —► Androstane-dione
Hyperplasia Stromal HSD5
5AR1/5AR2
Androstenedione —►Testosterone 
Testosterone —► DHT 
Androstenedione —► Androstane-dione
Endometrial Polyp None
The enzyme expression data, (basal expression (summarised in table 6.4) and large 
changes in enzyme expression relative to basal expression table 6.5) highlighted 
enzymes which could be targeted for inhibition that were not present in fertile 
samples but were highly expressed in endometrial disorders possibly leading to 
altered steroid metabolism. Cells lines were more homogenous than the biopsies, 
which leads to less variation between experiments and in enzyme expression which 
permitted the use o f statistical tests. Unlike the cell lines there were less biopsies 
available from each group (the case studies only investigated one biopsy) and 
biological variation between patients was more apparent.
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HSD2 inhibition in endometriosis samples may be a viable target or 5AR1 
expression in hyperplasia, PCOS or ovarian cyst patients. HSD5 expression 
increased in hyperplasia and ovarian cyst patients and HSD7 expression increased in 
the ovarian disorders following testosterone treatment and so these could also be 
viable targets. The level o f influence expression o f each o f these enzymes has on the 
production of a specific steroid(s) requires confirmation before inhibitor 
development.
6.6 Conclusions chapter six
Initial experiments with established cell lines permitted optimisation of cell culture 
techniques and experimental methods, as well as RNA extraction, reverse 
transcription and RT-PCR. After a sensitive, reproducible method was determined it 
was subsequently applied to biopsy samples.
The basal expression o f nine steroid converting enzymes was recorded in all cell 
lines and biopsies. A comparison o f basal enzyme expression in biopsies which 
exhibit similar testosterone metabolism profiles was conducted. Following this 
testosterone treatments were completed over 72 hours and changes in expression of 
each enzyme recorded.
Experiments with cell lines and biopsies highlight the same enzymes as important for 
steroid metabolism. There were a number o f enzymes which were either highly 
expressed (high basal expression) or produced the highest changes in fold expression 
after testosterone treatment relative to basal expression. These enzymes were 
aromatase, 5AR1, 5AR2, HSD2, HSD5, HSD8 and (to a lesser extent) HSD7.
Changes in enzyme expression were linked to changes in steroid concentration(s) in 
chapter 7 to determine if  expression of a specific enzyme(s) can directly affect the 
steroid profile.
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Chapter seven
Testosterone utilisation by endometrial cells: Comparison of 
metabolic (mass spectrometry) and enzyme expression profiles
Chapter Seven:  Testosterone  util isation by endometrial  cells:  Comparison o f  
metabol ic  (mass  spectrometry)  and e n z y m e  express ion  (PCR)  profi les
7.0 Introduction
This chapter describes the combination o f mass spectrometry and enzyme expression 
data (RT-PCR), under basal conditions (prior to testosterone treatment) and after 
testosterone treatment creating a unique view of testosterone metabolism in the 
endometrium. From these results important metabolism routes and enzymes have 
been observed in endometrial cell lines and in the endometria o f women with 
endometriosis suggesting altered testosterone metabolism pathways in comparison to 
fertile biopsies. Preliminary data from a limited number of endometrial biopsies 
from women with other benign disorders (PCOS, ovarian cyst, endometrial 
hyperplasia, and endometrial polyp) also demonstrated altered testosterone 
metabolism in comparison to the fertile group. Two biopsies from women with 
unexplained infertility were also investigated in this chapter.
Expression profiles for aromatase, 17p-HSDl, 17pHSD2, 17P-HSD4, 17p-HSD5, 
17p-HSD7, 17P-HSD8, 5AR1 and 5AR2 which catalyse the steroid conversion 
reactions described in chapter 6 were investigated for each cell line and pathology. 
Positive identification o f steroids was determined through optimised mass 
spectrometry (LC/MS and LC/MS/MS) analysis relative to identical steroid standards 
(chapters 4 and 5). The data presented in this chapter is a combination o f the results 
obtained in chapters 5 and 6.
A combination o f enzyme expression and steroid profiles after testosterone treatment 
permitted a comparison of;
1. fertile biopsies to cell lines,
2. fertile biopsies to endometriosis biopsies and,
3. fertile biopsies to each benign endometrial pathology.
From preliminary data a model o f testosterone metabolism was suggested in fertile 
biopsies through hyperplasia biopsies to endometrial cancer cell lines (figure 7.1), 
and from fertile biopsies to all other biopsy pathologies- endometriosis (6 biopsies), 
unexplained infertility (2 biopsies), PCOS (2 biopsies), ovarian cyst (1 biopsy), 
endometrial hyperplasia (1 biopsy) and endometrial polyp (1 biopsy), as illustrated in 
figure 7.2.
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This provides a unique method for determination of changes in the steroid profile 
and/or enzyme expression which may characterize each endometrial disorder. The 
information regarding testosterone metabolism and enzyme expression in the 
endometria o f women with PCOS, unexplained infertility, endometrial hyperplasia 
and endometrial polyp was limited in comparison to the fertile and endometriosis 
groups and the cell lines as there were low numbers o f samples in these groups, 
nevertheless it allowed us to demonstrate some interesting preliminary data, covering 
a range o f endometrial conditions.
This chapter will compare cell line and biopsy experiments principally focussing on 
the combination o f testosterone metabolism pathways (recorded in chapter 5) and the 
expression o f steroid converting enzymes (recorded in chapter 6). The data is 
presented as follows;
- Androgen production and relation to enzyme expression by cell lines and 
endometrial biopsies following testosterone treatment
- Roles o f androgens in the human endometrium
- Oestrogen production and aromatase expression by cell lines and 
endometrial biopsies following testosterone treatment
- Comparison o f testosterone metabolism by cell lines to fertile endometrial 
biopsies
- Comparison o f enzyme expression by cell lines with similar testosterone 
metabolism profiles (Ishikawa and HEC-1 A, COV434 and HEC-1B)
- Correlations between enzyme expression and steroid concentration by cell 
lines and biopsies
- Summary
- Conclusions
- Discussion
- Further work
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Chapter Seven: T estosterone utilisation by endometrial cells: Com parison o f  
m etabolic (m ass spectrometry) and enzym e expression (PC R ) profiles
7.1 Androgen production in established cell lines and endometrial biopsies from
fertile women and women with benign endometrial disorders
The initial route o f  testosterone m etabolism  varied in the cell lines and clin ical 
biopsies, in each case the major m etabolite w as correlated w ith high  basal enzym e  
expression  o f  5AR1 or the oxidative 17p-H SD s (H SD 2, 4 and 8) prior to testosterone  
treatment. Expression o f  these sp ecific  enzym es can be used to determine the ch ie f  
route o f  testosterone utilisation, for exam ple i f  D H T w as produced high expression  
o f  5AR1 w as observed and i f  androstenedione w as produced high basal expression  o f  
H SD 2, 4 or 8 w as observed. A  m ixture o f  D H T  and androstenedione w as correlated  
with expression  o f  5AR1 and expression  o f  either H SD 2, 4 or H SD 8 (as illustrated in 
figures 7.3 and 7.4 and described in table 7 .1). Therefore the major route o f  
testosterone m etabolism  in endom etrial ce lls  can be estim ated by analysis o f  the 
expression  o f  these four enzym es.
5
4.5 
4
3.5 
3
2.5 
2
1.5 
1
0.5
Basal expression of H SD 2,4 and 5AR1 in endom etrial cell lines and 
fertile  biopsies
HSD2 HSD4
I SARI
Basal expression of HSD8 in endometrial cell lines and 
fertile biopsies
i
7, 15
*  10
i
avg fertile Ishikawa HEC-1A HEC-1B RL95-2 C O V 4 3 4 avg  fertile Ishikawa HEC-1A HEC-1B RL95-2 COV434
Fig 7.3: Plots illustrating the basal expression  levels  o f  H SD 2, 4, 8 and 5AR1 in 
endometrial ce ll lines in com parison to fertile endometrial b iopsies. C ell lines and 
biopsies were grow n in sp ecific  m edia outlined in chapter 2.4. Expression o f  H SD 2, 
4, 8 and 5AR1 w ere calculated by RT-PCR w ith the use o f  specific  primers as 
described in chapter 2.6.
The m axim um  concentration o f  DH T observed appears to be related to the basal 
expression  o f  5A R 1, for exam ple the C O V 434 line exhibited the highest 5AR1 
expression  under basal conditions and the h ighest concentration o f  DH T w as 
recorded. The R L 95-2 ce lls  exhibited the low est expression  o f  5AR1 and no DH T  
was produced. The com bination o f  m ass spectrometry and Q RT-PCR suggested a
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relationship between 5AR1 expression and DHT production (this relationship was
further investigated in the cell lines Ishikawa, H EC-1B and C O V 434 figures 7.12,
7.17 and 7.18).
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Fig 7.4: Top plot illustrates the basal expression o f  H SD 2, 4, 8, aromatase and 5AR1 
in endometrial b iopsies, bottom plot illustrates the expression o f  H SD 2, 4 and 5A R 1. 
Cell lines were grown in specific m edia outlined in chapter 2.4 . Expression o f  
aromatase, H SD 2, 4, 8, aromatase and 5AR1 w as calculated by RT-PCR with the use 
o f  specific primers as described in table 2 .6 .
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The 5-alpha reductases catalyse the conversion o f testosterone to DHT or
androstenedione to androstanedione. Specific enzymes and/or isoforms have been
shown to exhibit different affinities for testosterone, for example 5AR2 was
described by Baxter and colleagues as having a higher affinity for testosterone than
5AR1.1 The opposite o f this was concluded in these experiments where 5AR1
expression appeared to correlate with DHT production suggesting that this enzyme
had a higher affinity for testosterone than 5AR2. This was confirmed in the RL95-2
cell line which highly expressed 5AR2 and according to Baxter’s results this would
result in production of DHT after addition o f testosterone, however this was not
observed in these experiments which suggests that conditions required for the 5AR2
conversion were not present in RL95-2 cells.
In fertile biopsies, biopsies from patients with unexplained infertility and RL95-2 
cells the majority of testosterone was rapidly converted to androstenedione in 
correlation with high expression o f HSD2, HSD4 and/or HSD8. In fertile and 
unexplained infertility biopsies oestrone and oestradiol were also produced probably 
through the aromatase enzyme.
Endometrial biopsies from fertile women, two women with unexplained infertility 
and RL95-2 cells produced no DHT after testosterone treatment, in correlation with 
this they exhibited low expression 5AR1 in comparison to the oxidative HSDs. 
There was a large variation in 5AR1 basal expression levels between the two 
unexplained infertility biopsies (figure 7.4) which was attributed to biological 
variation, however steroid profiles produced after testosterone treatment of both 
unexplained infertility biopsies were comparable to the fertile biopsies suggesting 
that DHT production via 5AR1 was not occurring in either o f these biopsies and the 
major route o f testosterone utilisation was through oxidation via HSD2, 4 or 8 to 
androstenedione.
Basal expression o f 5AR1 was similar in COV434 and HEC-1B cells, and so the
expression of HSD2 and HSD8 in these cell lines was compared (HSD4 expression-
the other enzyme which converts testosterone to androstenedione was not
significantly different between the two cell lines (P= 0.626) and so was not included 
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in this comparison). The basal expression o f both HSD2 and HSD8 was higher in
COV434 cells in comparison to HEC-1B, which was correlated with higher
concentration of androstenedione produced by the COV434 cell line, suggesting
HSD2 and/or HSD8 were converting testosterone to androstenedione in these cell
lines.
The majority o f endometriosis biopsies investigated demonstrated increased 5AR1 
expression relative to the fertile group (figure 6.22), which was linked to DHT 
production after testosterone treatment (no production o f DHT by fertile group). 
Production of androstenedione was recorded in all endometriosis biopsies in a similar 
profile to the fertile biopsies (figure 5.35) possibly due to expression o f one or more 
of the oxidative 17p-HSDs (HSD2, 4 or 8). Following determination o f these 
observations in endometriosis biopsies, other benign endometrial conditions were 
investigated (chapters 5 and 6) to ascertain how typical these observations were in 
relation to endometrial disorders.
In the COV434 and HEC-1B cell lines and biopsies from an endometrial polyp, and 
endometrial stromal hyperplasia, production o f DHT was recorded in preference to 
androstenedione after testosterone treatment. This was correlated to high basal 
expression of 5AR1 relative to the oxidative HSDs in these conditions suggesting 
this was required for the conversion o f testosterone to DHT in preference to 
androstenedione.
A mixture o f androstenedione and DHT was produced after testosterone treatment of 
the Ishikawa and HEC-1A cell lines and biopsies from the endometria o f women 
with endometriosis. In correlation with this these cell lines and biopsies all 
expressed at least one o f the oxidative 17p-HSDs (HSD2, 4 or 8) and 5AR1. In the 
ovarian cyst, PCOS and epithelial hyperplasia biopsies 5AR1 expression was low in 
comparison to the oxidative 17P-HSDs (HSD2, 4 and 8) so it was expected that 
androstenedione would be the major androgenic product, however following 
testosterone treatment 5AR1 expression increased which corresponded with an 
increase in DHT production.
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Table 7.1: Observed enzyme expression related to the production o f DHT and/or
androstenedione in cell lines and endometrial biopsies.
Androgen
produced
High
expression
Medium
expression
Low
expression
Cell Line/biopsy
DHT 5AR1 HSD4
HSD8
HSD2
HEC-1B 
COV434 
Endometrial polyp
Androstenedione
HSD2, 
(HSD4 or 
HSD8)
n/a 5AR1
RL95-2 
Fertile 
Unexplained infertility
Androstenedione 
and DHT
- 5AR1 
HSD2, (HSD4 or 
HSD8)
-
Ishikawa 
HEC-1A 
Endometriosis 
Ovarian disorders 
Endometrial hyperplasia
7.2 The roles of androgens in the endometrium
The expression o f HSD2, 4 8, and 5AR1 and production of corresponding steroids 
(androstenedione and DHT) in the endometrial cancer cell lines and biopsies 
suggests there maybe roles for these enzymes and androgens in endometrial function. 
The roles o f the androgens; androstenedione, DHT and androsterone in endometrial 
function and progression to endometrial disorders may be numerous.
The major role of androstenedione is as a circulatory precursor of adrenal (or 
adipose) origin which enters the endometrium and is converted through 
aromatisation to oestrogens.2 Other roles o f androstenedione in the endometrium 
were described by Maliqueo and colleagues as being induction o f cellular 
proliferation and a decrease in apoptosis o f normal endometrial stromal cells. 
Androstenedione has also been described as producing oestrogenic effects, such as 
causing abnormal menstrual cycling and progression to endometrial hyperplasia.4 
Androstenedione may therefore cause cellular proliferation in endometrial disorders, 
however androstenedione production after testosterone treatment was observed in 
fertile biopsies (figure 5.28) suggesting that androstenedione is produced in the 
normal endometrium and is not indicative o f a proliferative disorder.
An increased concentration o f DHT has been previously recorded in breast cancers5,6 
and it has been shown to cause proliferation and progression o f prostate cancers. 
DHT has also been shown to affect cellular proliferation in normal endometria by Ito 
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and colleagues,8 and is described as being a more potent androgen than testosterone
in both the normal and cancerous endometria. DHT may therefore cause cellular
proliferation and/or progression o f endometrial disorders which produce DHT, (this
would include the cell lines Ishikawa, HEC-1A, HEC-1B, (COV434) and endometria
from women with endometriosis, PCOS, ovarian cysts, endometrial polyps and
endometrial hyperplasia).
The role o f androsterone in the endometrium has not been defined, it is present in 
serum of normal females9 and is described as being a seven times weaker androgen 
than testosterone.10 It was essentially the reaction end product in these experiments, 
and was produced via DHT or androstenedione following testosterone treatment.
Further investigations into the roles of specific androgens possibly by specific steroid 
treatments or selective enzyme inhibition may elucidate their roles in endometrial 
disorders and cancers.
7.3 Aromatase expression and oestrogen production in endometrial cell lines 
and biopsies
Several studies o f steroid metabolism in breast cancer have lead to the hypothesis 
that in endometrial cancer and other endometrial disorders where aromatase is 
expressed an increase in oestradiol production may contribute to cellular 
proliferation.11,12 When investigating the endometrial cell lines Ishikawa, HEC-1A, 
HEC-1B and RL95-2 following testosterone treatment it was therefore expected that 
oestradiol would be produced via the aromatase enzyme. This would be confirmed 
by increased oestradiol and oestrone concentration recorded by mass spectrometry 
and QRT-PCR confirming aromatase expression. The ovarian granulosa cell line 
COV434 was included as a positive control which highly expressed aromatase and so 
was expected to produce large concentrations of oestradiol (and oestrone) after 
testosterone treatment.
The results obtained did not fit this hypothesis, oestradiol and oestrone were not
recorded as major metabolites o f testosterone after treatment o f any cell line. A
range o f aromatase expressions were recorded in the endometrial cell lines
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suggesting that irrespective of aromatase expression little or no oestrogen production
occurred after testosterone treatment.
From the combination o f mass spectrometry (chapter 5) with enzyme expression 
(chapter 6) it was possible to conclude that the major route o f testosterone 
metabolism was via the androgens androstenedione and/or DHT in correlation with 
expression o f the oxidative 17p-HSDs (2, 4 and 8) or 5AR1 as described previously, 
this resulted in the focus of this thesis being the determination o f testosterone 
utilisation via androgen production. Oestrogen production was low in comparison, 
however due to the significant amount o f literature dedicated to oestrogen analysis in 
steroid responsive tissues it was not disregarded.
The preferential production o f androgens rather than oestrogens following 
testosterone treatment could be explained by investigating the reaction mechanisms. 
Aromatisation o f testosterone to oestradiol, or androstenedione to oestrone is a 
complex multi-stage reaction which requires multiple co-factors and is widely 
described as the rate limiting step in oestrogen synthesis.13 In comparison, the 
conversions o f testosterone to DHT or testosterone to androstenedione are simple one 
step reactions. The affinity that each enzyme has for testosterone or the availability 
of co-factors in each cell line may also be key to understanding the metabolism 
routes, for example 5AR1 may have a higher affinity for testosterone than aromatase 
so in the COV434 cell line which highly expresses both enzymes production o f DHT 
may occur in preference to oestradiol after testosterone treatment, inhibition o f  
5AR1/2 would confirm this hypothesis.
It was also possible that testosterone treatments resulted in saturation o f the
aromatase enzyme inhibiting conversion o f androgens to oestrogens. Havelock and
co-workers described that in environments o f high androgen concentration ovarian
granulosa cells (in the presence o f FSH) converted testosterone to DHT through the
5-a reductases,14 in preference to aromatisation o f oestrogens. This probably
occurred in the COV434 cell line which highly expressed aromatase, but oestrogen
concentrations did not increase following testosterone treatment (figure 5.26). To
our knowledge there is no evidence o f testosterone saturation o f aromatase in 
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endometrial cell lines however, previously Thompson and colleagues demonstrated
saturation of aromatase in the ovarian cell line 2774 at approximately a 5pM
concentration o f testosterone,15 and George and colleagues demonstrated testosterone
saturating aromatase in the rat brain at concentrations o f lOOnM.16 This could
explain the observations of little or no oestrogens detected in the endometrial cell
lines following testosterone treatments in these investigations.
Oestradiol and oestrone were detected in both the Ishikawa and COV434 cell lines 
under basal conditions before testosterone treatment this was due to oestrogens 
present in the FCS. The concentrations o f oestradiol and oestrone decreased in the 
first eight hours after testosterone treatment o f both cell lines, possibly due to 
conversion to either sulphated oestrogens or other oestrogen analogues (figures 5.10 
and 5.26). RL95-2 cells did not produce any oestrogens after testosterone treatment, 
the concentrations o f oestradiol and oestrone remained essentially constant 
throughout the experiment. At 60 hours there was an increase in aromatase 
expression in RL95-2 cells (figure 6.11), this was not correlated with increased 
oestradiol or oestrone concentrations as there were no reaction precursors available 
(all testosterone had been converted to androsterone through the intermediate 
androstenedione in the first 36 hours).
Both oestradiol and oestrone were produced by the fertile biopsies following 
testosterone treatment, suggesting the aromatase enzyme was active in these cells. It 
is possible that aromatase in the fertile biopsies does not become saturated at the 
testosterone concentrations used in these experiments and that the essential co­
factors for aromatisation were present. These results agree with some recent studies
17which recorded low levels o f oestradiol in the endometria o f fertile women, 
however the majority o f past studies have recorded little or no oestrogen production 
in fertile endometria, detection here may be due to the improved sensitivity o f the 
mass spectrometry system in comparison to the previously used methods of RIA and 
TLC.18,19
The roles o f aromatase and oestradiol in progression o f endometriosis, endometrial
cancer and in endometrial hyperplasia have been widely investigated, with an
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increase in both leading to progression o f these disorders.20,21,22 In these
investigations it was possible to observe an increase in aromatase expression relative
to the fertile group in the majority o f endometriosis biopsies (4 o f 6 biopsies) and in
epithelial and stromal hyperplasia samples (1 biopsy) and in the ovarian cyst (1
biopsy) and endometrial polyp (1 biopsy), this was correlated with increased
oestradiol and/or oestrone concentration relative to the fertile group as described in
chapter 5 (however concentrations o f oestradiol and oestrone due to the FCS
recorded throughout these experiments makes positive correlations difficult to
determine). These results suggested there may be a role for aromatase and oestradiol
(or oestrone) in these disorders, although the major metabolism route was still via
DHT and/or androstenedione in correlation with the expression o f oxidative HSDs
and/or 5AR1.
The majority o f work describing endometrial steroid metabolism has been centred on 
aromatase and oestrogens, the information presented in this thesis suggests that 
androgens may also play a significant part in the development o f endometrial 
disorders. This hypothesis could not have been reached if oestrogens were added 
directly to the endometrial cells, addition o f an upstream, biologically abundant, 
steroid was essential to obtain a more complete picture o f steroid metabolism in the 
endometrium.
7.4 Comparison of testosterone metabolism from fertile endometrial biopsies to 
established cell lines
Enzyme expression in the cell lines/biopsies which produced similar steroid profiles 
was compared to confirm important enzymes which result in flux through specific 
steroid pathways. This comparison was also completed to determine the enzymes 
whose expression does not affect the steroid profile, together these results elucidated 
and eliminated enzyme targets.
Endometrial cancer cell lines are often used as models to investigate endometrial
function, as a result of these experiments it was shown that certain cell lines have
similar characteristic steroid profiles to specific endometrial pathologies (chapter 5).
For example the RL95-2 cell line and the fertile biopsies produced a similar 
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androgen profile after testosterone treatment, which was correlated with similar
expression o f  a number o f  enzym es outlined in figure 7.5.
0 14 Comparison of basal  e n z y m e  exp ress ion  in RL95-2 (R) cel ls  and
■g 12 j  fertile(F) b iops ies
1  10 
2 x 8
p  6ns
i- 4
go
1 2 
™ *7 o I I i i * I I
Fig 7.5: Com parison o f  basal expression levels o f  nine steroid converting enzym es in 
the RL95-2 cell line and 4 averaged fertile b iopsies. C ells were grown in specific  
m edia outlined in chapter 2.4. Expression o f  all enzym es was calculated by RT-PCR  
with the use o f  specific primers as described in chapter 2.6.
Expression o f  a number o f  enzym es was com parable in R L95-2 ce lls and fertile 
biopsies, (H SD 2, H SD 4, H SD 8, 5A R 1) which resulted in the similar route o f  
testosterone utilisation. If an investigator desired to study steroid m etabolism  in the 
fertile endometrium this cell line w ould be an ideal choice, how ever it should be 
noted that the oestrogen profiles differ possib ly due to the reasons outlined  
previously (chapter 7.3).
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Fertile biopsies
\  / /
5AR1 17b-HSD2 aromatase
Androstene-dione OestradiolDHT
5AR2 aromatase 17b. HSDs
Oestrone
Androsterone
RL95-2 cells
17b-HSD2
DHT Androstene-dione
aromatase
aromatase
Oestradiol 
17b-HSDs
Oestrone
Androsterone
Fig 7.6: Alteration in routes o f  testosterone m etabolism  from fertile b iopsies to 
R L95-2 cells. An arrow with a red cross indicates reaction was not occurring, 
increased arrow size indicates reaction route was increased relative to the fertile 
biopsies. Enzym es which catalyse each conversion are recorded on each arrow.
The route o f  androgen m etabolism  w as similar in fertile b iopsies and RL95-2 cells. 
Increased expression o f  H SD 2, 4, 8 and 5A R 2 in RL95-2 ce lls relative to the fertile 
biopsies was correlated to increased concentrations o f  androstenedione and 
androsterone after testosterone treatment suggesting these are important enzym es 
involved in these conversions. Testosterone w as converted to oestradiol in the fertile 
b iopsies but this w as not recorded in RL95-2 cells.
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Fig 7.7: Alteration in routes o f  testosterone m etabolism  from stromal fertile b iopsies  
to Ishikawa and H EC-1A cells. An arrow with a red cross indicates reaction was not 
occurring, increased arrow size indicates reaction route was increased (relative to the 
fertile b iopsies). Enzym es which catalyse each conversion are recorded on each  
arrow.
There were alterations in testosterone m etabolism  from fertile b iopsies to HEC-1 A 
and Ishikawa cells as illustrated by figure 7.7. Production o f  DHT in HEC-1 A and 
Ishikawa cells, (which was not observed in fertile b iopsies) was correlated with  
increased expression o f  5AR1 relative to the fertile b iopsies figure 7.3. H SD 2, 
H SD4 and H SD 8 were expressed in both cell lines, w hich was correlated with the 
production o f  androstenedione suggesting these enzym es were involved in this 
conversion. The HEC-1 A and Ishikawa cell lines demonstrated increased  
androsterone concentration after testosterone treatment which was linked to 
increased expression o f  5A R 2 relative to the fertile b iopsies.
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Fig 7.8: Alteration in routes o f  testosterone m etabolism  from fertile b iopsies to HEC- 
1B and C O V 434 cells. An arrow with a red cross indicates reaction w as not 
occurring, increased arrow size indicates this reaction route was increased (relative to 
the fertile b iopsies). E nzym es which catalyse each conversion are recorded on each 
arrow.
There were alterations in testosterone m etabolism  from fertile b iopsies to HEC-1 B 
and C O V 434 ce lls as illustrated by figure 7.8. In C O V 434 and HEC-1 B ce lls  
androstenedione was still produced fo llow in g  testosterone treatment but at a lower 
concentration than by the fertile b iopsies. This w as correlated to reduced expression  
o f  H SD 2 relative to the fertile b iopsies (figure 7 .3). There was som e conversion o f  
androgens to oestrogens in HEC-1 B ce lls although the major route o f  testosterone 
m etabolism  was through DH T in association with high expression o f  5AR1 (figure 
7.3).
7.5 Comparisons of cell lines with similar steroid profiles
Basal enzym e expression o f  the nine steroid converting enzym es under investigation  
was compared in cell lines with sim ilar testosterone m etabolism  routes (HEC-1 B and 
C O V 434, Ishikawa and HEC-1 A ), this w as com pleted to determine enzym es which  
are important (and irrelevant) for a sim ilar testosterone m etabolism  pathway.
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The major route o f  testosterone m etabolism  in C O V 434 and HEC-1 B ce lls was
through DHT which w as correlated with high expression o f  5AR1 relative to the
fertile b iopsies.
C o m p a riso n  o f  b asa l e n z y m e  e x p r e s s io n  in HEC-1B (B) an d  C O V 434 (C) c e lls
Fig 7.9: Comparison o f  basal expression o f  steroid converting enzym es in C O V 434  
and HEC-1 B cells. Each cell line was grown in specific medium (chapter 2.4) 
harvested and RNA extracted. Specific primers described in table 2.6 were used to 
establish expression levels o f  steroid converting enzym es through RT-PCR.
HEC-1 B and C O V 434 ce lls demonstrated sim ilar steroid m etabolism  profiles and 
exhibited low  (sim ilar) expression o f  5A R 2, midpoint expression o f  H SD 4, and high 
expression o f  5AR1 and H SD 8 under basal conditions relative to the other cell lines 
(figure 7.9). The difference in expression o f  H SD 2 and H SD 8 (both higher in 
C O V 434) was correlated with the higher concentration o f  androstenedione recorded  
in C O V 434 ce lls suggesting these enzym e were responsible for androstenedione 
production. There were differences in the expression o f  HSD1 and H SD 2, both were 
higher in C O V 434. There was significantly increased expression o f  H SD 5 (P=
0.019) and H SD 7 (P= 0 .000) in HEC-1 B ce lls in com parison to C O V 434. When 
attempting to correlate the higher expression o f  H SD5 and H SD 7 in HEC-1 B ce lls to 
steroid concentration no associations were apparent, suggesting these enzym es were 
not responsible for production o f  any o f  the steroids detected in these experim ents.
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Fig 7.10: Com parison o f  basal expression o f  steroid converting enzym es in Ishikawa 
and H E C -IA  ce lls . Each cell line was grown in specific medium (chapter 2 .4) 
harvested and RNA extracted. Specific primers described in table 2 .6  were used to 
establish expression levels o f  steroid converting enzym es through RT-PCR.
Ishikawa and H E C -IA  demonstrated sim ilar steroid profiles (chapter 5.8) and basal 
expression o f  a number o f  enzym es was similar, for exam ple both demonstrated low  
expression o f  H S D l, H SD 2, and 5A R 2 (figure 7.10), they also exhibited sim ilar 
m idpoint expression o f  H SD 7, and H SD 8 (chapter 6.3), which suggests these were 
the enzym es which dictated the sim ilar routes o f  testosterone metabolism recorded in 
these cells. Figure 7.10 illustrates significant differences in the basal expression o f  
the enzym es aromatase (P= 0 .0 0 1) and 5AR1 (P= 0 .008) both higher in Ishikawa. 
Expression o f  H SD 5 w as also higher in Ishikawa cells. 5AR1 was expressed in 
Ishikawa ce lls  at tw ice the amount o f  H E C -IA  ce lls under basal conditions, w hich  
was correlated with approxim ately tw ice the amount o f  DHT produced in Ishikawa 
cells (m axim um  o f  27.6nM  (Ishikawa) compared to a maximum o f  11.6nM in HEC- 
IA ce lls) again suggesting 5AR1 w as involved in the conversion o f  testosterone to 
DHT.
W hile the m etabolism  o f  androgens in the Ishikawa and H E C -IA  cell lines was 
sim ilar their oestrogen profiles differed. Initial oestrogen information w as not 
produced by added testosterone, but due to the high concentrations o f  oestrogens due 
to the FCS. The concentration o f  oestradiol and oestrone in the H E C -IA  cell line 
increased at the start o f  the experim ent and then remained essentially constant
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throughout the experiment (figure 5.17). The oestrone concentration in the Ishikawa
cell line decreased in the first 8 hours then remained constant throughout the
experiment (figure 5.10). Oestradiol concentration decreased in the Ishikawa cell
line from the high serum concentrations at time zero to a much reduced concentration
at 72 hours (figure 5.10). Castagnetta23 and co-workers investigated oestradiol
metabolism in the Ishikawa and HEC-IA cell lines, Ishikawa cells were
demonstrated to convert the majority o f  added oestradiol into sulphated oestrogens
and other oestrogen derivatives in preference to oestrone. This agrees with the
observed decrease in oestradiol concentration in the Ishikawa cell line investigated in
this thesis. HEC-IA cells inter-convert the majority o f added oestradiol to oestrone
(or reverse) through the 170-HSD enzymes, agreeing with the constant
concentrations o f the two oestrogens recorded in these experiments.
The differences in oestrogen metabolism in these cell lines was related to different 
expression o f  the HSD isoforms, HSD4 (oestradiol to oestrone) and HSD5 (oestrone 
to oestradiol) (figure 7.11). A significantly higher expression o f  HSD4 (P= 0.038) 
was recorded in HEC-IA cells in comparison to Ishikawa cells. These results were 
supportted by Castagnetta and colleagues who determined that Ishikawa cells 
demonstrated higher expression o f  the HSD5 in comparison to HEC-IA cells.24 
Higher expression o f  HSD4 in HEC-IA cells was also correlated with higher 
concentrations o f androstenedione (from testosterone).
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Fig 7.11: Comparison o f  basal expression o f  HSD4 (green) and HSD5 (brown) in 
Ishikawa and HEC-IA cell lines. Each cell line was grown in specific medium 
(chapter 2.4) harvested and RNA extracted. Specific primers for HSD4 and HSD5 
described in table 2.6 were used to establish expression levels o f  steroid converting 
enzymes through RT-PCR.
Irrespective o f  the metabolism o f  FCS originated oestradiol and oestrone to their 
reaction end products, aromatase can still act to convert the precursors, testosterone 
or androstenedione to the oestrogens, oestradiol and oestrone. Possible correlations 
between expression o f  aromatase and oestrogen concentration was observed in both 
Ishikawa and HEC-IA cell lines is discussed later (figures 7.14 and 7.16).
7.6 Changes in enzyme expression combined with steroid profiles for 
endometrial cell lines and biopsies (and an ovarian cell line) following 
testosterone treatment
Following addition o f  testosterone to the cell lines and biopsies the steroid-enzyme 
relationships described previously were further investigated by looking over a longer 
time course. Enzyme expression at a number o f  time points throughout a 72 hour 
period (as described in chapter 6), was combined with steroid profiles produced in 
chapter 5 to determine if  any changes in enzyme expression could be correlated with 
a change in the steroid profile.
This allowed observations o f  any relationships between changing expression and 
changes in steroid concentration following testosterone treatment.
The enzymes and steroids were chosen because;
1. they have been shown to be important in DHT or androstenedione 
metabolism (HSD2, HSD4, HSD8, 5AR1),
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2. they exhibited a significant increase in fold expression (P< 0.05) after 
testosterone treatment relative to basal expression and/or,
3. they were involved in oestrogen synthesis (aromatase).
The changes in expression levels o f  the specific enzyme(s) and the changes in steroid 
concentration(s) were combined together. The histogram on each graph represents 
enzyme expression at each time point (relative to GADPH) after testosterone 
treatment. Enzyme expression was normalised to 1 at time zero allowing expression 
changes relative to basal expression levels to be observed. The scatter graph (with 
smooth lines joining each data point) and scale on the right o f  each graph represents 
the concentration o f  that steroid(s). Androgen concentration was represented as a 
ratio to the internal standard methyl-testosterone, (to simplify the graphs the axes are 
just labelled as concentration). Oestrogen concentration was represented by peak 
area which is directly proportional to concentration. The combination o f  these two 
data sets onto the same graph provided a method for observing correlations between 
changes in enzyme expression and steroid concentration(s).
7.6.1 Correlations between enzyme expression and steroid concentrations in the 
Ishikawa cell line after testosterone treatment
Ishikawa cells exhibited high basal expression o f HSD5 relative to all the other cell 
lines. The enzymes which demonstrated significant changes relative to basal 
expression after testosterone treatment were 5AR1 (P= 0.041 at 40 hours) and HSD8 
(P< 0.04 at 40 and 48 hours). Relationships between enzyme expression and steroid 
concentration were determined.
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Fig 7.12: Correlation between 5AR1 expression and DHT concentration in Ishikawa 
cells over 72 hours after addition o f  a lOOnM testosterone media solution. Ishikawa 
cells were grown in specific medium (chapter 2.4) harvested and RNA extracted. 
Specific primers outlined in table 2.6 were used to establish 5AR1 expression levels 
through RT-PCR. DHT concentrations were obtained from the average values o f  
three experiments on the LCQ DECA mass spectrometer using an ESI source in 
positive mode with a C]g reversed phase column with an optimised methanol/water 
0.1% acetic acid elution system.
5AR1 catalyses the conversion o f  testosterone to DHT. It was possible to observe a 
trend between increasing expression o f  5AR1 and increasing concentration o f  DHT 
in the Ishikawa cell line (figure 7.12), this suggests 5AR1 was converting 
testosterone to DHT.
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Fig 7.13: Correlations between HSD8 expression and androstenedione concentration 
in Ishikawa cells over 72 hours after addition o f  a lOOnM testosterone media 
solution. The Ishikawa cell line was grown in specific medium (chapter 2.4) 
harvested and RNA extracted. Specific primers outlined in table 2.6 were used to 
establish HSD8 expression levels through RT-PCR. Androstenedione concentrations 
were obtained from the average values o f  three experiments on the LCQ DECA mass 
spectrometer using an ESI source in positive mode with a Cig reversed phase column 
and an optimised methanol/water 0.1% acetic acid elution system.
HSD8 catalyses the conversion o f  testosterone to androstenedione. It was possible to
observe a trend between increasing concentration o f  androstenedione and increasing 
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HSD8 expression in the Ishikawa cell line (figure 7.13), this suggests HSD8 was
converting testosterone to androstenedione.
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Fig 7.14: Correlations between oestradiol concentration and aromatase expression in 
Ishikawa cells over 72 hours after addition o f  a lOOnM testosterone media solution. 
The Ishikawa cell line was grown in specific medium (chapter 2.4) harvested and 
RNA extracted. Specific primers outlined in table 2.6 were used to establish 
aromatase expression levels through RT-PCR. Oestradiol concentrations were 
obtained from the average values o f  three experiments on the LCQ DECA mass 
spectrometer using an ESI source in positive mode using a luna phenyl-hexyl column 
with optimised methanol/water 0.1% formic acid elution system.
Aromatase converts testosterone to oestradiol. Figure 7.14 shows a possible 
correlation between aromatase expression and oestradiol concentration, however the 
high concentration o f  oestradiol (due to FCS) prior to testosterone treatment (0 
hours) and the errors associated with aromatase expression make any relationships 
difficult to determine. This graph is included in this chapter to provide a full picture 
o f  testosterone utilisation by the Ishikawa cell line, however oestrogen production 
was a secondary pathway and the primary focus o f  this work was to determine the 
route o f  testosterone metabolism through androgen production.
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7.6.2 Correlations between enzyme expression and steroid concentrations in the 
RL95-2 cell line after testosterone treatment
The metabolism o f  testosterone was rapid in RL95-2 cells in comparison to the other 
cell lines, (the majority o f  the androgenic end product androsterone was produced 
after 36 hours). Any initial correlations between testosterone converting enzyme 
expression and steroid concentration were only be valid over the first 36 hours as 
after this no reaction precursor was available. No correlations between the changing 
expression o f 5AR2, HSD2, HSD8 or aromatase and steroid concentrations were 
observed following testosterone treatment. The inclusion o f  more data points within 
the first 36 hours o f  the experiment could elucidate any correlations between steroid 
concentration(s) and changing enzyme expression.
7.6.3 Correlations between enzyme expression and steroid concentrations in the 
HEC-IA cell line after testosterone treatment
HEC-IA cells demonstrated the highest relative basal expression o f  HSD4 in 
comparison to all other cell lines (figure 6.4). The enzymes which exhibited 
significant changes in fold expression after testosterone treatment were 5AR2 (P= 
0.025 at 24 hours) and HSD5 (P= 0.033 at 24 hours). High expression o f  5AR2 was 
expected to correlate with decreased concentration o f  androstenedione, which was 
observed at 24 and 72 hours (figure 5.15).
262
C hapter Seven: Testosterone utilisation by endometrial cells: Comparison of
metabolic (mass spectrometry) and enzyme expression (PCR) profiles
ells
O 6 
O 5
0 4  .§
I 03 I
I
0  2 °
Time (hourt)
Fig 7.15: Correlation between testosterone concentration and HSD5 expression in 
HEC-IA cells over 72 hours after addition o f  a lOOnM testosterone media solution. 
The HEC-IA cell line was grown in specific medium (chapter 2.4) harvested and 
RNA extracted. Specific primers outlined in table 2.6 were used to establish HSD5 
expression levels through RT-PCR. Testosterone concentrations were obtained from 
average values on the LCQ DECA mass spectrometer using an ESI source in positive 
mode with a Cig reversed phase column and an optimised methanol/water 0.1% 
acetic acid elution system.
The concentration o f  testosterone decreased throughout these experiments as it was 
metabolised to other steroids, (this readily occurred due to the high initial 
testosterone concentration, and expression o f  HSD2, 4 8 and 5AR1). HSD5 
catalyses the conversion o f  androstenedione to testosterone. Testosterone 
concentration increased at 24 and 60 hours in correlation with increased expression 
o f  HSD5, suggesting HSD5 was converting androstenedione to testosterone in HEC- 
IA cells.
C o n -p a riso n  o f HSD5 e x p re s s io n  an d  t e s t o s te r o n e  c o n c e n tr a t io n  in HEC-IA
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Fig 7.16: Correlation between oestradiol concentration and aromatase expression in 
HEC-IA cells over 72 hours after addition o f  a lOOnM testosterone media solution. 
The HEC-IA cell line was grown in specific medium (chapter 2.4) harvested and 
RNA extracted. Specific primers outlined in table 2.6 were used to establish 
aromatase expression levels through RT-PCR. Oestradiol concentration was 
obtained from average values on the LCQ DECA mass spectrometer using an ESI 
source in positive mode using a luna phenyl-hexyl column with optimised 
methanol/water 0.1% formic acid elution system.
Aromatase converts testosterone to oestradiol and androstenedione to oestrone. 
Conversion o f  testosterone to oestrogens in HEC-IA cells was a secondary process, 
with the major metabolism route being androgen production, however there was 
some oestradiol produced as illustrated in figure 7.16. A trend between the 
increasing concentration o f  oestradiol and increasing expression o f  aromatase was 
observed suggesting aromatase was converting testosterone to oestradiol in HEC-IA  
cells. Again this graph is included in this chapter to provide a complete picture o f  
testosterone utilisation by the HEC-IA cell line, however oestrogen production was a 
secondary pathway and the primary focus o f  this work was to further determine the 
route o f  testosterone metabolism which was mainly through androgen production.
7.6.4 Correlations between enzyme expression and steroid concentrations in the 
HEC-1 B cell line after testosterone treatment
HEC-1B cells exhibited the highest basal expression o f  HSD7 (figure 6.6) and high 
basal expression o f  5AR1 (figure 6.8) relative to the other cell lines. The enzyme 
which exhibited a significant change in fold expression after testosterone treatment 
was HSD8 (P= 0.005 at 36 hours and P= 0.003 at 72 hours figure 6.13).
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Fig 7.17: Correlations between 5AR1 expression and DHT concentration in HEC-1 B 
cells over 72 hours after addition o f  a lOOnM testosterone media solution. The HEC- 
1B cell line was grown in specific medium (chapter 2.4) harvested and RNA 
extracted. Specific primers outlined in table 2.6 were used to establish 5AR1 
expression levels through RT-PCR. DHT concentrations were obtained from 
average values on the LCQ DECA mass spectrometer using an ESI source in positive 
mode with a Cig reversed phase column and an optimised methanol/water 0.1% 
acetic acid elution system.
5AR1 catalyses the conversion o f  testosterone to DHT. It was possible to observe a 
trend between the expression o f  5AR1 and concentration o f  DHT in the HEC-1 B cell 
line (figure 7.17). High expression o f  5AR1 in the first 12 hours was correlated to 
high DHT concentration, after the first 12 hours the expression levels o f  5AR1 
decreased in correlation with decreasing concentration o f  DHT this suggests 
testosterone was converted to DHT by the 5AR1 enzyme in HEC-1 B cells.
7.6.5 Correlations between enzyme expression and steroid concentrations in the 
COV434 cell line after testosterone treatment
The enzymes in COV434 cells which exhibited high basal expression were 
aromatase, HSD1, HSD8 and 5AR1 (relative to the other cell lines-chapter 6.3). The 
enzyme which exhibited significant changes in fold expression after testosterone 
treatment was 5AR1 P= 0.043 (16 hours) P= 0.006 (32 hours) and P= 0.047 (72 
hours) as illustrated in figure 6.14.
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Fig 7.18: Correlation between 5AR1 expression and concentration o f  DHT in 
CO V434 cells over 72 hours after addition o f  a lOOnM testosterone media solution. 
The COV434 cell line was grown in specific medium (chapter 2.4) harvested and 
RNA extracted. Specific primers outlined in table 2.6 were used to establish 5AR1 
expression levels through RT-PCR. DHT concentrations were obtained from 
average values on the LCQ DECA mass spectrometer with an ESI source in positive 
mode using a C|g reversed phase column with an optimised methanol/water 0.1% 
acetic acid elution system.
5AR1 catalyses the conversion o f  testosterone to DHT. It was possible to observe a 
trend between the increasing expression o f  5AR1 and increasing concentration o f  
DHT in COV434 cells (figure 7.18) which suggests 5AR1 is converting testosterone 
to DHT.
7.6.6 Correlations between enzyme expression and steroid concentrations in 
fertile biopsies following testosterone treatment
In the fertile biopsies the enzymes which exhibited high basal expression were HSD1 
and HSD2 (relative to all endometrial disorders except endometriosis). The enzyme 
5AR2 exhibited a significant change in expression after testosterone treatment (P=
0.016 at 24 hours) figure 6.37. 5AR2 expression increased at 48 hours which was 
correlated with a reduction in androstenedione concentration (the reaction precursor) 
and an increase in androsterone concentration (reaction end product) as illustrated in 
figure 7.19. High basal expression levels o f  the oxidative HSDs (HSD2, HSD4 and 
HSD8) in fertile biopsies was correlated with rapid conversion o f  testosterone to 
androstenedione (first 24 hours) with no production o f  DHT, after this 
androstenedione was converted into the end products oestrone (and oestradiol) in
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correlation with expression o f  aromatase (at 48 hours) and androsterone in
correlation with 5AR2 expression (at 72 hours).
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Fig 7.19: Steroid metabolism in stromal biopsies from fertile patients over 72 hours 
after addition o f  a lOOnM testosterone media solution. Oestrone and oestradiol 
concentrations were measured as peak areas (right hand axis). Androgen 
concentration was measured as a ratio to the internal standard (left axis). Results 
obtained from the average values o f  four fertile biopsies on the LCQ DECA mass 
spectrometer using an ESI source in positive mode using either a Cjg reversed phase 
column with an optimised methanol/water 0.1% acetic acid elution system  
(androgens) or a luna phenyl-hexyl column with optimised methanol/water 0.1%  
formic acid elution system (oestrogens).
Fertile biopsies
—P  ■ i.............
17b-HSD2 aromatase
'V
DHT Androstene-dione ^  Oestradi
5AR2 aromatase 17b. HSDs
Oestrone 
Androsterone
Fig 7.20: Typical metabolism route o f  testosterone in four fertile biopsies. An arrow 
with a red cross indicates reaction was not occurring. Enzymes which catalyse each 
conversion are recorded on each arrow.
The steroid profiles recorded in chapter 5 suggest the majority o f  oestradiol was 
produced by the initial conversion o f  testosterone to androstenedione (which 
correlates with high expression o f  HSD2, 4 and 8) followed by conversion to
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oestrone (aromatase) and conversion to oestradiol (in correlation to the highly
expressed HSD1 enzyme) some oestradiol could also have been produced directly
from testosterone through aromatase. There were no correlations between temporal
changes in enzyme expression and changes in steroid concentration(s) after
testosterone treatment due to the speed o f  these conversions.
7.6.7 Correlations between enzyme expression and steroid concentrations in 
unexplained infertility biopsies after testosterone treatment
In comparison to the fertile biopsies the unexplained infertility biopsies have similar 
enzyme expression (chapter 6.4.5) and steroid profiles for testosterone, 
androstenedione, androsterone, oestradiol and oestrone (DHT was not be detected at 
any time). The production o f  androstenedione was slower in the unexplained 
infertility biopsies in comparison to fertile biopsies which correlated to lower basal 
expression o f  HSD2 and HSD4. The largest change in fold expression relative to 
time zero in unexplained infertility biopsies was produced with increased expression 
o f  5AR2 at 48 and 72 hours.
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Fig 7.21: Steroid metabolism in stromal cells from unexplained infertility biopsies 
over 72 hours after addition o f  a lOOnM testosterone media solution. Oestrone and 
oestradiol concentrations are measured as peak areas (right hand axis). Androgen 
concentration was measured as a ratio to the internal standard (left axis). Results 
obtained from the average values o f  two unexplained infertility biopsies on the LCQ 
DECA mass spectrometer using an ESI source in positive mode using either a Cis 
reversed phase column with an optimised methanol/water 0.1% acetic acid elution 
system (androgens) or a luna phenyl-hexyl column with optimised methanol/water
0.1% formic acid elution system (oestrogens).
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Fig 7.22: Correlation between 5AR2 expression and androsterone concentration in 
unexplained infertility biopsies over 72 hours after addition o f  a lOOnM testosterone 
media solution. The unexplained infertility biopsies were grown in specific medium 
(chapter 2.4) harvested and RNA extracted. Specific primers outlined in table 2.6 
were used to establish 5AR2 expression levels through RT-PCR. Androsterone 
concentrations were obtained from the average values o f  two experiments on the 
LCQ DECA mass spectrometer using an ESI source in positive mode with a Ci8 
reversed phase column and an optimised methanol/water 0.1% acetic acid elution 
system.
5AR2 converts the androgen androstenedione to androsterone through the 
intermediate androstane-dione. It was possible to observe a trend between the 
increasing expression o f  5AR2 and increasing concentration o f  androsterone in the 
unexplained infertility biopsies (figure 7.22) suggesting androstenedione was 
converted to androsterone via 5AR2 (the conversion through the intermediate was 
also rapid).
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Fig 7.23: Alteration in routes o f  testosterone metabolism from fertile biopsies to 
unexplained infertility biopsies. An arrow with a red cross indicates reaction was not 
occurring, increased arrow size indicates this reaction route was increased (relative to 
the fertile biopsies). Enzymes which catalyse each conversion are recorded on each 
arrow.
The metabolism route o f  testosterone was similar in fertile and unexplained infertility 
biopsies, as illustrated by figure 7.23. Unexplained infertility biopsies and fertile 
biopsies produced oestrone and/or oestradiol following testosterone treatment, in 
correlation with aromatase expression suggesting that aromatase was converting 
either androstenedione to oestrone and/or testosterone to oestradiol in these biopsies. 
The similar enzyme expression and steroid profiles again suggested the reason for 
infertility in these women was not related to steroid metabolism in their endometria.
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7.6.8 Correlations between enzyme expression and steroid concentrations in
endometriosis biopsies after testosterone treatment
Trends in basal enzyme expression in relation to steroid metabolism were difficult to 
determine in endometriosis biopsies possibly due to the progression (severity) o f the 
disorder resulting in different levels o f  enzyme expression as described in chapter 
6.4.
The enzymes which exhibited high basal expression relative to the fertile biopsies in 
the majority o f endometriosis biopsies were aromatase, HSD1, HSD5, HSD7, 
5AR1 (chapter 6.4). Endometriosis biopsies show variations in basal expression o f  
steroid converting enzymes (chapter 6.4), however when investigating temporal 
changes in enzyme expression after testosterone treatment the endometriosis biopsies 
were grouped together, this was completed as the basal expression was normalised to 
one, resulting in only large changes in enzyme expression relative to this being 
observed. HSD2 exhibited the largest changes in fold expression after testosterone 
treatment relative to basal expression.
Endometriosis biopsies produced DHT, androstenedione, androsterone, oestradiol 
and oestrone after testosterone treatment, as described in chapter 5.9. Again the 
route o f synthesis o f  these steroids was associated with the expression o f three 
specific enzymes, production o f androstenedione in correlation with HSD2 
expression (HSD2 expression was recorded in half o f  the endometriosis biopsies 
figure 6.17), DHT in correlation with 5AR1 expression (recorded in 4 o f the 6 
biopsies) and production o f  oestradiol and oestrone associated with aromatase 
expression. This suggests these enzymes are involved in the utilisation o f  
testosterone in endometria from women with endometriosis.
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Fig 7.24: Alteration in routes o f  testosterone metabolism from fertile biopsies to 
endometriosis biopsies. An arrow with a red cross indicates reaction was not 
occurring, increased arrow size indicates this reaction route was increased (relative to 
the fertile biopsies). Enzymes which catalyse each conversion are recorded on each 
arrow.
There were significant differences in the route o f  testosterone metabolism in fertile 
biopsies in comparison to endometriosis biopsies. The presence o f  androstenedione, 
DHT, oestradiol and oestrone suggested three active pathways for testosterone 
metabolism, two o f  which may cause proliferation and/or progression o f  
endometriosis in these patients due to the production o f  the potent oestrogen 
oestradiol or potent androgen DHT, these pathways are outlined in figure 7.24.
The development o f  endometriosis is characterised by an increase in localised steroid 
hormones and inflammation. Localised changes in inflammatory responses and 
steroid production may give rise to increased risk o f  cancer development in tissues 
that are steroid dependent such as the endometrium, breast, and ovary. Ness and 
colleagues described the altered immune function and steroid production in women 
with endometriosis, they describe a number o f  growth factors and cytokines which 
act to promote endometriosis growth and progression.25 These growth factors can act 
on specific enzymes to alter expression for example SF-1 has been shown to be up- 
regulated in endometriosis which stimulates aromatase expression resulting in an
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increase in oestrogen concentration. It is possible that a number o f steroid
converting enzymes are up-regulated due to expression o f  these growth factors or
cytokines in the endometrium o f  women with endometriosis, such as HSD2,
aromatase and 5AR1 (chapter 6.4.1). The role each o f  these enzymes has on
progression o f  endometriosis requires further investigation with the use o f  inhibition
studies.
The role o f  5AR1 and its major product DHT is especially important as there is some 
disagreement as to its role in endometriosis. Androgens have been used to treat 
endometriosis possibly via regulation o f  pituitary gonadotropin expression which 
reduces oestrogen production. However an increase in some androgens (testosterone 
and androstenedione) would lead to a higher conversion o f  androgens to oestrogens.
In these endometriosis biopsies production o f  oestrogens is a secondary process to 
production o f DHT when testosterone was added. This could be due to the 
regulation o f  aromatase conversion by the androgen DHT, or could be due 5AR1 
having a higher affinity for testosterone than aromatase (5AR1 and aromatase are in 
direct competition for the same substrate). To decide which o f  these hypothesis are 
correct further experiments are required such as inhibition o f  5ARs with specific 
inhibitors or siRNA, if  enzyme affinity was the reason for no production o f  
oestrogens inhibition o f  5AR1 and 5AR2 should result in an increase in oestrogen 
concentrations.
7.6.9 Correlations between enzyme expression and steroid concentrations in 
endometrial biopsies from patients with PCOS following testosterone treatment
The enzyme which exhibited the highest basal expression relative to the fertile 
biopsies in the PCOS biopsies was HSD7 (figure 6.29). Large changes in fold 
expression in PCOS biopsies were observed after testosterone treatment with the 
enzymes HSD7 and HSD8 (figure 6.40), however there were no observed 
correlations between changes in steroid concentration and changes in expression o f  
HSD7 or HSD8.
The route o f testosterone metabolism in PCOS biopsies was associated with the
expression o f  four enzymes, HSD2, HSD8 (production o f  androstenedione), 5AR1
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(production o f  DHT) and to a lesser degree aromatase (conversion o f  androgens to
oestrogens). Production o f  DHT in these biopsies was similar to COV434 cells and
androstenedione production was similar to fertile biopsies, demonstrating both sides
o f  the androgen metabolism pathway were active. Testosterone metabolism was
altered from fertile to PCOS biopsies as illustrated by figure 7.25, production o f  the
potent androgen DHT and potent oestrogen oestradiol may cause further problems in
the endometria o f PCOS patients, inclusion o f  more PCOS biopsies is required to
confirm these preliminary observations.
7.6.10 Correlations between enzyme expression and steroid concentrations in an 
endometrial biopsy from a patient with an ovarian cyst following testosterone 
treatment
In the ovarian cyst biopsy there was high basal expression o f  aromatase relative to 
the fertile biopsies (figure 7.4), however the high concentrations o f  both oestradiol 
and oestrone in the cell media at time zero make it impossible to determine any 
correlations between oestrogen concentration and aromatase expression. There were 
large changes in the fold expression o f  HSD5, HSD7, HSD8, 5AR1 and 5AR2 at 48 
hours (figure 6.41). These large expression changes in this biopsy at 48 hours may 
be due to experimental error, due to the very high changes observed for each 
enzyme. There were some corresponding steroid increases-androstenedione and 
androsterone concentrations increased at 48 hours and DHT was synthesised at this 
time, however due to the number o f  enzymes which exhibited high expression 
specific correlations were impossible to determine.
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Fig 7.25: Alteration in routes o f  testosterone metabolism from fertile biopsies to 
endometrial biopsies from women with PCOS and ovarian cysts. An arrow with a 
red cross indicates reaction was not occurring, increased arrow size indicates this 
reaction route was increased (relative to the fertile biopsies). Enzymes which 
catalyse each conversion are recorded on each arrow.
The ovarian cyst and PCOS biopsies metabolised testosterone through similar 
pathways. The principal change in testosterone metabolism from fertile to PCOS or 
ovarian cyst biopsies was the production o f  DHT as illustrated in figure 7.25. In the 
ovarian cyst biopsy increased aromatase expression suggested increased oestradiol 
production, but corresponding steroid information was not available due to the high 
oestrogens recorded due to FCS.
Both PCOS biopsies exhibited low basal expression o f  HSD2 and 5AR1 relative to 
the fertile biopsies. In both PCOS biopsies however aromatase expression was 
highest followed by 5AR1,  and HSD2 exhibited the lowest basal expression (relative 
to each other), this could explain the production o f  oestradiol, DHT and 
androstenedione observed after testosterone treatment.
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7.6.11 Correlations between enzyme expression and steroid concentrations in a
biopsy from a patient with endometrial hyperplasia after testosterone treatment
The endometrial hyperplasia biopsy was split into stromal and epithelial cells, both 
cell types produced high basal expression o f  aromatase relative to the fertile biopsies 
(figure 7.4). The largest changes in fold expression were observed in both the 
stromal and epithelial cells with the enzymes HSD5, 5AR1 and 5AR2 at 72 hours 
(figures 6.42 and 6.43).
7.6.11.1 Epithelial endometrial hyperplasia biopsy
The epithelial hyperplasia biopsy exhibited high basal expression o f  aromatase.
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Fig 7.26: Correlation between oestrone and oestradiol concentrations and aromatase 
expression in an epithelial hyperplasia biopsy over 72 hours after addition o f  a 
lOOnM testosterone media solution. The epithelial hyperplasia biopsy was grown in 
specific medium (chapter 2.4) harvested and RNA extracted. Specific primers 
outlined in table 2.6 were used to establish aromatase expression levels through RT- 
PCR. Oestrone and oestradiol concentrations were obtained using a luna phenyl- 
hexyl column with optimised methanol/water 0.1% formic acid elution system on the 
LCQ DECA mass spectrometer using an ESI source in positive mode.
Aromatase converts testosterone to oestradiol and androstenedione to oestrone. It 
was possible to observe a trend between increased oestradiol and oestrone 
concentrations and increasing expression o f  aromatase in the endometrial epithelial 
hyperplasia biopsy, suggesting aromatase was converting testosterone to oestradiol 
and androstenedione to oestrone in this biopsy (figure 7.26).
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7.6.11.2 Stromal endometrial hyperplasia biopsy
The stromal cells from a woman with endometrial hyperplasia exhibited high basal 
expression o f  5AR1,  HSD7 and aromatase (relative to the fertile biopsies). Largest 
fold expression changes were observed with the enzymes HSD5, 5AR1 and 5AR2, 
all 72 hours after testosterone treatment.
The conversion o f  testosterone to DHT in the stromal biopsy from a woman with 
atypical endometrial hyperplasia was correlated with expression o f  5AR1, and 
production o f  oestradiol was correlated with aromatase expression, production o f  
androstenedione was a minor pathway which was correlated with low expression o f  
HSD2, 4 and 8 relative to the fertile biopsies. Androsterone and oestrone were the 
reaction end products which were produced via a number o f  pathways illustrated in 
figure 7.27.
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Fig 7.27: Alteration in routes o f  testosterone metabolism from stromal fertile 
biopsies to a stromal and epithelial hyperplasia biopsy. An arrow with a red cross 
indicates reaction was not occurring, increased arrow size indicates this reaction 
route was increased (relative to the fertile biopsies). Enzymes which catalyse each 
conversion are recorded on each arrow.
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The testosterone metabolism route in epithelial and stromal cells from a hyperplasia
biopsy was similar (although concentrations o f  each steroid and specific enzyme
expression values varied). This suggests that to progress from a fertile endometrium
to endometrial hyperplasia three changes were required.
1. Increased aromatase expression in correlation with increased oestradiol 
and/or oestrone concentrations.
2. Production o f  DHT in correlation with increased 5AR1 expression.
3. Decreased HSD2 expression (linked to bio-accumulation o f  oestradiol).
These observations only provide preliminary information concerning testosterone 
utilisation in endometrial hyperplasia, and these interesting findings require 
confirmation through the inclusion o f  more biopsies, however the results obtained 
here reflect previous results described in the literature, for example, increased 
aromatase expression, decreased HSD2 expression and increased oestradiol 
concentrations were reported in two recent studies by Ito and Li (and colleagues) in 
endometrial epithelial hyperplasia biopsies,26’27 however there is to our knowledge no 
information concerning the expression o f 5AR1 or role o f  DHT in stromal cells distal 
to epithelial hyperplasia.
Epithelial cells from endometrial hyperplasia have been widely studied, however 
information concerning steroid metabolism studies in the surrounding stromal cells is 
less explored. The results obtained in these experiments demonstrated that although 
the steroid profiles are similar, the stromal and epithelial cells utilise testosterone 
through different pathways at specific times in correlation with altered enzyme 
expression following testosterone treatment. It was probable that in vivo altered 
steroid metabolism in the stromal cells directly affects steroid metabolism in the 
epithelial cells. Stromal cell interactions with epithelial cells in the endometria have 
been previously shown to affect steroid metabolism, for example, Cheng and 
colleagues demonstrated HSD2 expression in endometrial epithelial cells was 
regulated by factors released from stromal cells.28 Further developments with co­
culture o f  both epithelial and stromal cells could produce information regarding this 
relationship.
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7.6.12 Correlations between enzyme expression and steroid concentrations in an
endometrial biopsy from a patient with an endometrial polyp following
testosterone treatment
The endometrial polyp biopsy demonstrated high basal expression o f  HSD5, 7, 8 and 
aromatase relative to the fertile biopsies. There were no large increases in fold 
expression o f  any enzymes after testosterone treatment o f  this biopsy (figure 6.44). 
Rapid metabolism o f  testosterone to the androgenic end product androsterone 
(mainly through DHT) and to the oestrogens oestradiol and oestrone occurs 24 hours 
after testosterone treatment. Prior to testosterone treatment there was high 
expression o f  5AR1 relative to HSD2 (figure 7.4), in correlation with this production 
o f  DHT from the precursor testosterone with little conversion to androstenedione was 
recorded, this was similar to testosterone conversion and enzyme expression in the 
HEC-1B cell line.
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Fig 7.28: Alteration in routes o f  testosterone metabolism from fertile biopsies to an 
endometrial polyp biopsy. An arrow with a red cross indicates reaction was not 
occurring, increased arrow size indicates this reaction route was increased (relative to 
the fertile biopsies). Enzymes which catalyse each conversion are recorded on each 
arrow.
Testosterone metabolism was altered from fertile biopsies to the endometrial polyp 
biopsy as illustrated in figure 7.28. Production o f  DHT which was not recorded in 
the fertile biopsies but occurred in the endometrial polyp biopsy. Increased
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conversion to the androgenic end product androsterone was observed in the
endometrial polyp biopsy which may be linked to increased expression o f  a number
o f 17P-HSDs or 3|3-HSDs. There was also increased expression o f  aromatase in the
endometrial polyp biopsy (relative to the fertile biopsies) which was correlated with
an increase in the conversion o f  androstenedione to oestrone.
7.7 Summary and discussion of correlations between steroid concentration and 
enzyme expression in cell lines and endometrial biopsies after testosterone 
treatment
Relationships between steroid converting enzyme expression and steroid 
concentrations were observed for most cell lines (except RL95-2) and some biopsies 
(summarised in table 7.2).
Table 7.2: Correlations between enzyme expression and steroid concentration for the 
cell lines Ishikawa, RL95-2, HEC-1A, HEC-1B and COV434 and the endometrial 
biopsies after testosterone treatment. ______________________________________
Cell Line/ Biopsy Increase in 
enzyme
Change in steroid concentration
5AR1 Increase in DHT
Ishikawa HSD8 Increase in Androstenedione
Aromatase Increase in Oestradiol
RL95-2 - -
HSD5 Increase in Testosterone
HEC-1A Decrease in Androstenedione
Aromatase Increase in Oestradiol
HEC-1B 5AR1 Increase in DHT
COV434 5AR1 Increase in DHT
Fertile - -
Unexplained Infertility 5AR2 Increase in Androsterone
Endometriosis 5AR1 Increase in DHT
PCOS - -
Ovarian Cyst 5AR1 Increase in DHT
Hyperplasia Aromatase Increase in Oestradiol
epithelial Increase in Oestrone
Hyperplasia
stromal
5AR1 Increase in DHT
Endometrial polyp - -
Increased expression o f  the enzyme 5AR1 was correlated with an increase in DHT 
concentration in three cell lines (Ishikawa, HEC-1B and COV434) and three biopsy
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pathologies (endometriosis, ovarian cyst and stromal hyperplasia). Expression o f
HSD5 was linked to a decrease in androstenedione concentration and an increase in
testosterone concentration in HEC-1A cells. Expression o f  HSD8 was linked to an
increase in androstenedione concentration in Ishikawa cells. Increased expression o f
aromatase was linked to an increase in oestradiol or oestrone concentration in
Ishikawa and HEC-1A and epithelial hyperplasia cells. Aromatase expression was
also linked to oestradiol production in the fertile and unexplained infertility biopsies,
however this only occurred at the start o f  the experiments as after 24 hours the
majority o f reaction precursor (testosterone) had been converted to other products.
The number o f  biopsies available for each endometrial pathology combined with the 
small number o f  data points for each biopsy and the longer times between these 
points makes it difficult to determine correlations between changes in enzyme 
expression and steroid concentration(s), the inclusion o f  more biopsies and time 
points would confirm any relationships.
These results suggest that expression o f  5AR1 in endometrial cancer cell lines and 
biopsies from benign endometrial pathologies was linked to the production o f DHT. 
For treatment o f  hormone responsive type one endometrial cancer, endometriosis or 
ovarian cysts 5AR1 inhibition may lead to reduced proliferation due to a reduction in 
production o f  this potent androgen.
7.8 Conclusions
Testosterone utilisation in each endometrial cancer cell lines was different. A
progression o f this work to include clinical biopsies from patients with endometrial
cancer would allow determination o f  the cell lines which utilises testosterone via the
most similar route. Some o f the cell line produced steroid profiles which were
similar to specific biopsy pathologies such as RL95-2 cells and fertile biopsies, (and
the endometrial polyp biopsy to the HEC-1B cell line), it may be possible to use
these cell lines as representative systems when primary biopsies are not available.
The same enzymes were highlighted as important for the route o f  testosterone
utilisation in cell lines and biopsies. These were 5AR1 (which produced DHT),
HSD2, 4 and 8 (which produced androstenedione) and to a lesser extent aromatase
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(which converted androgens to oestrogens). The roles o f  5AR1 and the oxidative
HSDs were initially determined based on the relationship between basal expression
and the major metabolite(s) following testosterone treatment (chapter 5). The
combination o f  the time course enzyme and steroid studies permitted further
investigations into these relationships and supported these initial conclusions as
increased expression o f  5AR1 (or the oxidative HSDs) resulted in increased reaction
product and decreased reaction precursor (observed at specific times) in a number o f
endometrial cell lines and pathologies.
Production o f  oestrogens through aromatase occurs in the biopsies from benign 
endometrial disorders and in Ishikawa, HEC-1A and HEC-1B cells, (although 
aromatisation was not the major pathway o f  testosterone metabolism in the cell 
lines). The use o f  an aromatase inhibitor would not be viable for treatment o f an 
endometrial disorder which metabolises testosterone in a similar way to the 
Ishikawa, HEC-1 A, and HEC-1B cell lines, as the use o f  an aromatase inhibitor may 
result in the production o f  more androgens (such as DHT) which could lead to an 
increase in proliferation.
The use o f  a 5AR1 inhibitor may be required to alter steroid metabolism from DHT 
production (observed in Ishikawa, HEC-1 A HEC-1 B, COV434, endometriosis, 
PCOS, ovarian cyst, endometrial hyperplasia and endometrial polyps) to that o f  the 
fertile biopsies (no DHT). These experiments highlight the importance o f  5AR1 and 
a possible role o f  DHT in proliferation and/or progression o f  these disorders. This 
generally ignored area o f  endometrial steroid metabolism could be more significant 
than is currently perceived.
In pathologies which converted testosterone to DHT and converted a higher amount 
o f  testosterone to oestradiol (or androstenedione to oestrone) compared to the fertile 
biopsies (endometrial hyperplasia and endometriosis) use o f  a dual procedure such as 
inhibition o f  aromatase in combination with inhibition o f  5AR1 may be required. 
Further experiments are required to determine the optimum procedures for treatment 
o f these conditions.
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These experiments have demonstrated the combination o f  mass spectrometry and
enzyme expression data (via QRT-PCR) following steroid treatment to reveal a novel
method for determination o f  steroid and enzyme interactions and possible targets for
inhibition. These experiments have also highlighted the importance o f  studying the
wider steroid pathway.
7.9 Discussion
A robust method for the identification o f  a number o f  androgens, oestrogens and 
progestins in endometrial established cell lines and biopsies using LC/MS 
(LC/MS/MS) was described in this thesis. The optimisation o f  extractions (SPE) o f  
steroids from cells and cell media was completed and in combination with mass 
spectrometry this permitted the positive, quantitative analysis o f  steroids.
The use o f cell lines to optimise experimental methods was essential to this work. 
The cell lines chosen here were used to elucidate testosterone metabolism routes and 
highlight potential enzyme targets. The application o f optimised cell line methods to 
endometrial biopsies from fertile women and those with endometriosis was vital to 
further understanding altered steroid metabolism in these conditions. A comparison 
o f testosterone metabolism pathways in fertile biopsies to endometrial cancer cell 
lines and endometrial disorders was also produced. The investigation o f  testosterone 
metabolism in other benign conditions was initiated to determine if  the observations 
recorded in endometriosis were typical o f benign endometrial disorders.
Two routes o f testosterone metabolism have been highlighted as important these 
were correlated with expression o f  specific enzymes;
1. the production o f  DHT, correlated with 5AR1 expression,
2. the production o f  androstenedione correlated with expression o f  HSD2, 4 
and/or 8.
The role o f aromatase seems less important in the endometrial cell lines than is 
currently perceived.
Expression o f  HSD2 was important for the production o f  androstenedione in fertile
biopsies and RL95-2 cells in preference to 5AR1 production o f  DHT or
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aromatisation to oestrogens. Expression o f  5AR1 and production o f DHT was
important in COV434 and HEC-1B cell lines and PCOS and endometrial polyp
biopsies. Expression o f  5AR1 and HSD2, 4 and 8 were important in the other cell
lines and biopsies that metabolise both androstenedione and DHT such as Ishikawa,
HEC-1 A and endometriosis biopsies.
In these experiments it has been demonstrated that the endometrium has the capacity 
to metabolise DHT and androstenedione after testosterone treatment in relation to the 
abundance o f  specific enzymes. It was also concluded that in situations where high 
aromatase expression was observed the assumption cannot be made that all 
testosterone will be converted to oestradiol such as the COV434 cell line. This 
conclusion could only be reached with the combination o f  mass spectrometry and 
QRT-PCR highlighting this invaluable method for determination o f  a more complete 
picture o f  steroid metabolism.
Oestradiol, itself has been shown to activate ER pathway which activates the 
aromatase promoter SF1.29 Increased expression o f  SF1 promotes aromatase 
expression, therefore the amount o f  ER expression in the cell line will influence the 
level o f  response to oestradiol (only a small amount o f  oestradiol may be required to 
cause a response). This together with the availability o f transcription factors 
associated with the ER and aromatase pathway may determine the amount o f  
aromatase expression.
The process o f  enzyme expression involves a number o f  steps. Nuclear DNA needs
to be transcribed to form mRNA and this in turn has to be translated to form the
proteins (the enzymes) which convert the steroids. Each step o f  this process may
require a number o f  co-factors or compounds for example ATP or NADPH which
provide energy for many reactions or more specific co-factors such as 3 ’-
phosphoadenosine-5’-phosphosulphate (which is the cofactor which supplies the
sulphate group in the conversion o f  active steroids to sulphated steroids by steroid
sulphotransferase). The availability o f these co-factors can inhibit enzyme activity,
for example if  a specific co-factor is not available the reaction may be slower or may
not occur at all. This can lead to disparities between mRNA expression and enzyme 
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activity, which may be the case for aromatase expression in the COV434 cell line.
The relationships between mRNA expression and enzyme activity may be simple as
is seen throughout these experiments with 5AR1, where an increase mRNA
expression results in an increase in DHT production suggesting all co-factors
required are present. Experiments where the protein level o f each enzyme is
measured, such as western blotting, would determine the link between mRNA
expression and protein production for each enzyme (the translation process).
Together a wider understanding of steroid biosynthesis in the endometrium and its 
disorders has been achieved in this project and therapeutic targets have been 
revealed.
7.10 Further Work
Correlations between enzyme expression and steroid concentration(s) were 
determined in the established cell lines and endometrial biopsies, after testosterone 
treatment providing novel information regarding steroid metabolism. Initial biopsy 
results were encouraging, the inclusion of more biopsies and experimental time 
points will permit confirmation o f any conclusions.
Further investigations into enzymes highlighted here as important (aromatase, 170- 
HSD2, 170-HSD4, 170-HSD8, and 5-a reductase 1) and investigations into the roles 
of DHT, androsterone and androstenedione is required to confirm the importance of 
these in relation to endometrial disorders. Following this the development of specific 
inhibitors could be achieved with the aim of altering steroid metabolism in each 
condition back to the normal route.
mRNA expression does not always equate to enzyme activity, for example some
enzymes can be highly expressed at the mRNA level but at the transcription level
protein is not produced. siRNA (small interfering RNA) occur naturally, and were
initially described as a regulatory mechanism to inhibit viral gene expression by
interfering with the translation process. Recently synthetic siRNA has been used to
inhibit the expression o f specific genes by causing knockdown o f mRNA and protein
expression (sequence selective inhibitors). Application o f siRNA to the
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endometrial cell lines and biopsies could be an ideal expansion o f this work. For
example inhibition o f expression o f specific enzymes (such as 5AR1 or aromatase)
using siRNA or specific enzyme inhibitors such as finasteride would highlight the
importance o f enzyme competition in relation to specific steroid production. siRNA
can also be utilised to knockdown specific enzymes and to determine the activity of
each enzyme.31
Enzyme activity could be further investigated by determining the rate o f production 
of each steroid over time, this would require inhibition o f further reactions o f the 
produced steroid and opposing reactions, for example to determine the activity of the 
HSD2 mediated conversion of oestradiol to oestrone inhibition of HSD1, 5 and 7 is 
required (which does the opposite reaction) and inhibition of competing enzymes 
such as HSD4 and HSD8 would also be required. The substrate oestradiol would 
then be added at a number of different concentrations and the reaction products 
recorded after a specific time, this would allow determination o f the concentration at 
which the enzyme reaches saturation (addition of more substrate will not increase the 
amount o f product/unit time). This would also allow us to determine the enzyme 
activity (conversion rate/unit time, before saturation) and would be an interesting 
expansion of this work.
The inclusion o f more steroid converting enzymes to elucidate further relationships 
between enzyme expression and steroid metabolism in the wider steroid bio-pathway 
would be an interesting progression o f this work. There has been some work by 
Purohit and co-workers investigating the role o f steroid sulphatase in bio­
accumulation o f oestrogens in endometrial disorders,32 further investigation into the 
role of sulphatase could further illuminate routes o f steroid metabolism in these 
endometrial pathologies, and would be an ideal extension o f this methodology.
An ideal expansion o f this work would be co-culture experiments, where epithelial 
and stromal cells are cultured together and interactions between the two cell types 
can be determined. Interactions between epithelial and stromal cells may be 
important for the growth and maintenance o f both benign and cancerous endometrial
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disorders. Cheng and colleagues found that a defect in stromal cells resulted in
HSD2 deficiency in the surrounding epithelium resulting in a decrease in the
conversion o f oestradiol to oestrone.33 Segawa and colleagues described a link
between aromatase expression in stromal cells and poorer survival rates for women
with endometrial cancer.34 This could be due to an increase in the local oestrogen
concentration inducing proliferation of the epithelial cells. These studies highlight
the importance o f the localised environment for progression and maintenance of
endometrial disorders, the significance o f the stromal-epithelial relationship requires
further investigation.
Further work with endometriosis biopsies organised into stages related to progression 
of the disorder could determine alterations in steroid and enzyme expression profiles 
through each stage o f the condition. This would determine trends in testosterone 
metabolism and enzyme expression in the four stages of endometriosis, and possibly 
highlight the ideal time to start treatment(s) with aromatase or 5AR inhibitors.
Further work to investigate the metabolism routes of other abundant circulatory 
steroids (DHEA, DHEAS, androstenedione, oestrone-sulphate or a combination of 
all) would also be an ideal expansion o f these experiments.
The procedure for analysis of specific steroid metabolism routes developed in this 
thesis could be directly applied to other steroid responsive tissues such as the brain, 
adrenal glands, breast or prostate, which would highlight important enzymes and 
steroids in these areas.
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Appendix 1
A 1.1: Conferences attended:
BMSS Meeting Edinburgh 2006 Poster presentation. “The capacity of the human 
endometrium to synthesise steroids: a metabolic (mass spectrometry) and genomic 
(RT-PCR) approach.”
ASMS Denver CO 2008 Poster presentation. “The capacity o f the human 
endometrium to synthesis steroids: a metabolomic (mass spectrometry) and gene 
expression (RT-PCR) approach”
BMSS Meeting York 2008 Oral presentation “The metabolism of steroids in the 
human uterus: Steroids biosynthesis from detection to steroid converting enzyme 
expression.”
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Fig 1: T he top ch ro m ato g ram s are selected  ion ch ro m ato g ram s for the and rogens 
testo ste rone  and an d ro sten ed io n e  32 hours a fte r testo sterone  trea tm en t in Ish ikaw a 
cells. T he grey area on each rep resen ts  the peak areas used to ca lcu late  
co ncen tra tion . The bottom  spec tra  are the co rresp o n d in g  m ass spec tra  for each peak. 
T esto stero n e  has an m /z ra tio  o f  289  and an d ro sten ed io n e  has an m /z ratio  o f  287, 
to g e th er w ith specific  re ten tion  tim es these  tw o stero ids are positive ly  iden tified  in 
Ish ikaw a cell m edia.
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A 1.3: E xam ple  o f  calculat ion o f  R N A  express ion through R T -q P C R
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Fig 1.2: E xam ple  o f  graph produced  by iC ycler so ftw are  fluo rescence  is p lo tted  
aga inst th resho ld  cycle . A C t value is p roduced  for each cD N A  d ilu tion  w hich  can 
be p lo tted  as a ca lib ra tion  graph.
A series o f  d ilu tio n s o f  the cD N A  is produced  these are 0 .2 , 0 .1 , 0.01 and 
0.001 n g /p L . T he C t value at w hich  these  d ilu tio n s fluo resce  is p lo tted  aga inst the 
log o f  the d ilu tion  value, th is should  p roduce a linear re la tio n sh ip .
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Fig 1.3: E xam ple o f  a ca lib ra tion  graph cD N A  co n cen tra tio n  (log  o f  the d ilu tio n ) is
p lo tted  aga inst the C t value determ ined  from  figure 1.2.
A ppe ndix  On e
50 5 2 54 55 58 60 62 64 66 68 70 72 74 76 78 80 8 2 84 86 88 90 9 2 94
Mes =*»«. ©e*s*u9-:
F ig 1.3: M elt cu rve p roduced  for G A D PH  bound p rim ers v ia  Q R T -P C R  using the 
iC ycler apparatus.
T he m elt curve perm its  investigation  into the effic ien cy  o f  the p rim er pair. I f  a sharp 
peak is observed  w ith one sig n ifican t m elt tem p era tu re  (as in figure 1.3) the prim ers 
are efficien t. T he ca lcu la tion  for de term ina tion  o f  basal exp ression  and chang ing  
expression  over tim e is described  in ap pend ix  2.
All calculations in the following appendix were obtained using microsoft excel. 
A2.1: Testosterone utilisation by HEC-1B cells comparison of two experiments
Time
(hours)
Ratio to IS 
Experiment 1
Ratio to IS 
Experiment 2
Average 
ratio to IS Standard deviation
0 0.442557 0.51663 0.479594 0.052377
12 0.343473 0.329307 0.33639 0.010017
24 0.168236 0.295431 0.231833 0.08994
36 0.153817 0.156925 0.155371 0.002198
48 0.084758 0.12311 0.103934 0.027119
60 0.060787 0.108798 0.084792 0.033949
72 0.038357 0.080561 0.059459 0.029843
Reduction in te s to s te ro n e  concen tra tion  in HEC-1B cells
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A2.2: Production of DHT by COV434 cells after testosterone 
treatment
Time
(hours)
Ratio to  IS 
Experiment 
1
Ratio to  IS 
Experiment 
2 Average ratio to IS
Standard
deviation
0 0.021651251 0.012582518 0.017116885 0.006413
8 0.055993176 0.070915775 0.063454476 0.010552
16 0.11858888 0.148060457 0.133324668 0.02084
24 0.13901928 0.148060457 0.143539869 0.006393
32 0.106884898 0.218250953 0.162567926 0.078748
40 0.138017765 0.155733183 0.146875474 0.012527
48 0.183376945 0.225850253 0.204613599 0.030033
72 0.1226287 0.123 0.12281435 0.000263
0, Production of DHT in COV434 cells
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A2.3 DHT Calibration (regression method)
Concentration 
nM (xlOA2) peak area IS peak area
Ratio peak area/peak 
area IS
Avg peak 
area SD
0.01 350328368 79600569609 0.004401079
0.01 396298528 77428211243 0.00511827 0.004763317 0.0003587
0.01 364944579 76498633967 0.004770603
0.05 1303963919 91742166727 0.014213354
0.05 1098560739 82796338145 0.013268229 0.013585777 0.0005435
0.05 1114494295 83949637712 0.013275749
0.1 2102036461 92484929771 0.022728421
0.1 2174856933 86056742852 0.025272359 0.025386405 0.0027168
0.1 2328829740 82704520200 0.028158434
0.125 2972522108 86746117983 0.034266918
0.125 2431413074 84341934616 0.028828045 0.031516106 0.00272
0.125 2522678554 80203797590 0.031453355
0.25 4446327604 85409331161 0.052059038
0.25 5128247966 91962507001 0.055764552 0.055304001 0.003041
0.25 4522731725 77859447961 0.058088412
0.5 9539519374 74033253352 0.128854521
0.5 9928572704 82358269303 0.12055344 0.122438454 0.0057118
0.5 9329622675 79126693174 0.1179074
1 20422556051 99249600713 0.205769655
1 19252172079 93596737889 0.205692768 0.210621846 0.0084709
1 20713241214 93978895271 0.220403114
5 51596918800 96033163635 0.537282298
5 50817487048 97858610598 0.519294999 0.514775073 0.0250746
5 45286016413 92847174308 0.487747923
10 78410498377 98414223515 0.796739491
10 82379825939 1.0168E+11 0.810189994 0.777134853 0.0460979
10 70490668114 97298955652 0.724475074
15 1.01982E+11 89873826525 1.134723581
15 1.06803E+11 90290784558 1.182874825 1.093610618 0.1154482
15 85329742799 88586773045 0.963233447
20 1.11187E+11 97442449885 1.14105694
20 1.30985E+11 1.02075E+11 1.283222792 1.166572025 0.1062171
20 1.05826E+11 98403055914 1.075436344
Ra
tio
 t
o 
IS
DHT calibration1.4
1.2
1
(S>
o 0.8■*-«
o
+*re 0 .6
a d
0.4
0.2
0
0 5 10 15 2 0  2 5
Concentration xlOA2 nM
Calibration series is linear from 100 to lnm solutions of DHT (it is over this range of concentrations 
that regression statistics are determined).
Concentration xlOO 
nM Average ratio (Xi-avgX)A2 SD
0.01 0.004763317 0.0001 0.000358651
0.05 0.013585777 0.0025 0.000543511
0.1 0.025386405 0.01 0.002716802
0.125 0.031516106 0.015625 0.002719979
0.25 0.055304001 0.0625 0.003040957
0.5 0.122438454 0.25 0.005711814
1 0.210621846 1 0.008470915
average 0.290714286 0.066230844 1.340725
DHT calibration series
0.2 5
y = 0 .2 l l x  +- 0 .004  
R2 = 0 .9940.2
0 .15
0.1
0 .0 5
0
0.6 0.8 10.2 0 .40
Concentration
\p p e n d ix  I wc
Regress ion
sta tis tics
SUMMARY
OUTPUT
Multiple R 0.9972056
R Square 0.9944190
Adjusted R
Square 0.9933029
Standard
Error 0.0061195
ANOVA
MS
Significance
Regression 1 0.033363351 0.033363351 890.91 133 7.92E-07
Residual 5 0.000187 3.744E-05
6 0.033550
Coefficients
Standard
Error P -value Lower 95%
Upper
95%
Lower
95.0%
Upper
95.0%
Intercept 0.0048793 0.0030942 1.5768857 0.17564 -0.00307 0.01283 -0.003 0.01
0.2110370 0.0070703 29.848137 7.9E-07 0.192862 0.192
RESIDUAL
OUTPUT
Observation Predicted Y Residuals
1 0.00698972 -0.0022264
2 0.01543120 -0.0018454
J 0.02598306 -0.0005966
4 0.03125898 0.0002571 1
5 0.05763862 -0.0023346
6 0.1 1039788 0.01204056
Sx/y= 0.006119523 
LOD = 0.086992162 pM/pL 
= 87nM
A2.4 Androstenedione rate equations combination of two experiments
Time
(hours)
Ratio to  IS 
Experiment 
1
Ratio to  IS 
Experiment 
2
Average ratio to 
IS
Standard
deviation
0 0 0 0 0
12 0.296567775 0.162338439 0.229453107 0.094914474
24 0.112285828 0.092090334 0.102188081 0.014280371
36 0.07172074 0.033867914 0.052794327 0.02676599
48 0.02332918 0.014005284 0.018667232 0.00659299
60 0.014802585 0.009298473 0.012050529 0.003891995
72 0.006823985 0.005113944 0.005968965 0.001209181
Time
(hours)
exp l
Ln(C0/C)
exp2
Ln(C0/C)
Average Ln 
(C0/C)
Standard
deviation
Rate of reaction 
K
0
12 0 0 0 0 0
24 0.971228119 0.661234882 0.8162315 0.21919832 0.03401
36 1.419495813 1.661536802 1.540516307 0.171148825 0.042792
48 2.542570853 2.544570163 2.543570508 0.001413725 0.052991
60 2.997473945 2.954154643 2.975814294 0.030631372 0.049597
72 3.771832191 3.552033878 3.661933035 0.155420878 0.05086
average rate of 
reaction
0.04605
s
4
I ^u
T  2
1 
0
Time (hours)
Androstene-dione decay in RL95-2 cells
y = 0.061x 0.656 
R2= 0.991
0 10 20 30 40 SO 60 70 80
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A2.7: Comparison of enzyme expression and steroid 
concentrations in Ishikawa cells
Time
(hours)
DHT (ratio 
to  IS)
Oestradiol 
(peak area) SD (DHT)
SD
(oestradiol)
0 0.010467 282130 0.003039 358800.1
8 0.021421 109472 0.012522 67320.81
16 0.033937 122088 0.007951 44352.57
24 0.032946 80091 0.018232 16652.36
32 0.049955 74418 0.023269 68112.77
40 0.063157 94625 0.035509 60689.56
48 0.051654 45257.5 0.034942 57859.01
72 0.050774 30466 0.002462
Enzyme Expression
Avg enzyme fold expression (rel to GADPH)
Time
(hours) 5AR1 arom atase SD (5AR1)
SD
(aromatase)
0 1.027254 1.038753 0.249149 0.223022
8 0.546795 0.569716 0.444072 0.381654
16 0.813979 1.168004 0.470783 1.090763
24 0.462599 0.230849 0.32932 0.114007
32 0.538462 0.260196 0.488476 0.230696
40 3.729493 1.186481 3.42008 1.21121
48 1.368435 0.45193 1.262009 0.178774
72 0.179664 0.554878 0.127997 0.506136
C o m p a r i s o n  b e t w e e n  DHT c o n c e n t r a t i o n  a n d  5AR1 exp re ss io n  
(I sh ikawa)
DHT
I .
T i r r e  ( h o u r s )
2  5
O< 7 U) ^
o
?  5
CL
X 1o a 
33
■B.5
0
Correlation b e tw e en  oestradiol concentration and 
arom atase expression  in Ishikawa
700000 
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400000  
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